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n Era of Reform
An Era of Reform is your resource for understanding the driving forces that have changed the face 
of the healthcare system in the United States. You’ll receive a detailed understanding of both the 
short- and long-term effects of The Patient Protection and Affordable Care Act of 2010 and 
The Health Care and Education Reconciliation Act of 2010, as well as direct insight into the key 
topics that factor into healthcare industry accounting and valuation activities, making it easy for 
you to interpret reform bill takeaways that affect your clients or your business.
In addition, An Era of Reform introduces an in-depth discussion of a new taxonomy framework for 
approaching healthcare industry issues. This framework serves as a vehicle to analyze the viability, 
efficiency, efficacy, and productivity of healthcare enterprises at length, in terms of four pillars:
•	Reimbursement Environment
•	Regulatory Environment
•	 Impact of Competitive Forces
•	Technology Development
An Era of Reform is an essential tool to enable you to provide specialized advice to your clients  
or to your organization in the wake of recent 2010 legislation and in the years to come. 
The Adviser’s Guide to Healthcare is a comprehensive resource and reference guide for professionals 
seeking a working knowledge of the factors involved in consulting with and valuing healthcare 
practices. Developed by one of the foremost consultants in the healthcare industry, Robert James 
Cimasi, this Guide is founded on his seasoned knowledge and industry experience. This 18-chapter, 
three book set is built around a new taxonomy framework for approaching economic value for the 
healthcare industry—the four pillars of reimbursement, regulation, competition, and technology. 
The four pillars framework is carried throughout each of the three books that comprise this set:
An Era of Reform: Provides in-depth discussions of the four pillars and the landmark  
legislation that has contributed to the current healthcare environment.
Professional Practices: Introduces different models of emerging healthcare practices  
and details industry subspecialties in terms of the four pillars framework.
Consulting with Professional Practices: Covers consulting related to healthcare  
practices and practice valuation strategies.
Keep up with the changing face of healthcare services and  
consulting practices with The Adviser’s Guide to Healthcare!
aicpa.org  |  cpa2biz.com
Robert James Cimasi
MHA, ASA, CBA, AVA, CM&AA
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Foreword
Whether we have been providing professional consulting services for many years, as I have, or we are 
relative newcomers to the field of consulting services, the current state of the healthcare environment 
certainly can tend to make us all feel a bit bewildered. The ongoing technological, economic, and politi-
cal changes that are happening require all of us to arm ourselves with the knowledge and skills necessary 
to address these changes. Bob Cimasi’s new, comprehensive, reference work is an essential tool if we 
are to be able to provide useful specialized advice to our clients.
This Guide, containing 18 chapters of up-to-date specialized information concerning every aspect of 
healthcare Professional Practices, is a monumental collection of detailed, useful information for CPAs, 
Business Valuators, Attorneys, Financial Planners, Health Care Executives, Administrators, and even for 
Physicians and Surgeons. It covers the waterfront of the types of entities providing healthcare services 
with specific attention to each medical and dental specialty.
In examining this vast range of entities and professionals, this Guide does not confine its presenta-
tions to highlights only. Rather, it delves deeply and precisely into the finer points of problems and 
opportunities confronting each of the specialized healthcare professional practice entities. A recurring 
theme throughout the book is to consider the delivery of healthcare professional services within the con-
text of what Bob Cimasi terms “the four pillars of the healthcare industry, i.e., regulatory, reimburse-
ment, competition, and technology.”
As a CPA, business appraiser, and consultant who has practiced for 56 years, I believe that this 
monumental book should be in the library of every CPA firm, business valuation firm, legal firm, finan-
cial planner, and consultant who hopes to continue to serve clients in the healthcare field competently 
in these rapidly changing times. As I have learned as the father of a long-time practicing critical-care 
internist and hospitalist, I believe that the book also is a must for the libraries of professional physi-
cians, surgeons, dentists, and administrators who are on the every-day firing lines trying to survive the 
sea of change in their respective professions. And before closing, I want to say some words about the 
author, Bob Cimasi. I have known Bob for many years, first as a participant in professional seminars 
and conferences in which he has been a presenter, and later on a more direct professional and personal 
basis. Throughout these years, I have been impressed with both his technical knowledge, and even more 
importantly, the unselfish and tireless sharing of his time, talent, and accumulated knowledge with his 
professional colleagues in the accounting, business valuation, and consulting professions. There are few 
people in the world that I have known who are of his caliber! This Guide confirms again what many of 
us know. Bob Cimasi is truly one-of-a-kind dedicated professional whose writings are worth reading.
Richard D. Thorsen, CPA/ABV, CMEA, CVA
May 2010
Past Member, Board of Directors and Vice President of the American Institute of CPAs (AICPA)
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Preface
“Tho’ much is taken, much abides.” (Ulysses) Lord Alfred Tennyson, 1833
I was born in 1950, the fourth child in our family, and the first born in a hospital—my older brothers and 
sisters having been delivered in my grandmother’s bed. In the small, upstate New York farming commu-
nity where I was raised, doctor house calls were not unusual. When an injury or sudden illness required 
a response by emergency services, the dispatcher would sound the community sirens, signaling the vol-
unteer firemen on duty to radio ahead from their emergency vehicle to the small, four-bed, rural hospital, 
which would then alert one of the three physicians in the community to rush to the hospital to provide 
emergency care. When our neighbors developed musculoskeletal conditions from working on the farms 
or in small manufacturing plants and machine shops, they would visit the town chiropractor who would 
perform manipulation and prescribe vitamins and various homeopathic remedies. The local dentist’s ser-
vices were in great demand with the prefluorination, widespread incidence of juvenile tooth decay. This 
was a time in U.S. history when Marcus Welby was not only a regular family television drama but was 
also a reasonable characterization of how healthcare services were perceived to be delivered by profes-
sional practices throughout much of the country. 
During the sixty year period since 1950, the U.S. population has doubled from just more than 150 
million to an estimated 300 million in 2010,1 and the average life expectancy has increased from ap-
proximately 68 years to 78 years.2 With the record number of births of the “baby boomer” generation 
from the late 1940s through the early 1960s, the proportion of the U.S. population over the age of 65 
increased from 8.1 percent in 1950 to an estimated 13.2 percent in 2010.3 This demographic shift is 
expected to continue, with the proportion of Americans over 65 expected to reach 20 percent of the total 
population by 2050—an estimated 360 percent increase over a single century.4 
This increased life expectancy, and the subsequent “graying” of the U.S. population, with the ac-
companying rise in the incidence and prevalence of the diseases, conditions, and injuries for which 
the elderly are more at risk, is expected to continue driving demand for healthcare services, as well as 
a dynamic evolution in the demand for, the supply of, and the very nature of healthcare professional 
practices.5 
Although age-related population trends are one of the key contributors to the changing demand for 
health services, other changes in the U.S. demographic and economic climate have significant bearing as 
well. The accelerated population shift from rural to urban areas during the last sixty years also may have 
influenced the increased incidence and prevalence of disease. Although the urbanization of the United 
1 “Current Population Reports,” Series P-25, Nos. 311, 917, 1095, National Population Estimates, U.S. Department of Commerce, Economics and Statistics Administration, Bureau 
of the Census, April 11, 2000, http://www.census.gov/population/estimates/nation/popclockest.txt (accessed 03/26/2010); “Current Population Reports: Population Projections 
of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050,” Series P25-1130, U.S. Department of Commerce, Economics and Statistics Administration, Bureau of 
the Census, 1996, p. 1. “Table 1. Projections of the Population and Components of Change for the United States: 2010 to 2050 (NP2008-T1),” by U.S. Department of Commerce, 
Economics and Statistics Administration, Bureau of the Census, Population Division, August 14, 2008.
2 “United States Life Tables, 2003,” by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 
National Vital Statistics Report, Volume 54, Number 14, (April 19, 2006), p. 34; “International Data Base,” United States Census Bureau, March 19, 2010, http://www.census.gov/
ipc/www/idb/country.php (accessed 03/26/2010).
3 “Chapter 2—Age and Sex Composition,” in “Demographic Trends in the 20th Century: Census 2000 Special Reports,” by Frank Hobbs and Nicole Stoops, U.S. Department of 
Commerce, Economics and Statistics Administration, United States Census 2000, November 2002, CENSR-4, p. 56; “Table 3: Projections of the Population by Age, Race, and 
Hispanic Origin for the United States: 1995–2050—Principal Alternative Series,” in “Current Population Reports: Population Projections of the United States by Age, Sex, Race, 
and Hispanic Origin: 1995 to 2050,” Series P25-1130, U.S. Department of Commerce, Economics and Statistics Administration, Bureau of the Census, 1996, p. 90.
4 Ibid.
5 “The Impact of the Aging Population on the Health Workforce in the United States,” by the National Center for Health Workforce Analysis, Bureau of Health Professions Health 
Resources and Services Administration, December 2005, p. 10; “Health, United States, 2008, With Special Feature on the Health of Young Adults,” U.S. Department of Health and 
Human Services, National Center for Disease Statistics, March 2009, http://www.cdc.gov/nchs/data/hus/hus08.pdf#120 (accessed 09/11/2009), p. 4.
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States was already under way in 1950, this shift continued to reshape the population distribution, with 
the urban population increasing from 64 percent of the U.S. population in 1950, to almost 80 percent in 
2010.6 
Additionally, the shift from an agrarian into an industrialized society, and once again into a service-
driven economy, has affected the American lifestyle and related health trends.7 The waning of family 
farms and rise of industrialized agriculture resulted in a shift in the U.S. diet. High-calorie commodities 
laden with fats, oils, and sugars, were mass produced at the expense of farming affordable, fresh, and 
nutritious produce.8 With this increased availability, and, consequently, the consumption of high caloric-
energy, came a decrease in energy expended, arising from the sedentary, high stress, and extended work 
day practices characteristic of many service industry sectors (for example, finance, legal, insurance and 
real estate, retail trade, and public utilities). The emergence and proliferation of automobile transporta-
tion, decreased emphasis on the family unit, and sedentary recreational habits led to a decrease in physi-
cal activity. These factors further fueled the impact of the fast food industry and processed food con-
sumption on the health of the U.S. population, now plagued by chronic diseases for which obesity and 
poor diet are often major co-morbidities.9 
The increased demand driven by these changes and other economic and demographic variables may 
have, in part, fueled the increase in healthcare expenditures from 5 percent of GDP in 1950, to more 
than 17 percent in 2010.10 Increased spending also may be a consequence of the surge in technological 
and other medical advances in the healthcare industry, promulgated at the close of World War II and 
encouraged by the increase in federal and state funding for healthcare expenditures.11 Since the adoption 
of Medicare in 1965, public (government) payors have come to fund more than half of all healthcare 
expenditures.12 
Also, among the driving forces of U.S. healthcare industry trends that impact professional practices 
are the supply and distribution of various types and multiple levels of healthcare professionals who work 
within a dynamic framework of myriad competing interests in order to meet the growing needs of an 
aging and, in many ways, less healthy population. As a result of technological and medical advances, 
specialized medicine flourished across the healthcare workforce, growing as a significant trend in the 
1950s.13 In response to the past and present surge in demand, the physician population has increased 
from 219,997 in 1950 to 954,224 in 2009, and the number of physicians per 100,000 individuals has 
increased from 142.2 to 316.4.
Despite these growing workforce trends, it is expected that, with a disproportionate number of physi-
cians retiring, an inadequate supply medical graduates, and the expected continuing growth in demand, 
the present shortage in supply of physician manpower will continue to worsen.14 As a result, there has 
6 “Table 1. Urban and Rural population: 1900–1990,” by the U.S. Department of Commerce, Economics and Statistics Administration, Bureau of the Census, October 1995,  
http://www.census.gov/population/censusdata/urpop0090.txt (accessed 03/26/2010); U.S. Census Bureau 2010 Census Planning Data Base, U.S. Department of Commerce, 
Economics and Statistics Administration, Bureau of the Census, 2010, http://www.census.gov/procur/www/2010communications /tract%20level%20pdb%20with%20census% 
202000%20data%2001-19-07.pdf (accessed 03/26/2010).
7 “Obesity and the Economy: From Crisis to Opportunity,” by Davis S. Ludwig, MD, PhD and Harold A. Pollack PhD, the Journal of the American Medical Association, Volume 301, 
Number 5, (February 4, 2009), p. 533; “The Role of Services in the Modern U.S. Economy,” by Douglas B. Cleveland, Office of Service Industries, January 1999.
8 Ibid.
9 Ibid.
10 “Health Care Expenditures in the OECD,” by the National Bureau of Economic Research, 2006, http://www.nber.org/aginghealth/winter06/w11833.html (accessed 03/26/2010); .
11 “Plunkett’s Health Care Industry Trends and Statistics 2008 (Summary),” By Jack W. Plunkett, Plunkett Research Ltd., 2007, p. 3.
12 “Chapter 6—Health Care Personnel,” and “Chapter 7—Financing Healthcare” in “Health Care USA: Understanding its Organization and Delivery,” by Harry A. Sultz and Kristina 
M. Young, Jones and Bartlett Publishers, Sixth Edition (2009), p.196, 234–235.
13 “Chapter 7—Financing Healthcare” in “Health Care USA: Understanding its Organization and Delivery,” by Harry A. Sultz and Kristina M. Young, Jones and Bartlett Publishers, 
Sixth Edition (2009), p. 231.
14 “Physician Characteristics and Distribution in the US 2010 Edition” American Medical Association, 2010, p. 458; “Table 201—Total and Active Physicians (MDs) and Physician-
to Population Ratios, Selected Years: 1950-2000,” in “Health Resources Statistics, 1965,” by the U.S. Department of Health, Education, and Welfare, National Center for Health 
Statistics, PHS Pub. No. 1509, 1966.
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been a further increase in diversification of the healthcare workforce, comprised of more than 13 mil-
lion individuals, with fewer than one million being physicians.15 The diversification, specialization, and 
collaboration of physician and nonphysician practitioners has increased, expanded, and enhanced to 
meet the compounding demand. This Guide addresses not just physician medical practices but discusses 
a comprehensive array of professional practice types, as well as the various practitioners that comprise 
the healthcare workforce, including allied health professionals, mid-level providers, and technicians and 
paraprofessionals, as well as complementary and alternative medical practitioners. 
Although professional practice enterprises currently account for $447 billion of a $2.26 trillion 
healthcare market (19.8 percent), recent efforts at regulatory and reimbursement reform suggest that 
healthcare professional practices may be facing an unprecedented dramatic transition.16 The evolution 
and increasing complexity of healthcare reimbursement, regulatory, competitive, and technological envi-
ronments has made it more difficult for professionals to maintain revenue yield while avoiding running 
afoul of regulatory edicts. 
A notable element of these challenges is an industry transition reflected in the recent increase in the 
number of hospital-employed physicians, and the dwindling of physician-ownership of private, indepen-
dent practices. A growing number of young physicians, plagued by medical school debt and intent upon 
achieving a more comfortable work-life balance, are opting out of private, independent practice and 
pursing salaried employment by hospitals and health systems. 
These trends have made it increasingly difficult for older independent practitioners to recruit junior 
partners, a struggle which, paired with the burden of rising costs, has led many physician-owners to sell 
their practices to hospitals and enter into salaried employment arrangements as well. This shift further 
away from the independent practice of medicine as a “cottage industry” in the United States may be 
viewed by patients as both a blessing and a burden of the changing healthcare delivery system. On one 
hand, the trend away from small, physician- or provider-owned, independent private practices holds the 
promise of improved quality and cost efficiency for the delivery of better and integrated medical care. 
Alternately, the “corporatization” of healthcare professional practices may result in a weakening of the 
independent physician- or provider-patient relationship, an intimacy and level of trust that was long a 
characteristic of the cottage industry healthcare delivery system of old.17 Given these trends in healthcare 
professional practices, it may not be far-fetched to believe that “Marcus Welby is dead!” (see chapter 2 
of Professional Practices).
These dramatic and ongoing changes, as well as the sheer size and complexity of the healthcare 
delivery system, have provided new opportunities in healthcare consultancy. Responding to the expand-
ing market in the current era of reform, many financial and management consulting firms have extended 
their service line to include healthcare advisory services. Accounting firms, which traditionally have 
served as primary business and financial advisors for their clients, also have steadily increased the scope 
of their healthcare professional practice advisory services. 
The persistent volatility of the healthcare industry landscape can be difficult to navigate. To be ef-
fective in offering services to healthcare professional practice clients, consulting professionals should 
possess an understanding of the history and background of professional practice enterprises, as well as 
the market mechanisms at work in the current healthcare environment—in particular, how those forces 
15 Ibid.
16 “Plunkett’s Health Care Industry Trends and Statistics 2008 (Summary),” By Jack W. Plunkett, Plunkett Research Ltd., 2007, p. 44.
17 “More Doctors Giving Up Private Practices,” by Gardiner Harris, New York Times, March 25, 2010; “The Social Transformation of American Medicine,” by Paul Starr, Basic Books 
Inc. 1982, p. ix.
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interact to shape the future direction of professional practices in the healthcare delivery system under 
pending legislative reform. 
Although consultancy for healthcare professional practices may present an attractive business devel-
opment opportunity for consultants, it is not an area that lends itself to ad hoc, generic advisory services. 
In light of the increasingly complex, diverse, and ever-changing scope and volume of information that 
contributes to a comprehensive understanding of the healthcare industry, consulting professionals who 
possess a more general background and expertise and pursue providing services to healthcare profes-
sional practices may endeavor to become better informed to avoid being viewed, in some regard, as 
jacks of all trades and masters of none. 
This three book set is designed to serve as a reference guide for those seeking a more in-depth 
knowledge of the healthcare marketplace; a working and applied understanding of the forces that affect 
the industry within which healthcare providers operate; and a primer regarding how consulting services 
may be offered to these enterprises specifically, healthcare professional practices, in an ever-changing 
reimbursement, regulatory, competitive, and technological healthcare environment. Such industry-spe-
cific knowledge should serve as a catalyst for these consulting professionals to better serve their existing 
clients and expand their services for potential new engagements.
This Guide may also prove useful to the licensed healthcare professionals who own independent 
practices, as well as their professional advisors, managers, and administrators. Providing these stake-
holders with in-depth background information and a context within which to view professional practice 
enterprises as part of a dynamic healthcare marketplace may enhance their ability to assist their organi-
zations in surviving and thriving in the future.
With the first publication of this Guide, we earnestly solicit reader comments, criticisms, and sugges-
tions for improvements in future editions. 
Sincerely,
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Introduction
These papers, advocating a more active participation in public 
affairs by physicians than has been the custom in this country, are 
reprinted with the belief that such broader activity on the part of 
my colleagues will help to free the State from many present evils. 
A good doctor must be educated, honest, sensible and brave. 
Nothing more is needed in its citizens to make a state great.
John B. Roberts, 1908
1
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The Four Pillars of the Healthcare Industry
When developing an understanding of the forces and stakeholders that have the potential to drive health-
care markets, it is useful to examine professional practice enterprises as they relate to the “four pillars” 
of the healthcare industry: reimbursement, regulatory, competition, and technology (see the following 
figure I-1). These four elements shape the professional practice and provider dynamic, while serving as 
a framework for analyzing the viability, efficiency, efficacy, and productivity of healthcare enterprises. 
The four pillars, discussed briefly in this introduction, will be further addressed in subsequent chapters 
devoted to each of these four topics.






























Chapter 2, Reimbursement Environment provides an overview of current and future trends in healthcare 
reimbursement. With healthcare reform on the horizon, it is vital for providers to maintain an applied 
understanding of healthcare payment sources (for example, Medicare, Medicaid, State Children’s Health 
Insurance Program, etc.), revenue and billing procedures (for example, the resource-based relative value 
scale payment system, relative value units and their components, Current Procedural Terminology 
codes, etc.), and payment plans (for example, fee-for-service plans, performance-based payment plans, 
and consumer driven health plans).
As healthcare expenditures rise, proponents of reform advocate for both a reduction in service costs 
and increases in quality of care. To achieve these goals, the industry variously has moved toward man-
aged care, pay-for-performance programs, gainsharing arrangements, and patient-centered models of 
medical practice (for example, boutique medicine, the medical home model, etc.). In addition, reim-
bursement for physician services has become a highly contested issue; repeated annual congressional 
overrides of reductions to physician payment rates for services under the sustainable growth rate system 
have created a large gap in current healthcare spending and target (sustainable) expenditures. To combat 
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these rising costs, for example, the high expenditures for imaging services, billing codes have, during 
the past decade, been “bundled.” Bundling has been utilized to reduce the overall payment for certain 
interrelated services by billing for them under one, combined code, rather than under independent codes. 
The emergence of bundled codes, among other trends, is evidence of the rapidly changing reimburse-
ment environment within the U.S. healthcare delivery system.
Regulatory
The U.S. healthcare industry is governed by a network of ever-changing state and federal regulations, 
relating to both physician and nonphysician professionals. Chapter 3, Regulatory Environment contains 
a detailed overview of the general provisions that apply to the various practitioners and providers in the 
healthcare industry.
Various key regulatory issues may influence the healthcare climate. For example, in recent years, 
there has been increased government scrutiny of regulatory violations of fraud and abuse laws, par-
ticularly as the violations relate to acquisition and compensation transactions between hospitals and 
physicians. Failure to comply with valuation standards for physician and executive compensation ar-
rangements (for example, fair market value and commercial reasonableness) may result in liability under 
the False Claims Act, the antikickback statute, and the Stark law. Chapter 3, Regulatory Environment 
includes a discussion of these concepts and regulations along with the definitions, applications, implica-
tions, and trends of additional federal and state healthcare laws and regulations (for example, Certificate 
of Need programs).
Competition
Additionally, rapid changes in the healthcare competitive market may be attributed to the ever-increasing 
demand for care from the aging baby boomer population and to the continuous development of new 
technologies, the latter which may enhance the quality and efficiency of the healthcare delivery system. 
In recent years, there has been a rapid growth in the number of limited-service providers, or “niche 
providers,” such as specialty and surgical hospitals (for example, orthopedic and heart hospitals), which 
are sometimes referred to as “focused factories.”1 As a result of this trend toward specialization, con-
cern has been raised that the medical care offered by niche providers may have a negative impact on the 
profitability of general acute care hospitals, which traditionally have provided specialty and primary care 
to patients. Similarly, there has been a movement toward increasing the scope and volume of mid-level 
provider-issued care, resulting in additional market competition for physicians.
The changing demographics of the patient population (that is, the baby boomer population) and the 
physician workforce also may have a lasting impact on the healthcare competitive environment. There 
has been an increase in concern related to the shortage of physician manpower and the limited number of 
available residency slots that restrict physician entry into the healthcare market. Among the most notable 
concerns is the perceived shortage of primary care physicians; with many medical students opting for 
careers in higher-paying medical specialties, primary care physicians are pressed more than ever to meet 
patient demand for services. Additionally, women and minorities make up a much higher percentage 
of the physician workforce than they have in the past (in most specialties), effectively diversifying the 
traditionally Caucasian male physician demographic. Although they provide patients with more choices 
for care, they also are presenting challenges related to the demands of achieving a practice—lifestyle 
balance.
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These issues and numerous others, such as healthcare and insurance reform, shape the unique and 
dynamic healthcare competitive environment. Chapter 4, Impact of Competitive Forces includes a more 
detailed examination of these issues within the context of Porter’s five forces of competition.
Technology
Significant technological advances during the past few decades have had a notable impact on the U.S. 
healthcare delivery system. Electronic health record technologies gradually have been integrated into 
medical records maintenance systems, replacing traditional paper files. Similarly, Computerized physi-
cian order entry has streamlined the process of ordering prescriptions and minimized error caused by 
handwritten orders. Although these new electronic approaches to healthcare delivery are saving em-
ployers money, physician unwillingness to adopt these new technologies has impeded their widespread 
emergence into the healthcare market. Regardless, new and improved management technology is slowly 
becoming an important facet of the healthcare industry.
Progress in clinical technology also has flourished in recent years, including highly controversial 
practices such as stem cell research. However, one of the various genres of medical services that may 
have drawn the most attention is imaging; services that utilize the technology, such as the various types 
of magnetic resonance imaging, computed tomography (for example, positron emission tomography-
computed tomography, single photon emission computed tomography, and picture archiving and com-
munications systems), and teleradiology services, have become a staple in modern diagnostic radiology 
practice.
Oncologists and surgeons also have seen major advancements in the treatment and detection of 
cancer and in minimally invasive or noninvasive surgery, respectively. For oncologists, radiation ther-
apy methods are improving continuously, and their use of innovative alternative and supporting tech-
nologies, such as image-guided radiation therapy, which is used during intensity-modulated radiation 
therapy; gamma knives; and stereotactic radiosurgery, is increasing. The use of robotics has become a 
rapidly advancing trend, and surgeons with robotics experience are sought after for their skills. Robotic 
technologies have been used for urologic, gynecologic, and cardiothoracic procedures, among others. 
Although expensive, robotic technology minimizes the degree of invasiveness, shortens recovery time, 
and improves patient outcomes.
These advancements in medical technology have helped to revolutionize modern medicine. The 
cost of implementing and maintaining these new devices and procedures, however, may counterbalance 
efforts to control healthcare expenditures. The future of healthcare may well depend on a compromise 
between the advancement of medical technological capabilities and the cost of supporting those technol-
ogies that allows practitioners to provide the best quality care possible. Chapter 5, Technology Develop-
ment includes a more detailed discussion of the impact of technology on healthcare practices.
Structure of this Guide
This Guide serves as a resource for consulting professionals who provide services to professional prac-
tices and related healthcare providers. It is divided into three books:
1. An Era of Reform, consisting of six chapters, begins with an abridged history of healthcare, from 
the origins of medicine to the transformation of modern healthcare in the twentieth and twenty-
first centuries (chapter 1). The next several chapters (chapters 2–5) provide a more comprehen-
sive look at the reimbursement, regulatory, competitive, and technological environments as they 
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apply to healthcare practice. The last chapter (chapter 6) provides an overview of the healthcare 
environment and related healthcare reform bills, at the time of the submission of this Guide.
2. Professional Practices, consisting of eight chapters, discusses the myriad of practice structures 
(chapter 1), medical specialties, and professionals seen in healthcare to date. This discussion 
includes emerging models of healthcare enterprises, physicians, mid-level providers, technicians 
and paraprofessionals, allied health professionals, alternative medicine practitioners, and a new 
paradigm for professional practices (chapters 2–8, respectively), as well as information regarding 
the scope of subspecialties, types of providers, and practitioners of each service type.
3. Consulting With Professional Practices, consisting of four chapters, provides a descriptive 
overview for consultants advising professional practice clients on matters related to healthcare 
consulting (chapter 1); benchmarking strategies related to healthcare and valuation (chapter 2); 
compensation and income distribution (chapter 3); and financial valuation of healthcare enter-
prises, assets, and services (chapter 4). The information provided in these chapters should supply 
the reader with the tools necessary to translate healthcare consulting theory into practice.
It should be noted that the second and third books of this Guide focus on the professional practice 
component of the U.S. healthcare delivery system and do not directly address other healthcare sectors, 
including inpatient (for example, hospitals), outpatient and ambulatory (for example, ambulatory surgery 
centers and diagnostic imaging centers), long term care (for example, nursing homes and hospice), and 
home health sectors. However, many of the concepts and much of the content in the second and third 
books of this Guide may be applicable to consulting projects in these other healthcare sectors, as well.
Reader Tools: Sidebars, Tables, and Figures
To enhance the utility of this Guide as a navigable source for readers of various backgrounds, certain 
tools have been developed and appear throughout:
1. Sidebars. These supplemental features have been integrated into the content of each chapter and 
have been grouped as follows:
a. Key terms. Key terms are important words used in text that may need to be defined for the 
reader. This tool can be found at the beginning of each chapter and serves to identify those 
terms that appear within the text of corresponding chapters as well as in the glossary at the 
end of this book. Key terms may be discussed, or, at least, mentioned in multiple chapters.
b. Key concepts. Similar to key terms, key concepts are the important concepts mentioned in 
text that may require further elaboration or emphasis and a list of key concepts can be found 
at the beginning of each chapter. This tool serves a bimodal role, to further stress important 
ideas discussed in the chapter and to further discuss ideas that may have only been mentioned 
in passing. 
c. Key sources. This feature points to significant sources, both used within this Guide and fun-
damental to the chapter content. These sources serve as chapter-specific bibliographies, and, 
therefore, may be found in multiple chapters. Key sources can be found at the end of each 
chapter.
d. Associations. A brief list of topic-relevant associations provides the reader with contact 
information for associations referenced within a chapter. A list of related associations can be 
found at the end of each chapter.
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e. Factoids. These are brief, related facts of interest either mentioned in text or supplemental to 
a topic discussed in a particular chapter that help build a contextual framework for the reader 
that may aid in explaining the material. You will find factoids located close to the content 
that they address within each chapter.
2. Tables. Tables are used to display benchmark data, to demonstrate numerical trends, and to draw 
comparisons. They are referenced in text, but they may be used to display extra information not 
discussed in the content of the chapter.
3. Figures. Pictorial and graphical depictions have been used to complement the text and enhance 
the reader’s comprehension of the material. These figures are referenced and discussed in text. 
Professional Practice Taxonomy
Healthcare reform is driven by complex, polar, and potentially conflicting market factors, such as in-
creased spending; a growing and graying demographic; workforce shortages and inefficiencies; prob-
lematic chronic and acute health indicators; and shortcomings in the delivery of efficient, quality care. 
The subsequent chapters detail these issues, their implications, and the reform initiatives proposed to 
delicately counterbalance the U.S. healthcare delivery system on the nation’s scale of justice. However, 
before delving into the complexities of healthcare reimbursement, regulation, competition, and technol-
ogy, the dynamic healthcare provider workforce should be addressed.
Provider versatility has been growing and changing to complement an evolving healthcare indus-
try.2 The diverse healthcare workforce is instrumental to improving efficacy, quality of care, financial 
efficiency, patient satisfaction, workforce productivity, and professional satisfaction.3 In order to capi-
talize on this potential, institutions adopt models that strategically allocate physician and nonphysician 
manpower resources on the basis of scope and skill set—ensuring that the right care is provided by the 
right provider at the right time and place.”4 Implementation models are characterized by (1) the site of 
service (for example, hospital, clinic, or community), (2) the guidelines that regulate provider practice 
and compensation within an intraprofessional care model, (3) the system by which scope of practice is 
defined for each provider classification, (4) the degree to which providers are liable for their professional 
actions, and (5) the degree to which they model efficacy and efficiency.5
The intraprofessional care models that have been implemented most successfully stem from sev-
eral provider taxonomies, which were intended to mirror the complex relationships within the existing 
healthcare workforce. The most influential provider taxonomies (detailed in tables I-1[A-D] and I-2) 
are each based on a different system of classification that focuses on a portion of the industry dynamic 
and include those developed by (1) the Human Resources and Services Administration, which utilizes 
a four-tiered hierarchal system and aggregates specific occupations based on the degree of training and 
type of services provided (table I-1A); (2) the American Medical Association, which classifies profes-
sionals based on the specialized area of medical practice under which they provide their services (table 
I-1B); and (3) the Centers for Medicare and Medicaid Services, which categorizes professionals based 
on how they bill these professionals for services (table I-1C). Although these taxonomies are based on 
key structural considerations, they each neglect certain industry facets, and discrepancies arise due to 
the limitations that this unilateral rationale presents. The models used to enhance the delivery of intra-
professional care face similar limitations, as institutions typically focus on only one, highly customized 
model, foregoing a more industrywide perspective by neglecting models that represent the other industry 
sectors.6
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Alternately, multiple models can be synthesized to represent an industrywide, intrapersonal dy-
namic.7 Elements from three models, the physician extender model, the triage model, and the parallel 
model, were used to derive the taxonomical system for classifying healthcare professionals that is uti-
lized in this Guide (detailed in tables I-1D and I-2).
Traditionally, all nonphysician clinicians are referred to as “allied health professionals.”8 However, 
advances in technology and capability paired with the change in healthcare demand during the course 
of medical history have rendered this system of classification far too rudimentary for the diversity that 
the workforce now holds. As the healthcare industry continues to change and market demand for pri-
mary, preventative, and rehabilitative care increases, the varying degrees of responsibility, expertise, 
and autonomy afforded to the increasingly diverse nonphysician healthcare workforce is reassessed and 
the scope of practice continues to expand.9 By creating a taxonomy based on these three representative 
models, allied health professionals may be partitioned into appropriate substrata of nonphysician provid-
ers, because they would function within the ideal intraprofessional workforce dynamic.
Under the physician extender model, the scope of nonphysician professional practice lies entirely 
within the scope of physician practice.10 These physician extenders (hereinafter “technicians and para-
professionals”) supplement physician care, either as highly technical or technological support or as man-
power support.11 Specifically, one subset of the professionals defined within this model is trained in a 
highly specialized technical or technological field and provides services that physicians rely upon but are 
incapable of providing independently. The other subset of professionals, physician extenders, provides 
routine medical and administrative services to relieve physicians of a portion of their workload, allowing 
them to focus on more difficult and complex tasks. From an official standpoint, these professionals may 
or may not be licensed or certified (depending on which subset of the provider population they belong to 
or which role they tend to fill most appropriately).
The original rationale behind the classification of “mid-level providers,” as defined for the purposes 
of this Guide, derives from the triage model.12 Under this model, nonphysician professionals are trained 
to provide a specific subset of physician services, and they traditionally serve as a source of physician 
relief by providing triage care and enhancing patient throughput.13 Historically, these providers could 
only practice under direct or indirect supervision of a physician.14 As demand increased, namely for the 
provision primary care services, the autonomy of mid-level providers increased.15 To date, these profes-
sionals are relied upon for the provision of specialized services that are incident to physician services 
but also exercise a certain measure of independence, because they can autonomously provide a specific 
scope of services in lieu of physicians.16 The services which mid-level providers are authorized to pro-
vide in lieu of physicians typically are limited to a portion of primary care practice healthcare services, 
and, consistent with the triage model, complex cases are handed off to physicians, because they may fall 
outside that predetermined scope of service.17
The parallel model lies on the opposite end of the spectrum. Under this model, the scope of the al-
lied health professional practice is separate, distinct, and, essentially, parallel to the scope of physician 
practice.18 These allied health professionals are nonphysician practioners who practice independently 
and offer services that, despite some overlap with physician care, are largely outside the scope of physi-
cian practices.19 Although allied health professionals (as defined in this Guide) and physicians some-
times may compete due to shared patient populations and practice objectives, the specific services they 
provide typically have distinct differences.
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Table I-1A: Healthcare Professional Practices Provider Taxonomies 
Organization: Bureau of Labor Statistics  Classification System: A six-digit hierarchal structure resulting in four levels of aggregation 
(categories): Category 1=Major Group, Category 2=Minor Group, Category 3=Broad Occupation, Category 4=Detailed Occupation.
Category Definition Subcategories
Healthcare Practitioners and 
Technical Occupations
Major Occupational Group A—Professional occupations 
concerns with the study, application, and/or administration 
of medical practices or theories. Some occupations are con-
cerned with interpreting, informing, expressing, or promoting 
ideas, products, etc. by written, artistic, sound, or physical 
medium. This category also includes technical occupations, 
involved in carrying out technical and technological functions 
in health. May perform research, development, testing, and 

















Occupational Therapist Respiratory Therapists
Physical Therapist Speech-Language Pathologist
Radiation Therapists Exercise Physiologists





Miscellaneous Health Diagnosing/Treating Practitioners
Health Technologists and Technicians
Clinical Laboratory Technologists/Technicians
Medical and Clinical Laboratory 
Technologists
Medical and Clinical Laboratory 
Technicians
Dental Hygienists




Diagnostic Medical  
Sonographers
Magnetic Resonance Imaging 
Technologists
Nuclear Medicine Technologists





and Technical Occupations 
(continued)
Emergency Medical Technicians/Paramedics
Health Practitioner Support Technologists/Technicians
Dietetic Technicians Surgical Technicians
Pharmacy Technicians Veterinary Technicians
Psychiatric Technicians Ophthalmic Medical Technicians
Respiratory Technicians
Licensed Practical and Licensed Vocational Nurses
Medical Records and Health Information Technicians
Opticians, Dispensing
Miscellaneous Health Technologists/Technicians
Orthotists and Prosthetists Other
Hearing Aid Specialists
Other Healthcare Practitioners/Technical Occupations
Occupational Health and Safety Specialists/Technicians
Occupational Health and Safety 
Specialists
Occupational Health and Safety 
Technicians
Miscellaneous Health Practitioners/Technical Workers
Athletic Trainers Other
Healthcare Support  
Occupations
Major Occupational Group K - Occupations concerned with 
other health care services for children and adults, mainly  
cater to the provision of support services.
Nursing, Psychiatric, and Home Health Aides
Home Health Aides Nursing Assistants
Psychiatric Aides Orderlies
Occupational Therapy/Physical Therapist Assistants/Aides
Occupational Therapy
Occupational Therapy Assistants Occupational Therapy Aides
Physical Therapy
Physical Therapy Assistants Physical Therapy Aides
Other Healthcare Support Occupations
Massage Therapists
Miscellaneous Healthcare Support Occupations
Dental Assistants Medical Equipment Preparers
Medical Assistants
Notes:
* “Chapter 6. Occupation and Industry Classification Systems,” in “Nursing Aides, Home Health Aides, and Related Health Care Occupations—National and Local Workforce 
Shortages and Associated Data Needs” by the U.S. Department of Health and Human Services, Health Resources and Services Administration, 2009, http://bhpr.hrsa.gov/
healthworkforce/reports/nursing/nurseaides/chap6.htm.
** “2010 Standard Occupational Classification,” by the Bureau of Labor Statistics, January 2009, p. 16-19.
† “MOG—Level Definitions,” in “Occupational Classification System Manual,” by the U.S. Bureau of Labor Statistics, National Compensation Survey, http://www.bls.gov/ncs/
ocs/ocsm/comMOGADEF.htm#mogaanchor (accessed 01/04/09).
Table I-1A: Healthcare Professional Practices Provider Taxonomies (continued) 
Organization: Bureau of Labor Statistics  Classification System: A six-digit hierarchal structure resulting in four levels of aggregation 
(categories): Category 1=Major Group, Category 2=Minor Group, Category 3=Broad Occupation, Category 4=Detailed Occupation.
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Table I-1B: Healthcare Professional Practices Provider Taxonomies 
Organization: Centers for Medicare and Medicaid  Classification System:  Based on System for Billing for Services
Category Definition Subcategories
Physician As stated in Section 1861(r) SSA to include the 
professionals listed here
N/A
MDs* Doctor of Optometry*
DOs* Chiropractor*
Doctor of Dental Surgery/ 
Dental Medicine*
Interns and Residents*
Doctor of Podiatric Medicine*
Allied Health Providers As stated in 42USC sec. 295p to include those pro-
fessionals who: (A) who has received a certificate, 
an associate’s degree, a bachelor’s degree, a mas-
ter’s degree, a doctoral degree, or post baccalau-
reate training, in a science relating to health care; 
(B) who shares in the responsibility for the delivery 
of health care services or related services, includ-
ing: (i) services relating to the identification, evalu-
ation, and prevention of disease and disorders; (ii) 
dietary and nutrition services; (iii) health promotion 
services; (iv) rehabilitation services; or (v) health 
systems management services; and (C) who has 
not received a degree of doctor of medicine, a 
degree of doctor of osteopathy, a degree of doctor 
of dentistry or an equivalent degree, a degree of 
doctor of veterinary medicine or an equivalent 
degree, a degree of doctor of optometry or an 
equivalent degree, a degree of doctor of podiatric 
medicine or an equivalent degree, a degree of 
bachelor of science in pharmacy or an equivalent 
degree, a degree of doctor of pharmacy or an 
equivalent degree, a graduate degree in public 
health or an equivalent degree, a degree of doctor 
of chiropractic or an equivalent degree, a graduate 
degree in health administration or an equivalent 
degree, a doctoral degree in clinical psychology or 
an equivalent degree, or a degree in social work or 
an equivalent degree or a degree in counseling or 
an equivalent degree.
Mid-Level Provider—also known as: Non-Physician  
Practitioner/Physician Extender—Health professionals  
who may deliver covered Medicare services if the services  
are incident to a physician’s service or if there is  
specific authorization in the law
Physician Assistant/Advanced Practice Nurses
Physician Assistant*,**,† Certified Registered Nurse  
Anesthetists*,**,†
Nurse Practitioners*,**,† Certified Nurse Midwives*,**,†
Other
Qualified Clinical Psychologists*,**,† Respiratory Therapy Workers††,‡,‡‡,§







EMT/Paramedic††,‡,‡‡,§ Operating Room Technicians††,‡,‡‡,§
Health Information Admin/
Tech††,‡,‡‡,§
Ophthalmic/Optometric Medical  
Assistants††,‡,‡‡,§
Occupational Therapists††,‡,‡‡,§ Medical Transcriptionists††,‡,‡‡,§
Orthotists and Prosthetists††,‡,‡‡,§ Vocational Rehab Counselors††,‡,‡‡,§
Physical Therapists††,‡,‡‡,§ Other Rehabilitation Workers††,‡,‡‡,§
Radiologic Service Workers††,‡,‡‡,§ Other Social and Mental Health  
Workers††,‡,‡‡,§
Notes:
* “Physicians” in “The Public Health and Welfare,” United States Code Title 42 1395x(r).
** “Ratio of Physician to Physician Extenders (Resolution 303, I-97),” by Kay K. Hanley, MD, December 1998, CMS Report 10-1-98.
† “ ‘Incident to’ Services,” MLN Matters, SE0441.
†† “Definitions, Federal Health Insurance for the Aged and Disabled, Center for Medicare and Medicaid Services, Department of Health and Human Services” 42 CFR 405.400.
‡ “Chapter 6A: Definitions, General Provisions, Health Professions Education, Public Health Service, The Public Health and Welfare,” United States Code Title 42 p.295.
‡‡ “Civil Remedies Decision CR1961,” by the Departmental Appeals Board, Department of Health and Human Services, June 16, 2009, p. 3.
§ “Interdisciplinary, Community-Based Linkages, Title VII, Part D, Public Health Service Act,” by the Advisory Committee on Interdisciplinary, Community-Based Linkages, 2006, 
Fifth Annual report to the Secretary of the U.S. Department of Health and Human Services and to the Congress.
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Table I-1C: Healthcare Professional Practices Provider Taxonomies 
Organization: American Medical Association  Classification System: As utilized in the Health Care Careers Directory 2009-2010
Category Definition Subcategories
Physician There are two types of physicians: MD—Doctor  
of Medicine—and DO-Doctor of Osteopathic 
medicine … Both MDs and DOs may legally use 










Podiatry “Specialize in diagnosing and treating disorders, 




Veterinary Medicine Provide healthcare professional and support 
services for the care of pets, livestock, and zoo, 
sporting, and laboratory animals
N/A
Veterinarian*,**
Nursing Registered Nurses*,** Licensed Vocational Nurses**
Licensed Practical Nurses**
Mid-Level Provider - also known as: Non-Physician Practitioner/ 
Physician Extender - Health professionals who may deliver covered Medicare services if the 
services are incident to a physician’s service or if there is specific authorization in the law
Advanced Practice Nurses
Nurse Practitioners†,††,‡ Certified Nurse Midwives†,††,‡





“Participate in the delivery of health care, diag-
nostic, and rehabilitation services, therapeutic 
treatments, or related services,” and excludes 
“the MODVOPP professions: medicine (allopathic), 
osteopathic medicine, dentistry, veterinary medi-
cine, optometry, podiatry, and pharmacy—as well 
as chiropractic, clinical psychology, any level of 
nursing education, and graduate degrees in public 
health or health administration.”
Physician Assistant




Dentistry and Related Fields
Dentist*,** Dental Hygienist*,**
Dental Assistant*,** Dental Lab Technician*,**
Communication Sciences
Audiologist*,** Speech-Language Pathologist*,**






Art Therapist*,** Music Therapist*,**
Dance/Movement Therapist*,**
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Table I-1C: Healthcare Professional Practices Provider Taxonomies (continued) 
Organization: American Medical Association  Classification System: As utilized in the Health Care Careers Directory 2009-2010
Category Definition Subcategories
Allied Health  
Professional  
(continued)
Health Information and Communication
Cancer Registrar*,** Medical Coder*,**
Health Information Administrator*,** Medical Librarian*,**
Health Information Technician*,** Medical Transcriptionist*,**
Laboratory Science
Blood Bank Technology-Specialist*,** Clinical Laboratory Technician/ 
Medical Laboratory Technician*,**
Clinical Assistant*,** Cytogenetic Technologist*,**




Diagnostic Molecular Sonographer*,** Magnetic Resonance Technologist*,**
Histotechnician*,** Medical Dosimetrist*,**
Histotechnologist*,** Nuclear Medicine Technologist*,**
Pathologists’ Assistant*,** Radiation Therapist*,**
Phlebotomist*,** Radiographer*,**





Ophthalmic Dispensing Optician*,** Teacher of the Visually Impaired*,**
Optometrist*,** Vision Rehabilitation Therapist*,**
Orientation and Mobility Specialist*,**
Therapy and Rehabilitation
Occupational Therapist*,** Physical Therapist Assistant*,**
Occupational Therapy Assistant*,** Therapeutic Recreation Specialist*,**
Physical Therapist*,**
Other
Anesthesiologist Assistant*,** Nursing Aides, Orderlies, Attendants*,**
Anesthesia Technologist/Technician*,** Occupational Health and Safety Technician*,**
Athletic Trainer*,** Orthotists and Prosthetists*,**
Cardiovascular Technician/Technologist*,** Orthotics and Prosthetics Technicians*,**
Electroneurodiagnostic Technologist*,** Perfusionist*,**
Emergency Medical Technician-Paramedic*,** Pharmacy Technician*,**
Exercise Science (Personal Fitness Trainer, 
Exercise Physiologist, and Exercise Science 
Professional)*,**
Polysomnographic Technologist*,**




Medical Assistant*,** Respiratory Therapy Technicians*,**
Medical Equipment Preparer*,** Surgical Assistant*,**
Medical Illustrator*,** Surgical Technologist*,**
Notes:
* “Health Care Careers Directory 2009-2010,” by the American Medical Association, p. iii-iv.
** “Coming Together, Moving Apart: A History of the Term Allied Health in Education, Accreditation, and Practice,” by Fred G. Donini-Lenhoff, MA, Journal of Allied Health, Spring 2008, Volume 37, 
Number 1, p. 46-49
†  “Physicians” in “The Public Health and Welfare,” United States Code Title 42 1395x(r).
†† “Ratio of Physician to Physician Extenders (Resolution 303,I-97),” by Kay K. Hanley, MD, December 1998, CMS Report 10-I-98.
‡ “‘Incident to’ Services,” MLN Matters, SE0441.
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Category Definition Subcategories
Physicians Doctors of allopathic or osteopathic medicine. Both allopathic 
and osteopathic physicians may specialize in many of the 
same areas, though the process required to achieve special-




Allied Health Professionals Non-physician providers of health services who provide 
primary healthcare services. Allied health professionals may 
work with physicians, mid-level providers, paraprofessionals 
and technicians, but they are professionally licensed to work 





Midlevel Providers Non-physician providers who may or may not provide health-
care services independently of a superior licensed provider. 
Depending on state licensing criteria, mid-level provides (e.g. 
nurse practitioners, physicians’ assistants, dental hygienists) 
may work independently in the provision of services, or may 











Certified Registered Nurse 
Anesthetists
Dieticians & Nutritionists
Nurse Practitioners Nurse Midwives
Technical Service Providers
Dental Hygientists Opticians
Dental Assistants Dental Assistants
Technicians &  
Paraprofessionals
Non-physician providers who may never provide healthcare 
services independently of a supervising licensed provider. 
This category of provider is divided between licensed and 
unlicensed paraprofessionals.
Assistants
Social and Human Service 
Assistants
Physical Therapist Assistants
Anesthesiologists Assistants Dental Assistants




Personal Care Aides Psychiatric Aides
Home Health Aides Physical Therapist Aides




Radiation Therapists Respiratory Therapists
Table I-1D: Healthcare Professional Practices Provider Taxonomies  
Organization: Health Capital Consultants  Classification System: N/A















Medical and Clinical Laboratory Respiratory Therapy
Radiologic Medical Records and Health 
Information
Emergency Medical Occupational Health and 
Safety
Dietetic Orthotics and Prosthetics
Pharmacy
Nurses
Licensed Vocational Nurses Licensed Practical Nurses
Other
Medical Dosimetrist Medical Equipment Preparers






Providers who may or may not be physicians, but who practice 
forms of therapy and treatment outside the mainstream 
practice of medicine, e.g. homeopathic medicine. Alternative 
medicine practitioners may provide primary or secondary care, 
and are generally licensed to work independently of supervi-
sion by another licensed provider.
Whole Medical Systems
Eastern Whole Medical Systems
Traditional Chinese Medicine Ayurvedic Medicine








Dietary Supplements Herbal Remedies
Manipulative & Body-Based Practices






Table I-1D: Healthcare Professional Practices Provider Taxonomies (continued) 
Organization: Health Capital Consultants  Classification System: N/A
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Profession Health Capital 
Consultants
BLS1, 2, 3 CMS4, 5, 6, 7, 8, 9, 10, 11, 12 AMA11, 12, 13, 14, 15
Chiropractors Allied Health Health Diagnosing Occupations Physician Complementary and  
Alternative Medicine
Dentists Allied Health Health Diagnosing Occupations Physician Dentistry and Related Fields
Psychologists Allied Health Social Scientists and Urban Planners Mid-Level Provider* Mid-Level Provider*
Podiatrists Allied Health Health Diagnosing Occupations Physician Podiatrists
Optometrists Allied Health Health Diagnosing Occupations Physician Optometry
Aromatherapy Alternative Medicine Other Health Diagnosing/Treating 
Practitioners
Auxiliary personnel—not covered 
for therapy services
Allied Health
Ayuredic Medicine Alternative Medicine Miscellaneous Health Diagnosing/
Treating Practitioners





Alternative Medicine Other Health Diagnosing/Treating 
Practitioners
Complementary and Alternative 
Medicine
Allied Health
Biofield Therapy Alternative Medicine Other Health Diagnosing/Treating 
Practitioners
Complementary and Alternative 
Medicine
Allied Health
Cognitive Behavioral Theory Alternative Medicine Other Health Diagnosing/Treating 
Practitioners
Auxiliary personnel—not covered 
for therapy services
Allied Health
Dietary Supplements Alternative Medicine Other Health Diagnosing/Treating 
Practitioners
Auxiliary personnel—not covered 
for medical services
Allied Health
Expressive Creative Arts 
Therapy
Alternative Medicine Other Health Diagnosing/Treating 
Practitioners
Complementary and Alternative 
Medicine
Allied Health
Herbal Remedies Alternative Medicine Other Health Diagnosing/Treating 
Practitioners
Auxiliary personnel—not covered 
for medical services
Allied Health
Homeopathic Alternative Medicine Miscellaneous Health Diagnosing/
Treating Practitioners
Auxiliary personnel—not covered 
for medical services
Allied Health
Massage Therapy Alternative Medicine Other Health Diagnosing/Treating 
Practitioners
Auxiliary personnel—not covered 
for therapy services
Allied Health
Meditation & Prayer Alternative Medicine Other Health Diagnosing/Treating 
Practitioners
Complementary and Alternative 
Medicine
Allied Health
Mental Healing Alternative Medicine Other Health Diagnosing/Treating 
Practitioners
Auxiliary personnel—not covered 
for medical services
Allied Health
Naturopathic Alternative Medicine Miscellaneous Health Diagnosing/
Treating Practitioners
Auxiliary personnel—not covered 
for medical services
Allied Health
Reiki Alternative Medicine Other Health Diagnosing/Treating 
Practitioners
Auxiliary personnel—not covered 
for medical services
Allied Health
Therapeutic Touch Alternative Medicine Other Health Diagnosing/Treating 
Practitioners





Alternative Medicine Other Health Diagnosing/Treating 
Practitioners
Auxiliary personnel—not covered 
for medical services
Allied Health





Table I-2:   Healthcare Professional Practices Provider Taxonomies Comparison Chart
(continued)
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Profession Health Capital 
Consultants
BLS1, 2, 3 CMS4, 5, 6, 7, 8, 9, 10, 11, 12 AMA11, 12, 13, 14, 15
Audiologists/Speech- 
Language Pathologists
Mid-Level Health Assessment and Treating 
Occupations
Allied Health—Professionals/ 
Qualified Auxiliary Therapy  
Personnel
Allied Health










Certified Registered Nurse 
Anesthetists
Mid-Level Health Assessment and Treating 
Occupations
Mid-Level Provider* Mid-Level Provider*
Nurse Midwives Mid-Level Health Assessment and Treating 
Occupations
Mid-Level Provider* Mid-Level Provider*
Nurse Practitioners Mid-Level Health Assessment and Treating 
Occupations
Mid-Level Provider* Mid-Level Provider*
Physician Assistants Mid-Level Health Assessment and Treating 
Occupations
Mid-Level Provider* Mid-Level Provider*





Pharmacists Mid-Level Health Assessment and Treating 
Occupations
Pharmacists Pharmacy
Occupational Therapists Mid-Level Health Assessment and Treating 
Occupations
Allied Health—Professionals/
Qualified Auxiliary Therapy 
Personnel
Allied Health
Physical Therapists Mid-Level Health Assessment and Treating 
Occupations
Allied Health—Professionals/
Qualified Auxiliary Therapy 
Personnel 
Allied Health





DOs Physician Health Diagnosing Occupations Physician Physician
MDs Physician Health Diagnosing Occupations Physician Physician
Anesthesiologists Assistants Technicians and 
Paraprofessionals










Personnel—not covered for therapy 
services
Allied Health
Cardiovascular Technicians Technicians and 
Paraprofessionals























Home Health Aides Technicians and 
Paraprofessionals





Table I-2:   Healthcare Professional Practices Provider Taxonomies Comparison Chart (continued)
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Profession Health Capital 
Consultants
BLS1, 2, 3 CMS4, 5, 6, 7, 8, 9, 10, 11, 12 AMA11, 12, 13, 14, 15
Medical Assistants Technicians and 
Paraprofessionals









































Personal Care Aides Technicians and 
Paraprofessionals





Psychiatric Aides Technicians and 
Paraprofessionals





Psychiatric Technicians Technicians and 
Paraprofessionals





Respiratory Therapists Technicians and 
Paraprofessionals














Surgical Technologists Technicians and 
Paraprofessionals









Other Healthcare Support 
Occupations
Clinical Social Workers are Mid-




Dental Assistants Technicians and 
Paraprofessionals





Dietetic Technicians Technicians and 
Paraprofessionals














Medical Transcriptionists Technicians and 
Paraprofessionals
































Medical Dosimetrist Technicians and 
Paraprofessionals





Table I-2:   Healthcare Professional Practices Provider Taxonomies Comparison Chart (continued)
(continued)
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Table I-2:   Healthcare Professional Practices Provider Taxonomies Comparison Chart (continued)
Profession Health Capital 
Consultants










Radiation Therapists Technicians and 
Paraprofessionals





Radiologic Technicians Technicians and 
Paraprofessionals





Radiologic Technologists Technicians and 
Paraprofessionals





Licensed Practical Nurses Technicians and 
Paraprofessionals





Licensed Vocational Nurses Technicians and 
Paraprofessionals





Pharmacy Aides Technicians and 
Paraprofessionals





Pharmacy Technicians Technicians and 
Paraprofessionals
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1 “Chapter 6. Occupation and Industry Classification Systems,” in “Nursing Aides, Home Health Aides, and Related Health Care Occupations—National and Local Workforce  
Shortages and Associated Data Needs” by the  “U.S. Department of Health and Human Services, Health Resources and Services Administration, 2009, http://bhpr.hrsa.gov/
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2 “2010 Standard Occupational Classification,” by the Bureau of Labor Statistics, January 2009, p. 16-19.
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2003.
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12 “Incident to’ Services,” MLN Matters, SE0441.
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This Guide distinguishes among five general types of health professionals. The trifurcation of non-
physician practitioners in mainstream medicine, as described previously, serves as the rationale behind 
allied health professionals, mid-level providers, and technicians and paraprofessionals, as they are 
defined herein. In addition to the physician and nonphysician professionals who practice conventional 
medicine, a class of professionals exists that provides complementary and alternative medical services 
that, to date, is treated as a parallel (sometimes intertwined) but unconventional subset of the healthcare 
workforce. In brief, the five taxonomical categories of professional providers, as they are discussed in 
this Guide, are defined as:
1. Physicians—Doctors of allopathic or osteopathic medicine. Both allopathic and osteopathic phy-
sicians may specialize in many of the same areas, though the process required to achieve special-
ization certifications occasionally differs between the two forms of medicine.
2. Allied health professionals—Nonphysician providers of health services who provide primary 
healthcare services. Allied health professionals may work with physicians, mid-level provid-
ers, and paraprofessionals and technicians, but they are professionally licensed to work autono-
mously in the provision of services. This Guide discusses five distinct allied health professions: 
dentists, optometrists, chiropractors, psychologists, and podiatrists.
3. Mid-level providers—Nonphysician providers who may or may not provide healthcare services 
independently of a superior licensed provider but are, by in large, moving into increasingly 
autonomous practice types. These professionals typically provide primary care services in lieu 
of physicians. Depending on state licensing criteria, mid-level providers (such as nurse practitio-
ners, physicians’ assistants, and dental hygienists) may work independently in the provision of 
services. Mid-level providers are further divided between clinical service providers and technical 
service providers.
4. Technicians and paraprofessionals—Nonphysician providers who may never provide health-
care services independently of a supervising licensed provider. These individuals either serve to 
alleviate a manpower deficit or to contribute to the technological sophistication, efficiency, and 
quality of physician services; in either case, their scope of practice is contingent upon the scope 
of their physician’s practice and nonexistent otherwise. On the basis of these two types of physi-
cian extenders, this category of provider is divided between licensed and unlicensed technicians 
and paraprofessionals.
5. Alternative medicine practitioners—Providers who may or may not be physicians but who prac-
tice forms of therapy and treatment outside the mainstream practice of medicine, for example, 
homeopathic medicine. Alternative medicine practitioners may provide primary or secondary 
care, and they generally are licensed to work independently of supervision by another licensed 
provider.
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1 Historical 
Development
The history of medicine is, in fact, the history of humanity itself, 
with its ups and downs, its brave aspirations after truth and 
finality, its pathetic failures. The subject may be treated variously 
as a pageant, an array of books, a procession of characters, a 
succession of theories, an exposition of human ineptitudes, or as 
the very bone and marrow of cultural history. As Matthew Arnold 
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Key Concept Definition Citation
Assyro-Babylonian Medicine Established in 4 BC by the people of southern Mesopota-
mia; regarded medicine as an abstraction to be treated 
with priestly reverence.
“Chapter III: Antiquity,” in “The Greatest Benefit to 
Mankind: A Medical History of Humanity,” by Roy Porter, 
HarperCollins Publishers Ltd., p. 46–47. “A History of 
Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947, 
p. 32.
The Rod and Serpent in Assyro-
Babylonian Medicine
First seen as the symbol attributed to the Babylonian lord 
of physicians, Ninazu, and his son. The serpent repre-
sented the healing god, Sachan.
“The Rod and Serpent of Asklepios. Symbol of Medicine,” 
by J. Schouten. (Pp. 260+ix; illustrated. 65s.) London: 
Elsevier, 1967.
Galenic Medicine Based on the findings of Claudius Galen and his followers. 
Pioneered the fields of anatomy and physiology, methods 
of animal dissection, and an understanding of the circula-
tion of blood. Although this generation of medicine was 
significant to developments in scientific inquiry, false 
assumptions about animal-to-human anatomic translation 
and hematology served in the medical world’s disfavor as 
time progressed.
“Chapter 3: The Reawakening,” in “Doctors: The Illustrated 
History of Medical Practices,” by Sherwin B. Nuland, 
Random House Inc., 1988, p. 71; “The Western Medical 
Tradition 800 BC to AD 1800,” by Lawrence I. Conrad, et. 
al., Cambridge University Press, 1995, p. 225.
The Rod and Serpent in Galenic 
Medicine
Reappeared in depictions of the Greek god of healing, 
Asklepios, in which he is seen holding a staff with a snake 
coiled around it.
“The Rod and Serpent of Asklepios. Symbol of Medicine,” 
by J. Schouten. (Pp. 260+ix; illustrated. 65s.) London: 
Elsevier, 1967.
Types of Roman Universities (1) community-funded, (2) state-funded, and (3) ecclesias-
tically funded.
“A History of Medicine,” by Arturo Castiglioni, Alfred A. 
Knopf, Inc., 1947 p. 325.
The Rod and Serpent in Roman 
Civilization
Reappeared in depictions of the Roman god of healing, 
Asclepius, in which he is seen holding a staff with a snake 
coiled around it.
“The Rod and Serpent of Asklepios. Symbol of Medicine,” 
by J. Schouten. (Pp. 260+ix; illustrated. 65s.) London: 
Elsevier, 1967.
Greco-Arabian Medicine The solution to shortcomings of the medical education of 
the Middle Ages; involved incorporation of Arabian medical 
texts, as introduced by scholars and physicians who in-
fused Arabian medicine, with the scholarship of philosophy, 
and attempted to compromise their differences.
“Chapter IV: Medicine and Faith,” in “The Greatest Benefit 
to Mankind: A Medical History of Humanity,” by Roy Porter, 
HarperCollins Publishers Ltd., p. 98–9; “A History of 
Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947, 
p. 325–29.
The Rod and Serpent Today Used as the modern symbol for medicine. “The Rod and Serpent of Asklepios. Symbol of Medicine,” 
by J. Schouten. (Pp. 260+ix; illustrated. 65s.) London: 
Elsevier, 1967.
Reason for a Resource-Based  
Relative Value Scale
Was intended to bring medical practice more in line with a 
prospective payment system in which payments are made 
based on set fees for types of procedures or diagnosis. 
Medicare payments are based on the relative value as-
signed to each procedure’s work, practice expense, and 
malpractice costs with payment adjusted by a geographic 
and a universal conversion factor. Every physician uses the 
same payment schedule under the Medicare program.
“A Guide to Consulting Services for Emerging Healthcare 
Organizations” by Robert James Cimasi, CBI, CBC, John 
Wiley and Sons, Inc., p. 24–25.
Overview
Modern medicine is the product of continuous (if sometimes sporadic) advances in scientific, sociopoliti-
cal, and philosophic thought throughout many centuries. Paul Starr1 addresses this evolution of medical 
thought and practice in his book, The Social Transformation of American Medicine, examining “first, the 
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rise of professional sovereignty; and second, the transformation of medicine into an industry and the 
growing, though still unsettled, role of corporations and the state.”2 This chapter describes the chronologi-
cal progression of medicine in accordance with this bimodal transformation, specifically, the centuries of 
progress in healthcare practitioner and professional practice credibility. 
Origins of Medicine
The original concept of the practice of medicine derived from the concern for human pain. From this 
source, a sequence of facts, ideas, and discoveries resulted in the development and evolution of medical 
thought, knowledge, study, and practice.3 Without an understanding of the basic origins and principles 
of medicine, one can neither understand the modern practice of medicine nor anticipate developments 
related to healthcare professional practice.
Because it deals with the vital interests of both individuals and societies—with 
life and death, and with so much that matters in between—medicine has 
long had an unusually complex and intimate relationship to social and cultural 
developments at large . . . In other words, medical history involves social and 
economic as well as biologic content and presents one of the central themes in 
human experience. After all, what is more basic in the life of any people than life 
itself? Richard  Harrison Shryock, 1966
The original concept of medicine derived from the concern for human pain.
“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947 p. 3–12.
Medicine and Religion and Astrology
The Mediterranean region gave rise to civilizations that heavily influenced the advance of human knowl-
edge, innovation, and society.4 The region endured five thousand years of war, politics, development, 
and demise, fostering not only the origin and intensive development of art and science but also the birth 
of monotheistic religion.5 Therefore, the evolution of medicine is inherently linked to the civilizations 
that rose and fell in the Fertile Crescent, as well as the religions and spiritualities on which these societ-
ies relied.6 In 4 BC, the people of southern Mesopotamia attempted to establish a systematic medical 
concept. The outcome of their effort became known as Assyro-Babylonian Medicine.7
For the Sumerians, Babylonians, and Assyrians, medicine was a highly revered abstraction treated 
with magical and priestly reverence.8 These civilizations intently studied astronomy, and the assumed 
relationships between physiology and celestial findings led to the development of medical concepts.9 As 
astronomy evolved to include stories, divinities, and beliefs, the concepts developed into religious sys-
tems.10 The reliance on divine healing became a concept of medical practice: the Assyrians relied on the 
healing god, Nabu, and the Babylonians turned to the lord of magicians, Marduk, and the god of medi-
cine, Ea, to sustain and restore health.11 Further, the Babylonian caste of physicians was led by Ninurta, 
a god who served as their chief. Ninazu, the lord of physicians, and his son, Ningischzida, are known 
most notably for their symbol, the rod and serpent (the serpent representing the healing god Sachan).12
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Sumerian, Assyrian, and Babylonian civilizations intently studied astronomy, 
and medical concepts developed as a result of the assumed relationships 
between physiology and celestial findings.
“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947 p. 31–44.
The Greek god of healing, 
Asklepios, also was depicted 
holding a staff with a snake coiled 
around it, similar to the symbol 
attributed to the Babylonian gods 
Ninazu and Ningischzida.13 (Aes-
culapios, his Roman counterpart, 
carried a rod as well.) This single-
serpent symbol image in Greek 
and Roman cultures was attrib-
uted to their healing and medical 
deities, and it serves as a mod-
ern symbol of medicine in most 
countries. Note, however, that the 
United States uses both the single-
serpent symbol, Asklepian, and the 
double-serpent symbol, Caduceus, 
to represent medicine.14
The people of Israel, dating 
back to 1500 BC, recognized the 
practice of medical healing as attributed to “the one God.”15 This idea was reaffirmed through the tra-
ditions of Christianity, which emerged from a disease-plagued society.16 Jesus Christ’s depiction as a 
“healer” translated not only into spiritual salvation but also into his divine ability to miraculously heal 
physical ailments.17 Christianity centers on “a different valuation of human life, a fraternal concept of 
equality and charity which imposed on all the faithful the most severe sacrifices in order to lessen the 
suffering of others.”18 This concept influenced attitudes toward medicine in areas where people were si-
multaneously adopting religion and fighting widespread disease. Intellectuals collaborated almost exclu-
sively on religious issues with underlying ethical implications, and medicine was commonly among the 
most pressing issues discussed.19 Despite stages of resistance, the church ultimately acknowledged the 
importance of medicine, namely when it recognized Claudius Galen (see Galenic Medicine) as a canoni-
cal authority.20
Box 1-1 summarizes key early religious figures, places, and medical concepts.
Askleopios (left) and Caduceus (right). Source: History of the American Medical Writer’s 
Association Part 5” By Cynthia Haggard, Clarifying, April 8, 2009, http://clarifying.word-
press.com/2009/04/08/history-of-the-american-medical-writers-association-part-5/ (Ac-
cessed 2/17/10).; “Physician Payment Reform, a California Lesson?” By Steve Sweetman, 
Healthcare Updates from Steve Sweetman: Regional Contracts Director for The Scooter 
Store, September 15, 2009, http://stevesweetman.wordpress.com/2009/09/15/physician-
payment-reform-a-california-lesson/ (Accessed 2/17/10).
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Box 1-1: Early Medical Figures, Places, and Concepts
Deities and Religious Figures*,**,†
Nabu Mesopotamia Assyrian god of healing
Marduk Mesopotamia Babylonian lord of magicians
Ea Mesopotamia Babylonian god of medicine
Ninurta Mesopotamia Babylonian god who led the caste of physicians
Ninazu Mesopotamia Babylonian lord of the physicians, represented by rod and serpent symbol
Ningischzida Mesopotamia Son of Ninazu, also represented by rod and serpent symbol
Askleopios Greece Greek god of healing
Aesculapios Rome, Italy Roman god of healing
Buddah (Siddhattha Gotama) Kapilavastu, Nepal A spiritual leader and the founder of Buddhism
Jesus Christ Nazareth, Israel Son of God, thought to have a divine ability to heal physical ailments
Places§
Fertile Crescent Western Asia, including the 
fertile regions of present-day 
Iraq and Syria
Medicine rooted in both religious and empirical treatments evolved from the 
Mesopotamian civilization
Medical Concepts and Symbols*,§§,‡
Rod and Serpent Representation of the healing god Sachan in Babylonia
Asklepian The staff of Asklepios around which a serpent or serpents are wrapped to symbolize medicine
Caduceus Double serpent winding around a staff; a symbol for medicine
Vedas A collection of doctrinal Ayurvedic medical texts
Ayurvedic Sages Educated by the medical deity prior to transcription of the Vedas
Palatine Archiaters Court physicians
* “A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
** “Rod and Serpent,” by Edwin Clarke, Book Review of “The Rod and Serpent of Asklepios. Symbol of Medicine,” by J. Schouten. (Pp. 260+ix; illustrated. 65s.) London: Elsevier, 
1967, in the British Medical Journal, Vol. 3, No. 5561, Aug. 5, 1967.
† “The Western Medical Tradition 800 BC to AD 1800,” by Lawrence I. Conrad, et. al., Cambridge University Press, 1995.
§ “The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy Porter, HarperCollins Publishers Ltd.
§§ “The Symbol of Modern Medicine: Why One Snake Is More Than Two,” By Robert A. Wilcox and Emma M. Whitham, Annals of Internal Medicine, Vol. 138, No. 8, Apr. 15, 2003.
‡ “A History of Medicine,” by Louis N. Magner, Marcel Dekker, Inc., 1992.
Philosophy and Science of Medicine
Following from ancient tradition, religion shaped the way early Greeks perceived medicine.21 The dawn 
of Greek philosophy influenced the origins of a much more scientific approach to medicine, spurring a 
pursuit for cures through “critical thought based on observation and experience.”22 Philosophers of both 
Western (for example, Thales of Miletus, Plato, Aristotle, Anaximander, and Anaximenes) and Eastern 
(for example, Zoroaster, Confucius, Buddha, and Pythagoras) origins contributed to a mathematical, 
cosmic, and physiological concept of nature and the biologic system.23
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Ancient philosophers, including Thales of Miletus, Plato, Aristotle, 
Anaximander, Anaximenes, Zoroaster, Confucius, Buddha, and Pythagoras, 
contributed to a mathematical, cosmic, and physiological concept of nature 
and the biologic system.
“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947 p. 129–41.
Similar to their Western counterparts, the people of the Orient viewed medicine as inherently inter-
twined in religious tradition. Buddhism and Hinduism were instrumental to ancient Chinese and Indian 
medicine.24 Although both Eastern and Western medical traditions stemmed from the similar religious 
origins and progressed into parallel eras of proliferative philosophy, they diverged as a result of the 
differing roles that religion would play in the centuries that followed. Hinduism has a profound impact 
on Indian medicine (known as Ayurvedic Medicine) as does Buddhism on traditional Chinese medicine 
(see chapter 7 of Professional Practices).25 In fact, it is believed that the Vedas, a collection of doctrinal 
Ayurvedic medical texts, is inspired by the teachings of the Hindu divinity Dhanvantari.26 According to 
Indian tradition, the medical deity transcribed the Vedas only after educating many Ayurvedic sages.27 
Unlike Eastern medicine, and despite centuries of ecclesiastic resistance, philosophic (and later, scien-
tific) foundations for Western medicine formed, solidified, and, over time, replaced religion as drivers of 
medical practice.
Box 1-2 outlines the key philosophers and locations in the history of early medicine.
Hippocrates
“A physician who is a lover of wisdom is the equal to a god.” Hippocrates
During its “golden age,” Greece prospered in countless social aspects, wisdom, knowledge, develop-
ment, beauty, literature, and culture. “[I]t seemed as if an impulse to grandeur and glory and a striv-
ing for liberty and beauty pervaded all Greece.”28 Among the unmatched intellectuals of this era was 
Hippocrates, recognized as “the wisest and the greatest practitioner of his art.”29 Born in 460 BC, Hip-
pocrates served as both a priestly and empirical authority of medicine, and he authored the Corpus with 
his students, which includes works on medical specialties and pathologies, the practice of medicine, and 
medical ethics.30 Several influential philosophers and intellectuals in the area of medicine (for example, 
Galen and Erotius) published commentaries on Hippocrates and his teachings.31 Additionally, many of 
his contemporaries, including Plato, praised his efforts as an author and inspirer of important medical 
texts.32
Hippocrates served as both a priestly and empirical authority of medicine 
during the golden age of Greece; he was responsible for compiling the  
Oath of Hippocrates, as well as writing and inspiring works that  
became part of the Corpus.
“Chapter III: Antiquity,” in “The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy Porter,  
HarperCollins Publishers Ltd., p. 56;“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc.,  
1947, p. 148–49.
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Box 1-2: Early Philosophers and Key Locations for Medicine
Eastern Philosophers*,**
Name Birth/Death Location Claim to Fame
Zoroaster 660–583 BC Iran Philosopher and religious reformer; founder of Zoroastrianism, or 
Parsiism
Confucius 551–479 BC State of Lu (present-day Shandong 
province, China)
Most famous Chinese philosopher/teacher/political theorist
Western Philosophers§
Plato 428–347 BC Greece Renowned philosopher and author
Aristotle 384–322 BC Greece Student of Plato, renowned for knowledge of art, science, and 
philosophy
Thales of Miletus 639–544 BC Miletus (present-day Turkey) The first philosopher in the Greek tradition
Anaximander 610–546 BC Miletus (present-day Turkey) Pupil of Thales, who focused on the cyclical rhythm of generation and 
corruption
Anaximenes 570–500 BC Miletus (present-day Turkey) Follower of Thales, who thought the essential substance of life was air
Pythagoras 580–489 BC Croton, Italy Founder of Italic School of Philosophy, who connected math, music, and 
medicine
Places§§
Place Location Role in Medical History
Fertile Crescent Western Asia, including the fertile Medicine evolved from the Mesopotamian civilization
 regions of present-day Iraq and Syria
* “Zoroaster: The Prophet of Ancient Iran” by A.V. Williams Jackson, Columbia University Press, 1919, p. 15.
** “The Analects of Confucius” by Simon Leys, W.W. Norton & Company, Inc, 1997, p. xxi.
§ “A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
§§ “The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy Porter, HarperCollins Publishers Ltd.
The first of Hippocrates’ ethical texts was the Oath of Hippocrates, “which covers the duty of the 
physician to his teacher, his pupils, and his patients, clearly shows that a relationship existed between 
Hippocratic medicine and priestly medicine; but it raises medicine to a height and human dignity that 
assures it its own position as a science.”33 Figure 1-1 contains an excerpt from the classic Oath of 
Hippocrates.
Medical students commonly take the Hippocratic Oath (or a modification thereof) is to demonstrate a 
commitment to uphold ethical standards as they practice medicine.34 Although many attribute to Hip-
pocrates the physician’s commitment to “first do no harm” (translated from the Latin phrase “primum 
non nocere”), the true origins of the phrase are unknown and arguably not of Hippocratic origin.35 Box 
1-3 outlines the three most influential figures and their works during this time period.
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Figure 1-1: Excerpt From the Classic Hippocratic Oath*
I swear by Apollo Physician and Asclepius and Hygieia and Panaceia and all the gods  
and goddesses, making them my witnesses, that I will fulfill according to my ability  
and judgment this oath and this covenant:
To hold him who has taught me this art as equal to my parents and to live my life in partnership 
with him, and if he is in need of money to give him a share of mine, and to regard his offspring as 
equal to my brothers in male lineage and to teach them this art—if they desire to learn it—without 
fee and covenant; to give a share of precepts and oral instruction and all the other learning to my 
sons and to the sons of him who has instructed me and to pupils who have signed the covenant and 
have taken an oath according to the medical law, but no one else.
I will apply dietetic measures for the benefit of the sick according to my ability and judgment;  
I will keep them from harm and injustice.
I will neither give a deadly drug to anybody who asked for it, nor will I make a suggestion to  
this effect. Similarly I will not give to a woman an abortive remedy. In purity and holiness  
I will guard my life and my art.
I will not use the knife, not even on sufferers from stone, but will withdraw in favor of  
such men as are engaged in this work.
Whatever houses I may visit, I will come for the benefit of the sick, remaining free of all intentional 
injustice, of all mischief and in particular of sexual relations with both female and male persons,  
be they free or slaves.
What I may see or hear in the course of the treatment or even outside of the treatment in regard to 
the life of men, which on no account one must spread abroad, I will keep to myself, holding such 
things shameful to be spoken about.
*  “Hippocratic Oath” Johns Hopkins University, http://guides.library.jhu.edu/content.php?pid=23699&sid=190555 (Accessed 9/10/09).
Box 1-3: Influential Figures During the Time of Hippocrates*
Name Birth/Death Location Claim to Fame
Hippocrates 460–370 BC Greece Thought to be one of the wisest authorities on medicine at the time; 
authored medical books on specialties and pathologies, the practice of 
medicine, and ethics, including the Oath of Hippocrates, which is still 
used today to swear in graduating medical students
Julius Caesar 100–44 BC Rome, Italy Granted Roman citizenship to physicians, elevating their social status
Claudius Galen AD 138–201 Pergamon (Asia Minor) A physician and author best known for his study of anatomy and 
theories on the circulation of the blood, in his best known work, Ars 
Parva
* “A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
Professional Practice and Status of the Physician
The practice of medicine originated in Greece and spread slowly throughout the Roman Empire.36 
People regarded medical practice as a trade of foreigners, and Greek physicians were regarded with 
little, if any, respect.37 Many assumed the title of “physician” without the training, further contributing 
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to the defamation of the profession.38 However, in 46 BC, Julius Caesar granted physicians the right to 
Roman citizenship, an honor that elevated the reputation of physicians in Roman society.39 Soon there-
after, it became necessary to establish medical schools to repel the invasion of unqualified “pseudo-phy-
sicians” seeking easy profit in Rome.40 The number of medical schools approved by the Roman Empire 
increased, the most celebrated of which could be found in Marseille, Lyon, Saragossa, Antioch, Athens, 
and Alexandria.41 A medical licensure process was mandated, and both private and public libraries were 
developed to preserve the valued tests and manuscripts.42 Court physicians, called “palatine archiaters,” 
played an essential role in politics and legal affairs and designated celebrated physicians in the empire.43 
As the practice of medicine became systemized, so did the social position of physicians.44 Although the 
medical advances made by the Roman Empire were minimal, Rome was first to incorporate a system of 
medicine that became an important part of its intricate system of laws.45
The Roman Empire was first to incorporate a system of legal medicine, 
which was an important part of Rome’s intricate system of laws.
“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947 p. 233–35.
Galenic Medicine
Solidifying Hippocratic theories through dissection and experimentation helped reduce the mystery and 
doubt that surrounded physicians and helped enhance the quality of medical care in the Roman Em-
pire.46 The first influential strides in this direction were made by Galen of Pergamon in Asia Minor (AD 
129–200), a student of Hippocrates, who published fifteen commentaries to Hippocrates’ work.47 He was 
appointed physician of the gladiators, an honorable and sought after position.48 Galen quickly became 
known as an extraordinary practitioner, writer, and student.49
A student of philosophy and medicine, Galen was a pioneer in the field of anatomy, translating his 
findings from animal dissection to human application.50 His philosophical background drove many of 
his hypotheses, chiefly those related to the physiological explanation for human blood circulation.51 
Though Galenic medicine represented a huge step forward for evidence-based medicine, it also impeded 
advances in anatomy and physiology due to its inherent flaws and blind adoption by the medical and 
religious communities.52
Drawbacks of Galenic Medicine: findings based entirely on animal dissection 
and false perceptions regarding the circulation of human blood.
“Chapter 3: The Reawakening,” in “Doctors: The Illustrated History of Medical Practices,” by Sherwin B. Nuland, 
Random House Inc., 1988, p. 71; “The Western Medical Tradition 800 BC to AD 1800,” by Lawrence I. Conrad, et. 
al., Cambridge University Press, 1995, p. 225; “A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 
1947 p. 218–19.
Rise of the Medical University
The oldest universities, though originating from the ancient Latin schools and persevering through the 
Roman Empire, did not flourish until the end of the thirteenth century.53 As academia increased in so-
phistication, three kinds of universities emerged: community-funded, state-funded, and ecclesiastically 
funded.54 Although some schools focused entirely on medicine, others (termed Studia Generalia) also 
incorporated law, theology, and philosophy in their curricula.55
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The church’s influence on medical curricula often slowed the advance of anatomical and physiologi-
cal understanding due to its resistance to findings of clinical and experimental research.56 The Christian 
belief that disease was a consequence of sin left healing to the devices of nature.57 Through the transla-
tion of Arabian medical texts, scholars developed Greco-Arabian medicine, which confronted the short-
comings of medical education in the early Middle Ages.58 The physician Abu Ali al-Husayn Abdallah 
ibn Sinna (known in the West as “Avicenna”) compiled the first comprehensive medical text in Arabic.59 
His work, Kitab al-Qanun (The Canon of Medicine), synthesized the philosophies and teachings of 
Hippocrates, Galen, Dioscorides, and Alexandrian physicians.60 His mastery of medical science became 
legendary, and ibn Sinna became known as the “Galen of Islam.”61
Despite the barriers posed by the Inquisition, scholars, philosophers, and physicians, such as Pietro 
d’Abano, infused Arabian medicine into the scholarship of philosophy while attempting to compromise 
their differences.62 This movement gave rise to the University of Padua, which pioneered public dissec-
tions of human cadavers and gave rise to revolutionary work in dentistry and medieval medicine and 
to publications, including Galen’s Ars Parva (a commentary of Torrigiani), and Aphorisms of Hip-
pocrates.63 Greco-Arabian medicine also gave rise to the University of Bologna, the first literary collec-
tion of clinical cases, and the work of Ugo Borgognoni of Lucca, the latter of which set the foundation 
of modern surgery.64 The University of Montpellier was the first institution to award a doctorate degree, 
and at one point, Bologna and Montpellier had the most stringent dissection requirements.65 However, 
the University of Montpellier lost its prominence when the popes retreated from Avignon and religious 
warfare decimated the area.66
Renaissance: Revival of Anatomy and Physiology
Liberation from Galenic medicine and the scholasticisms encouraged by the church began with the work 
of early Renaissance Anatomists in the late 1400s and early 1500s.67 Artist-anatomists such as Andrea 
Verrochio and Leonardo da Vinci were pioneers in the field.68 Da Vinci performed dissections of human 
carcasses and made drawings of his observations.69 He also refuted many of the statements made by his 
Galenic predecessors; due to his objective perspective of anatomy, his work was not immediately recog-
nized with the respect it deserved.70 
Andreas Vesalius also refuted aspects of Galen’s work, claiming that Galen’s anatomical knowl-
edge applied only to animals and was incredibly flawed when applied to humans.71 His discoveries in 
anatomy, released in the mid-1500s, are medical landmarks.72 By contradicting Galen’s deductions from 
animal dissection and philosophical conjecture, Vesalius was the first to describe the vasculature and 
anatomy of the human heart.73 By daring to question the doctrinal teachings of their honored predeces-
sors, these and other artists, anatomists, philosophers, and scientists heralded an era of enlightenment, 
through which “the sluices of objective inquiry and experiment had been opened.”74 Box 1-4 indicates 
the most influential figures and important locations in the history of healthcare during the Renaissance 
and Inquisition.
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Box 1-4:  Influential Figures and Important Places During the Time of the Renaissance and Inquisition*,**
Influential Figures
Name Birth/Death Location Claim to Fame
Abu Ali al-Husayn (Abdallah 
ibn Sinna or “Avicenna)
AD 980–1037 Bukhara, Persia Compiled first comprehensive medical text in Arabic, Kitab al-Qanun 
(The Canon of Medicine)
Pietro d’Abano AD 1250–1315 Padua, Italy Infused Arabian medicine into the scholarship of philosophy
Ugo Borgognoni of Lucca Second half of the 
twelfth century–1252
Bologna, Italy A Bolognese surgeon during the Crusades, he simplified the treatment 
of lesions of the extremities and fractures; none of his works exist 
today, but he has been quoted by his son, Theodoric of Lucca
(AD 1205–1258)
Andrea Verrochio AD 1435–1488 Florence, Italy Painter and anatomist; teacher of Leonardo da Vinci; his students 
examined cadavers
Leonardo da Vinci AD 1452–1519 Florence, Italy Greatest artist anatomist; revolutionized anatomy with his anatomical 
sketches based on actual cadavers
Andreas Vesalius 1515–1564 Brussels, Belgium First to describe vasculature and anatomy of the human heart; refuted 
Galen’s theories of anatomy
Important Places
Place Location Role in Medical History
University of Padua Padua, Italy Pioneered public dissection of human cadavers
University of Bologna Bologna, Italy Held the first literary collection of clinical cases
University of Montpellier Montpellier, France Became the first institution to award doctorate degrees
* “A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
** “The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy Porter, HarperCollins Publishers Ltd.
Seventeenth Century: The Dawn of Scientific Liberty
Anatomical Advances
Countless influential figures significantly contributed to the overhaul of Galenic medicine, laying the 
foundation for the modern school of medical thought. The work of da Vinci and Vesalius prompted ad-
vances in anatomy and physiology.75 Michael Servetus’s breakthroughs in pulmonary circulation, Fab-
recius’s discovery of the valves in veins, and William Harvey’s revelations on the enigmatic circulation 
of the blood gave mathematical, mechanical, and methodical meaning to the sciences of physiology and 
pathological anatomy.76 These findings prompted a contagion of anatomical investigations like Adrien 
Spigelius’s studies of the liver, Giulio Casseri’s inquiries of the anatomy of abdominal organs, and An-
tonio Maria Valsalva’s observation of the human ear.77
Antoni van Leeuwenhoek’s discovery of the microscope in the early 1670s triggered interest in the 
molecular implications of human anatomy.78 Van Leeuwenhoek is credited with the discovery of red 
blood corpuscles, the advanced study of vessel walls, and the estimation of blood’s velocity.79  
The conceptualization of toxicology, knowledge of contagious diseases, and developments in surgery 
were furthered by brilliant minds, including Marcello Malpighi, Jean-Baptiste van Helmont, and  
Francois Mauriceau.80 
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Progress in Hygiene
A series of devastating epidemics terrorized Europe from the fourteenth century through beginning of 
the eighteenth century. During this period, Europeans suffered from scurvy, malaria, typhus, smallpox, 
diphtheria, influenza, and, perhaps most notably, the various infestations of The Black Death.81 The 
Black Death decimated Europe from 1320–1420, with mortality counts of barely less than two-thirds 
the original population.82 The notable devastation endured through the seventeenth century, prompting 
the focused study of the causes of disease, the results of which led to the emergence of epidemiology, as 
well as, perhaps most important, the rise of modern hygiene.83 Giovanni Maria Lancisi, a renowned cli-
nician and epidemiologist, responded to the influenza epidemic in Italy by proposing a series of hygiene 
improvements, namely, the need to drain stagnant bodies of water and to purify the air in places where 
disease ran rampant.84 
The epidemic-related devastation of the seventeenth century, which saw 
outbreaks of scurvy, malaria, typhus, the Bubonic plague, smallpox, 
diphtheria, and influenza, prompted the dawn of epidemiology, and, more 
important, modern hygiene.
“Chapter IX: The New Science,” in “The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy 
Porter, HarperCollins Publishers Ltd., p. 236–40;“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, 
Inc., 1947, p. 560–63.
Because disease was a significant problem in the military, sanitary measures and disease contain-
ment within the military became an area of significant focus.85 The first substantial investigations into 
military hygiene were conducted by Florentine Orazio Monti and Antonio Porzio.86 Porzio made no-
table advances on the subject of epidemic avoidance in armies, demonstrating the detrimental effects of 
intrabarrack contamination and, ultimately, civilian contamination.87
Bernardino Ramazzini of Capri became the father of industrial hygiene and authored the first 
treatise on occupational disease: De morbis artificum.88 Ramazzini compiled research on the diseases 
of miners and issued a report of his findings that resembled a modern occupational risk assessment.89 
He also studied the harmful effects of metals on artisans, the risks associated with surgeon exposure to 
mercurial inunctions, and the exposures to lead, antimony, and countless other toxins endured by chem-
ists, pharmacists, gilders, painters, tinners, and colored-glass workers.90 Not only was Ramazzini the 
first investigator of occupational disease, but he was also a remarkable general clinician, focusing on the 
methodical investigation of disease toward the proper course of action.91
Bernardo Ramazzini of Capri became known as the father of industrial 
hygiene; he authored the first treatise on occupational disease, 
De morbis artificum.
“Chapter X: Enlightenment,” in “The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy Porter, 
HarperCollins Publishers Ltd., p. 296; “A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc.,  
1947, p. 564.
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Legislators began passing sanitation laws toward the end of the seventeenth century.92 When the 
plague broke out in Rome, the city took measures to contain the disease by means of regulatory sanitary 
controls.93 For example, the College of Physicians was asked to report all patients who had been treated 
for certain diseases in the past six months.94 Physicians took appropriate measures to disinfect victims 
of the plague, and the city gave physicians permits to euthanize and perform autopsies on any patients 
dying of contamination.95 The executions caused uproar among civilians, which brought an end to these 
measures for disease control.96 Nonetheless, they prompted more efforts toward military hygiene.97 
From these advances in hygiene, preventative and sanitary control measures became areas of legislative 
reform that developed throughout the eighteenth and nineteenth centuries.98
Beginning in the seventeenth century and continuing through the eighteenth 
and nineteenth centuries, advances in hygiene, methods for arriving at 
pathological conclusions, and preventative and sanitary control measures 
became areas of legislative reform.
“Chapter XIII: Public Medicine,” in “The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy 
Porter, HarperCollins Publishers Ltd., p. 397–400, 405–7; “A History of Medicine,” by Arturo Castiglioni, Alfred A. 
Knopf, Inc., 1947, p. 567.
Eighteenth Century: The Shift Toward the 
“Science” of Medicine
The reformist attitudes of physicians and scientists initiated scientific progress in the eighteenth century. 
They believed that health improvement was imperative “to human emancipation . . . from suffering, 
want, and fear.”99 As the dark age of the ecclesiastic resistance to scientific advance culminated, advo-
cates argued that medicine should be more philosophical and method-based.100 Although the eighteenth 
century became known for Emmanuel Kant’s suggestion “that philosophy is the queen of all the sci-
ences,” it is more renowned for landmark progress in the exact sciences.101 Countless discoveries in 
chemistry, physics, biology, physiology, anatomy, and pathology yielded a single conclusion: without an 
applied understanding of each of these areas of science, the practice of medicine is arbitrary.102 Box 1-5 
outlines the most influential figures and a few key events in medical history during the seventeenth and 
eighteenth centuries.
According to Emmanual Kant and his followers: “philosophy is the queen  
of all sciences.”
“A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947, p. 580–82.
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Box 1-5: Influential Figures and Important Events During the Seventeenth and Eighteenth Centuries
Influential Figures*,**,§
Name Birth/Death Location Claim to Fame
Michael Servetus 1511–1553 Villanueva, Spain Discovered pulmonary circulation
Hieronymus Fabricius ab 
Aquapendente
1533–1619 Padua, Italy The greatest comparative anatomist; published that veins contained 
valves in his work, De venarum ostiolis (On the Valves and the Veins) in 
1603
William Harvey 1578–1657 Folkeston, England Premier name in the discovery of the modern theories of circulation
Adrian Spigelius 1567–1625 Brussels, Belgium Studied the liver
Giulio Casseri 1552–1616 Padua, Italy Studied abdominal organs
Antonio Maria Valsalva 1666–1723 Bologna, Italy Studied the human ear
Antoni van Leeuwenhoek 1632–1723 Delft, Holland Invented the microscope in the early 1670s, with which he is believed 
to have discovered red blood corpuscles and advanced the study of 
vessel walls
Marcello Malpighi 1628–1694 Crevallcore, Italy Conceptualized toxicity
Jean-Baptiste van Helmont 1577–1644 Brussels, Belgium Known for his knowledge of contagious diseases
Francois Mauriceau 1637–1709 Paris, France A obstetric pioneer renowned for his contribution to surgical medicine
Giovanni Maria Lancisi 1654–1720 Rome, Italy Renowned epidemiologist, who, in responding to an influenza epidemic, 
improved public hygiene by draining stagnant bodies of water and 
purifying the air in disease-ridden areas
Orazio Monti 1724–1787 Vienna, Austria Conducted the first substantial investigations of military hygiene in his 
book, Trattato della Consuetudine, con il Modo do Governare gli Eserciti 
ed i Naviganti
Antonio Porzio 1637–1715 Vienna, Austria Made advances in epidemic avoidance in armies, with his book De 
Militum in Castris Sanitate Tuenda in 1865
Bernardino Ramazzini 1633–1714 Capri, Italy Father of industrial hygiene
Emmanuel Kant 1724–1804 Königsberg, Prussia Philosopher
Events*,§§
Name Definition
Black Death A plague that decimated two thirds of Europe’s population
De morbis artificum First treatise on occupational disease written by Bernardino Ramazzini
College of Physicians  Physicians association; by the end of the seventeenth century, reported all patients treated for certain 
diseases
* “A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
** “The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy Porter, HarperCollins Publishers Ltd.
§ “Memorie storico-culturali delle Accademie orcianesi”, by Franco Marini, Fondazione Cassa di Risparmio, www.fondazionecarifano.it/EventsDocs/2007/AccademieOrcianesi.
htm (accessed 03/15/10).
§§ “The Black Death and the Transformation of the West,” by David Herlihy, Harvard University Press, 1997.
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Nineteenth Century: The Practice of Medicine
Study of the Medical Sciences
The knowledge a man can use is the only knowledge which has life and growth 
in it and converts itself into practical power. The rest hangs like dust about the 
brain or dries like raindrops off the stones. (Froude) Sir William Osler, 1899
The nineteenth century saw an increase in the number of medical schools and efforts to teach the his-
tory of scientific advancement in a focused, discipline-centric manner, which heralded the concept of the 
practice of medicine. The famed text, Practice, published in 1843 by Sir Thomas Watson, remained the 
prominent treatise on general medicine for more than forty years.103 However, with Watson’s work be-
coming perceived as outdated, in 1981, Sir William Osler wrote his magnum opus—The Principles and 
Practice of Medicine: Designed for the Use of Practitioners and Students of Medicine—while working 
at Johns Hopkins School of Medicine.104 Osler’s text, first published in 1982, established him as a lead-
ing authority on medicine and sold hundreds of thousands of copies; multiple editions were published 
throughout his life and posthumously.105 
Impact of the Industrial Revolution on the  
Practice of Medicine
Following a lull attributed to the French and American revolutions and unrest in central Europe, medi-
cal progress began gaining momentum.106 Urban and industrial growth spurred demand for sanitary 
conditions.107 “Together with the great increase in material and cultural growth, a deeper sense of hu-
man dignity was penetrating even to the lowest classes.”108 However, in many countries, a “realistic 
tendency and the pursuit of materialistic aims” shattered this idealism.109 Finally, medicine was regarded 
as a necessary scientific field. Efforts to overcome “transcendental tendencies and further the progress 
of the natural sciences” resulted in experimental investigation and observation of all forms of life.110 
Scientists sought to understand complex biological issues that philosophical hypotheses previously 
disregarded.111 As a result, various schools of thought emerged and advances in science fostered medical 
specialization.112
Diversified Schools of Medicine
AllopAthic Medicine
Since its inception as a mythical abstraction, medicine has transformed into a rational science. Through 
expansion of logical thought, the study of social value systems113 medical knowledge, and technological 
capabilities, allopathic (traditional) Western physicians adopted “a method of healing founded on a sci-
entific basis”114 At the time of its establishment in 1847, the American Medical Association (AMA) was 
largely comprised of allopathic physicians.115 The AMA recognized the potency of Western medicine 
and understood that danger may result from inadequately regulated growth and expansion of biologically 
based methodologies.116
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As the frontiers of scientific medicine extended, quackery found even broader fields of operation. 
Scientific explorations into the mysteries of vitamins, hormones, and antibiotics not only provided 
better medical care for the public, but also opened up new sources of gain for the unscrupulous. 
While scientific research kindled the imagination of crafty promoters who sought easy ways to 
riches, its failure to discover cures for various major ailments made the boastful claims of pre-
tending healers all the more impressive.117
As such, the AMA served to scientifically and ethically appraise innovative medical developments, 
as well as educational standards, and hoped to regain public support and trust.118
AlternAtive Medicine
Allopathic practitioners were skeptical of “cultist” or “sectarian” physicians who practiced unconven-
tional forms of medicine, such as homeopathic, eclectic, naturopathic, chiropractic, and osteopathic 
medicine.119 Allopathic sentiments toward alternative medical practices were distrustful and condemn-
ing, to say the least. Oliver Wendell Holmes, a prominent physician, attributed with coining the term 
“anesthesia,” went as far as to call homeopathic practitioners, “a mingled mass of perverse ingenuity, of 
tinsel erudition, of imbecile credulity, and of artful misrepresentation.”120 Though not as prominent as 
allopathic medicine, practioners of alternative medicine exist today. To reduce public aversion and dis-
trust, the alternative medicine field has developed education and training requirements, as well as regula-
tion and licensing measures to legitimize its practices.121 
Homeopathic therapies utilize medicine that would typically induce disease symptoms in healthy 
individuals to treat individuals with that disease; homeopathy still exists as a school of medicine.122 
Eclectics use herbal medicines and remedies to treat pathologic conditions.123 Among less threatening 
therapies, eclectics are known primarily for their use of arsenic and mercury treatments.124 Naturopathic 
physicians utilize natural elements like water, heat, and massage in their therapies.125 Chapter 7 of 
Professional Practices contains more information about alternative medicine in the modern healthcare 
industry. 
The practice of chiropractic medicine has transformed from a form of alternative medicine into an 
allied health profession. The origins of chiropractic medicine involved beliefs that vertebral alignment 
would serve to remedy diseases; progress in science and medicine cultivated skepticism toward practi-
tioners of this philosophy.126 Over time, a reduced focus on these abstract chiropractic practices reduced 
skepticism from medical practitioners; although some chiropractors still employ questionable methods, 
modern chiropractic practice is mainstream and widely accepted.127 See chapter 6 of Professional Prac-
tices for further discussion of chiropractic medicine as an allied health professional practice.
One of the two most reputed schools of medicine in the United States is osteopathic medicine.128 An-
drew Taylor Still founded osteopathic medicine, treating patients by assessing not only their symptoms 
but also their overall health and environment.129 He opened the American School of Osteopathy in 1892 
in Kirksville, Missouri.130 By the 1960s, there were six schools for osteopathy, and, as of 1985, Doctors 
of Osteopathic Medicine were certified in all specialties.131 Because osteopathic medicine contributes a 
great deal to the modern practice of medicine, chapter 1 of Professional Practices addresses in detail the 
similarities and differences between Doctors of Medicine and Doctors of Osteopathic Medicine.
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As of April 1985, Doctors of Osteopathy (D.O.) were certified  
in all specialties.
“History of Osteopathy” In “An Osteopathic Approach to Diagnosis and Treatment,” by Eileen L. DiGiovanna and 
Stanley Schiowitz, 1997, p. 1–3.
Diversified Roles of Medicine
The practice of medicine in the nineteenth century expanded from strictly clinical practice to include 
legal medicine, public health, and medical research. Legal medicine involves the implementation of 
medical expertise for legal and judicial purposes.132 In the later portion of the century, the scientific and 
medical communities began to grapple with the social and economic implications of healthcare.133 As 
such, medicine “assume[d] its role as a social science,” transforming itself from an elite and sophisti-
cated trade134 The national prevalence of infectious disease resulted in an emphasis on community and 
hygienic medicine.135
Public health is an area of science and medicine characterized by a “community health point of 
view.”136 All public health research, policies, and programs stemmed from the same objective: to provide 
“defen(s)e against disease as a social problem” by way of preventative medicine.137 Unfortunately, prog-
ress in prevention is difficult to quantify, and its value within the healthcare industry is not concrete.138 
As a result, preventative care is dismissed as inferior, and public health has faced significant resistance 
and alienation from the medical community.139
Lastly, growth in holistic medical research paired with paralleled growth in scientific knowledge fa-
cilitated the publication of substantial medical literature in serial journals, with the American Journal of 
Medical Sciences entering print in 1838 and the New England Journal of Medicine and Surgery entering 
print in 1812.140 This constant flow of new research findings and an increasing knowledge-base resulted 
in the perpetual tendency toward specialization that continues to drive current trends in medicine.
Specialization of the Sciences
The nineteenth century saw the first significant period in technical progress that proved extremely im-
portant to the advance of both science and medicine.141 Through continued advances in chemistry and 
physics, the disciplines of physiological and pathological chemistry emerged. A more intensive knowl-
edge-base was established for biology, chemistry, anatomy, and physiology, which gave rise to fields 
like biochemistry, cytology, genetics, endocrinology, anthropology, immunology, and microbiology.142
Through his investigations of fermentation and pathogenic bacteria, Louis Pasteur pioneered a 
branch of microbiology now known as bacteriology.143 Pasteur’s work influenced both clinical and  
laboratory medicine through his discovery of pasteurization, a process widely used today in the pres-
ervation of perishable products.144 Pasteurization involves the strategic application of heat to kill 
microbes without injuring the quality of its media (for example, wine, beer, etc.).145 Through the discov-
ery of pasteurization, the development of antirabic treatment, and his observations of anthrax, chicken 
cholera, staphylococci, and streptococci, Pasteur became recognized as “one of the greatest and noblest 
pioneers of civilization.”146 Pasteur improved healthcare and enhanced its economic benefits through his 
contributions to the fields of clinical, hygienic, and social medicine.147
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Specialization of Medicine
Specialized forms of internal medicine emerged contemporaneously with developments in pathology 
and microbiology.148 The nineteenth century marked the discovery of anesthesia and asepsis which 
resulted in unmatched advances in the study of surgery.149 Surgical specialization fostered the incep-
tion of plastic surgery, neurosurgery, pathological (namely, cancer related) surgery, surgical procedures 
in gynecology and obstetrics, and countless other areas.150 Similar scientific milestones enhanced both 
diagnostic and therapeutic capabilities in various medical fields including obstetrics and gynecology, 
pediatrics, otology, laryngology, rhinology, urology, dermatology, syphilology, orthopedics, dentistry, 
neurology, and psychiatry.151
SpeciAlty diAgnoSticS
Physicians in the nineteenth century were among the first to engage in the identification, classification, 
and reporting of various pathologies and diseases.152 In order to conduct the necessary laboratory proce-
dures, physicians had to possess a substantial amount of knowledge in a condensed area of medicine.153 
As a result, the range of available specialties grew, became more focused, and ultimately led to more 
specialized medical research.154 At the turn of the twentieth century, diagnostic medicine endured a 
transformation, with Wilhelm Conrad Roentgen’s discovery of x-rays in 1895 that promulgated the rapid 
advancement of quantum physics and Antoine Beclere’s implementation of the first x-ray machine in 
1906.155 Soon after, these nuances in radiation diagnostics would leak into therapeutics, with discoveries 
in radiation therapy (see chapter 5, Technology Development for an in depth discussion of radiation as a 
diagnostic and therapeutic technology).156
SpeciAlty therApeuticS: phArMAcology And phySiology
The practice of medicine has not always been about understanding a problem to arrive at its solution. 
For much of history, diagnostic medicine was an enigma—frequently neglected, unequivocally lacking, 
and often hypothetical.157 The treatment of diseases, however, always has been at the apex of the medi-
cal practice.158 Physician inquiry in specialized areas of medicine allowed for the expansion of diag-
nostic capabilities in the nineteenth century.159 Additionally, the nineteenth century brought with it the 
unparalleled evolution of therapeutic technology.160 It was not until the 1800s that pharmacology gained 
scientific credibility through animal and clinical trial investigations.161 Ancient forms of physiotherapy 
slowly transformed over time, only to emerge in various specialized forms including hydrotherapy, mas-
sage, mechanotherapy, electrotherapy, and heat therapy.162 Box 1-6 summarizes the key people, places, 
and events of the nineteenth century in medical history.
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Box 1-6: Influential Figures, Key Places, and Important Events During the Nineteenth Century
Influential Figures*,**,†,††,‡,‡‡
Name Birth/Death Location Claim to Fame
Sir Thomas Watson 1792–1882 Devonshire, England Authored Practice, a premier medical text published in 1843; it was the 
prominent general medical treatise for forty years
Sir William Osler 1849–1919 Montreal, Canada Authored The Principles and Practice of Medicine, a premier medical 
text published in 1892, which solidified him as the leading authority on 
medicine at the time for both students and practitioners
American Medical 
Association
1847–Present U.S. A group of predominantly allopathic physicians that lobbies for 
physicians rights and supremacy
Oliver Wendell Holmes 1809–1894 U.S. Prominent physician who coined the term “anesthesia”
Andrew Taylor Still 1828–1917 U.S. Founder of osteopathic medicine, the practice of treating patients based 
on symptoms and overall health
Louis Pasteur 1822–1896 Paris, France Pioneered bacteriology, a subfield of microbiology; also discovered 
pasteurization
Wilhelm Conrad Roentgen 1845–1923 Germany Discovered x-rays in 1895
Antoine Beclere 1856–1939 Paris, France Implemented the first x-ray treatment of glandular tuberculosis
Places‡‡
Place Location Role in Medical History
American School of Osteopathy Kirksville, MO, U.S. First osteopathic school, founded by Andrew Taylor Still in 1892
Events*,**,‡,§,§§
Name Definition
Anesthesia A numbing agent
American Journal of Medical Science  Began printing in 1838 to help the spread of medical information
New England Journal of Medicine and Surgery  Began printing in 1812 and to facilitate the growth of medical knowledge
Fermentation  The enzymatic decomposition of an organic substance in the absence of oxygen; usually produces a gas
Pathogenic Bacteria  Bacteria that causes disease
Pasteurization  A process which preserves perishable products involving strategic application of heat to kill microbes 
without injuring the media
Antirabic Treatment  A treatment for rabies developed at the Pasteur Institute
Anthrax  A fatal bacterial infection of warm-blooded animals
Chicken Cholera  A disease affecting poultry, Pasteur’s work with the disease led him to discover vaccinations
Staphylococci  A set of spherical bacteria
Streptococci  A set of spherical bacteria, which grow in chains and can cause serious diseases; used to make 
Streptomycin, an antibiotic
Asepsis  The state of being free from disease-causing germs
X-ray  Discovered in 1895, promulgated the rapid advancement of quantum physics
* “A History of Medicine,” by Arturo Castiglioni, Alfred A. Knopf, Inc., 1947.
** “The Greatest Benefit to Mankind: A Medical History of Humanity,” by Roy Porter, HarperCollins Publishers Ltd.
† “The Life of Sir William Osler,” by Harvey Cushing, Oxford, 1925.
†† “Our History, Illustrated Highlights,” the American Medical Association, 2009, www.ama-assn.org/ama/pub/about-ama/our-history/illustrated-highlights.shtml, (accessed 
09/10/09).
‡ “Dr. Holmes at 200—The Spirit of Skepticism” by Charles S. Bryan, M.D., and Scott H. Podolsky, M.D., New England Journal of Medicine, Vol. 361, no. 9 (August 27, 2009), 
p. 846.
‡‡ “An Osteopathic Approach to Diagnosis and Treatment,” by Eileen L. DiGiovanna and Stanley Schiowitz, 1997.
§ “Early History of X Rays,” by Alexi Assmus, Beamline Publication, Stanford University, Summer 1995.
§§ “Two Centuries of American Medicine,” by James Bordley III, MD and A. McGehee Harvey, MD, W.B. Saunders Company, 1976.
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Twentieth and Twenty-First Centuries: The 
Transformation of Modern Healthcare
The twentieth century will be remembered chiefly, not as an age of political 
conflicts and technical inventions, but as an age in which human society dared to 
think of the health of the whole human race as a practical objective. 
Arnold Toynbee, 1931
By the twentieth and twenty-first centuries, healthcare professionals had earned credibility, and continu-
ing developments in modern medicine only fortified the perpetual growth of their medical authority.163 
Starr noted:
The rise of the professionals was the outcome of a struggle for cultural authority as well as for 
social mobility. It needs to be understood not only in terms of the knowledge and ambitions of 
the medical profession, but also in the context of broader changes in the culture and society that 
explains why Americans became willing to acknowledge and institutionalize their dependence 
on the professions. The acceptance of professional authority was, in a sense America’s cultural 
revolution.164
Technological Advances
With physicians developing expertise in exceedingly specialized areas of medicine, the expectation was 
that they would administer care with the same level of expertise.165 As such, the demand for innovative 
technologies increased to allow for the provision of services that advanced diagnoses required. Over 
time, demand took a completely different form to account for more than just advances in diagnostics and 
therapeutics, and, moreover, it grew at astronomical rates.166 To match a growing and shifting demand, 
increased spending, demographic trends, and a pathologic shift (discussed further herein), existing tech-
nologies evolved to improve the quality and efficiency of services delivered.167
Accompanying the increase in spending, healthcare practitioners became viewed not only as healers 
but also as businessmen. As the demand for increasingly expensive medical technology grew, the old 
adage, “no Buck Rogers,” defined the cyclical relationship between technological demand and business 
investment. Within that context, demand for more sophisticated management technologies to enhance 
practice efficiency and reliability increased significantly.168 Chapter 5, Technology Development exten-
sively addresses both management and clinical technology.
The Inception of Medicare and Medicaid Services
The economic devastation that plagued a war-torn middle- and working-class at the dawn of the Great 
Depression gave rise to the concept of “health security” in the newly urbanized and industrialized United 
States.169 Despite resistance from conservative stakeholders, that is, the AMA, the Progressive move-
ment emerged in hopes of relinquishing “inequities and poverty in America.”170 President Franklin D. 
Roosevelt (FDR) attempted to implement a national health insurance program, first, in 1935, through 
the Social Security Bill, a part of The New Deal, and, again, through the National Health Act of 1939.171 
Both attempts were in vain, and FDR’s sudden, tragic death in 1945 left health reform in the hands of 
his successor, Harry S. Truman.172
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Truman was a zealous proponent of “universal, comprehensive coverage,” and actively sought enact-
ment of a program for the entirety of his presidency.173 However, he faced opposition from the AMA, 
perceived to be “the country’s richest and most influential post-World War II lobby.”174 His stance 
on healthcare was viewed by the AMA and other conservative stakeholders as “socialistic” and “un-
American.”175 Although his vehement support for health reform did not result in the implementation of 
a national health program during his presidency, Truman did live to see the inception of a program that, 
though not as ambitious as the ones he or FDR proposed, represented significant progress in the direc-
tion of change.176
In the 1960s, John F. Kennedy’s presidential campaign once again targeted the recession, unem-
ployment, and stagnant economy introduced by World War II.177 Starr stated that, “[t]he triumph of the 
liberal agenda in the mid-1960s brought a new generation of programs and policies in health care.”178 
Starr also recognized that the need for an increase in “health manpower” would result in an expansion of 
education programs and initiatives.179
President Lyndon B. Johnson, like President Kennedy, recognized the connection between bad 
healthcare and poverty and lobbied for social programs to ensure the poor received healthcare cover-
age.180 Although Medicare had been a political issue since the late 1950s, it was not until the “Demo-
cratic sweep in 1964” that a Congressional majority passed the Medicare program and President John-
son signed the bill into law.181 The Medicare program of the 1960s was comprised of three layers: (1) 
Medicare Part A, “the Democratic plan for a compulsory hospital insurance program under Social 
Security;” (2) Medicare Part B, “the revised Republican program of government-subsidized voluntary 
insurance to cover physicians’ bills;” and (3) Medicaid, “the expanded assistance to the states for medi-
cal care.”182 The introduction of the Medicare and Medicaid programs dramatically increased access to 
care for indigent individuals and proved to be the first of many steps toward healthcare reform.183
Shift to Managed Care
Following the movement toward a prospective payment system (PPS) in the late 1980s, the U.S. 
healthcare delivery system underwent fundamental changes that proved, in some ways, as significant as 
the introduction of Medicare in the mid 1960s. The sea change in the U.S. healthcare delivery system 
during those decades continues to present both challenges and opportunities for healthcare professional 
providers and investors alike.184 As one of the largest payors of healthcare benefits, the government con-
tinues to attempt to control healthcare costs by developing reimbursement policies that serve as signifi-
cant drivers of current trends in healthcare delivery.185
Although most professions saw an increase in compensation since the 1990s, physician compensa-
tion has been fairly stagnant.186 Physicians have invested in ancillary services providers not only in an 
effort to counter reductions in professional fee reimbursement revenue but also to exercise control over 
their practice environment and ability to provide technologically advanced, high-quality care to their 
patients.187 The realignment of the Inpatient Prospective Payment System (IPPS) with the introduction of 
severity adjusted diagnostic related groups (DRGs), as well as heightened initiatives aimed at restrict-
ing physician ownership of ancillary services and technical component revenue streams (most recently 
through the Children’s Health and Medicare Protection provision removing the whole hospital exception 
to the Stark law) have raised some investor concerns.188
The overall impact of this and other attacks on physician ownership appears to be aimed at consign-
ing physicians to nothing more than “sharecroppers.” This perceived diminution of the professional 
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standing and investor interest of physicians is further exacerbated by widespread acceptance among 
even the most ardent proponents of physician independence, such as Arnold Relman, M.D., Harvard 
professor and former editor of the New England Journal of Medicine, who, by neglecting to condone 
physician ownership and advocating for a U.S. healthcare system where, “. . . most physicians would be 
salaried employees of not-for-profit, prepaid group practices,” may have redefined his stance on physi-
cian “independence.”189
From the perspective of many, the inevitable outcome of these efforts at placing additional re-
strictions on physician independence will be to relegate these professionals and their practice of 
medicine, to the status of, at best, the healthcare equivalent of sharecropping, and, at worst (per 
Relman), the status of hired help.190
Historically, Medicare and Medicaid paid for hospital services using a cost plus method of reim-
bursement, in which hospitals received reimbursement in excess of all of their costs.191 In 1983, the fed-
eral government introduced a PPS in an effort to remedy the rising healthcare costs.192 Under this PPS, 
hospitals are reimbursed an average, qualified, and predetermined fee for every recognized DRG.193 The 
government has also developed a PPS for ambulatory surgery centers, home healthcare, hospital outpa-
tient services, rehabilitation facilities, and skilled nursing facilities.194
In 1983, the federal government introduced a prospective payment system 
(PPS) in an effort to remedy the rising healthcare costs.
“Assessing payment adequacy and updating payment in fee-for-service Medicare” in Report to the Congress: 
Medicare Payment Policy, March 2005, p. 29–32.
In 1989, the resource based relative value system (RBRVS) was introduced as a mechanism to 
control the costs of physicians’ services borne by the Medicare program.195 This new payment system, 
based on estimates of resource costs incurred in an efficient medical practice, replaced the previous 
customary prevailing and reasonable charge system.196 The five-year implementation and subsequent 
updates to this system affected the reimbursement levels of various specialties unevenly with primary 
care physicians generally faring well under the new system.197 The RBRVS was intended to bring medi-
cal practice more in line with a PPS in which payments are made based on set fees for types of proce-
dures or diagnosis For more information about trends in reimbursement, see chapter 2, Reimbursement 
Environment.198
In 1989, the resource-based relative value System (RBRVS) was  
introduced as a mechanism to control the costs of physicians’  
services borne by the Medicare program.
“A Guide to Consulting Services for Emerging Healthcare Organizations” by Robert James Cimasi, CBI, CBC,  
John Wiley and Sons, Inc., p. 24–25.
Managed competition between larger, consolidated provider entities was an inevitable goal of the 
shift to managed care and capitation from a fee-for-service medical system.199 The expeditious consoli-
dation of healthcare entities, in both public and private sectors, into emerging healthcare organizations 
within both private and public sectors is a result of the gradual transition into managed care through 
regulatory action at both state and federal levels.200
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Health maintenance organizations and preferred provider organizations have sought to combine 
the roles of insurance companies, utilization review organizations, and medical services providers in 
order to offer prepaid medical plans to subscribers, forcing cost containment by integrating operational 
and financial functions.201 The transition into managed care has reinforced the primary care physician’s 
role as “gatekeeper.”202 As such, the value attributed to primary care physicians has increased, though 
the trend toward specialization prevails.203
The inception of managed care, as well as the industry hype instigated by Starr’s romanticized call 
for “corporatization,” promulgated the increased integration of healthcare organizations.204 However, the 
industry did not see the desired improvements in quality and efficiency promised by managed care.205 
Most organizations only consolidated in order to survive the backlash of managed care; in light of this 
misalignment, increased integration has only furthered the fragmentation of healthcare delivery.206 
Consolidation to date has, in some respects, deterred from managed care’s intended goal: the fluid and 
comprehensive continuum of quality care. In all respects, however, organizational integration has merely 
created a façade of increased consolidation in a healthcare system that remains, inherently, a “cottage in-
dustry.”207 Although managed care was, at one time, believed to be the Pied Piper of cottage healthcare, 
transformation into postindustrial care is also contingent upon the standardization of care, accounting for 
performance measures, and employed transparent reporting practices.208
Inpatient and Outpatient Market Trends
The Bureau of Health Professions predicted that between 2000 and 2020, the U.S. population would in-
crease by 18 percent.209 Also, the number of people aged sixty-five and older is anticipated to account for 
13 percent of the total world population in 2030.210 The market for outpatient services more than doubled 
from 1987 to 2007 in order to offset trends in population demand.211 Continuing increases in healthcare 
costs containment pressures should preserve growth in outpatient demand.
The Bureau of Health Professions predicted that, between 2000 and 2020, 
the U.S. population would increase by 18 percent. Also, the number of 
people aged sixty-five and older is anticipated to account for 13 percent of 
the total world population by 2030.
“Trend Watch” American Hospital Association, 2002, p. 62.
It would be incorrect to assume that the expansion of outpatient care is the sole factor influencing 
the healthcare market and competitive arena. Demand is bifurcated due to increased incidence of sev-
eral chronic diseases paired with emerging infectious diseases that are resistant to existing therapies.212 
Though not as drastic, inpatient demand has increased from 96 million visits in 1995 to 119 million 
visits in 2006, with the percentage of inpatients older than sixty-five years of age nearly doubling from 
1970 to 2006.213 An expected population increase by 2030 of 30 million people suggests that both outpa-
tient and inpatient markets can expect positive trends in demand.214
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The Healthcare Manpower Shortage: A Barrier to  
Managed Care
In 1980, the Graduate Medical Education National Advisory Committee projected a surplus of 70,000 
physicians in the year 2000. As a result of this estimate, a cap on medical school enrollment was put 
in place to control supply of physicians to the market.215 Due to “tightly controlled” managed care in 
the 1990s, the projections of a physician surplus in the next decade were reaffirmed, and the number of 
graduates per year remained unchanged for nearly twenty-five years.216 However, in 2006, foreseeing a 
physician shortage, the Association of American Medical Colleges (AAMC) recommended a 30 percent 
increase in U.S. medical school enrollment by 2015 in hopes of alleviating the shortage.217
The healthcare industry faces present and projected healthcare professional manpower shortages 
due to the repercussions of previously capped medical school enrollment, the economic recession, and 
the demographic shift.218 Based on the number of additional physicians needed to meet current market 
demands, the projected 10 percent physician shortage is expected to double in the next decade.219 In No-
vember of 2008, the AAMC projected a physician shortage of 159,000 physicians by the year 2025.220 
In 2000, thirty states experienced nursing shortages greater than 3 percent.221 In recent years, the average 
age of registered nurses has increased steadily due to a six-fold decrease in nursing school enrollment 
since 2002, higher average ages of recent graduating classes, and aging of the nursing population as 
a whole.222 The U.S. Department of Health and Human Services anticipates 1 million unfilled nursing 
positions by 2020.223
In November of 2008, the Association of American Medical Colleges (AAMC) 
projected a physician shortage of 159,000 physicians by the year 2025.
“The Complexities of Physician Supply and Demand: Projections Through 2025,” by Michael J. Dill and Edward S. 
Salsberg, Center for Workforce Studies, Association of American Medical Colleges, November 2008, p. 6.
The U.S. Department of Health and Human Services anticipates 1 million 
unfilled nursing positions by 2020.
“Nursing, doctor numbers worsen,” By Gregory Lopes, The Washington Times, July 27, 2007, www.newser.com/
archive-science-health-news/1G1-166859372/nursing-doctor-numbers-worsenbusiness.html (accessed  
April 10, 2009).
In addition to the shortage of physicians across all specialties, there is a growing shortage of physi-
cians seeking to practice in primary care medicine.224
Possibly the largest factor contributing to the shortage is the disparity in pay, as specialists often earn 
twice the pay of primary care physicians and work more predictable hours.225 Given that medical stu-
dents graduate with a significant amount of debt (often more than $100,000), the reason for choosing a 
more lucrative specialization is obvious.226
Old Medical Adage
“Primary care physicians (PCPs) believe they treat the conditions that patients have, while 
specialists and surgeons believe their patients have the conditions they treat.”
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Because medical schools rely on funds from advanced specialties for their student training programs, 
the programs tend to have a highly specialized emphasis.227 Additionally, training in primary care has 
been hindered by cuts to training grants (Section 747, Title VII Public Health Service Act) that provide 
medical students with exposure to primary care settings outside the academic medical center, often in 
rural and medically underserved areas.228 Potential solutions to the shortage of primary care physicians 
include providing more financial incentives to attract new graduates to the primary care practice, as well 
as expanding exposure to primary care practices during medical school.229
Old Medical Adage
“Specialists and surgeons relegate the complaints of primary care  
physicians as ‘the revenge of the C student.’ ”
Further, analysts project that allied health professionals will see a 1.6 to 2.5 million practitioner 
shortage in coming years.230 Factors driving the allied health practioner shortage are similar to that of the 
nursing shortage: allied health professionals earn more money working than they do teaching, resulting 
in a lack of academic faculty.231 Additionally, underfunded educational institutions and community col-
leges do not inform waitlisted students about the availability of seats at other teaching institutions.232
Box 1-7 outlines several of the most important twentieth century figures and events as they relate to 
the healthcare profession.
There is a projected shortage of 1.6 to 2.5 million allied health professionals. 
“Workforce Shortage Crisis,” By George Lauer, Allied Health Professionals Week Highlights, January 27, 2007, 
www.californiahealthline.org/Features/2009/Shortage-of-Allied-Health-Workers (accessed April 10, 2009).
The Healthcare Professional’s Duty to the State
The practice of medicine began as hypothetical thought and transformed over time into a scientific 
industry in growing demand. Ultimately, a company’s success is a function of market control and profit. 
However, market competition within the healthcare industry is ultimately driven by the ethical duties 
unique to the medical profession. In addition to the duty to “primum non nocere”—first (or above all) do 
no harm—healthcare professionals are also expected to exhibit “[q]ualities such as wisdom, compassion, 
human concern, and service.”233 However, business objectives built around these ethical values may 
conflict with the entrepreneurial objectives that take priority in most industries.234 Further, due to the 
community-based nature of many healthcare services, industry trends are driven largely by public opin-
ion on matters related to health status.235 As such, the healthcare professional’s ethical duties are rooted 
deeply in community benefit.236 Healthcare delivery is subject to a unique sixth force of the competitive 
equation: the requirement that community benefit maintain weighted significance in the decisions that 
impact the provision of care.237
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Box 1-7: Influential Figures and Key Events During the Twentieth Century
Influential Figures*,**,†,††
Name Birth/Death Location Claim to Fame
Franklin D. Roosevelt 1882–1945 Washington, D.C., U.S. U.S. President from 1932–45, who attempted to implement a national 
health insurance program in 1935 and again in 1939
Harry S. Truman 1884–1972 Washington, D.C., U.S. U.S. President from 1945–53, who attempted to implement a national 
health insurance program
John F. Kennedy 1917–63 Washington, D.C., U.S. U.S. President from 1961–63, whose term was plagued by a recession, 
unemployment, and a stagnant economy
Lyndon B. Johnson 1908–73 Washington, D.C., U.S. U.S. President from 1963–69, who, with assistance from a democratic 
sweep, passed Medicare parts A and B, and Medicaid
Paul Starr 1949–present Princeton, N.J., U.S. Renowned sociologist who won the Pulitzer Prize for his book, The 
Social Transformation of American Medicine
Events‡
Name Definition
Bureau of Health Professions  Part of the U.S. Department of Health and Human Services, deals with grants, studies, and designations of 
the health workforce
* “Harry S. Truman Versus the Medical Lobby,” by Monte M. Poen, University of Missouri Press, 1979.
** “A Brief History: Universal Health Care Efforts in the U.S.,” by Karen S. Palmer, MPH, MS, Physicians for a National Health Program, Spring 2009, www.pnhp.org/facts/a_brief_
history_universal_health_care_efforts_in_the_us.php?page=all (accessed 02/17/2010)
† “The Social Transformation of American medicine,” by Paul Star, Basic Books Inc. 1982.
†† “Paul Starr: Biographical Sketch”, Princeton University, October 19, 2008, www.princeton.edu/~starr/starrbio.html (accessed 02/24/10)
‡ “Projected supply, demand, and shortages of registered nurses: 2000–2020,” By the United States Department of Health and Human Services, Health Resources and Services 
Administration, Bureau of Health Professions, National Center for Health Workforce Analysis, July 2002, www.ahcancal.org/research_data/staffing/Documents/Registered_
Nurse_Supply_Demand.pdf (accessed 04/10/09).
According to the AMA’s 1908 publication, The Doctor’s Duty to the State:
The doctor’s highest duty is to be honest and to fight for honesty in his profession and the state...
He, as others, sees in history the same process exhibited in the remote effects of corporate and 
governmental vice...To whom then shall the state look for preservation of its health, to whom 
shall the state call for help in time of trouble, in whom shall the state place its hope for deliver-
ance...The honest citizen; and the honest doctor is his best representative.238
Unfortunately, the public’s perception of healthcare providers gradually has eroded during the past 
decade, with patients becoming increasingly distrustful of hospitals, doctors, and drug companies and 
with a growing perception that there has been a lapse in attention to the healthcare professional’s highest 
ethical duty.239 In the face of rapidly accelerating changes in the healthcare industry, it is an increasing 
challenge for healthcare professionals to maintain their professional obligations as well as their financial 
solvency. Notwithstanding this duality of objective, medical ethics remain a market driver that distin-
guishes healthcare from all other industries. 
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The History You Don’t Know
The only thing new in the world is the history you don’t know. Harry S. Truman 
(1974), in Plain Speaking: An Oral Biography of Harry S. Truman
Discussed in subsequent chapters of this Guide, and as mentioned in the introduction, the healthcare 
industry’s four pillars, the reimbursement, regulatory, competitive, and technology environments, are 
founded in the historical development of medicine and science. These historical foundations have played 
a significant role in influencing the development of several other aspects of the healthcare delivery 
system, for example, the organizational structure and emerging models of healthcare, and they also have 
had an impact on the practice of the healthcare consulting, both of which are discussed in more detail in 
subsequent books of this Guide: Professional Practices and Consulting with Professional Practices. 
 Key Sources
Key Source Description Citation Hyperlink
The Social Transformation of 
American Medicine
Paul Starr’s work discussing the 
evolution of American Medicine.
“The Social Transformation of American 
medicine,” by Paul Star, Basic Books Inc. 
1982.
n/a
Oath of Hippocrates An oath taken by physicians 
that was originally written by 
Hippocrates but has been revised 
multiple times to date.
Original: 
“The Hippocratic Oath: Text, Translation, 
and Interpretation,” by Ludwig Edelstein. 
Baltimore: Johns Hopkins Press, 1943.
Modern: 
“The Hippocratic Oath and the Ethics of 
Medicine,” by Steven H. Miles, Oxford 









Centers for Medicare and 
Medicaid
“The US federal agency which 
administers Medicare, Medicaid, 
and the Children’s Health 
Insurance Program.”
“Mission, Vision & Goals,” Centers for 




The Doctor’s Duty to the State Roberts’ work discussing the 
healthcare professional’s state 
and federal responsibility to 
community benefit.
“The Doctor’s Duty to the State,” by 
Roberts, J. B. (1908), Chicago, IL: 
American Medical Association.
n/a
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 Associations




Description Citation Hyperlink Contact 
Information
National American Medical 
Association 
“The American Medical 
Association helps doctors help 
patients by uniting physicians 
nationwide to work on the most 











www.ama-assn.org American Medical 
Association





National Association of 
American Medical 
Colleges (AAMC) 
The AAMC represents all 131 
accredited U.S. and 17 accredited 
Canadian medical schools; 
approximately 400 major teaching 
hospitals and health systems, 
including 68 Department of Veterans 
Affairs medical centers; and nearly 
90 academic and scientific societies. 
Through these institutions and 
organizations, the AAMC represents 
125,000 faculty members, 75,000 











www.aamc.org Association of American 
Medical Colleges
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Key Concept Definition Citation
Reimbursement Payment for provider services made by patients and third-party payors. Unlike most 
businesses, healthcare providers may have hundreds of different contracts with 
payors, each with varying terms and rates for the same services.
Source: “Reimbursements” in “Medical Practice 
Management System” by Linda Nadeau, Thomson 
Delmar Learning, 2007, pg. 198; “Financial 
Environment of Health Care Organizations” in 
Essentials of Health Care Finance, Sixth Edition” by 
William O. Cleverley and Andrew E. Cameron, Jones 
and Bartlett Publishers, Inc., 2007, pg. 36–37.
Pay-for-Performance 
(P4P)
A remuneration system in which part of the payment is dependent on performance as 
measured against a defined set of criteria.Although a P4P system can be structured 
in several ways, the common elements to all systems are (1) a set of targets or 
objectives that define what will be evaluated; (2) measures and performance 
standards for establishing the target criteria; and (3) rewards—typically financial 
incentives—-that are at risk, including the amount and the method for allocating the 
payments among those who meet or exceed the reward threshold.
“Pay-for-Performance in Health Care” by Jim Hahn, 
Congressional Research Service, The Library of 
Congress, November 2, 2006, p. CRS-2-4.
Medical Home A patient-centered model of healthcare delivery and payment reform that focuses on 
improving the quality of care and reducing costs through its emphasis on the role of 
primary care.
“Medical Home Models: Improving Care and 
Reducing Costs in Healthcare, White Paper Analysis of 
HIN Monthly E-Survey Results on Trends Shaping the 
Healthcare Industry” by Laura M. Greene, Healthcare 
Intelligence Network, May 2009.
Resource Based 
Relative Value System 
(RBRVS)
The scale on which Medicare bases its standardized physician payment schedule. 
The RBRVS determines payments based on the value of the resources necessary to 
provide a particular service.





(accessed October 5, 2009).
Relative Value Unit 
(RVU)
The RBRVS assigns each procedure a relative value unit, or RVU. Three types of RVUs 
exist: one for physician work (wRVU), one for practice expense (PE), and one for 
malpractice costs. The three components of the RVU can be broken down as follows:
1. Work. The estimated value of the time, effort, expertise, and intensity of the 
service, approximately 55 percent of the RVU value.
2. Practice expense. The estimated value of overhead and other expenses 
necessary to run the practice, approximately 42 percent of the RVU value. 
3. Professional Liability Insurance (PLI). The estimated value of malpractice cost 
for the service—approximately 3 percent of RVU value. 
“Gauging Emergency Physician Productivity: Are 
RVUs the Answer,” by John Proctor, MD, MBA, 
American College of Emergency Physicians, ACEP 
Reimbursement Committee, www.acep. org/practres.




A coding system that provides the payor information in regard to the procedures 
performed in the treatment of patients. The system does not relay diagnosis 
information. HCPCS codes are used by hospitals to report information on procedures 
performed for outpatient services and by physicians to report information in 
connection with the performance of procedures in both the inpatient and outpatient 
settings. Two HCPCS levels exist: Level I codes are referred to as Current Procedural 
Terminology (CPT) codes, and Level II codes are temporary codes used to represent 
services, supplies, and procedures for which CPT codes do not yet exist.
“Billing and Coding for Health Services” in Essentials 
of Health Care Finance, Sixth Edition, by William O. 
Cleverley and Andrew E. Cameron, Jones and Bartlett 
Publishers, Inc., 2007, pg. 18.
Current Procedural 
Terminology (CPT)
A system developed by the American Medical Association that is used by providers to 
report information to patients and insurers about services and procedures provided to 
patients.
“CPT Coding” in “Understanding Health Insurance:  
A Guide to Billing and Reimbursement, Ninth Edition” 
by Michelle A. Green and JoAnn C. Rowell, Delmar 
Cengage Learning, 2008, p. 191.
Diagnosis-Related 
Group (DRG)
A way to categorize patients in hospitals based on the relative intensity of services 
related to that diagnosis. Patients typically are classified based on their admitting 
diagnosis, which is grouped with other diagnoses into a DRG so that the hospital can 
identify groups of patients that require roughly the same amount of resources.
“Health Law: Cases Materials and Problems,” by 




Laws that provide healthcare coverage and monetary payments to employees injured 
at work or suffering from an occupational disease and monetary benefits for the 
dependents of employees killed on the job. In addition, the laws limit the financial 
liability of employers, and they nearly eliminate the financial liability of co-workers for 
most accidents.
“Workers’ Compensation” in “Understanding Health 
Insurance: A Guide to Billing and Reimbursement, 
Ninth Edition” by Michelle A. Green and JoAnn C. 
Rowell, Delmar Cengage Learning, 2008, p. 532.
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Key Concept Definition Citation
Indian Health Services 
(IHS)
An agency located within the United States Department of Health and Human 
Services. It provides healthcare services to approximately 1.9 million American 
Indians and Alaska Natives, directly through tribal healthcare programs and indirectly 
through purchases from private providers.
Indian Health Service Introduction” by Indian 
Health Services, IHS.gov, June 2009, www.ihs.gov/
PublicInfo/PublicAffairs/Welcome_Info/IHSintro.asp, 
(accessed August 10, 2009); “IHS Fact Sheets” by 
Indian Health Service, IHS.gov, June 2009, http://
info.ihs.gov/QuickLook09.asp, (accessed August 10, 
2009).
Commercial Insurers Plans that are offered by life insurance companies, casualty insurance companies, 
and companies that were formed for the sole purpose of offering health insurance.
“The Financial Environment” in “Healthcare 
Finance: An Introduction to Accounting and Financial 
Management, Third Edition” by Louis C. Gapenski, 
Health Administration Press/Association of University 
Programs in Health Administration, 2005, p. 35.
Fee Allowance 
Schedule
A managed care reimbursement scheme by which the fees for procedures are 
explicitly laid out and the physician agrees to accept those fees as full payment, 
unless the discounted charges are less than the fee schedule in which case the plan 
pays the lesser of the two.
“The Managed Health Care Handbook, Third Edition,” 
by Peter R. Kongstvedt, Ernst & Young, 1996,  
p. 140–41.
Relative Value Scale 
(RVS)
The reimbursement scheme by which each procedure is assigned a relative value 
which is multiplied by a negotiated factor (the multiplier), usually a discount, to arrive 
at a payment.
“The Managed Health Care Handbook, Third Edition,” 




A managed care reimbursement scheme using a scale that adjusts fees based on 
individual medical specialties. In this approach, each specialty has a per-member-per-
month budget (for example, $2 per member per month for OB/GYN), and actual costs 
are measured against that budget. If costs exceed the budget, then fees are lowered 
but only for that specialty and vice versa if costs are better than budget. This system 
requires a highly sophisticated tracking system and a large enough patient base to 
make the analysis statistically significant, which makes it well suited for independent 
practice associations.
“The Managed Health Care Handbook, Third Edition,” 
by Peter R. Kongstvedt, Ernst & Young, 1996, p. 181.
Retainer A managed care reimbursement scheme that involves a set monthly payment amount 
for each physician, reconciled at periodic intervals based on actual utilization, either 
as a pre-negotiated discount on charges or on some other objective measure. This 
ensures the availability of physicians to members and provides for the steady income 
desired by physicians, while still allowing payment on the basis of actual utilization. 
“The Managed Health Care Handbook, Third Edition,” 
by Peter R. Kongstvedt, Ernst & Young, 1996, p. 186.
Hourly & Salary 
Reimbursement
A way to pay physicians at an hourly rate or a salary for performing services. This 
type of arrangement is common in emergency departments or other settings in which 
a physician needs to be available for a defined period of time. This arrangement also 
works when buying on-call coverage to back up an in-house physician.
“The Managed Health Care Handbook, Third Edition,” 
by Peter R. Kongstvedt, Ernst & Young, 1996, p. 186.
Single Fee 
Reimbursement
A scheme under which fees are paid for a procedure no matter how much time and 
effort is required. Two applications of this method exist:
1. Case rates or flat rates. The same rate is paid for a procedure no matter what 
choice of treatment used; for example, a physician is reimbursed the same 
amount for delivering a baby regardless of whether it was a vaginal birth or 
delivery by way of a cesarean section surgery.
2. Global fees. A flat rate encompassing more than a single type of service. 
For example, a global fee for surgery may include all preoperative and 
postoperative care as well as one or two follow-up office visits. A global fee 
for obstetrics may include all prenatal and postnatal care. 
“The Managed Health Care Handbook, Third Edition,” 
by Peter R. Kongstvedt, Ernst & Young, 1996,  
p. 186–87.
Bundled Case Rates 
or Package Pricing
A form of reimbursement that combines institutional and professional charges into a 
single payment; for example, a plan may negotiate a bundled case rate of $20,000 for 
cardiac bypass surgery, which covers all staff for preoperative and postoperative care. 
Usually outlier provisions exist for cases that become catastrophic. 
“The Managed Health Care Handbook, Third Edition,” 
by Peter R. Kongstvedt, Ernst & Young, 1996, p. 187.
Periodic Interim 
Payments (PIPs) and 
Cash Advances
A managed care reimbursement plan that advances the provider a set amount of 
cash equivalent to a defined time period’s expected reimbursable charges. As claims 
come in from a physician, the claims are subtracted from the PIP, which is routinely 
replenished. In this way, the physician has a positive cash flow, as well as the use of 
the plan’s money, interest free. This method may be employed in a plan with a heavy 
POS enrollment. 
“The Managed Health Care Handbook, Third Edition,” 
by Peter R. Kongstvedt, Ernst & Young, 1996, p. 187.
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Overview
Healthcare reimbursement is the payment received by providers for the services they render to patients. 
Most providers will be reimbursed for their services by patients and by third-party payors, including, 
but not limited to, employers, insurance companies, and government agencies.1 Unlike most businesses, 
which bill their customers based on a fixed-price per unit set by the business and multiplied by the quan-
tity sold, healthcare providers may have hundreds of different contracts with payors, each with varying 
terms and rates for the same services.2 These payments may take a variety of forms, including payment 
at a fee set by the provider, a discounted fee negotiated by the parties, a fee schedule set by the payor, a 
relative value scale that takes into consideration various costs incurred by the provider rendering the ser-
vice in a particular geographic locale, capitation based on the number of individuals enrolled in a plan, 
bundled payments which pay providers on a per-diem or per-case rate multiplied by the length of stay, 
or a prospective payment system (PPS), which reimburses providers a set amount in accordance with a 
patient’s diagnosis or treatment.3
In 2007, U.S. healthcare expenditures totaled $2.2 trillion, or 16.2 percent of the gross domestic 
product (GDP).4 U.S. healthcare costs have exceeded general inflation for twenty years.5 To combat 
these rising costs, private payors, state governments, and the federal government have implemented 
PPSs, fee schedules, selective contracting agreements, and managed care principles, but these efforts 
have had little success in slowing this continued growth.6 In addition, healthcare reform has taken center 
stage in federal and state politics, with reform efforts aimed at reducing the cost of care and improving 
healthcare by tying provider reimbursement to patient outcomes, allowing providers to receive a share 
of the savings attributable to their cost-cutting efforts, increasing the coordination of care, increasing the 
reliance on capitated payments, and bundling provider payments.
In 2007, the average healthcare expenditure per person was $7,421. Nearly 
a third of the money spent in 2007, 31 percent, was used to pay for hospital 
care. Another 25 percent was spent on dental services, home health, and 
other professional services; durable medical equipment, over-the-counter 
drugs, and other personal healthcare; and public health research, structure, 
and equipment. Rounding out the expenditures, physician and clinical 
services comprised 21 percent of the spending, prescription drugs 10 
percent, program administration and net cost 7 percent, and nursing  
home care 6 percent. In terms of payment sources, state and federal 
government payors were responsible for 46 percent of these expenditures, 
private insurance paid for 35 percent, patients covered 12 percent  
out-of-pocket, and other private payors funded the remaining 7  
percent of healthcare expenditures.
www.cms.hhs.gov/NationalHealthExpendData/downloads/PieChartSourcesExpenditures2007.pdf.
Healthcare Revenue Cycle
The revenue cycle describes the process by which a provider practice schedules patients, diagnoses con-
ditions, documents diagnoses, bills payors, and collects billable charges from the payor and the patient 
to recover revenue for the services provided.7 See figure 2-1 for a pictorial description of the revenue 
cycle in healthcare.
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Elements of the Revenue Cycle
Figure 2-1: The Healthcare Revenue Cycle
1. Scheduling and
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Step 1: Scheduling and RegiStRation
The revenue cycle typically begins when a patient schedules his or her appointment.8 The importance 
of a practice’s scheduling system should not be underestimated, as patient-physician relationships and 
a healthy revenue cycle depend on it.9 Although a system that overbooks appointments may lead to a 
stressful office environment that could negatively affect revenue, a steady flow of patients is what brings 
in revenue to the practice.10 Therefore, to maximize revenue, when developing a scheduling system, pri-
vate practices should give sufficient thought to the type of patients to be seen, their medical conditions, 
provider tasks that need to be completed throughout the day (for example, chart review and dictation), 
the provider’s scheduling preferences, and the likelihood of walk-ins and no-shows.11
A key element of the revenue cycle is an effective registration system that accurately collects patient 
information. This is especially important when dealing with claims that are paid by third-party payors, 
because erroneous or omitted information may delay reimbursement.12 To ensure revenue maximiza-
tion, a patient’s demographic information should be verified every time the patient sees a provider.13 In 
addition, staff should check the patient’s eligibility status and satisfy any pre-authorization requirements 
before the patient receives services in order to avoid the denial of a claim.14
Volume Management
Volume management is critical to a successful practice, because the main objective of an appoint-
ment scheduling system is to have a continuous succession of patients each day.15 Too often, healthcare 
practices use off-the-shelf software or appointment books, and they proceed to schedule patients in the 
V1-B-Chapter 02.indd   61 9/28/10   3:17 PM
The Adviser’s  Guide to Healthcare 
62
predetermined time slots without considering whether this schedule realistically accommodates the 
needs of the practice.16 To better manage patient volume, an appointment scheduling system should be 
set according to the amount of time each provider prefers to spend per patient type and appointment 
type, the maximum number of patients to schedule per day, and the amount of time required per appoint-
ment type for every provider in the practice.17 An appointment system based on these criteria will ensure 
a workable schedule that maximizes patient satisfaction and physician efficiency.18
Step 2: diagnoStic and pRoceduRal coding
Accurate coding and documentation are necessary to ensure proper payment, as treatment information in 
a patient’s medical record is used to trigger payment in the billing process.19 The proper education of the 
provider and staff, and the regular review of coding procedures, can help ensure accuracy and the legiti-
mate maximization of practice revenue.20
In the case of diagnostic services, providers typically bill for both a professional fee component and 
a technical component (see the following section, Professional Component versus Ancillary Services 
and Technical Component), or they may report a global diagnostic code, which is a combination of both 
the professional fee and technical components.21 If reporting is done with a global diagnostic code, re-
imbursement is equal to the sum of the professional fee and technical components that could have been 
billed separately for the services.22
Providers typically bill for a professional component (PC), technical 
component (TC), or the global diagnostic code (PC + TC) when  
billing for diagnostic services.
www.cms.hhs.gov/NationalHealthExpendData/downloads/PieChartSourcesExpenditures2007.pdf.
The Health Insurance Portability and Accountability Act of 1996 (HIPAA) requires providers to 
classify (1) diagnoses and (2) clinical procedures by using several coding systems (see chapter 3, Health 
Insurance Portability and Accountability Act of 1996 (HIPPA)).23
The most commonly implemented coding systems include the International Classification of 
Diseases, Ninth Revision (ICD-9), the Healthcare Common Procedure Coding System (HCPCS), for 
classifying ancillary services and procedures, the imminent ICD-10, the Current Procedural Terminol-
ogy (CPT-4) for physician procedures in both inpatient and outpatient settings, the Current Dental Ter-
minology for dental procedures (to be implemented on October 1, 2013), and the National Drug Code 
system.24 For diagnosis reporting, all healthcare providers, including both physician professional prac-
tices and other facilities (for example, hospitals), use the ICD-9, Clinical Modification (ICD-9-CM).The 
ICD-9 Procedure Coding System (ICD-9-PCS) is used for procedure reporting for hospital inpatients. 
Despite the fact that ICD-9 is used universally for classifying diagnoses, procedural reporting is not 
as simple. Procedural coding depends on (1) whether the designated provider is a physician or a facil-
ity and, (2) in the circumstance of a facility provider, whether the procedure was performed within an 
inpatient or outpatient system. Procedures and services submitted on a claim must be linked, by way of 
appropriate CPT, HCPCS Level II, or ICD-9 codes, to the ICD-9-CM code that corresponds to the diag-
nostic reasoning behind the claim.25 Table 2-1 illustrates the coding systems used for services provided 
by each provider type within each setting.26
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The most commonly implemented coding systems include: ICD-9, HCPCS, 
ICD-10, CPT-4, Current Dental Technology, and the National Drug Codes.
“Overview: Transaction Code Sets Standards,” by Centers for Medicare and Medicaid, 04/26/2009, www.cms.hhs.
gov/TransactionCodeSetsStands/ (accessed September 15, 2009).
Table 2-1: HIPAA-Designated Coding*
Inpatient Outpatient
Diagnosis Procedure Diagnosis Procedure
Physician ICD-9-CM CPT ICD-9-CM CPT
Facility ICD-9-CM ICD-9-CM ICD-9-CM HCPCS (CPT and 
HCPCS Level II)
* “Billing and Coding for Health Services” In Essentials of Health Care Finance, Sixth Edition, By William O. Cleverley and Andrew E. Cameron, Jones and Bartlett Publishers, 
Inc., 2007, p. 17.
International Classification of Diseases 9th Revision—Clinical Modification
The ICD-9 system has codes that supply a payor with information regarding both the patient diagnosis 
and the procedures performed in treating the diagnosis.27 HIPAA requires all healthcare providers to 
use the ICD-9 codes when reporting diagnosis information to payors.28 In addition, HIPAA requires that 
hospitals use the ICD-9 procedural codes when reporting information to payors detailing the treatment 
of hospital inpatients.29
Shift from ICD-9 to ICD-10 Coding
In early 2009, the United States Department of Health and Human Services (HHS) announced a final 
rule that called for the replacement of the current ICD-9 code set used to report healthcare diagnoses and 
procedures with the International Classification of Diseases, Tenth Revision (ICD-10) set by October 1, 
2013.30 The adoption of the new system offers several benefits, including the facilitation of quality data 
reporting, support for pay for performance payment methodologies, improved billing accuracy, and al-
lowances for international comparison of the incidence and spread of disease.31
Differences between ICD-9 and ICD-10
Note the several major differences between the current ICD-9 code set and the new ICD-10 code set: 
• Size. The ICD-9 code set contains 17,000 codes and parts of the code set are running out of space, 
whereas the ICD-10 code set contains more than 155,000 codes and has ample room for the addi-
tion of new diagnoses and procedures.
• Specificity. The new ICD-10 code set provides for greater specificity when diagnosing conditions. 
For example, under the new system, 1,170 codes describe angioplasty, whereas the ICD-9 code set 
has only one.
• Basic information. It is anticipated that the ICD-10 system will improve the quality of care pro-
vided through the communication of basic information the ICD-9 code does not provide, such as 
informing providers about which side of a patient’s body the condition occurred.32
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Financial Impact of the Shift
The switch to the ICD-10 code set will not be without costs. According to a 2008 study, physicians will 
incur significant expenditures associated with the change in six key areas: employee education and train-
ing, business processes, billing documents, information technology systems, documentation, and disrup-
tions in cash flow.33 Although the extent of these expenditures will vary by practice, the study estimates 
that they will range from a little more than $83,000 for a “small” practice, consisting of three physicians 
and two administrative employees, to slightly more than $2.7 million for a “large” practice, consisting of 
100 providers, ten full time coders, and fifty-four medical records employees.34
Expenditures for the shift from ICD-9 to ICD-10 is estimated to  
cost anywhere from $83,000 to $2.7 million, depending on the  
size of the practice.
“The Impact of Implementing ICD-10 on Physician Practices and Clinical Laboratories: A Report to the ICD-10  
Coalition” by Nachimson Advisors, LLC, Nachimsonadvisors.com, October 8, 2008, http://nachimsonadvisors.com/
Documents/ICD-10%20Impacts%20on%20Providers.pdf, (accessed October 7, 2009) p. 3–4, 6.
Healthcare Common Procedure Coding System (HCPCS)
The Healthcare Common Procedure Coding System (HCPCS) provides a payor information in regard 
to the procedures performed in the treatment of patients.35 The system does not relay diagnosis informa-
tion.36 Hospitals use HCPCS codes to report information on procedures performed for outpatient ser-
vices; physicians use them to report information in connection with the performance of procedures in 
both the inpatient and outpatient settings.37 There are two HCPCS levels: Level I codes are referred to as 
Current Procedural Terminology (CPT) codes, and Level II codes are temporary codes used to represent 
services, supplies, and procedures for which CPT codes do not yet exist.38
Current Procedural Terminology (CPT)
Current Procedural Terminology (CPT) is a system developed by the American Medical Association 
(AMA) that providers use to report information to patients and to insurers about services and procedures 
provided to patients.39 In response to the Medicare Prescription Drug, Improvement, and Modernization 
Act of 2003 (MMA), the Centers for Medicare and Medicaid Services (CMS) adopted regulations that 
require “new, revised, and deleted CPT codes be implemented” on the first day of January each year.40
Many times, multiple combinations of HCPCS and CPT codes apply to a particular procedure.41 
Despite the many ways in which to code for a procedure, however, providers are not allowed to sepa-
rate, or “unbundle,” codes for different components of a comprehensive procedure if a code exists for 
the entire procedure.42 CMS developed the National Correct Coding Initiative (NCCI) in an effort to 
prevent improper coding (for example, unbundling CPT codes in an effort to receive higher payments) 
and standardize national coding procedures.43 The NCCI policy manual lists HCPCS and CPT codes 
that cannot be reported together unless a NCCI-associated modifier is used in a clinically appropriate 
manner.44 NCCI denies claims when certain pairs of codes are reported together because one of the two 
codes may represent a component procedure to the procedure described by the other code, or because the 
two described procedures cannot possibly be performed together.45 Additionally, some procedures that 
are integral to more comprehensive procedures (for example, wound irrigation is essential to the com-
prehensive treatment of all wounds) do not have CPT codes at all, and, therefore, should not be reported 
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separately.46 For more information on the liability associated with improper coding see chapter 3, False 
Claims Act (FCA).
Modifiers
Modifiers are two-digit codes added to five-digit CPT codes to clarify the services and procedures 
performed.47 Modifiers may be added to CPT codes for a number of reasons, including that the proce-
dure was performed more than once, performed by more than one physician, or discontinued because 
of threats to a patient’s health.48 Both the AMA and CMS update the list of modifiers on a continuous 
basis.49 The expansion of modifiers presents the potential for some of the same operational and financial 
challenges as does the expansion of CPT codes.50 A provider’s costs may increase if billing time in-
creases and the need for staff training arises.51 However, as with expansions to the CPT coding system, 
an increase in the number of modifiers may lead to increased revenue, because the added modifiers may 
lead to reimbursement for procedures and services not previously covered.52
Step 3: documentation to captuRe the chaRge
Upon completion of the coding and documentation process, “the revenue cycle moves from the clinical 
side to the business side.”53 Capturing the charge entails the transfer of a provider’s coding and docu-
mentation to the actual bill.54 Providers are tasked with recording the appropriate procedure and diag-
nosis codes on an encounter form, and their business staff is responsible for ensuring that the encounter 
form is accurate before using it to bill patients and third-party insurers.55
Electronic Charge Capture
To improve charge capture and revenue generation, the more technologically advanced practices have 
begun using personal digital assistants to capture charges.56 The electronic capture systems are then tied 
into the practice’s practice management system, a computer system designed to collect registration and 
insurance information, facilitate billing and collections, and perform other operational functions so that 
charges can be downloaded and posted electronically.57 These systems help reduce errors that may occur 
in the capture process, and they reduce the time between service and charge entry.58
Capturing Revenue for Office- and Hospital-Based Professional Practices
Office-based professional practices can capture inpatient charges in a variety of ways. Typically, if a 
practice has not adopted an electronic charge capture system as described previously, it may rely on the 
older method of charge capture which requires the physician to actually note every consult or procedure 
he or she performs on a paper form.59 Other practices hire staff to review hospital charts onsite for all pa-
tients seen by the practice’s physicians.60 In addition, to capture charges when the office-based practice 
is closed, some providers have set up a phone message system to which the physician can call, in order 
to record the relevant patient information, and from which the staff performs the relevant billing actions 
when the office reopens.61
Hospital-based professionals typically capture charges in much the same way as their office-based 
counterparts, using either paper forms or electronic charge capture devices, although their bills are then 
submitted to the hospital’s billing department.62
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Step 4: patient and inSuRance Billing
Once a provider has properly coded and documented the services provided, its staff must ensure the ac-
curacy of the charge captures in order to facilitate accurate and timely billing of patients and third-party 
insurers.63 Many providers implement practice management systems, process claims electronically, work 
to maintain relationships with payors, develop internal information system processes, and develop other 
steps to ensure the effectiveness of the billing process.64 Without an effective billing process, the rev-
enue cycle will breakdown, money will be lost, and the full financial potential of the practice will not be 
realized.65 Details on billing to particular payors are included in Current Reimbursement Environment.
Step 5: account Follow-up and collectionS
Submitting claims to third-party payors and sending bills to patients are not always sufficient to ensure 
timely payment, and follow-up on overdue accounts is often necessary to correct billing errors or to 
encourage payment by those who refuse to pay or cannot pay in a timely manner.66 Thus, the revenue 
cycle is complete with the successful performance of the account follow-up and collection process.67 A 
practice’s past due accounts should be continually monitored, and when attempting to collect payment, 
it should use frequent phone calls, e-mails, and collection letters and other forms of communication as 
needed.68
Use of Lockboxes
Instead of handling the collection and processing of payments themselves, providers may decide to use a 
lockbox service. For a fee, lockbox services open a provider’s mail, collect payments, and deposit pay-
ments into the provider’s account.69 A lockbox service is convenient in that it saves the practice the time 
and resources of performing these procedures themselves. However, if the lockbox service is slow to 
process the payments, a payor who has properly paid its bill may receive another statement from the pro-
vider requesting payment, thereby creating more work for the provider and frustration for the patient.70
Accounting for Bad Debt
Regardless of the amount of effort a provider puts into the collection process, some account balances 
may never be collected. In these instances, providers will likely write the “balance off the accounts 
receivable as bad debt.”71 At this time, the provider must then decide whether to send the account to an 
outside collection agency, which will attempt to recover the balance for a fee, or give up all attempts at 
recovery because it may cost more to further pursue payment than to receive the outstanding amount.72
Changing Nature of the Revenue Cycle
Experts predict that competitive pressure, as well as newly adopted and pending revenue cycle manage-
ment regulations, will force providers to assess their revenue cycle management systems, resulting in 
system upgrades and the purchase of new systems over the next several years.73 Providers with older 
revenue cycle management systems may need to upgrade these systems in order to improve patient 
satisfaction and convenience and to allow providers to more efficiently manage their revenue cycles.74 
Patient satisfaction, convenience, and increased efficiency will result from, among other things, the 
patient’s ability to pre-register, schedule, and pay for their services by way of their provider’s website.75 
Similarly, providers will benefit from new systems that improve efficiency by way of checking the 
payor’s rules to ensure that the services to be performed are covered by the payor, automatically creating 
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bills from the electronic medical record, bypassing clearinghouses and submitting claims directly to pay-
ors, enabling providers to receive electronic funds transferred directly from the payor to the provider’s 
bank, and allowing providers to integrate their financial and clinical data.76
Current Reimbursement Environment
Public Payors
As the baby boomer generation becomes eligible for Medicare, public payor spending is expected to 
grow at a greater rate than private payor spending, surmounting 50 percent of total national health 
expenditures by 2016.77 This prevalence of public payors in the healthcare marketplace typically tends 
to set the benchmark for private reimbursement rates.78 Among these influential public payors are Medi-
care, Medicaid, State Children’s Health Insurance Program (SCHIP), TRICARE, Civilian Health and 
Medical Program of the Department of Veteran Affairs (CHAMPVA), workers’ compensation, and 
Indian Health Services (IHS).
medicaRe
Overview
Medicare was created in 1965 as Title XVIII of the Social Security Act.79 The program, originally 
known as the Health Insurance for the Aged and Disabled Act, is an entitlement program available to 
individuals over the age of sixty-five.80 During the 1970s, benefits were extended to include the disabled 
and individuals with end-stage renal disease (ESRD).81 Medicare is divided into four parts: (1) Part A, 
which covers inpatient hospital care; (2) Part B, which covers outpatient visits; (3) Part C, which people 
can choose as a managed care replacement of Part A and B; and (4) Part D, created under the MMA and 
implemented in 2006, which covers prescription drug benefits.82 Individuals may enroll in coverage for 
Parts A and B, in which they pay a premium only for Part B, or they may elect to enroll in Medicare 
Advantage (MA), also known as Medicare Part C, managed care plan that will cover both inpatient and 
outpatient services. Individuals may or may not decide to enroll in Part D.83
Medicare reimburses providers using a combination of fee-for-service (FFS), managed care ar-
rangements, and payments from health savings accounts (HSA).84 Medicare does not process or pay 
claims directly, rather it contracts with insurance companies to perform these services for them.85  
Fiscal intermediaries are insurance companies that handle claims for hospitals, skilled nursing facilities, 
intermediate care facilities, long-term care facilities, and home health agencies.86 By contrast, carriers 
process claims for physicians, providers, and suppliers.87 In addition, private companies provide medical 
and hospital coverage to enrollees of MA (Part C).88
Medicare reimburses for services provided to enrollees of Medicare Part A and Medicare Part B. 
Medicare Part A provides insurance coverage for inpatient care in acute care hospitals, critical access 
hospitals, and skilled nursing facilities, and Medicare Part B covers a portion of the costs associated with 
the beneficiary’s physician services, outpatient hospital care, and other services not covered by Part A.89 
Under federal law, all providers and suppliers must submit claims if they provide a Medicare-covered 
service to a beneficiary enrolled in Medicare Part B90 (see chapter 3, False Claims Act (FCA)).
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Medicare should be billed as the primary payor when: 
• An employee has chose not to enroll in, or has recently dropped, his or her coverage in a group 
health plan;
• An employee is not yet eligible for group health plan coverage or has depleted his or her benefits 
under the plan;
• The insurance plan only covers the self-employed;
• The insurance plan is an individual plan and was not obtained through a group;
• The patient has coverage through TRICARE;
• The patient is younger than sixty-five, is covered by Medicare due to a disability or ESRD, and 
does not have employer-sponsored health insurance;
• The patient is younger than sixty-five, has ESRD, and is covered by an employer sponsored health 
insurance plan, but the patient has been eligible for Medicare for more than thirty months;
• The patient has left a company through which they were covered under a group health plan and has 
coverage under federal Consolidated Omnibus Budget Reconciliation Act); or
• The patient has both Medicare and Medicaid.91
Medicare administrative contractors are required to pay clean claims, that is, those with the req-
uisite data needed to process and pay the claim, within thirty days from receipt, and must pay interest 
on those clean claims paid after thirty days.92 Federal regulation also mandates that MA organizations 
pay 95 percent of clean claims submitted by nonparticipating providers in thirty days and pay interest 
on clean claims that are not paid prior to this deadline.93 In addition, MA organizations must include a 
prompt payment provision in their contracts with participating providers, although the organization and 
the participating provider are free to agree upon its terms.94 Typically, if an electronic claim is submitted, 
providers can receive Medicare reimbursement in fourteen days.95
As mentioned previously, Medicare pays for services provided by physicians, allied health profes-
sionals, nurse practitioners, and other paraprofessionals, with few exceptions.96 In particular, Medicare 
makes certain distinctions for reimbursement based on the site of service of particular allied health 
practices. For more information on reimbursement of nonphysician providers, refer generally to topics 
covered in Professional Practices, chapters 4 and 5, and specifically to the following sections in those 
chapters: Dental Reimbursement, Optometric Reimbursement, Chiropractic Reimbursement, Psychology 
Reimbursement, and Podiatry Reimbursement.
A unique aspect of the Medicare reimbursement system is the participating physician program, 
which originated with the 1984 Deficit Reduction Act.97 Under the program, Medicare and physicians 
enter into participating provider (PAR) agreements by which the providers agree to accept the reim-
bursement amount set by the Medicare physician fee schedule (MPFS), as payment in full for every 
claim.98 The physician may bill the patient for the patient’s share of the co-insurance and the patient’s 
deductible, but it cannot balance bill the patient, that is, attempt to collect the difference between its 
usual fee and Medicare’s lower allowed charge.99
Like any other third-party payor system, Medicare beneficiaries may be subject to premiums, deduct-
ibles, and co-insurance, all of which vary according to their coverage, income, and services sought.100
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Medicare reimburses providers at different rates depending on whether payments are being made under 
Part A or Part B (that is, inpatient or outpatient), and reimburses outpatient procedures at different rates 
based on the site of service. For reimbursement under Part A, hospitals are reimbursed under the Inpa-
tient Prospective Payment System (IPPS) using diagnosis-related groups (DRGs) that classify patients 
based on the average per discharge cost of caring for their diagnosis.101 Each DRG is assigned a relative 
rate based on its average cost, which is then multiplied by the input-price level of each market to deter-
mine the payment rate for the DRG.102 In certain cases, these payments are increased for hospitals with 
academic medical centers or for hospitals that serve a disproportionate amount of low-income patients, 
although payments are reduced for some transfer cases. Finally, additional reimbursement may be paid 
in cases of patients who represent particularly expensive outliers.103
For reimbursement under Part B, hospital outpatient departments (HOPD), ambulatory surgery 
centers (ASCs), and physician offices are all reimbursed under distinct payment systems.104 When physi-
cians provide services and perform procedures in their offices, they are reimbursed under the MPFS 
for their professional services. When procedures are provided in hospitals or ASCs, however, they are 
reimbursed under both the MPFS (for the physician services) and the hospital Outpatient Prospective 
Payment System (OPPS), which reimburses for the cost of facilities, equipment, supplies, and hospital 
staff for services provided in a HOPD or ASC.105 OPPS payments are classified by service groups called 
Ambulatory Payment Classifications (APC), each of which includes services that are clinically similar to 
one another and require similar resources.106 Each APC has a relative weight that reflects the median cost 
of services in that group.107
For most services performed in an ASC, payment is made under a revised ASC payment system 
that began implementation in 2008. The revised system bases ASC payment rates on the APC relative 
weights for similar services and extends payment to more surgical services in ASCs.108 The new pay-
ment system aligns ASC reimbursement rates at a percentage of the OPPS rates.109 Due to the need to 
ensure budget neutrality between the old ASC payment system and the revised system, the reimburse-
ment rate for ASC procedures was set at 65 percent of the HOPD rate in 2008.110 CMS cut this rate to 59 
percent of the HOPD rate in 2009 and only increased the conversion factor for payments to ASCs by 1.2 
percent for 2010, despite an increase of 2.1 percent for HOPDs for the same year.111 However, CMS sig-
nificantly expanded Medicare reimbursement for procedures performed in ASCs to any procedure that 
does not pose a significant safety risk and that would not require longer than a twenty-four-hour stay.112
Few procedures performed in ASCs exist that are not reimbursed at the OPPS percentage. Of these, 
services performed in ASCs that are generally performed in physician offices at least 50 percent of the 
time constitute “new, office-based procedures,” which CMS began paying for in ASCs in 2008.113 In an 
effort to prevent physicians from moving their practices out of their offices and into ASCs, CMS deter-
mined that it would reimburse for these services performed in an ASC at a rate that is the lower of the 
ASC rates (that is, the percentage of the OPPS rate) or the practice expense portion of the MPFS pay-
ment rate that would apply to the procedure if it had been performed in a physician’s office.114 Based on 
the same objective of discouraging shifting procedures to ASCs, CMS also excludes from the revised 
ASC payment rates reimbursement for separately payable radiology services, instead applying the same 
reimbursement policy as for office-based procedures.115 CMS also decided to reimburse for drugs pro-
vided in ASCs at the OPPS rate, rather than the ASC revised rate, under the same theory.116
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Appendix A, found at the end of this chapter, shows historic changes in Medicare payments charged 
in the industry segments discussed in this section.
Physician Reimbursement and Billing: The Resource Based Relative Value  
Scale (RBRVS)
Medicare reimbursement is based on a standardized physician payment schedule based on a resource-
based relative value scale (RBRVS), which determines payments based on the value of the resources 
necessary to provide a particular service.117
History and Background
The RBRVS was introduced in 1988 as a mechanism to control the cost of physicians’ services borne 
by the Medicare program. William C. Hsiao from the Harvard School of Public Health developed it 
from the results of a 1988 study that was conducted in order to address the growing inequity between 
reimbursement rates for procedural services and those for cognitive clinical services, as well as the rapid 
increase in Medicare spending.118 The system also was intended to bring medical practice payment more 
in line with a PPS, whereby reimbursement is based on a predetermined, fixed amount, and away from a 
purely FFS system.119 The RBRVS system was implemented in 1992, and it is updated annually by the 
CMS.120
The RBRVS was created by William C. Hsiao in 1988 in order to (1) address 
the growing inequity of reimbursement rates for procedural services  
for cognitive clinical services and (2) address the rapid increases  
in Medicare spending.
“Resource-based Relative Value Units: A Primer for Academic Family Physicians,” by Sarah E. Johnson, MD, and 
Warren P. Newton, MD, MPH, Family Medicine, March 2002, p. 172–73.
Hsiao’s Research
Dr. Hsiao’s research consisted of examining components of providing care, such as physician work, 
practice costs, and the opportunity costs associated with training.121 Through a series of surveys, the 
Hsiao study determined the relative value of the service-specific work component by establishing ways 
of quantifying work, including the time spent before, during, and after a procedure, as well as measur-
ing the intensity of the work.122 By conducting interviews with physicians, Hsiao and his team were able 
to develop a common scale describing and quantifying the resource costs needed to provide physician 
services across all fields of medicine.123
Transition from Customary Prevailing and Reasonable (CPR) to Prospective Payment System with 
Resource-Based Relative Value Scale
The Omnibus Reconciliation Acts of 1989 and 1990 implemented a new fixed-fee schedule for Medicare 
services.124 The MPFS became effective January 1, 1992, and replaced the previous customary prevail-
ing and reasonable (CPR) charge system with the RBRVS, which is based on estimates of resource 
costs incurred in an efficient medical practice.125 CPR payments were based on fees charged by provid-
ers by specialty within particular regions of the country, whereas the RBRVS fee schedule is a list of 
predetermined payments for healthcare services provided to patients.126 The RBRVS was intended to 
place greater emphasis on time spent with a patient when assessing health, diagnosing conditions, and 
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listening to complaints, thereby distributing Medicare payments more equitably among physicians who 
traditionally had seen higher payments to specialists and lower payments to family practitioners.127
Utilizing Relative Value Units (RVU) When Determining Fees and Costs
The MPFS constitutes a list of payment rates for different services based on their particular HCPCS 
codes.128 The MPFS bases its payments on a single cross-specialty RBRVS with payment determined by 
a procedure’s relative value units (RVUs).129
There are three RVU components: one for physician work, one for practice expense, and one for 
malpractice costs. These components can be broken down as follows:
1. Work. The estimated value of the time, effort, expertise, and intensity of the service— 
approximately 55 percent of the RVU value.
2. Practice expense. The estimated value of overhead and other expenses necessary to run the  
practice—approximately 42 percent of the RVU value. 
3. Professional liability insurance. The estimated value of malpractice cost for the service— 
approximately 3 percent of RVU value.130
These RVU components, as well as total RVU, are often adjusted using modifiers. Local geographic 
differences are accounted for by multiplying each RVU component by its corresponding geographic 
practice cost index (GPCI). By multiplying total RVU (the sum of geographically adjusted components) 
by a conversion factor (CF), the dollar amount of governmental reimbursement may be determined.131
The formula for calculating the Medicare physician reimbursement amount for a specific procedure 
and location is as follows: 132
Payment = [(wRVU * GPCI work) + (RVU PE * GPCI PE) + 
(RVU malpractice * GPCI malpractice)] * CF
RVUs are updated annually by committees from the AMA. Committees listen to testimony from 
practitioners and update the RVU modifiers as necessary.133 The three RVU components, GPCI, and CF 
are discussed further in the following sections.
Work Component
The work RVU component represents a physician’s contribution of time and effort to the completion of 
a procedure. For example, a colonoscopy will have a higher work RVU than an intermediate office visit 
because the colonoscopy requires more time and skill.134 The higher the value of the code, the more skill, 
time, and work it takes to complete.
Practice Expense Component
The practice expense RVU component is based on numerous expenses that are incurred as a cost of pro-
viding the service or overhead of the practice, including the costs associated with office space, supplies, 
equipment, and nonadministrative staff.135 The practice expense RVU component is calculated using a 
bottom-up methodology in which direct costs (for example, costs than can be assigned, such as the cost 
of supplies) are calculated and indirect costs (for example, costs that cannot be assigned but are the costs 
of owning a practice, such as the cost of having a waiting room) are allocated.136
The practice expense RVU component may be a different type of RVU depending on whether 
services were provided in a facility setting (for example, a hospital), or in a nonfacility setting (for 
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example, a freestanding center) because of differences in the cost of operation.137 The formula discussed 
previously can therefore be rewritten as:
2009 Facility Payment Amount =
Payment = [(Work RVU * Work GPCI) + (Facility PE RVU * PE GPCI) + 
(MP RVU * MP GPCI)] * [Conversion Factor adjusted for budget neutrality]
2009 Nonfacility Payment Amount =
Payment = [(Work RVU * Work GPCI) + (Nonfacility PE RVU * PE GPCI) + 
(MP RVU * MP GPCI)] * [Conversion Factor adjusted for budget neutrality]138
Services that are billed by a nonfacility receive a higher practice expense RVU component than 
services billed by a facility because the practice expenses are higher for a physician office than for a 
hospital.139 When a service is billed by a nonfacility, the practice expense RVU component compensates 
the physician’s practice for the costs of owning and operating a practice, but when a service is billed by 
the facility, costs associated with clinical personnel, equipment, and supplies are incurred by the facility, 
not the practice.140 This makes the practice expense RVU component lower.141 The 2009 practice ex-
pense RVU components are often described as “transitioned” or “transitional,” because 2009 is the third 
year of transition to a new methodology for calculating practice expense. The new methodology will be 
implemented fully in 2010.142
A sample set of RVU data can be found in appendix B at the end of this chapter to illustrate how to 
calculate the various components involved in determining compensation using this approach.
Malpractice Expense Component
Section 1848(c) of the Social Security Act, “Payment for Physician Services,” requires CMS to de-
velop resource-based malpractice RVU components as part of the method for physician reimburse-
ment.143 These RVUs correspond to the relative malpractice practice expense for medical procedures.144 
These values are updated at least every five years and typically comprise the smallest component of the 
RVU.145 Due to the variation in malpractice costs among states and specialties, the malpractice compo-
nent must be weighted geographically and across specialties.146
Geographic Practice Cost Index
The Geographic Practice Cost Index (GPCI) accounts for the geographic differences in the cost of main-
taining a practice. Every Medicare payment locality has a GPCI for the work, practice, and malpractice 
component.147 A locality’s GPCI is determined by taking into consideration median hourly earnings of 
workers in the area and the average cost of office rental, medical equipment and supplies, and other mis-
cellaneous expenses.148 There were eighty-nine GPCI payment localities as of 2009.149
Conversion Factor
The CF is a monetary amount that is multiplied by the RVU from a locality to determine the payment 
amount for a given service.150 This conversion factor is updated yearly by a formula that takes into ac-
count (1) the previous year’s conversion factor, (2) the estimated percentage increase in the Medicare 
Economic Index for the year (which accounts for inflationary changes in office expenses and physician 
earnings), and (3) an update adjustment factor.151 All physician services, except anesthesia services, use 
a single conversion factor.152
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The CF is part of an annual update made to the 
MPFS by CMS based on an updated formula man-
dated in the Balanced Budget Act of 1997, which 
includes application of the sustainable growth rate 
(SGR) when determining MPFS rates.153 Based on 
inflation, Medicare enrollment, growth of GDP, 
and regulatory developments, the SGR represents 
a spending target set for total annual expenditures 
under Medicare on Part B services, and annual ad-
justments are made to the MPFS based on whether 
actual spending came in above or below the tar-
get.154 If actual spending is above the target, pay-
ment update rates are adjusted down; likewise, if 
actual spending is below the target, payment update 
rates are adjusted up. 155
The SGR formula has indicated downward 
adjustments to the MPFS every year since 2002; 
however, CMS averted the adjustment in 2003, 
and the United States Congress has intervened and 
overridden the MPFS decreases to the CF for the 
past several years, typically replacing scheduled 
cuts with increases in payment.156 The annual changes in physician reimbursement from 1998 through 
2009, after Congressional intervention, are shown in table 2-2.
Professional Component Versus Ancillary Services and Technical Component
The MPFS differentiates between two distinct revenue streams: the professional services component and 
the ancillary services and technical component (ASTC).157 To use the performance of diagnostic services 
as an example, a provider performs the technical component when he or she executes functions such as 
taking an x-ray or administering an electrocardiogram.158 Providers then perform the professional com-
ponent when they interpret the results of those tests or write reports.159 Providers must use the appropri-
ate procedure code modifiers on submitted claims to distinguish between the services they performed 
and those performed by others, such as the hospital, technicians, or other staff, because a provider may 
only bill for services he or she provides.160
CMS Anti-Markup Rule
If a provider orders a diagnostic test from another supplier, he or she may bill Medicare for the techni-
cal component of that diagnostic test, even though he or she didn’t perform the technical component.161 
However, that provider may not “mark-up” the bill he or she submits for Medicare reimbursement above 
the amount he or she paid for the test to reflect additional professional component costs associated with 
reading and interpreting the test.162 Additionally, the 2008 MPFS expanded this anti-markup provision 
to both professional and technical component revenue generated by tests performed outside the office 
of the billing physician.163 For example, with a group practice, both the professional component and the 
technical component must be performed in the same building, rather than the technical component being 
performed at a separate diagnostic testing facility.164 However, the 2009 MPFS lessened the rigidity of 
Table 2-2:  Medicare Updates: Changes in Physician 
Payment*













Average: 1998-2009  1.07%
* “Estimated Sustainable Growth Rate and Conversion Factor, for Medicare 
Payments to Physicians in 2010,” Centers for Medicaid and Medicare Services, 
November 2007, p. 8, http://www.cms.hhs.gov/SustainableGRatesConFact/
Downloads/sgr2010p.pdf (accessed October 10, 2009).
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the 2008 MPFS rule by incorporating the following two exceptions for times when the billing physician 
is exempted from the “anti-markup rule:”
1. The technical component is supervised by a physician who performs “substantially all” (that 
is, 75 percent or more) of his or her professional services for the billing physician, physician 
organization, or supplier.
2. The technical component is conducted and supervised in the “same building” as the medical 
office of the ordering physician or authorized nonphysician provider is located.165
Incidentally, an increasingly volatile regulatory environment surrounding physician ownership is 
being driven by competition over who should benefit from ASTC revenues. Federal legislators consis-
tently have advocated against physicians earning profits, which compounds the problem of declining 
reimbursement under the MPFS for the professional component of diagnostic imaging services, which 
has not kept up with inflation indices and has resulted in consistent decreases in physician professional 
component fee reimbursement yield.166 To attempt to counteract this trend, physicians have attempted to 
invest in ASTC revenue stream enterprises, for example, ASCs; independent diagnostic testing facilities, 
surgical hospitals, physical therapy, etc.167 However, there have been incessant legislative and regula-
tory efforts undertaken at the federal and state levels, in large part due to massive lobbying initiatives by 
oligopoly hospitals and their trade associations, to prevent this trend by restricting physician investment 
in ASTC revenue stream enterprises.168 These measures have served to relegate independent physicians 
in private practice to receiving only professional fee component revenues or to acquiesce by accepting 
employee status under the substantial control of hospital systems or large corporate players.169 In cases 
in which physicians receive only the professional fee component, many physician owners are finding it 
very difficult to recover both the operating and capital expenses associated with running a practice.
Participating Providers (PARs)—Medicare Allowable Charge
In 2008, approximately 95 percent of all physicians billing Medicare were participating providers 
(PARs).170 To encourage physicians to enter into PAR agreements, Congress has developed special 
incentives including:
• direct payment of all claims; 
• a 5 percent higher fee schedule than for non-participating providers (non-PARs); 
• bonuses provided to Medicare administrative contractors for recruitment and enrollment of PARs;
• publication of an annual, regional PAR directory made available to all Medicare patients; 
• a special message printed on all unassigned Medicare Summary Notice forms mailed to patients, 
reminding them of the reduction in out-of-pocket expenses if they use PARs and stating how much 
they would have saved by choosing PARs;
• hospital referrals for outpatient care that provide the patient with the name and full address of at 
least one PAR provider each time the hospital provides a referral for care; and
• faster processing of assigned claims.171
In 2008, 94.9 percent of all physicians billing Medicare  
were participating providers.
“Providers and Suppliers: Table VI.6—Medicare Participating Physician Program” in “Centers for Medicare and 
Medicaid Services Data Compendium” CMS/OFM, December 2008, http://www.cms.hhs.gov/Data 
Compendium/16_2008_Data_Compendium.asp#TopOfPage, (accessed August 18, 2009).
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When a PAR bills Medicare for reimbursement 10 percent of cost (the difference between the cost of 
the service and the allowable fee) is written off by the PAR.172
Nonparticipating Providers (non-PARs)
Nonparticipating providers (non-PARs) are providers that have not agreed to accept the Medicare 
reimbursement amount for every claim. Yet, non-PARs are allowed to accept Medicare assignment on a 
claim-by-claim basis (see Nonparticipating Providers Accepting Medicare Assignment on a Claim-by-
Claim Basis), if they agree to:
• file all Medicare claims,
• restrict their fees for non-assigned claims in accordance with the aforementioned “limiting charge,” 
• forgo balance billing patients,
• collect only the patient deductible and co-insurance amounts at the time of service when accepting 
assignment on a claim, 
• require patients to sign a “surgical disclosure notice” when charges for nonassigned surgical fees 
exceed $500, and
• accept assignment on clinical laboratory charges.173
However, it should be noted that even though they have not accepted Medicare’s fee as payment in 
full, non-PARs are subject to a “limiting charge,” which dictates what they may charge Medicare benefi-
ciaries for covered services.174
Nonparticipating Providers Accepting Medicare Assignment on a Claim-by-Claim 
Basis—95 Percent of Medicare Allowable Charge (80 Percent Medicare,  
20 percent Patient)
Non-PARs that accept assignment on a claim-by-claim basis are subject to an allowable fee that is 5 
percent less than the allowable fee that PARs are paid for similar services.175 For example, if the Medi-
care allowable fee schedule for a PAR pays $100 for a service, Medicare would pay the PAR 80 percent 
of the allowable fee, or $80. The patient would be responsible for paying the PAR the remaining 20 
percent, or $20. However, a non-PAR accepting assignment on the same claim will have an allowable 
fee of 5 percent less, or $95 for the same service. Then, Medicare would pay the non-PAR 80 percent of 
the non-PAR fee schedule of $95, or a payment of $76. The patient would be responsible for paying the 
non-PAR the remaining 20 percent, or $19.
Although Medicare reimbursement differences can lead to a non-PAR being reimbursed more for a 
service than a PAR, a non-PAR’s prices are decreased by limiting charges and increasing costs for pa-
tients, which may decrease a non-PAR’s competitive advantage (see chapter 4, Boutique and Concierge 
Medicine).176
Nonparticipating Providers Rejecting Medicare Assignment—115 Percent of 95 Percent 
of Medicare Allowable Charge (100 pPercent from Patient)
A non-PAR may also treat Medicare patients without accepting the claim for assignment. When a non-
PAR decides not to accept assignment on a particular claim, he or she may only charge a maximum of 
15 percent above the non-PAR fee.177 For example, if the Medicare allowable fee schedule for a PAR 
pays $100 for a particular service, Medicare would pay a non-PAR accepting assignment on a claim for 
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the same type of service an allowable fee of 5 percent less, or $95. However, a non-PAR that chooses 
to submit a Medicare claim for the same type of service but chooses not to accept assignment may bill 
an amount equal to 115 percent of the allowable fee for non-PARs.178 Thus, the provider could charge a 
fee equal to 115 percent of $95, or $109.25. In this instance, the provider must file the unassigned claim 
with Medicare, which will then write the beneficiary a check for $76, or 80 percent of the allowable fee 
of $95. The provider must then collect the $76 from the patient, plus the patient’s 20 percent co-insur-
ance rate, or $19, and the additional $15 that the non-PAR was allowed to bill because he or she chose 
not to accept assignment on the claim. The ability to charge more than the Medicare allowable fee is 
offset by the increased risk that the provider faces from fact that he or she must collect the entire billable 
amount from the patient (see chapter 4, Boutique and Concierge Medicine).
medicaid and State childRen’S health inSuRance pRogRam
Overview
Medicaid is a state-administered health insurance program for low-income individuals and certain 
federally recognized eligibility groups.179 Medicaid is funded by participating state governments that 
receive federal matching funds as long as they operate their Medicaid programs within parameters set by 
the federal government.180
These parameters determine mandatory eligibility groups and mandatory services, that is, the groups 
and services the state must cover to receive federal Medicaid money.181 In addition to individuals be-
low a certain income threshold, the federal government mandates that states offer Medicaid coverage to 
children six and older whose families earn below 100 percent of the federal poverty level, children under 
age six below whose families earn 133 percent of the federal poverty level, parents who earn below 
their state’s welfare eligibility cutoff for 1996 (roughly 50 percent of the federal poverty level), pregnant 
women earning at or below 133 percent of the federal poverty level, elderly and disabled individuals 
earning at or below 74 percent of the federal poverty level who are receiving Supplemental Security 
Income, certain working disabled individuals, and Medicare buy-in groups.182
In addition to mandatory groups and services, states may also receive federal funds for covering 
other “optional” groups and services.183 States have significant discretion regarding to whom they extend 
Medicaid benefits beyond the mandatory groups, and many states opt to extend benefits to individuals 
who are above the income cutoffs found in the mandatory groups.184 Additionally, many states extend 
Medicaid benefits to individuals with significant recurring healthcare expenses and long-term healthcare 
needs.185
Although the federal government determines the medical services that will be covered and paid 
for by the federal portion of the program, Medicaid programs vary widely from state to state, as state 
governments are free to add additional services or expand eligibility to additional groups.186 Manda-
tory services include physician services; inpatient and outpatient hospital care; skilled nursing facility 
care; laboratory and x-ray services; early and periodic screening, diagnostic, and treatment services for 
individuals under the age of twenty-one; family planning and supplies; federally qualified health center 
services; rural health clinic services; nurse midwife services; certified pediatric and family nurse prac-
titioner services; nursing facility services for individuals age twenty-one and older; and home health 
services for individuals entitled to skilled nursing facility care.187 Optional services, by contrast, may 
include prescription drugs, dental services, and medical care provided by allied health professionals and 
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other nonphysician providers.188 It is important to look at a particular state’s Medicaid coverage manual 
to determine which optional groups and services that state covers.
Children’s Health Insurance Program (CHIP)
In addition to Medicaid, each state, territory, and the District of Columbia have implemented the Chil-
dren’s Health Insurance Program (CHIP), a state–federal partnership that provides assistance to 
children and pregnant women in families whose income is above the threshold for Medicaid.189 Enacted 
under the Balanced Budget Act of 1997, and formerly known as SCHIP, CHIP covered approximately 
4.8 million children in 2008, which is in addition to the number of children already covered under Med-
icaid (22.6 million in 2008).190
CHIP covered approximately 4.8 million children in 2008 which  
is in addition to the number of children already covered  
under Medicaid (22.6 million in 2008).
“Monthly CHIP Enrollment,” by Kaiser State Health Facts, http://www.statehealthfacts.org/comparemaptable.
jsp?ind=236&cat=4&st=3 (accessed October 6, 2009); “Monthly Medicaid Enrollment for Children,” Kaiser State 
Health Facts, www.statehealthfacts.org/comparemaptable.jsp?ind=612&cat=4 (accessed October 6, 2009).
CHIP programs vary among states which determine, within federal parameters, who may be eligible 
for CHIP funds, as well as other details such as benefits, payment levels, and administration.191 As part 
of their autonomy over CHIP programs, states are free to set premiums and co-payment rates on a slid-
ing scale based on income; funds are then matched by the federal government up to a certain capped 
amount.192
After a temporary reauthorization of the program in 2007, the Children’s Health Insurance Program 
Reauthorization Act of 2009 (CHIPRA) most recently reauthorized SCHIP through September 2013.193 
It is estimated that CHIPRA could extend CHIP and Medicaid coverage to 6.5 million children by 
2013.194 CHIPRA extends previous SCHIP coverage by now including dental services under the CHIP 
program, and it requires states offering coverage for mental health and substance abuse to have mental 
health parity.195
Billing and Reimbursement
Reimbursement for services provided to Medicaid patients are paid by states on either a FFS basis or 
under a pre-paid managed care arrangement.196 The Medicaid program requires the use of the CMS-
1500 claim form when seeking FFS reimbursement.197 Providers should consult their state’s Medicaid 
managed care organization (MCO) billing manual in order to determine how to bill for noncapitated 
managed care services, as these procedures may vary by state.198 Deadlines for filing a Medicaid claim 
range from two months to one year from the date of treatment.199 Thus, it is important for providers to be 
familiar with their particular state’s rules and deadlines for claim submission. Federal regulation re-
quires states to promptly pay practitioners for clean claims submitted for services rendered to Medicaid 
recipients.200 Under the regulation, states must pay 90 percent of clean claims in thirty days, 99 percent 
of clean claims within ninety days, and all other claims within twelve months of receipt unless limited 
exception apply.201
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Each state is free to develop its own reimbursement process and payment rates, with three 
exceptions: 
(1) For institutional services, payment may not exceed amounts that would be paid under Medicare 
payment rates; 
(2) For disproportionate share hospitals (DSH), hospitals that treat a disproportionate number of 
Medicaid patients, different limits apply; and 
(3) For hospice care services, rates cannot be lower than Medicare rates.202
Thus, states may impose deductibles, co-insurance, or co-payments on certain recipients for particu-
lar services.203 PARs in the Medicaid program must accept direct payments from Medicaid for services 
rendered as payment in full, and they may not bill patients the difference between their usual fee and the 
Medicaid reimbursement rate for covered benefits.204 Medicaid reimburses on a lump-sum basis, mean-
ing providers will receive one payment for several submitted claims.205
Medicaid is considered the “payor of last resort.”206 Thus, for Medicaid patients who also are 
covered by an insurance plan or another government program, including Medicare, TRICARE, 
CHAMPVA, or IHS, these plans or programs must be billed first.207 Claims should only be submitted to 
Medicaid if one of the other payors denies responsibility for payment or reimburses at a rate that is less 
than Medicaid’s fee schedule, or if Medicaid reimburses for procedures that are not covered by the other 
plans or programs.208
Disproportionate Share Hospital (DSH) Payments
Disproportionate share hospital (DSH) payments are a form of additional reimbursement under Med-
icaid for hospitals that care for a large number of Medicaid and uninsured patients.209 DSH payments 
are allotments from the federal government which augment basic Medicaid reimbursement, and under 
federal law, states are required to supplement DSHs in order to receive this additional Medicaid fund-
ing.210 DSH payments are intended to supplement hospitals when costs are not adequately covered by 
traditional Medicaid and Medicare payments, by SCHIP payments, or by other health insurance.211
DSH payments are calculated differently for each state according to a statutory formula, but no state 
receives more than 12 percent of its annual total Medicaid benefits in DSH allotments.212 The states with 
the highest DSH allotments are California, New York, Texas, Louisiana, and New Jersey.213 In order to 
receive its DSH allotment, a state must submit an annual report and a certified audit documenting pay-
ments made to DSHs, though the state has discretion over the hospitals to which it distributes DSH pay-
ments.214 The only limit on this discretion is that a state may not distribute DSH payments to any hospi-
tal with a Medicaid utilization rate less than 1 percent, and the state must distribute DSH payments to all 
hospitals that have either a Medicaid inpatient utilization rate exceeding one standard deviation or more 
above the mean for all hospitals in the state, or a low-income utilization rate of more than 25 percent.215 
If a state wants to distribute DSH payments to additional hospitals, it is free to do so; however, the state 
must distribute payments at a rate in line with the Medicaid DSH payment methodology or based on the 
hospital’s low-income utilization rate.216
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TRICARE, formerly known as the Civilian Health and Medical Program of the Uniformed Services 
(CHAMPUS), is the Department of Defense’s healthcare program for active duty military personnel; 
members of the National Guard and Reserves; retirees, their dependents, and survivors; and certain for-
mer spouses.217 The program uses military healthcare as the main provider of services, and supplements 
it with civilian healthcare providers, facilities, pharmacies, and suppliers.218 TRICARE covers approxi-
mately 9.4 million beneficiaries worldwide through a variety of plans, including FFS and managed care 
plans.219
Billing and Reimbursement
TRICARE reimburses providers for services rendered to beneficiaries using both FFS and managed care 
arrangements.220 The allowable fee is determined using Medicare’s RBRVS system, except TRICARE 
uses a slightly higher conversion factor and has made minimal modifications to the geographic re-
gions.221 TRICARE only renders payment for services provided by authorized providers, those providers 
that meet licensing and certification requirements, and those who have been certified to treat beneficia-
ries.222 Providers seeking reimbursement must submit claims using the CMS-1500 claim form within one 
year from the date the services were rendered.223
TRICARE offers a variety of programs with different beneficiary cost-sharing requirements, includ-
ing co-insurance, annual enrollment fees, co-pays, catastrophic caps, and deductibles.224 PARs must 
accept the allowable fee as payment in full, which prohibits them from billing the patient for more than 
the allowable charge for covered services.225 Nonparticipating, authorized providers may accept the al-
lowable fee on a case-by-case basis, or they can refuse to accept the fee, and bill the patient an amount 
not exceeding 15 percent above the TRICARE fee schedule.226 Excluded from the 15 percent limiting 
charge are claims from independent laboratory and diagnostic laboratory companies, claims for durable 
medical equipment, and claims from medical supply companies.227 A potential downside to not accept-
ing TRICARE’s allowable fee schedule is that the beneficiary files the claim using DD Form 2642 and 
is reimbursed by TRICARE.228 Thus, the provider must attempt to collect the entire bill from the benefi-
ciary, which is not always an easy task. TRICARE takes pride in the timeliness of its claims processing, 
paying more than 99 percent of claims in thirty days and all claims within sixty days.229
TRICARE is a primary payor if a beneficiary qualifies for Medicaid coverage, but it assumes sec-
ondary payor status if a patient is covered by another primary health plan.230 In addition, TRICARE will 
not pay for occupational injuries or diseases covered by workers’ compensation laws unless these bene-
fits have been exhausted.231 Thus, to ensure prompt payment, providers must understand the relationship 
among TRICARE and other insurance or health plans.
civilian health and medical pRogRam oF the depaRtment oF  
veteRan aFFaiRS (champva)
Overview
The Civilian Health and Medical Program of the Department of Veteran Affairs (CHAMPVA) 
is the Department of Veterans Affairs’ (VA) healthcare program for the spouses and children of veter-
ans who meet certain eligibility requirements. The CHAMPVA program and the beneficiaries are both 
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responsible for a portion of the beneficiaries’ healthcare costs.232 To be eligible for the program, a bene-
ficiary must be the spouse or child of a veteran who was declared to have a permanent service connected 
disability; the surviving spouse or child of a veteran who died as a result of his or her service related 
disability; the surviving spouse or child of a veteran who, at the time of his or her death, was determined 
to be permanently or totally disabled due to a service connected disability; or in certain instances, the 
surviving spouse or child of a service member who died in the line of duty.233
Billing and Reimbursement
The CHAMPVA program reimburses providers for services rendered on a FFS basis up to the 
CHAMPVA allowable amount, which is equal to Medicare and TRICARE’s allowable amount for simi-
lar services.234 All claims for reimbursement must be submitted to the CHAMPVA Health Administration 
Center within one year from the date of service.235 Claims submitted by providers should use the CMS 
1500 or the UB-04 (institutional providers) forms, and an itemized list of charges for each service must 
accompany every claim.236
CHAMPVA typically does not sign contracts with providers.237 Instead, providers elect to partici-
pate in the program by either submitting a claim or agreeing to treat a beneficiary.238 Providers choos-
ing to treat CHAMPVA beneficiaries must accept the allowable rate as payment in full; they cannot bill 
the patient for the difference between their usual fee for the service and the VA allowable amount.239 
A provider is free to refuse to accept the CHAMPVA allowable rate if he or she makes this fact clear 
to the patient before treatment is rendered.240 In these instances, the patient is responsible for paying 
the entire bill and submitting a claim to CHAMPVA for reimbursement up to the allowable amount.241 
CHAMPVA reimburses more than 95 percent of their claims within thirty days.242
It is important for providers to understand the relationship among payors, because CHAMPVA 
assumes the role of both primary and secondary payor. If a beneficiary is eligible for Medicaid, has a 
Medicaid or CHAMPVA supplemental insurance policy, or is eligible for a state’s Victims of Crime 
Compensation Program, CHAMPVA assumes the role of primary payor and all claims should be filed 
with CHAMPVA first.243 However, some CHAMPVA members may be enrolled in Medicare, covered 
by a workers’ compensation policy, or have other health insurance. In these instances, Medicare, the 
relevant workers’ compensation program, or the other health insurance plan should be billed first and 
CHAMPVA will assume the role of secondary payor.244
otheR puBlic payoRS
Workers’ Compensation
Federal and state laws mandate that employers provide workers’ compensation coverage for their em-
ployees.245 Workers’ compensation laws provide healthcare coverage and monetary payments to em-
ployees injured at work or suffering from an occupational disease. They also provide monetary benefits 
for the dependents of employees killed on the job.246 In addition, the laws limit the financial liability of 
employers, and they nearly eliminate the financial liability of co-workers for most accidents.247
The Department of Labor’s Office of Workers’ Compensation Programs (OWCP) oversees four 
workers’ compensation programs covering federal employees: The Energy Employees Occupational 
Illness Compensation Program, the Federal Employees’ Compensation Program, the Longshore and Har-
bor Workers’ Compensation Program, and the Black Lung Benefits Program.248
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In addition, each state establishes a workers’ compensation board or commission, tasked with ad-
ministering workers’ compensation programs that cover employees of private companies and state and 
local governments.249 Depending on the state, employers can comply with workers’ compensation laws 
by obtaining coverage through:250
• State insurance (or compensation) funds—Agencies that provide workers’ compensation insurance 
coverage to both public and private employers.
• Self-insurance plans—Plans under which employers set aside a percentage of capital funds to 
cover expenses that may arise. 
• Commercial workers’ compensation insurance—Policies purchased from commercial insurance 
companies.
• Combination programs—Programs under which employers cover their workers through a combi-
nation of any of the aforementioned methods.
Billing and Reimbursement
Providers treating ill or injured employees covered under one of the four federal workers’ compensa-
tion acts are reimbursed according to the Department of Labor’s OWCP fee schedule for the Federal 
Employees’ Compensation Program Act, the Longshore and Harbor Workers’ Compensation Program 
Act, and the Energy Employees Occupational Illness Compensation Program Act.251 A modified ver-
sion of the fee schedule is used to reimburse providers treating patients covered under the Federal Black 
Lung Benefits Act.252 The OWCP’s schedule is based in part on the fee schedule developed by CMS with 
some program specific adjustments.253 Claims for reimbursement should be submitted to the Depart-
ment of Labor using the UB-04 form for inpatient hospital charges and the CMS-1500 form for physi-
cian services.254 In addition, various forms, progress reports, and supplemental reports may be required 
as well.255 Bills must be submitted to OWCP by December 31 of the year following the year in which 
services were provided or by December 31 of the year following the year when the condition was first 
accepted as covered by the workers’ compensation program, whichever is later.256
Medicare claims for physician services must be submitted using the CMS-
1500 claim form, whereas ambulance companies, ambulatory surgery 
centers, home health agencies, hospice organizations, hospitals, psychiatric 
drug or alcohol treatment facilities, skilled nursing facilities, sub-acute 
facilities, stand alone clinical or laboratory facilities, and walk-in clinics 
must submit the UB-04 claim form. Medicare claims must be filed before 
December 31 of the year in which the services were provided, except 
in instances in which the service was provided between October 1 and 
December 31. These claims receive an extension, and must be filed before 
December 31 of the following year.
“Understanding Health Insurance: A Guide to Billing and Reimbursement, Ninth Edition” by Michelle A. Green and 
JoAnn C. Rowell, Delmar Cengage Learning, 2008, p. 305, 449.
Most state workers’ compensation programs reimburse providers using a fee schedule based on 
RUVs established by the state compensation board or commission, but some states have developed man-
aged care plans, as well.257 The claims forms, progress reports, and supplemental reports used, as well as 
the filing deadlines for them, vary from state to state.258
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Providers treating patients eligible for coverage under workers’ compensation programs must accept 
assignment, meaning they must accept the compensation as payment in full.259 Patients covered by work-
ers’ compensation programs are charged no fees at the time of treatment; they pay no deductible and no 
co-payment.260 In addition, the patient’s employer pays all premiums.261
indian health SeRviceS (ihS)
The Indian Health Services (IHS) Agency is located within HHS.262 The agency provides healthcare 
services to approximately 1.9 million American Indians and Alaska Natives directly through tribal 
healthcare programs and indirectly through purchases from private providers.263 Most of the agency’s re-
sources fund the care of American Indians or Native Alaskans living on or near reservations or Alaskan 
villages.264 However, Congress has provided some funding for programs for eligible individuals in urban 
areas as well.265
Billing and Reimbursement
On occasion, IHS needs to purchase healthcare services from private providers.266 In these instances, 
IHS contracts with non-IHS facilities and providers to deliver healthcare services when 
1. no IHS facility exists;
2. the direct care element is incapable of providing the required emergency or specialty care; 
3. the direct care element has an overflow of medical care workload; or 
4. supplementary alternate resources are needed.267
Typically, IHS pays providers for these services in accordance with the terms of the negotiated 
contract.268 When these services are purchased from hospitals participating in the Medicare program, the 
MMA provides IHS with the authority to limit the reimbursement amount to rates similar to those paid 
by the Medicare program.269 Providers should submit their claims to the IHS fiscal intermediary, Blue 
Cross Blue Shield (BCBS) of New Mexico, using the appropriate claim form.270
IHS is considered a payor of last resort, so if a patient has other insurance, providers should submit 
claims to the patient’s insurance provider first “notwithstanding any state or local law or regulation to 
the contrary.”271 The contract standards between IHS and BCBS of New Mexico call for 95 percent of 
clean claims submitted to the IHS fiscal intermediary to be completed within twenty-one days.272
Private Payors
Private health insurance consists of commercial insurers, BCBS plans, MCOs, and self-funded plans. In 
2007, private health insurance financed 35 percent of the amount spent on personal healthcare.273
commeRcial inSuReRS
Overview
Commercial health insurers entered the health insurance market in the 1940s.274 Commercial health 
insurance refers to plans that are offered by life insurance companies, casualty insurance companies, 
and companies that were formed for the sole purpose of offering health insurance.275 Commercial insur-
ers are taxable entities organized as either mutual or stock insurers.276 Mutual insurance companies are 
owned by their policyholders, whereas stock insurance companies are owned by their stockholders.277 
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Commercial insurers typically offer a variety of health insurance plans, which offer varying trade-offs 
between cost, the variety of the services covered, and the flexibility to select providers.
Billing and Reimbursement
To compete in today’s health insurance market, many commercial insurers offer a variety of plan op-
tions. Thus, it can be hard to generalize patient and insurance billing requirements for commercial insur-
ers, because co-pay and deductible amounts, reimbursement methods, claim form requirements, claims 
submission deadlines, remittance schedules, policies, and the claim submittal process will vary by plan. 
Further complicating matters, it is uncommon for commercial insurers to publish their billing manuals or 
inform providers of changes to their claims process.278 Thus, to avoid claim denials and to ensure maxi-
mum reimbursement, it may be important for providers to routinely contact commercial insurers with 
whom they frequently work in order to stay informed of any changes to the claims process.
Blue cRoSS Blue Shield
Overview
Blue Cross began providing private health insurance in 1929 by offering coverage for hospital ex-
penses.279 Blue Shield began providing insurance to cover expenses associated with physicians’ services 
in 1939.280 In 1986, the independent boards of directors of the national Blue Cross and Blue Shield 
(BCBS) accrediting associations merged to form a single nonprofit BCBS Association (BCBSA).281 
Today, the BCBSA consists of thirty-nine independent BCBS companies.282 The BCBSA works to coor-
dinate the nationwide plans by establishing standards for new plans and programs; assisting local plans 
with enrollment activities, national advertising, public education, professional relations, and statistical 
and research activities; and serving as the primary contractor for processing Medicare hospital, hospice, 
and home health claims.283
During the 1990s, many nonprofit BCBS plans were in need of additional capital in order to compete 
with for-profit insurers and requested permission from their respective state governments to convert to 
for-profit corporations.284 In the instances in which the plans were allowed to convert to for-profit status, 
the transitions were closely watched to ensure that the plans’ charitable assets were preserved.285
BCBS plans offer a variety of health insurance options, including FFS coverage, indemnity plans, 
managed care plans, a federal employee program, Medicare supplemental plans, and Healthcare Any-
where—an option that allows enrollees of independently owned and operated plans to receive the ben-
efits of their plan from other BCBS plans worldwide.286
Billing and Reimbursement
BCBS reimburses providers using a variety of FFS payments and managed care arrangements.287 The 
allowable fee varies based on the plan—some plans use the physician fee schedule and others use a 
“usual, customary, and reasonable” system to determine the amount commonly charged by providers in 
the region.288 BCBS requires PARs to accept the allowable fee as payment in full.289 Non-PARs may col-
lect their full fee from the patient, who will in turn receive payment directly from BCBS.290
Depending on the enrollee’s coverage and the services sought, patients usually are subject to deduct-
ible and co-pay requirements, with co-pay amounts commonly ranging from 20 percent to 25 percent.291 
The CMS-1500 claim form is accepted by most BCBS plans, and it typically must be filed within one 
year from the date of service unless the provider’s contract states otherwise.292 Although reimbursement 
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Managed care plans integrate the financing (that is, insurance) and provision of health services under 
the administration of one MCO in an effort to contain costs.294 Because managed care plans assume risk, 
they focus on managing care as well as managing costs. Under managed care, costs are contained by 
holding providers accountable to offer quality services at predetermined levels of reimbursement. Man-
aged care plans hold providers accountable for providing care to a population through
1. clinical practice standardization,
2. selective contracting,
3. low-cost settings,
4. reduced discretionary hospital admissions, and
5. effective staff use.295
These mechanisms ensure that financial risk is shared by the managed care plan and the providers, 
forcing them both to be accountable for the delivery, cost, and quality of services.
Typically, managed care plans are created by an insurer that owns its own provider network or by an 
insurer that creates a network by way of contracts with independent providers.296 Managed care plans are 
structured in a variety of ways, each with their own unique characteristics. However, three of the more 
popular forms of managed care plans are health maintenance organizations (HMO), preferred provider 
organizations (PPO), and point-of-service plans (POS).
Health Maintenance Organizations (HMOs)
Health maintenance organizations (HMOs) are responsible for providing, or arranging for the pro-
vision of, healthcare services (including preventative care) for plan enrollees by way of contractual 
arrangements with providers.297 The HMO structure benefits health plans, enrollees, and providers.298 
Health plans benefit because they are able to limit their financial risk by contracting with providers to 
care for the enrolled population for a fixed amount per member per month. Enrollees receive the benefit 
of little or no deductibles and nominal or no co-payments for the care they receive; providers benefit 
from a steady stream of income regardless of how often enrollees seek care.299
The HMO came into existence in Los Angeles in 1923 with the founding of 
the Ross-Loos Clinic. The clinic, founded by two physicians, Donald E. Ross 
and H. Clifford Loos, provided medical and hospital care to Los Angeles 
Department of Water and Power employees and their families in exchange 
for monthly payments.
“Private Health Insurance and Managed Care” in “Introduction to Health Services, Seventh Edition” by Alma 
Koch., Thomson Delmar Learning, 2008, p. 115; www.economicexpert.com/a/Ross:Loos:Medical:Group.htm.
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HMO enrollees must receive all of their care from the plan’s PARs except for care provided in emer-
gency situations or in instances in which the plan offers a POS option.300 Under some HMO models, 
enrollees must select a primary care physician to oversee and coordinate their healthcare. This physi-
cian also helps to control costs by limiting which providers the enrollee has access to; by acting as a 
“gatekeeper,” the physician’s authorization is required before the plan will pay for specialized or refer-
ral services.301 In addition, because enrollees are typically limited to seeking care from the plan’s PARs, 
HMOs do assume responsibility for quality assurance and are able to transfer some of the financial risk 
to their preferred providers.302
The following are common forms of HMOs:303
1. Staff model HMOs directly employ all the physicians who provide healthcare services to plan 
enrollees. 
2. Group model HMOs contract with one physician practice to provide care to plan enrollees.
3. Network model HMOs contract with many independent physician practices that may also treat 
other patients who are not enrolled in the plan.
4. Independent Practice Association HMOs contract with an association of independent physi-
cians who maintain their own private practices but have joined together to enter into an agree-
ment to treat the plan’s enrollees.
Preferred Provider Organizations (PPOs)
A preferred provider organization (PPO), a hybrid of an HMO and traditional health insurance plan, 
is a managed care plan that allows members to choose from an array of healthcare providers that have 
contracted with the plan to provide services on a discounted basis.304 The health plan, the members, and 
the providers all benefit when the member chooses to receive services from a provider on the preferred 
provider list.305 Health plans benefit through increased purchasing power, which allows them to negotiate 
lower prices; members benefit because they are charged lower co-insurance and deductibles when they 
see in network providers; and providers benefit because being a preferred provider status may make plan 
members more likely to choose them when seeking medical treatment.306
The PPO evolved in California in 1982 in response to the legislature’s  
desire to have a system that “would allow selective contracting for  
Medicaid through private insurers.”
“Understanding Health Insurance and the PPO” Sheila Guilloton, Examiner, June 15, 2009, www.examiner.com/ 
x-11804-Health-Care-Examiner~y2009m6d15-Understanding-health-insurance-and-the-PPO, (accessed July 10, 
2009).
PPO members are not required to have a gatekeeper physician authorize the care they receive, nor 
are PPO members required to use the preferred providers on their plan’s list, although going outside the 
network will result in higher co-insurance rates and deductibles.307 However, because members are not 
limited to seeking care from the list of preferred providers, PPOs do not usually cover preventative care 
because they do not undertake the same responsibility for quality assurance as HMOs.308 Also different 
from HMOs, PPOs do not transfer financial risk to their preferred providers.309
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Point-of-Service (POS) Plans
Point-of-service (POS) plans combine many of the elements of HMOs and PPOs.310 POS plans are usu-
ally an addition to an HMO product that allows members the benefit of seeking care from non-PARs.311 
As with an HMO, when members seek care from in-network providers they typically pay no deductible 
or coinsurance.312 However, similar to a PPO, members are free to seek services outside the network 
subject to higher cost sharing in the form of deductibles and coinsurance.313 Although the cost is higher, 
this freedom of choice is why many consider POS plans to be the least restrictive form of managed 
care.314
Like members of an HMO, POS enrollees must choose a primary care physician from the list of in-
network providers to oversee the provision of healthcare services.315 This primary care physician is also 
responsible for referrals to specialists and hospitals.316 Should a POS member choose not to seek a refer-
ral from his or her primary care physician before undergoing treatment, his or her expenses associated 
with this treatment typically will be higher.317
Reimbursement
Types of Managed Care Reimbursement
MCOs use a variety of methodologies to negotiate and calculate reimbursement for their contracted 
healthcare providers. The most commonly utilized reimbursement methods for both primary and spe-
cialty care physicians are risk-based reimbursement methods like capitation or FFS.318
Capitation
In order to reduce healthcare service utilization, MCOs have passed some of their risk to providers in the 
form of capitation.319 Capitation is a pre-paid reimbursement method that pays a provider a set price for 
providing medical services to a defined population for a defined set of services, regardless of service uti-
lization. Providers must manage the financial risk of providing adequate care by calculating the expected 
volume of referrals, the average cost, and their ability to control utilization.320 These decisions need to 
be based on actuarial or historical data to determine an appropriate capitation amount and acceptable 
amount of risk to the organization.321
Capitated contracts allow providers to budget for expected medical costs while accepting both the 
financial risk and potential rewards, and they provide providers with financial incentives that encourage 
them to become more active participants in controlling (and accepting responsibility for) utilization.322
Full Risk Capitation
Full risk capitation occurs when a healthcare plan, facility, or provider accepts the entire financial risk 
for a plan’s members.323 However, due to the significant risk involved, any medical group undertaking 
full risk capitation must have strong financial management skills and management information sys-
tems.324 In absence of such safeguards, many MCOs will refuse such arrangements in order to avoid the 
risk of failure.325 Usually, large groups or an organized system of providers are best suited to support full 
risk capitation.326
Blended Capitation
Blended capitation is a payment method that combines per-member-per-month rates and FFS remunera-
tion to pay for physician services as a way to counterbalance the faults identified with a purely capi-
tated or a purely FFS payment system. In the healthcare context, the FFS payment method encourages 
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providers to see many patients and perform difficult and unpleasant procedures.327 However, a purely 
FFS system does not provide the physician with an incentive to reduce costs associated with his or her 
practice style, nor does it encourage cooperation among physicians.328 Similarly, capitation rewards 
provider activities that strive for high clinical quality and customer service.329 However, without adjust-
ments, a purely capitated form of remuneration may lead a physician to withhold preventative services, 
narrow his or her scope of practice, and refuse to treat patients that are in need of a greater amount of 
care due to the fear of financial burden.330 As a result, organizations have moved toward reimbursing 
their providers using a per-member-per-month capitation system in combination with FFS payments for 
specified procedures in an attempt to better balance the multiple objectives of encouraging individual 
productivity and clinical cooperation.331
Fee for Service (FFS)
Fee-for-service (FFS) health coverage occurs when healthcare providers receive separate compensation 
for each service they provide (for example, an office visit, procedure, etc.).332 Critics condemn FFS sys-
tems, stating that physicians tend to over-treat patients upcode andunbundle services in order to receive 
higher reimbursement.333 Nonetheless, FFS systems are often used as an incentive for healthcare provid-
ers to join an MCO in markets where managed care penetration is low.334
MCOs can sometimes negotiate discounts with providers, based either directly on charges or based 
on volume:
1. Straight discount on charges. Discounting a specific amount off the reimbursement rate for every 
procedure code. 
2. Discount based on volume or a sliding scale. The degree of discount is based upon a pre-agreed 
set of procedural volume ranges. For example, if the provider performs five or less of a specific 
procedure per month, he or she earns a 10 percent discount. However, should the provider per-
form six to ten procedures per month, he or she earns a 15 percent discount. Many plans combine 
a discount arrangement with a fee maximum. The fee maximum is a fee schedule; the plan pays 
the lesser of the discounted charges or the fee maximum.335
Specialty Care Reimbursement
The most commonly utilized reimbursement methods for specialty care physicians (SCPs) are risk-based 
models: FFS and capitation.336 However, SCPs are reimbursed by way of additional methods including: 
(1) relative value scales or fee allowance schedules, (2) performance-based FFS, (3) retainers, (4) hourly 
and salary wages, (5) single fees, (6) bundled case rates or package pricing plans, (7) DRGs, and (8) 
periodic interim payments and cash advances.337
Billing Managed Care Organizations
To ensure timely payment and maximum reimbursement, it is important that a provider’s staff be aware 
of the managed care contracts in effect in their practice, the rules of the various plans, and how these 
contracts affect the claims process.338 Providers should be aware of the co-pay and deductible amounts, 
plan requirements, policies, and if applicable, the length of time it takes a plan to remit payment for the 
practice’s various contracts, as they will usually vary by plan.
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HMO Billing
Patients in HMOs typically pay a fixed premium to enroll in the plan and co-payments at the time of 
treatment ranging from $1 to $35, unless the co-pay is waived because a co-insurance payment, a fixed 
percentage of the bill the patient is required to pay after meeting their deductible, is required instead.339 
It should be noted that all providers are typically required to file claims with procedure codes for all 
services rendered, even those directly employed by the HMO and those compensated on a capitated 
basis.340 In turn, HMOs use these claims to adjust rates and track the quality of care.341
PPO Billing
PPOs contract with providers to render services to the plan’s enrollees on a reduced fee basis.342 Patients 
in most PPOs have the freedom to receive care from providers outside the plan, with the trade-off being 
higher out-of-pocket expenses.343 Members of a PPO usually pay higher premiums, deductibles, and 
co-payments than those paid by members of HMOs, but these payments are generally lower than FFS 
plans.344
POS Plan Billing
Providers in POS plans generally are reimbursed according to the terms of the contract, except that 
specialty services typically are paid on a FFS basis.345 Patients in a POS plan pay only small co-pays 
or charges, no co-insurance, and no deductibles for care received from network providers and out-of-
network providers to whom they have a referral to see.346 However, when a patient sees a non-network 
specialist without first obtaining a referral from his or her primary care physician, the patient usually 
will be subject to higher out-of-pocket expenses in the form of a larger deductible and 20–25 percent 
coinsurance charges.347
conSumeR dRiven health planS—the ShiFt FRom deFined BeneFitS to  
deFined contRiButionS
To combat the problem of ever increasing premiums for employee health insurance, many employ-
ers have begun to implement “defined contribution” health insurance plans instead of the traditional 
“defined benefit” plans.348 The goal is to model health insurance programs after “defined contribution” 
pension programs, such as 401(k)s.349 Unlike a defined benefit system, in which an employer has the 
obligation to contribute the necessary premium for a certain health insurance benefit package, a defined 
contribution system allows an employer to contribute a designated amount of money and give the em-
ployee the freedom to do with it what he or she chooses.350
The shift toward defined contribution health insurance plans has directed the focus from the em-
ployer to the employee when it comes to making healthcare decisions.351 Many forms of defined contri-
bution leave substantial decisions to employee (that is, the consumer of the healthcare services), putting 
the employee in the driver’s seat when it comes to deciding which services are worth purchasing from 
whom to purchase them.352 To accomplish this, employers occasionally will present employees with 
what amounts to a voucher to purchase insurance on their own, but more often, employers will create 
an account for each employee into which the employer, the employee or both will contribute funds, and 
from which the employee will be able to draw to purchase health services.353
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Health Savings Accounts (HSAs)
One of the most common models of defined contribution health insurance is the establishment of a 
health savings account (HSA), coupled with enrollment in a high-deductible health plan (HDHP), 
whereby employers and employees both contribute to a special account from which the employee can 
draw funds to pay for health services.354 HSAs were first introduced in the MMA. An individual, an em-
ployee, or his or her employer may make contributions to an HSA. If the employer contributes, the value 
of those contributions is not taxable to the employee. Similarly, if the employee makes contributions, 
they count as “above-the-line” deductions.355
Individuals excluded from HSA eligibility are those covered by insurance other than a HDHP, those 
who can be claimed as a dependent on someone else’s tax return, veterans who have received medical 
care or prescription drugs from a VA facility within the last three months, active duty military personnel, 
and Medicare recipients who did not have an HSA prior to enrolling in Medicare.356 However, an indi-
vidual is not precluded from enrolling in an HSA if he or she has automobile, dental, vision, disability, 
or long-term care insurance or is covered by an employer wellness plan, as long as the wellness plan 
does not pay for a significant portion of one’s medical care.357 In addition, enrollees are allowed to have 
insurance coverage for a specific disease or illness, as long as the coverage, when invoked, pays only a 
set monetary amount.358 No requirement exists that an individual have earned income, nor are there any 
upper-end limits on income, that would restrict an individual’s ability to contribute to an HSA.359
Legislative Support
In 2006, President George W. Bush signed into law the Health Opportunity Patient Empowerment Act 
of 2006, which provided new opportunities for HSA participants to build their funds. Included among 
the provisions of the act was an allowance for employers to transfer funds from flexible spending ar-
rangements (FSAs) or health reimbursement arrangements (HRAs) to an HSA plan for those employees 
wishing to switch. The new act also increased the maximum HSA contribution amount to a statutorily 
defined amount (indexed for inflation), eliminated the system of prorating HSA contributions based on 
the number of months that an individual was eligible and replaced it with a system allowing individuals 
who enrolled in a month other than January to make a contribution equal to a full year’s enrollment. Ad-
ditionally, the act allowed for a one-time transfer from an individual retirement arrangement (IRA) to an 
HSA, which avoided early withdrawal and income taxes, eliminated FSA coverage previously deemed 
as disregarded coverage which reduced HSA contribution for a given year, set an earlier date for cost-of-
living index adjustments, and allowed greater employer contributions for lower-paid employees.360
However, legislative support for HSAs has waned a bit under President Barack Obama’s administra-
tion, as lawmakers struggle to develop a comprehensive plan for national healthcare reform. A common 
theme in the new administration is the setting of tighter limits on contributions to HSAs and the increas-
ing oversight of how the money is spent.361
Prevalence and Growth of HSAs
According to a 2009 census conducted by America’s Health Insurance Plans (AHIP), the number of in-
dividuals covered by HSAs and HDHPs has increased steadily every year since their inception, with just 
more than eight million individuals covered as of January 2009.362
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According to a 2009 census conducted by America’s Health Insurance Plans 
(AHIP), the number of individuals covered by HSAs or HDHPs has increased 
steadily every year since the plans were established, with just more than 
eight million individuals covered as of January 2009.
“January 2009 Census Shows 8 Million People Covered By HSA/High-Deductible Health Plans” by Anna Yoo, 
America’s Health Insurance Plans, ahipresearch.org, May 2009, www.ahipresearch.org/pdfs/2009hsacensus.pdf, 
(accessed August 27, 2009).
Reimbursement with HSAs and HDHPs
Providers may receive reimbursement from an individual with an HSA in a variety of forms, including 
debit card, checks, and “automatic claims forwarding.”363 The fact that an individual has an HSA does 
not mean that a provider will be paid the day the services are provided, because some HSAs encourage 
their patients not to pay for the provider’s services until the plan informs the patient of the amount.364 To 
combat this issue, providers should insist on payment at the time of service, always check their patient’s 
insurance eligibility to determine how much of the deductible has been met, and if the entire deductible 
has been met, whether the service is covered by their HDHP and whether the patient has co-insurance 
requirements.365 Performing these tasks at the time of service can ensure the provider receives the appro-
priate payment in a timely manner, without having to go through the costly and time consuming process 
of seeking payment from the patient at a later date or reimbursing the patient due to an overpayment.366
SelF inSuRance
Self-insurance plans, often referred to as “self-funded” plans, have been one of the leading trends in the 
health insurance industry since the late 1970s.367 Self-insuring employers make a conscious choice to 
undertake the risks associated with the cost of healthcare and set aside money to pay these costs as they 
arise.368 Often, a self-insurer will hire a commercial insurer or third-party administrator to run its medical 
benefits program and adjudicate claims.369
Self-insurance plans vary by the amount of risk an employer is willing to assume.370 In a fully self-
funded plan, the employer undertakes the responsibility for 100 percent of the healthcare expenses sub-
mitted for reimbursement.371 Typically, this type of funding is limited to employers or groups of 5,000 
or more, as medical expenses for large groups can be reasonably predicted.372 However, employers with 
fewer than 5,000 employees often are unwilling to assume the risk of funding their entire health insur-
ance program.373 Thus, these employers may opt for a partially self-funded plan.374 The most common 
type of partially self-funded plans is the “minimum premium plan.”375 Under a minimum premium plan, 
the employer covers claims up to a predetermined amount, and an insurance policy assumes liability for 
claims thereafter.376 Another popular form of partially self-funded plans involves combining self-funding 
with stop-loss insurance.377 Under these plans, the employer covers employee claims up to a predeter-
mined amount per employee, at which time stop-loss insurance covers any employee who exceeds his or 
her out-of-pocket maximum.378
Employers choose to self-insure as an alternative to purchasing health insurance policies for sev-
eral reasons. First, self-insurers avoid the charges, fees, and profits that insurance companies build into 
the price of insurance premiums.379 In addition, because self-insurance technically is not insurance, 
state taxes assessed on premium revenue can be avoided.380 Perhaps the most important benefit of self-
insurance is the fact that the Employee Retirement Income Security Act of 1974 exempts self-insured 
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plans from state regulation.381 This exemption provides the self-insured considerable flexibility to design 
benefit programs as they see fit, and it provides them with the opportunity to save considerable money 
by avoiding state mandates requiring the coverage of particular services.382
Self-insured employers contract directly with providers and reimburse them according to the terms 
of the contract. Employers have designed self-insurance programs to provide coverage for their employ-
ees using a variety of plans, including indemnity, HMOs, PPOs, and POS.383 However, some states may 
prohibit a self-insured employer from signing capitated contracts with physicians.384 The forms used and 
the claims process likely will vary by employer, as will the coverage, co-insurance amount, and length 
of time for remittance, as the employer will design its plan in accordance with its particular needs.
Self-Pay
Individuals may pay out-of-pocket for their own healthcare costs for a number of reasons, including 
a lack of health insurance, a desire to keep a medical condition from their health insurer, or due to the 
conscious decision not to purchase health insurance.
Having decided to treat a self-pay patient, a provider must determine what form of payment to accept 
for these medical services, what to charge for these services, and how to collect the payment due.
Most public insurers, like Medicare, set their reimbursement rates independently of a provider’s 
actual charges.385 In addition, most private insurers have the bargaining power to negotiate discounts.386 
However, most self-pay patients will lack the ability to set their payment amount or negotiate lower 
charges, and as a result, at times, they have been presented with bills up to two and a half times higher 
than what public or private insurers would pay for the same procedure.387 This billing practice has led to 
multiple class action lawsuits against providers, and it has resulted in settlements by which the provid-
ers offer both prospective and retrospective discounts to their self-pay patients.388 Thus, to avoid costly 
litigation at a later date, a provider may choose to offer all self-pay patients discounts similar to those 
negotiated by other payors.
Once a provider has determined what form of payment to accept and what to charge self-pay pa-
tients, he or she must face the question of how to collect payment. Staff training and a requirement that 
the bill be paid in full before the patient leaves can help reduce the chance that the provider will have to 
write off the visit as bad debt.389 In addition, some providers require self-pay patients to give both their 
driver’s license and Social Security numbers to ensure they are more readily pursuable should collection 
become an issue.390
Payor Mix and the Effect on the Revenue Cycle
It is important to realize that a healthcare provider’s payor mix can have a profound impact on their 
practice’s financial performance. Today, many providers are reimbursed for treating patients by an array 
of payment sources using a variety of payment methods, FFS, capitation, and self-pay, all of which can 
affect financial performance.391
When determining the appropriate payor mix to ensure financial viability, providers must be aware 
that it is not uncommon for Medicare, Medicaid, and major health plans to reimburse at levels that are 
less than the full or average cost of providing the services.392 In addition, providers must take into ac-
count the discounts they offer on billed charges to health plans and the uninsured, and they should 
consider the likelihood that they may not collect a large portion of the charges billed to the uninsured 
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patients they treat.393 Thus, to remain viable, a provider may need to offset the losses incurred on these 
patients by increasing the prices charged to other patients, specifically marketing their services to attract 
payors that traditionally reimburse at a more favorable level, or limiting the number of patients they will 
accept from lower reimbursing payors.
In addition to having an appropriate payor mix, financial viability also may depend on a provider’s 
mix of payment methods; having too many or too few of one type of method may negatively affect a 
practice’s revenue. When providers are reimbursed on a FFS basis, practice revenues increase as pa-
tient visits and the intensity of the services provided increase.394 However, under a capitation payment 
method, a provider’s profits are higher if its patients require minimal medical services and have few, if 
any, chronic conditions.395 The provider’s mix of self-pay and uninsured patients and their effect on a 
provider’s practice is dependent on the patients’ abilities to pay their bills and the effort expended by 
the practice to collect the payments. If a majority of the self-pay and uninsured patients are affluent and 
have no trouble paying their bills at the time of service, a provider’s revenue may increase, as they can 
avoid the billing and collection process altogether. However, if these patients are not affluent or have 
trouble paying their bills, it is likely that the practice’s revenue will decrease because it may now have 
to make multiple attempts to receive payment through the billing and collection process or write off 
the debt altogether. A provider’s awareness of his or her practice’s reimbursement mix and its effect on 
financial performance may help ensure financial viability by providing useful insight when considering 
new contracts, renegotiating existing contracts, or dropping less lucrative contracts.396
Emerging Reimbursement Trends
Move Toward Capitation
Originally viewed as a cost saving alternative to FFS arrangements, many capitation contracts actu-
ally have been replaced by FFS arrangements because the risk can be difficult for physicians to manage 
without the requisite economic and actuarial skills.397 A recent study released by the Center for Studying 
Health System Change, shows that the shift from FFS remuneration toward capitation as a method of 
physician reimbursement has waned from the mid-1990s.398 According to the data, the number of phy-
sicians accepting capitated payments fell 9.5 percent, from 54.2 percent in 1996-97, to 44.7 percent in 
2004-05.399
However, beginning in 2008, it appears that capitation as a replacement for FFS may be making 
a comeback. The resurgence was led, at least in part, by BCBS of Massachusetts and its “Alternative 
Quality Contract” (AQC).400 Unlike previous generation capitation plans designed by insurance compa-
nies to place the risk on providers while offering little or no rewards for improved quality of care, the 
AQC offers providers the opportunity to earn substantial rewards for quality.401 The new contract reim-
burses providers on a per-member-per-month basis, with increases yearly for inflation, combined with 
incentive payments for meeting national standards in quality, effectiveness, and patient experience.402
In addition, in 2008 the Massachusetts state legislature established the Special Commission on the 
Health Care Payment System to recommend improvements to the state’s current payment system that 
would “motivate and reward effective, efficient, and patient centered care.”403 The commission con-
cluded that the state should transition to a global payment model used by all payors, including the state 
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and federal government, within five years.404 The commission recommended that the payment model 
include, in addition to other features, accountable care organizations (ACO), consisting of hospitals, 
physicians or other clinicians, and nonclinicians, to manage and coordinate care to meet patient needs, 
patient-centered care, pay-for-performance (P4P) incentives, and financial risk sharing among ACOs and 
carriers.405
Healthcare Reform Efforts
Although healthcare reform has been a recurring policy theme throughout the past few decades, reform 
efforts took center stage with the 2008 presidential election and the subsequent leadership under the 
Obama administration. Twenty-first century reform efforts share many common themes, all aimed at 
combating the problems of uninsured individuals and the rising cost of services.406
A significant amount of reform rhetoric has been defined by proposals of a public insurance option 
and a healthcare exchange that would provide consumers with a choice between private insurance and 
the government-run plan.407 However, there has been resistance to that idea, and at least one proposal in-
cludes the possibility of creating a nonprofit consumer owned and operated health insurance plan instead 
of a public option.408 Further, many reform proposals include provisions to penalize individuals who fail 
to obtain health insurance coverage, though at least one proposal includes subsidies for the purchase of 
health insurance with tax credits.409
Many common elements to the reform proposals exist. Among these elements are
 1. the creation of standardized health insurance benefits packages; 
 2. reforms of state insurance markets for small and nongroup health insurance;
 3. limits on an insurer’s ability to charge higher premiums based on health status, gender, and 
other factors; 
 4. the elimination of insurance coverage denials due to pre-existing conditions; 
 5. prohibitions on cost sharing for preventative treatments; 
 6. credits to make premiums affordable; 
 7. limits on out-of-pocket expenses; 
 8. coverage of preventative services; 
 9. the promotion of quality healthcare by the use of provider incentives; 
10. the elimination of lifetime and annual limits on dollar value for individual and group policies; 
and
11. requirements that employers either provide health insurance for their employees or contribute to 
a fund on their behalf.410
To control costs, one proposal would implement the use of ACOs and medical homes, as well as 
bundle provider payments for acute and post-acute care and simplify paperwork.411 In addition, the plan 
would require the restructuring of physician payments under Medicare by eliminating the SGR and 
through rewarding primary care services, care coordination, and efficiency.412
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Increased Emphasis on Quality: Pay-for-Performance (P4P) 
and Gainsharing
pay-FoR-peRFoRmance
In the wake of an ongoing national controversy with several recent studies finding that medical errors 
are a leading cause of death in the United States, demands have been waged by both private and pub-
lic payors regarding the accountability of providers. After a 1999 study from the Institute of Medicine 
reported that as many as 44,000–98,000 deaths may be linked directly to medical errors, increased focus 
has been placed on paying physicians based on the quality of their services, as a way of improving qual-
ity and lowering costs.413
A 1999 study from the Institute of Medicine (IOM) reported that as many as 
44,000–98,000 deaths may be linked directly to medical errors.
“Errors in Health Care: A Leading Cause of Death and Injury” in “To Err is Human: Building a Safer Health System” 
edited by Linda T. Kohn, Janet M. Corrigan and Molla S. Donaldson, Committee on Quality Health Care in America, 
Institute of Medicine, 2000, p. 26.
Pay-for-performance (P4P) is a remuneration system in which part of the payment is dependent on 
performance as measured against a defined set of criteria.414 Although a P4P system can be structured in 
several ways, the common elements to all systems are (1) a set of targets or objectives that define what 
will be evaluated; (2) measures and performance standards for establishing the target criteria; and (3) 
rewards—typically financial incentives—that are at risk, including the amount and the method for allo-
cating the payments among those who meet or exceed the reward threshold.415 Proponents of P4P remu-
neration systems argue that they have the potential to improve the quality of care and slow the growth in 
healthcare costs through improvements in quality and provider efficiency.416
P4P’s Impact on Practice Revenue
The impact of P4P on quality outcomes has been demonstrated by two distinct studies. A 2003 study 
conducted by CMS and Premier, Inc., measured cost and quality improvements among P4P providers for 
five different patient populations.417 The study concluded that “if all hospitals nationally were to achieve 
the three-year cost and mortality improvements found among the [study] project participants for [the five 
different patient populations], they could save an estimated 70,000 lives per year and reduce hospital 
costs by more than $4.5 billion annually.”418
A second study, conducted by researchers from University of California, Los Angeles, and supported 
by the Hawaii Medical Service Association in Honolulu, showed improved quality of care among P4P 
providers in PPO settings, as well as an increased number of patients going to P4P physicians.419 The 
study analyzed eleven quality indicators for patients enrolled in PPOs over six years and found that the 
patients who visited only physicians who were participating in the study had significantly higher odds of 
receiving recommended care as measured by the indicators.420
However, some providers are worried that the transition from a FFS payment system to a P4P model 
could have a profound impact on practice revenue. Providers may have to undertake the time consum-
ing process of hand collecting and reviewing the data needed to satisfy reporting requirements or make 
a significant capital investment in an electronic health records system.421 Regardless of the collection 
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method used, the bonuses for achieving the requisite reporting standards may not be sufficient to off-
set the costs associated with the data collection process.422 In addition, providers who practice in low-
income, minority communities may see their revenue fall, as it is likely that these providers will miss 
out on incentive pay because of lower quality scores due to their treating patients who may be less likely 
to obtain preventative care, follow treatment recommendations, and return for further investigation into 
abnormal test results than their wealthier counterparts.423
healthcaRe pRoFeSSional pRactice gainShaRing aRRangementS
The term “gainsharing” refers to a shared savings program “under which a hospital gives physicians a 
share of the reduction in the hospital’s costs (that is, the hospital’s cost savings) attributable in part to 
the physician’s efforts.”424
History and Background
In 2008, CMS proposed a new exception to the Stark law for certain incentive payment (that is, P4P) 
and shared savings programs, including gainsharing arrangements.425 An exception to the Stark law is 
necessary, despite the fact that successful gainsharing programs can foster high quality, cost-effective 
care, because the arrangements involve making payments to physicians whose efforts contribute to 
these successes. The concern is that “improperly designed or implemented programs pose [a high risk of 
program or patient abuse],” and that “additional risk is posed by [gainsharing arrangements] that reward 
physicians based on overall cost savings without accountability for specific cost reduction measures.”426 
Recognizing the potential for abuse, but also the potential to improve quality and cost effectiveness, the 
proposed exception to the Stark law for properly structured gainsharing arrangements focuses on three 
crucial aspects: transparency, quality controls, and safeguards against payments for referrals.427
Office of the Inspector General’s (OIG’s) Denial and Subsequent Approval
Historically, gainsharing arrangements were found to violate the civil monetary penalty statute and the 
antikickback statute, despite the potential cost-saving benefits of well-structured arrangements.428 In 
2005, however, the Office of Inspector General (OIG) began to approve gainsharing arrangements in 
light of their cost-saving and quality improving potential, despite the fact that the basic arrangements 
themselves were still technical violations of the statutes, reasoning that the potential for fraud was re-
duced when certain safeguards were present.
In those arrangements that it approved, the OIG looked for three types of safeguards: (1) measures 
that promote accountability and transparency, (2) adequate quality controls, and (3) controls on pay-
ments related to referrals.429 To this end, in 2008, OIG approved an existing arrangement between a 
hospital and four cardiology groups and one other radiology group that sought to pay the physicians a 
portion of cost savings resulting from physician efficiency.430 The cost savings paid to physicians were 
derived from the use of supplies and equipment during certain procedures.431 Savings were created 
through the standardization of procedures and reduction in the inappropriate use of supplies and medical 
devices.432 Although the agreement could have led to illegal payments to physicians, the transparency 
of the calculated payments, a cap on the amount of payments, and the fact that there was found to be no 
encouragement for physicians to reduce services, resulted in the OIG declining to issue sanctions against 
the group thereby permitted their gainsharing arrangement.433
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Legislative Parameters and Safeguards
To be protected under the exception to the Stark law proposed by CMS, a gainsharing arrangement must 
abide by the following requirements. These also represent common elements considered by the OIG 
when reviewing a gainsharing arrangement.
1. The arrangement must include patient care quality or cost savings measures (or both) which 
are in CMS’s Specifications Manual for National Hospital Quality Measures and supported by 
objective, independent medical evidence indicating that the measures would not adversely affect 
patient care.
2. The arrangement must employ cost savings measures that use an objective methodology, are ver-
ifiable, supported by credible medical evidence indicating that the measures would not adversely 
affect patient care, can be traced individually, and reasonably relate to the services provided.
3. The arrangement must be able to be reviewed prior to implementation and at least annually there-
after to ascertain the program’s impact on patient quality of care. Such reviews must be indepen-
dent medical reviews conducted by a person or organization with relevant clinical expertise.
4. The arrangement must provide for immediate and corrective action (up to and including termina-
tion of the program) in the event a review reveals an adverse impact on quality.
5. The arrangement must limit participation in the program to those physicians who are members of 
the hospital’s medical staff at the commencement of the program. Participating physicians par-
ticipate in “pools” of five or more (formed at the commencement of the program) among whom 
the aggregate cost savings that result from the efforts of the physicians in the “pool” be shared on 
a per capita basis.
6. The arrangement must support the distribution of shared savings program payments with written 
documentation.
7. The arrangement may not determine eligibility for physician participation in the program based 
on the volume or value of referrals or other business generated between the physician the 
hospital.
8. The arrangement may not limit the discretion of physicians to make medically appropriate deci-
sions for their patients, nor may it limit the availability of, or access of physicians to, any specific 
item, supply, or device that is linked through objective evidence to improved outcomes, is clini-
cally appropriate, and was available at the commencement of the program.434
Payments made under shared savings programs
1. must be distributed on a per capita basis,
2. may not include any amount that takes into account the provision a greater volume of federal 
healthcare patient procedures or services than the volume provided by the participating physician 
or qualified physician organization during the period of the same length immediately preceding 
the commencement of the program as that covered by the payment, and
3. must be limited in duration (no shorter than one year and no longer than three years) and 
amount.435
Two potential ways to limit amount of payments exist, one or both of which may be adopted:
1. limits based on set percentages of cost savings available to hospital through program, and
2. limits to address the risk that physicians will continue to receive financial rewards for already 
implemented changes.436
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Also, arrangements in which physicians receive payments for actions taken that result in a reduction 
below a predetermined target based on objective historical and clinical measures will not be protected.
Additionally, CMS is considering whether to extend the exception for qualified physician organi-
zations to multispecialty physician practices composed of both PARs and non-PARsparticipating and 
nonparticipating physicians. To promote transparency, hospitals and participating physicians will be 
required to disclose the nature of the program to patients affected by it.
Requirements related to transparency include:
1. tracking of the ages and payors of the patient population treated by participating physicians (to 
prevent cherry picking, etc);
2. limiting physician payment to only that which is related to the physician’s own efforts, combined 
with the efforts of the other physicians in their pool, on a per capita basis;
3. applying all measures uniformly to all patients, including Medicare beneficiaries (and not apply-
ing them disproportionately to federal healthcare program beneficiaries), with the possibility of 
having the program audited; and
4. prohibiting the counseling or promotion of a business arrangement or other activity that violates 
any federal or state law.437
Increased Reimbursement to Encourage Implementation of 
Electronic Health Records (EHR)
With the passage of the American Recovery and Reinvestment Act of 2009 (ARRA), the government 
adopted, as part of the overarching economic stimulus package, a stimulus plan to promote the universal 
implementation of electronic health records (EHR).438 Through the Health Information Technology for 
Economic and Clinical Health (HITECH) Act, incorporated into the ARRA, providers are incentivized 
with increased reimbursement rates to implement EHR systems.439 As part of this process, the HITECH 
Act officially established the Office of the National Coordinator for Health Information Technology 
(ONCHIT) and HIT Policy and Standards Committees to recommend, develop, and promote a national 
HIT infrastructure.440
In particular, the HITECH Act permits the secretary of HHS to appropriate funds each year, begin-
ning 2009 through 2013, to promote the implementation of EHR.441 Under the act, nonhospital-based 
physicians will receive financial incentives or penalties through Medicare for use or nonuse of EHRs. 
Beginning in 2011, eligible professionals can receive incentive payments of 75 percent of allowed Medi-
care charges to a total maximum of $44,000 over a five-year period if meaningful use of an EHR system 
begins by 2012.442 Adoption by 2013 reduces the total maximum charges to $39,000, and adoption by 
2014 reduces the total maximum charges to $24,000.443 Beginning in 2015, practitioners not adopting 
meaningful EHR use will receive a 1 percent reduction in their MPFS payment.444 This will increase to a 
2 percent penalty in 2016 and 3 percent penalty in 2017. The secretary of HHS will have the discretion, 
if less than 75 percent of practitioners have not adopted meaningful use of EHRs before 2018, to raise 
the penalty to as high as 5 percent. Medicaid providers will also receive incentives.445
Similarly, hospitals will receive millions of dollars in increased reimbursement under Medicare and 
Medicaid for successfully implementing HIT and certified EHR systems.446 Additionally, rural health 
clinics, federally qualified health centers, and other providers other than physicians and hospitals will be 
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eligible for incentive funding under Medicaid or through grants offered for the implementation of EHR 
systems.447
Although the term “meaningful use” has yet to be defined, it would include electronic prescribing, 
information exchange between systems, qualitative reporting methods, additional coding of the use of 
and EHR system, and the ability to complete survey responses in the system.448 ONCHIT would set stan-
dards for EHS systems for the hospital setting and the Certification Commission for Health Information 
Technology would certify software meeting this definition. In 2011, funding will become available for 
Medicare ($23.1 billion) and Medicaid ($21.6 billion) incentives.449
A total of $1.5 billion will go toward federal grants for the implementation of EHR systems and 
capital improvements of EHR systems.450 In 2011, for every $10 the federal government provides toward 
state planning and implementation grants to promote HIT, the state must provide $1. In 2012, this ratio 
drops to seven to one. Starting in 2013, for every $3 of federal grant money the state must provide $1.451
Reimbursement of Aesthetic and Reconstructive Procedures
As technological advances in recent years have increased the accessibility of plastic surgery, the number 
of many procedures has increased despite downswings in the economy. In 2008, there were 17 million 
plastic surgery procedures performed in the United States, a number up 3 percent from the previous 
year.452 Of these, 12.1 million were cosmetic procedures, divided between surgical (1.7 million) and 
minimally-invasive (10.4 million), while 4.9 million were reconstructive procedures.453
Despite this increased prevalence, however, reimbursement for elective cosmetic procedures has 
remained minimal. In the field of plastic surgery, the two types of procedures are treated differently by 
payors. Aesthetic, or cosmetic, procedures typically are performed at the election of the patient to re-
shape a normal part of the body to the patient’s satisfaction.454 Because aesthetic procedures are elective 
surgeries, they generally are not covered by health insurance plans.455
By contrast, reconstructive procedures are necessary for the correction of physical disfigurement or 
function or to restore a normal appearance following trauma or disease.456 Examples include skin grafts 
and the rebuilding of bones for burn and accident victims.457 These procedures generally are covered by 
most health insurance policies, though specific coverage may vary by procedure, as well as the degree to 
which the procedures are covered.458
When procedures that typically are classified as cosmetic are medically necessary to correct a prob-
lem or relieve symptoms (for example, a patient needs rhinoplasty to correct a breathing problem), insur-
ance carriers may treat that procedure as reconstructive and cover part or all of the cost of the surgery.459 
In such cases, the payor will generally require verification of the true reason for the surgery (that is, 
whether it was truly reconstructive or merely cosmetic), as well as require that the physician obtain prior 
approval and then supply post-procedure documentation from which the payor can determine how much 
it will reimburse.460
Like most private payors, Medicare and Medicaid do not cover cosmetic procedures that are not 
medically necessary.461
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Concierge Medicine
Recent years have seen the emergence of the practice of concierge, or boutique, medicine. Although this 
trend is further explored in chapter 4, Boutique and Concierge Medicine, and in chapters 1 and 2 of Pro-
fessional Practices, in terms of reimbursement, it is important to understand that boutique medicine is 
not a substitution for traditional insurance. Patients will typically keep their traditional health insurance 
to pay for any tests or scans ordered by their physician. Medicare beneficiaries cannot be charged more 
than 115 percent of the rate for services, and many politicians have said that the annual fees patients pay 
is a lot more than the Medicare rate and, thus, is illegal billing.462
Medical Home Model
The term “medical home” was coined in 1967 and originally was used by the American Academy of Pe-
diatrics “to describe a single source of medical information about a patient.”463 The term evolved over-
time and is now used to describe a patient centered model of healthcare delivery and payment reform, 
which focuses on improving the quality of care and reducing costs through its emphasis on the role of 
primary care.464
The medical home is comprised of seven components: (1) “a personal physician” who provides 
a patient with ongoing, comprehensive care; (2) “physician-directed medical practices” in which the 
physician and his or her team members assume responsibility for the ongoing care of their patients; (3) 
“whole person orientation” which tasks the physician with the responsibility to ensure that the patient 
receives all necessary care, including care provided by other qualified healthcare professionals; (4) “co-
ordinated or integrated care” calls for the use of information technology, registries, and health informa-
tion exchanges to coordinate and integrate patient care within the community; (5) “quality and safety” 
improvements through the use of a variety of quality improvement activities, feedback, and evidence 
based decision support systems; (6) “improved access” is sought through the timely access to care and 
improved communication with patients; and (7) “payment” methods that reimburse physicians for direct 
patient interaction, coordinating patient care, adopting information technology for quality improvement, 
and achieving quality improvement goals, which allows physicians to share in the savings attributed to 
reduced hospitalizations.465
In addition to being endorsed by various medical associations, the medical home model has gained 
the attention of the federal government. The Tax Relief and Health Care Act of 2006 mandated a Medi-
care medical home demonstration project to measure the effectiveness of the model.466 The two-year 
project will examine the efficacy of “targeted, accessible, continuous, and coordinated care to Medi-
care beneficiaries with chronic or prolonged illnesses requiring regular medical monitoring, advising, 
or treatment” and is slated to run from 2010 through 2012.467 This reform initiative is also discussed 
in chapters 2 and 3 of Professional Practices—as well as various sections in chapter 2 of Professional 
Practices.
Payment Bundling
Bundling is a method of reimbursement that combines institutional and professional charges into a 
single payment (see chapter 4, Physician or Provider Suppliers, and chapter 2 in Professional Prac-
tices).468 Recently, several proposals have been advanced by legislators to reduce Medicare costs by 
various methods of bundling payments to hospitals and physicians for services provided over the course 
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of a patient’s treatment plan. This trend is demonstrated by the United States Senate Finance Commit-
tee’s “Proposals to Improve Patient Care and Reduce Health Care Costs,” whereby it released a plan to 
use the bundling of payments for inpatient and post-discharge care.469 Further, CMS has also created a 
pilot program to examine the benefits of bundling Part A and Part B Medicare payments.470
The intent of the Senate Finance Committee’s proposal is to bundle payments for acute inpatient 
care and post-acute care occurring or initiating up to thirty days following a patient’s discharge, includ-
ing home health, skilled nursing, rehabilitation, and long-term hospital services. This bundled payment 
would include the inpatient Medicare Severity Diagnosis-Related Group (MS-DRG) amount plus post-
acute care costs for the treatment of patients in that MS-DRG, including any expected or planned read-
missions within the thirty-day window. Although the hospital would receive the bundled payment even 
if no post-discharge care was given, the bundled amount will have already been adjusted to “capture sav-
ings from the expected efficiencies gained from improving patient care and provider coordination within 
the bundled payment system.”471
In addition to the Senate Finance Committee’s proposals, the Acute Care Episode Demonstration 
(ACE) project is a pilot program developed by CMS to provide for greater efficiencies and continuity of 
care amongst Part A and Part B providers (also discussed in chapter 2 of Professional Practices). The 
three-year program effectively eliminates the MPFS and provides one, global payment under the IPPS. 
The new, bundled payment will cover both hospital and physician fees for one “episode of care” for 
cardiovascular or orthopedic procedures. Participating sites (referred to as “Value-Based Care Centers”) 
have met certain volume thresholds, have quality care initiatives in place, and have competitively bid for 
their bundled DRG payments. The program also provides for gainsharing arrangements with physicians 
who meet or exceed quality standards.472 Further, patients who choose to receive care from participating 
demonstration providers based on quality and cost are eligible to receive up to 50 percent of the savings 
to Medicare, as long as such payments do not exceed the patient’s Part B premium of $1,157 per year.473
Proponents of bundled payments assert that the move toward bundled payments could provide 
higher coordination between providers and more efficient levels of care.474 However, critics articulate 
concern regarding the level of savings and patient care improvement that a blanket bundling of payments 
will actually generate. For example, the AMA expressed concern that such bundling proposals could 
result in the withholding or limiting of appropriate post-discharge or inpatient services.475 The AMA 
also called for the appropriate distribution of the payments to individual providers, risk-adjustment for 
patients whose care exceeds the amount accounted for in the bundled payment, and safeguards to ensure 
that patient care decisions remain in the hands of the individual providers.476 Similarly, in a letter to the 
Senate Finance Committee, the American Hospital Association stated that the administration’s approach 
to bundling payments was “problematic” and would require a “paradigm shift in health service deliv-
ery” resulting in the revision or withdrawal of numerous regulations promulgated to manage the current 
healthcare delivery and payment system.477 Finally, the American Association of Medical Colleges, 
which supports the concept of care coordination provided through bundling, criticized Medicare’s ACE 
program for not ensuring that payments are made directly to all parties (that is, physicians) who provide 
the services.478
Although no actual bundling policy has been implemented, recent actions by both the Senate and 
CMS have demonstrated that such initiatives on the healthcare horizon and may soon become a part of 
the healthcare reimbursement environment.
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Accountable Care Organizations (ACOs)
Also being proposed for inclusion in the healthcare reimbursement environment is a concept called 
the “accountable care organization” (ACO) or accountable care system.479 These entities would bring a 
patient’s healthcare providers voluntarily together in order to better coordinate patient care.480 This could 
be a combination of primary care physicians, nurse practitioners, specialists, and allied health practitio-
ners, as well as hospitals, nursing homes, ASCs, or any other entity in the patient’s continuum of care.481 
Because of this, ACOs could more effectively implement initiatives to improve the quality and control 
the cost of care and be held accountable for the resulting outcomes and spending.482 This method can be 
distinguished from the medical home model discussed previously because a separate entity focuses on 
coordinating all of a patient’s healthcare providers instead of placing the responsibility on physicians 
and their staff.483 A combination of additional physician payment updates, capitation, P4P, and gainshar-
ing bonuses could be used to incentivize healthcare providers to join ACOs and reduced co-insurance or 
lower deductibles could be used to incentivize private-pay patients.484 For more information see chapter 
2 in Professional Practices. 
Conclusion
Major shifts are taking place in the healthcare reimbursement environment. As healthcare reform efforts 
that focus on reducing costs begin to gain traction, providers may feel even more squeezed between the 
cost of services and the value of reimbursement. As more emphasis is placed on quality improvement 
efforts like P4P and gainsharing, however, providers are likely to see increased efficiency, which should 
reduce the cost of service and give providers some degree of reprieve. These trends will most likely be 
dictated by federal and state government payors, which, as the benchmarks for all healthcare reimburse-
ment, will lead any future developments of the reimbursement environment.
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General Practice  2%  0.20%  3%   0%  0%   6%
Internal Medicine  2% -0.10%  5%   0%  0%   5%
General Surgery  2%  0.20%  0%  -1%  0%   4%
Orthopedic Surgery  1% -0.40% -1%  -1%  0%   2%
Anesthesiology  2% -0.70% -7%  14% -1%   3%
Radiology  2% 0.40% -5%   0%  0% -16%
Chiropractor 1% -1.30% -8%  -2% -1%   4%
Podiatrist  2%  1.30% -1%   2%  2%   6%




-1%  1.50% -5%   1%  1%   8%
Diagnostic Testing 
Facility
 3% -2.40% -2%   0% -1% -34%
Source (1) (2) (3) (4) (5) (6)
Sources:
1 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2005; Final Rule”, Federal Register, Vol. 69, No. 219 (November 15, 2004), 
p. 66401 (change in total allowed charges).
2 “Medicare Program; Revisions to payment policies under the Physician Fee Schedule for Calendar Year 2006; Proposed Rule” Federal Register, Vol. 70, No. 151 (August 8, 2005), 
p. 45860.
3 “Medicare Program; Revisions to Payment Policies, Five-Year Review of Work Relative Value Units, Changes to the Practice Expense Methodology Under the Physician Fee Sched-
ule, and Other Changes to Payment Under Part B; Revisions to the Payment Policies of Ambulance Services Under the Fee Schedule for Ambulance Services; and Ambulance 
Inflation Factor Update for CY 2007,” U.S. Department of Health and Human Services: Centers for Medicare and Medicaid Services, Federal Register, Vol. 71, No. 231,  
December 1, 2006, p. 69766.
4 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, and Other Part B Payment Policies for CY 2008”, Federal Register, Vol. 72, No. 227  
(November 27, 2007), p. 66390.
5 “Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, and Other Part B Payment Policies for CY 2009”, Federal Register, Vol. 73, No. 130  
(July 7, 2008), p. 38595.
6 “Medicare Program, Payment Policies Under the Physician Fee Schedule, and Other Part B Payment Policies for CY 2010, Proposed Rule”, Federal Register, Vol. 74, No. 132  
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Appendix B 
Sample Analysis of Compensation—General Surgery 
Table 1: Range of Annual Total Compensation (Excluding Trauma Call Coverage) per Level of Work RVU Productivity





















































 7,000 $45.00 $  315,000 $ 0.00 $      0 $  335,000 $20,000 $  335,000 $82,000.00 $16,400 $  351,400 $ 50.20
 7,500 $45.00 $  340,000 $ 0.00 $      0 $  360,000 $20,000 $  360,000 $82,000.00 $16,400 $  376,400 $ 50.19
 8,500 $45.00 $  380,000 $10.00 $      0 $  400,000 $20,000 $  400,000 $82,000.00 $16,400 $  416,400 $ 48.99
 1,100 $45.00 $  480,000 $10.00 $ 22,000 $  500,000 $20,000 $  522,000 $82,000.00 $16,400 $  538,400 $489.45
30,500 $45.00 $1,400,000 $10.00 $220,000 $1,420,000 $20,000 $1,640,000 $82,000.00 $16,400 $1,656,400 $ 54.31
Table 2: Industry Annual Work RVU Production (wRVU)
Notes N=









MGMA WRVU—ALL (13) 671  33% 5,565 6,893 7,308 8,703 10,681
AMGA WRVU—ALL (15) 756  33% 5,410 7,163 7,585 9,537 11,002
Sullivan Cotter WRVU—ALL (16) 181  33% 5,250 6,335 6,858 8,004 10,114
Weighted Average Industry Annual WRVU Production (17) 100% 5,577 6,936 7,383 8,803 10,703











MGMA Comp/WRVU—ALL (13) 671  33% $41.13 $49.25 $54.09 $59.94 $77.51
AMGA Comp/WRVU—ALL (15) 756  33% $37.68 $48.07 $50.95 $62.00 $74.25
Sullivan Cotter Comp/WRVU—ALL (16) 181  33% $36.69 $45.26 $47.45 $54.59 n/a
Weighted Average Industry Compensation per Work RVU (19) 100% $42.26 $50.11 $53.41 $61.46 $76.83
Notes:
 1. Hypothetical total annual work RVUs to be performed by employed physicians.
 2. According to hypothetical agreements, employed physicians will be compensated $45.00 for each work RVU generated.
 3. Calculated base cash compensation given per work RVU production in Column A ($45/work RVU).
 4. Per hypothetical agreements, employed physicians will be compensated an incentive amount of $10.00 for each work RVU generated above 8,500.
 5. Calculated compensation given per work RVU production in Column A ($55/work RVU for over 8,500 work RVU).
 6. Calculated cash compensation given per work RVU production in Column A, that is, $45/work RVU under 8,501 and $55/work RVU over 8,500 (Column C + Column E).
 7. Per hypothetical agreements, employed physicians will be compensated for meeting established quality of care and patient satisfaction performance measures of up to $20,000 
per each year of the Employment Term.
 8. Calculated cash compensation given per work RVU production in Column A, that is, $45/work RVU under 8,501 and $55/work RVU over 8,500 + Quality Incentive Payment 
(Column C + Column E + Column G).
 9. Total nose coverage cost to subject enterprise per employed physician.
10. One-fifth of nose coverage cost (Column J5) (assuming amortization of nose coverage cost over five-year employment agreement).
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Table 1: Range of Annual Total Compensation (Excluding Trauma Call Coverage) per Level of Work RVU Productivity





















































 7,000 $45.00 $  315,000 $ 0.00 $      0 $  335,000 $20,000 $  335,000 $82,000.00 $16,400 $  351,400 $ 50.20
 7,500 $45.00 $  340,000 $ 0.00 $      0 $  360,000 $20,000 $  360,000 $82,000.00 $16,400 $  376,400 $ 50.19
 8,500 $45.00 $  380,000 $10.00 $      0 $  400,000 $20,000 $  400,000 $82,000.00 $16,400 $  416,400 $ 48.99
 1,100 $45.00 $  480,000 $10.00 $ 22,000 $  500,000 $20,000 $  522,000 $82,000.00 $16,400 $  538,400 $489.45
30,500 $45.00 $1,400,000 $10.00 $220,000 $1,420,000 $20,000 $1,640,000 $82,000.00 $16,400 $1,656,400 $ 54.31
Table 2: Industry Annual Work RVU Production (wRVU)
Notes N=









MGMA WRVU—ALL (13) 671  33% 5,565 6,893 7,308 8,703 10,681
AMGA WRVU—ALL (15) 756  33% 5,410 7,163 7,585 9,537 11,002
Sullivan Cotter WRVU—ALL (16) 181  33% 5,250 6,335 6,858 8,004 10,114
Weighted Average Industry Annual WRVU Production (17) 100% 5,577 6,936 7,383 8,803 10,703











MGMA Comp/WRVU—ALL (13) 671  33% $41.13 $49.25 $54.09 $59.94 $77.51
AMGA Comp/WRVU—ALL (15) 756  33% $37.68 $48.07 $50.95 $62.00 $74.25
Sullivan Cotter Comp/WRVU—ALL (16) 181  33% $36.69 $45.26 $47.45 $54.59 n/a
Weighted Average Industry Compensation per Work RVU (19) 100% $42.26 $50.11 $53.41 $61.46 $76.83
11. Calculated cash compensation given per work RVU production in Column A, that is, $45/work RVU under 8,501 and $55/work RVU over 8,500 + Quality Incentive Payment + 
amortization of nose coverage (Column H + Column J).
12. Calculated proposed total annual compensation (Column L5) divided by Work RVUs generated (Column B5).
13. Industry Annual Work RVU Productivity for all general surgeons. Source: Medical Group Management Association (MGMA) “Physician Compensation and Production Survey 2009 
Interactive Report Based on 2008 Data.”
14. Industry Annual Work RVU Productivity for midwest general surgeons. Source: Medical Group Management Association (MGMA) “”Physician Compensation and Production 
Survey 2009 Interactive Report Based on 2008 Data.”
15. Industry Annual Work RVU Productivity for all general surgeons. Source: American Medical Group Association (AMGA) “2009 Medical Group Compensation and Financial Survey: 
2009 Report Based on 2008 Data.”
16. Industry Annual Work RVU Productivity for all general surgeons. Source: Sullivan Cotter and Associates, Inc. “2008 16th Annual Physician Compensation and Productivity Survey 
Report.”
17. Weighted average industry annual work RVU production based upon survey weight of consideration (Column D).
18. Survey weight of consideration based upon geographical location and number of survey responses.
19. Weighted average industry compensation per work RVU based upon survey weight of consideration (Column D).
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Key Concept Definition Citation
Corporate Practice 
of Medicine 
The corporate practice of medicine doctrine was created by the American Medical 
Association (AMA) to protect the public as well as the profession of medical doctors. 
The doctrine essentially bans unlicensed individuals and entities from engaging in 
the practice of medicine by restricting them from employing licensed physicians. 
The intent of the doctrine was to ensure that only licensed professionals delivered 
medical care and that lay persons and entities not influence treatment decisions. 
The premise underlying the doctrine was that it would protect patients from 
potential abuses because commercialized medicine would ultimately divide a 
physician’s loyalty between profits and the delivery of quality patient care.
“Corporate Medicine in 21st Century Health Care,” 
John W. Jones, Esq., Physician’s News Digest, June 
2007, www.physiciansnews.com/law/607jones.
html, (accessed July 9, 2009); People v. United 




Accountability Act of 
1996 (HIPPA) 
The HIPAA Privacy Rule provides standards for the use and disclosure of “protected 
health information” (PHI) to safeguard patient privacy. PHI is anything that relates 
to a patient’s past, present, or future physical or mental health condition and the 
provision of healthcare services to the patient and the past, present, or future 
payment for the provision of healthcare to the individual. The Privacy Rule governs 
health plans, healthcare clearinghouses, and any healthcare provider that transmit 
health information in electronic form in connection with a transaction for which the 
secretary of Department of Health and Human Services (HHS) has adopted HIPPA 
standards (“covered entities”). The act was updated by the Health Information 
Technology for Economic Clinical Health (HITECH) Act, located within the Recovery 
and Reinvestment Act of 2009, and allows patients to request an audit trail that 
shows all disclosures of their PHI, prohibiting the sale of a patient’s PHI without 
his or her authorization, and requiring individuals to be notified if there is an 
unauthorized disclosure or use of their PHI.
45 C.F.R. 160.103; 45 C.F.R. 164; “Summary of 
the HIPAA Privacy Rule,” OCR Privacy Brief, United 
States Department of Health and Human Services, 
May 2003, p. 4, www.hhs.gov/ocr/privacy/hipaa/
understanding/summary/privacysummary.pdf 
(accessed June 17, 2009).
False Claims Act 
(FCA)
Creates civil liability for knowingly presenting false or fraudulent claims for 
reimbursement to the federal government. Amended in 1986, it has become one 
of the primary weapons used to combat healthcare fraud. Under the statute’s qui 
tam (whistleblower) provisions, any private citizen can enforce the FCA by filing 
a complaint alleging fraud against the federal government. The incentive is the 
potential to share in the recovery of any ill-gotten funds. In 1998, the Office of 
Inspector General (OIG) and the Department of Justice issued guidelines limiting 
enforcement actions.
“False Claim Act” 31 U.S.C. 3729; “Health Care 
Fraud Report: Fiscal Year 1998,” Department 
of Justice, justice.gov, 1998, www.justice.gov/
dag/pubdoc/health98.htm#national (accessed 




“Health plans, healthcare clearinghouses, and any health care provider who 
transmits health information in electronic form in connection with a transaction 
for which the Secretary of HHS [Department of Health and Human Services] has 
adopted [HIPAA] standards.”
“Summary of the HIPAA Privacy Rule,” OCR 
Privacy Brief, United States Department of Health 
and Human Services, May 2003, p. 2, www.hhs.
gov/ocr/privacy/hipaa/understanding/summary/
privacysummary.pdf (accessed June 17, 2009).
Office of the 
Inspector General 
(OIG)
“The mission of the Office of Inspector General (OIG), as mandated by Public Law 
95-452 (as amended), is to protect the integrity of Department of Health and Human 
Services (HHS) programs, as well as the health and welfare of the beneficiaries 
of those programs. OIG has a responsibility to report both to the Secretary and 
to the Congress program and management problems and recommendations to 
correct them. OIG’s duties are carried out through a nationwide network of audits, 
investigations, evaluations and other mission-related functions performed by OIG 
components.”
“Mission.” U.S Department of Health Services, 
Office of the Inspector General, http://oig.hhs.gov/ 
(accessed July 14, 2009).
The Department of 
Health and Human 
Services (HHS)
“The Department of Health and Human Services (HHS) is the United States 
government’s principal agency for protecting the health of all Americans and 
providing essential human services, especially for those who are least able to help 
themselves.”
“About HHS,” U.S Department of Health and Human 
Services, www.hhs.gov/about/ (accessed July 14, 
2009).
Fraud Enforcement 
and Recovery Act of 
2009 (FERA)
Expands government resources to combat fraud in the housing and mortgage 
arena, and expands the scope of the FCA by clarifying the term knowingly to 
mean; a person who acts, “1) has actual knowledge of the information; 2) acts 
in deliberate ignorance of the truth or falsity of the information; or, 3) acts in 
reckless disregard of the truth or falsity of the information.” FERA also reduces the 
government’s burden of proof, no longer requiring it to provide “proof of specific 
intent to defraud,” and expanded the definition of claim.
Sec. 4 Clarifications to the False Claims Act to 
Reflect the Original Intent of the law,” United States 
Senate, Fraud Enforcement and Recovery Act 
S.386, April 2009, http://thomas.loc.gov/cgi-bin/
query/F?c111:3:./temp/~c111f3yFGF:e10867: 
(accessed May 1, 2009); “Fraud Enforcement and 
Recovery Act of 2009 (FERA),” Anne Sharamitaro, 
Esq. and Kelly Gordon, Health Capital Topics, Vol. 2, 
No. 5, May 2009.
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Health Care Quality 
Improvement Act 
of 1986
Among other things, established the National Practitioner Data Bank to improve the 
availability of information obtained during the peer review process.
“Title IV of Public Law 99-660: The Health Care 
Quality Improvement Act of 1986.”
Medicare and 
Medicaid Patient & 
Program Protection 
Act of 1987 
(MMPPPA)
Amended the 1987 antikickback statute by including an alternative civil remedy to 
violation: exclusion from the Medicare Program.
“Medicare and State Health Care Programs: Fraud 
and Abuse,” OIG Anti-Kickback, Department of 
Health and Human Services, July 29, 1991, 42 
CFR Part 1001.; “Medicare and Medicaid Patient & 







Legislation that pushed Certificate of Need regulations to the forefront of 
government healthcare cost containment efforts. The act required that federal 
agencies pass health policy planning guidelines and establish “a statement of 
‘national health planning goals’ ”.
“The National Health Planning and Resources 
Development Act of 1974,” Pub. L. No. 93-641, 
Jan. 4, 1975, § 1501; Frank A. Sloan, et. al., Cost, 
Quality, and Access In Health Care: New Roles for 
Health Planning In A Competitive Environment, p. 
31 (Josey-Bass Publishers 1988).
Balanced Budget 
Act of 1997 
Added a civil monetary penalty of treble damages, or three times the illegal 
remuneration, plus $50,000 per violation of the antikickback statute.
“The Balanced Budget Act of 1997,” Pub. L. 105-
33, Section 4304 (Aug. 5, 1997).
Patient Safety and 
Quality Act (PSQIA)
Legislation that established a voluntary reporting system for medical errors to 
increase the availability of such and more efficiently address issues related to 
patient care and quality.
“Patient Safety and Quality Improvement; Final 
Rule” 42 CFR Part 3, Center for Medicare and 




Health (HITECH) Act 
Legislation used to promote widespread adoption of health information technology, 
particularly electronic health records (EHRs). Also used to protect the privacy 
and security of PHI by allowing patients to request an audit trail that shows all 
disclosures of their PHI, prohibiting the sale of a patient’s PHI without his or her 
authorization, and requiring individuals to be notified if there is an unauthorized 
disclosure or use of their PHI.
“Health Information Technology for Economic and 
Clinical Health,” found in “American Recovery and 
Reinvestment Act of 2009,” Pub. L. No. 111-5  
(Feb. 17, 2009), Title XIII.
Stark Law The federal physician self-referral law, or “Stark law,” prohibits physicians from 
referring Medicare or Medicaid patients to an entity for designated health services 
(defined by HHS) if the physician, or an immediate family member, has a financial 
relationship with that entity. It began in 1989 and has been revised many times. 
Stark I (1989)—The Ethics in Patient Referrals Act—physicians can’t refer to family 
members.
Stark II Phase I (2002) and Phase II (2004)—physicians can’t refer if they have an 
ownership interest.
Stark II Phase III (2007)—any financial arrangement is a direct compensation 
arrangement.
Stark IV (2009)—physician with any ownership is considered part of the whole 
physician organization. 
There are many specified exceptions to Stark law. 
42 U.S.C. 1395nn(a)(1)(A); 60 Fed. Reg. 41914 
(Aug. 14, 1995); 69 Fed. Reg. 16054 (Mar. 26, 
2004); “Phase III Regulations Result in Dramatic 
Changes to Stark Law,” J. Kelly Barnes, et al., BNA 
Health Law Reporter, Vol. 16, No. 40, October 11, 
2007, p. 1220; 72 Fed. Reg. 51028 (Sept. 5, 2007).
Antikickback 
Statute
Enacted in 1972, the federal antikickback statute makes it a felony for any person 
to “knowingly and willfully” solicit or receive or to offer or pay, any “remuneration” 
directly or indirectly in exchange for the referral of a patient for a healthcare service 
paid for by a federal healthcare program. Penalties were amended by Medicare and 
Medicaid Patient and Program Protection Act of 1987 and The Balanced Budget Act 
of 1997. Congress enacted “safe harbors,” which detail specific regulatory criteria 
that must be met to shield an arrangement from liability and are meant to protect 
practices unlikely to result in fraud or abuse. 
“Criminal Penalties for Acts Involving Federal 





Regulate Medicare and Medicaid reimbursements and services in an attempt to 
“ensure effective, up-to-date health care coverage and to promote quality care for 
beneficiaries.”
“Mission, Visions & Goals,” Department of Health 
and Human Services, Centers for Medicare 
and Medicaid Services, www.cms.hhs.gov/
MissionVisionGoals/ (accessed July 14, 2009).
(continued)
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Osteopath “Osteopathic medicine is dedicated to treating and healing the patient as a whole, 
rather than focusing on one system or body part. An osteopathic physician will often 
use a treatment method called osteopathic manipulative treatment (also called 
OMT or manipulation)—a hands-on approach to make sure that the body is moving 
freely. This free motion ensures that all of your body’s natural healing systems are 
able to work unhindered. A doctor of osteopathic medicine (D.O.) is a physician 
licensed to practice medicine, perform surgery, and prescribe medication.”
“Doctor of Osteopathy” Medical Encyclopedia, 






Improvement Act of 
2003 (MMA)
Implemented an eighteen-month moratorium on the development of new specialty 
hospitals, which represented a compromise between the idea that the “whole 
hospital” exception should be removed for all hospitals and the position of removing 
it only for specialty hospitals. The moratorium officially ended on June 8, 2005.
“Medicare Prescription Drug, Modernization, and 
Improvement Act of 2003” §507(a)(1)(B); “Valuation 
of Healthcare Ancillary Service Providers,” Robert 
James Cimasi ASA, CBA, AVA, FCBI, CM&A, CMP, 
President, Health Capital Consultants, National 
Association of Certified Valuation Analysts: 
Consultants’ Training Institute 2007, September 13, 
2007, p. 10. 
Emergency Medical 
Treatment and 
Active Labor Act 
(EMTALA)
Enacted by Congress in 1986 “to ensure public access to emergency services 
regardless of ability to pay. Section 1867 of the Social Security Act imposes specific 
obligations on Medicare-participating hospitals that offer emergency services 
to provide a medical screening examination (MSE) when a request is made for 
examination or treatment for an emergency medical condition (EMC), including 
active labor, regardless of an individual’s ability to pay. Hospitals are then required 
to provide stabilizing treatment for patients with EMCs. If a hospital is unable to 
stabilize a patient within its capability, or if the patient requests, an appropriate 
transfer should be implemented.”
“EMTALA Overview” Department of Health and 
Human Services, Centers for Medicare and 
Medicaid, www.cms.hhs.gov/emtala/ (accessed 
July 14, 2009).
Certificate of Need 
(CON)
Requires that healthcare providers obtain state approval before either developing 
new services, or expanding existing services.
“Certificate-of-Need Law in Illinois Slammed 
by Feds, AMA” by Amy Lynn Sorrel, American 
Medical News, Oct. 6, 2008, www.ama-assn.org/
amednews/2008/10/06/gvsb1006.htm, (accessed 
June 22, 2009). 
Sherman Antitrust 
Act
Prohibits any “contract, combination . . . or conspiracy, in restraint of trade or 
commerce to combat unfair competition and abuse of monopolistic power.” Used by 
federal government to combat kickbacks and self-referral joint ventures.
15 U.S.C. § 1; “Health Care Fraud: Enforcement 
and Compliance,” By Robert Fabrikant, et al., Law 





Federal law which carries both criminal and civil penalties with the aim of 
protecting the public from, “parties who conduct organizations affecting interstate 
commerce through a pattern of criminal activity.” Makes it illegal for any person 
to use or invest any income derived from a “pattern of racketeering activity” in 
an enterprise, to acquire or maintain control of any enterprise through a pattern 
of racketeering activity, and for any person employed by or associated with any 
enterprise to conduct the affairs of the enterprise through a pattern of racketeering 
activity.
“Health Care Fraud: Enforcement and Compliance,” 
by Robert Fabrikant, et al., Law Journal Press, 
2007, p. 3-84, quoting 115 Cong. Rec. 9566, 9568 
(April 18, 1969), statement of Sen. McClellan; 18 
U.S.C. 1962.
The Occupational 
Safety and Health 
Act of 1970
Established standards for occupational health and safety, and requires states 
to enact legislation implementing standards and procedures developed by the 
Department of Labor.
“Individual Providers and Caregivers,” “Problems 
in Health Care Law, Ninth Edition,” Robert D. Miller, 




Requires laboratories to regulate all laboratory testing performed on humans, 
except the testing performed for research purposes, in order to improve the 
accuracy, reliability, and timeliness, of test results. Requires that healthcare 
providers that perform laboratory testing on specimens derived from humans to 
obtain a certificate and abide by established standards in order to operate these 
services. Overseen by CMS.
“Overview: Clinical Laboratory Improvement 
Amendments” Centers for Medicare and Medicaid 
Services, May 07, 2009, www.cms.hhs.gov/clia/, 
(accessed June 30, 2009); “Clinical Laboratory 
Improvement Amendments” United States Food 
and Drug Administration, June 16, 2009.
The United States 
Nuclear Regulatory 
Commission (NRC)
An independent agency created by Congress in 1974 to ensure the safe use of 
radioactive material (including those used in medical facilities) for civilian purposes 
through a combination of regulatory requirements, licensing, safety oversight, 
operational evaluation, and support activities. Under section 274 of the Atomic 
Energy Act of 1954, the NRC is authorized to delegate its authority to oversee 
certain licensees to state regulatory commissions, or agreement states.
“Medical, Industrial, and Academic Uses of Nuclear 
Material” United States Nuclear Regulatory 
Commission, June 02, 2008, www.nrc.gov/
materials/medical.html, (accessed June 30, 2009); 
The Atomic Energy Act of 1954, Public Law 83-703, 
68 Stat. 919 Sec. 274 August 30, 1954.
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Section 1122 
of the 1972 
Social Security 
Amendments
Allowed the secretary of Health, Education, and Welfare to enter into agreements 
with states that had a “designated planning agency,” an agency responsible 
for determining whether healthcare facilities could make capital expenditures. 
States failing to institute health policy planning programs could lose Medicare and 
Medicaid cost reimbursement.
“Compilation of the Social Security Laws: 
Limitation on Federal Participation for Capital 
Expenditures,” United States Government, Sec. 
1122, 2009, www.socialsecurity.gov/OP_Home/









Healthcare Act of 
2009
Introduced before the U.S. House of Representatives in February 2009 as a new 
attempt to pass a federal cap on noneconomic damages in medical malpractice 
suits, which has been a continuing congressional goal since the same bill was first 
introduced in the House in 2002.
“H.R. 4600: Help Efficient, Accessible, Low-Cost,  
Timely Healthcare (HEALTH) Act of 2002: Related 
Legislation,” govtrack.us, www.govtrack.us/
congress/bill.xpd?bill=h107-4600&tab=related 




Prohibits “unfair methods of competition in or affecting commerce . . .,” One of the 
federal government’s primary means of combating unfair competition and abuse of 
monopolistic power.
15 U.S.C. § 1.
Deficit Reduction 
Act (DRA)
Enacted February 8, 2006, and continued the suspension of CMS’s enrollment of 
new specialty hospitals (from MMA) for about six months, until the release of the 
CMS’s final report on specialty hospitals as required by the DRA.
“Moratorium on Specialty Hospitals Expires” by 
Jennifer Gordon, Dallas Business Journal, http://
assets.bizjournals.com/dallas/stories/2005/06/20/
story8.html (accessed June 25, 2009).
Overview
The U.S. healthcare industry is replete with overlapping state and federal regulations which shape the 
practice of medicine and delivery of healthcare services in the twenty-first century. A significant number 
of regulations apply to both physician and nonphysician practitioners. While regulation has traditionally 
been directed at physicians and allied health professionals, regulation of mid-level providers has in-
creased resulting from the expanding scope of services provided under their own Medicare or Medicaid 
provider numbers. This chapter discusses the general provisions of federal and state regulations, noting 
whether they apply solely to medical professionals or to allied health professionals and mid-level pro-
viders as well. The regulatory environment surrounding these specific professions will be examined in 
further detail in the chapters dedicated to each profession.
Healthcare Liability
Generally speaking, liability is a measure of responsibility and accountability under the law.1 Liability 
within healthcare is uniquely allocated, as practitioners and practices cannot completely shelter each 
other from all the various laws governing medicine. Historically, healthcare professionals were liable 
solely for their professional actions, that is, the provision of medical care to patients. As healthcare grew 
in complexity, from the practice of medicine to the business of medicine, practitioners began to face 
liability as industry entrepreneurs as well. As such, liability in healthcare can be classified, as it affects 
both practice and practitioner, into three distinct categories: professional liability, financial liability, and 
tax liability (see chapter 1 in Professional Practices).2 Hospitals and practices, as business enterprises, 
are held liable for the way in which they file their taxes; depending on the affiliation, ownership, and ar-
rangement structure, a practitioner can be held liable for tax purposes as well (see IRS Tax Status).3 Prac-
titioners with ownership interest may be financially liable for any violations related to business practices 
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and, as a result, may suffer personal losses (see Fraud and Abuse Laws).4 Lastly, each practitioner shoul-
ders a certain amount of professional liability for services rendered based on their scope of practice and 
supervision or supervisory status (see Tort Reform).5 As healthcare grows in complexity, both medically 
and entrepreneurially, the liability that practitioners and practices face likely will increase in complexity 
as well. 
The Shift from Cottage Industry to Corporate  
Practice of Medicine
Historically, the practice of medicine has been a “cottage industry” with little crossover seen between 
specialties and practices (see chapter 1, Shift to Managed Care). The gradual corporatization of medi-
cine necessitates the regulation of emerging entrepreneurial concerns, that is, business arrangements, 
fraud and abuse, tax compliance, and practitioner compensation. The Corporate Practice of Medicine 
doctrine is the most fundamental legislative manifestation of the healthcare transition from a “cottage 
industry” to, effectively, the corporate practice of medicine. 
Corporate Practice of Medicine (CPOM)
The American Medical Association promulgated the Corporate Practice of Medicine (CPOM) to prohibit 
unlicensed individuals from engaging in the practice of medicine by employing licensed physicians.6 
CPOM was intended to ensure that licensed physicians could provide medical care without pressure 
from lay persons whose goals may not be in the best interest of the patient, as medicine should not “be 
subject to commercialization or exploitation.”7 
The CPOM is regulated by the states.8 Although restrictions vary by jurisdiction, forty-eight states 
and the District of Columbia have some form of regulation that follows a CPOM standard.9 Of these 
forty-eight states, eight have statutory provisions restricting the CPOM.10 In thirty states, the CPOM 
has been restricted or outlawed by case law, opinions of the state attorney general, or state licensing 
boards.11 Although, in eight of the states where the CPOM is regulated, the trend is less restrictive, and 
corporations are allowed to employ physicians as long as they do not interfere with the physician’s inde-
pendent medical judgment.12 Currently, five states affirmatively permit the CPOM.13 Because the regula-
tions vary significantly, it is important to understand restrictions regarding the CPOM on a state-by-state 
basis.
Certain healthcare organizations are generally exempt from the application of the CPOM doctrine. In 
all states, physicians are allowed to incorporate as professional corporations. In some states, the orga-
nization of health maintenance organizations (HMOs) and contracts between HMOs and professionals 
for the provision of services are exempted specifically from the doctrine.14 Further, some states exempt 
nonprofit healthcare entities under the rationale that the lack of profit incentive eliminates the dangers 
associated with the CPOM.15
As a result of CPOM, new practice areas have surfaced that may be prone to running afoul of current 
statutes. A new practice area that may violate existing CPOM restrictions is the growth in “quick clin-
ics,” or physician offices generally found in large “doc-in-a-box” stores or pharmacies.16 Although retail-
ers in states with CPOM restrictions typically cannot open in-store clinics and staff physicians, CPOM 
laws generally allow corporations to rent or lease space to providers.17
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Another growing trend in CPOM violation is the practice of nonphysician-owned spas offering 
Botox injections and other medical procedures with physicians staffed as medical directors.18 Under this 
arrangement, unlicensed spa owners may be involved in the unlicensed practice of medicine, and the 
physician may be aiding and abetting.19 At least one state, California, has issued regulations prohibiting 
this practice.20
CPOM also has been influenced by the creation of new enforcement strategies and regulations that 
aid in the prevention of fraud. In 2005, the New York Court of Appeals held that no-fault insurance 
carriers could refuse payment for medical services provided by fraudulently incorporated medical busi-
nesses.21 The court based its holding on two premises: (1) a business corporation law that prohibits indi-
viduals from owning a share in a professional service corporation if they are not licensed to practice in 
the same profession as the corporation and (2) an insurance regulation that excludes payments made to 
unlicensed or fraudulently licensed providers.22 The defendant corporation argued that it should be reim-
bursed because all its patients received care from licensed providers.23 However, because the corporation 
was owned by nonphysicians, the court found the organization to be in clear violation of state law.24
Despite these regulations, CPOM has found its way into the marketplace 
through new entities that utilize technology to address patient concerns 
while bypassing traditional methods of patient consultation. Examples of 
this trend include companies that provide medical consultation services by 
phone or e-mail and “quick clinics” that generally are found in larger “big 
box” stores and can take advantage of the store’s clientele while allowing 
patient consumers to do efficient one-stop shopping (that is, they can shop 
while they wait for a physician to see them). These particular types of 
entities should be cognizant of the most recent CPOM in their states to avoid 
running afoul of restrictions.
“Demand Growing for Corporate Practice of Medicine,” By Devon Herrick, Consumer Driven Health Care, National 
Center for Policy Analysis, Jan. 1, 2006, http://healthcare.ncpa.org/commentaries/demand-growing-for-corporate-
practice-of-medicine (accessed June 24, 2009).
Healthcare Regulation at Federal and State Levels
Healthcare can be regulated at both the state and federal level. State legislation and enforcement mea-
sures actually may stem from federally elicited incentives or compliance standards (that is, Medicaid 
reimbursement (see chapter 2, Medicaid and State Children’s Health Insurance Program). Conversely, 
some issues are federally regulated, which constitutionally binds states in compliance. Under these cir-
cumstances, federal guidelines are preserved but tailored through supplemental state law to meet state-
specific needs.
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Licensure
State laws typically control the licensure of healthcare providers under the state’s police powers. 
Through these laws, states can regulate entry into the field, restrict professional scope of practice, and 
hold professionals accountable accordingly. State licensing laws specify the minimum level of qualifi-
cation needed to practice in a field. It is argued that licensure is intended to ensure the public’s safety 
by providing a standard for the evaluation of provider expertise and accurate assessment of the risks of 
substandard care.25 However, the domination of professional licensure boards by the professionals them-
selves also has been criticized as serving the interests of the profession more than the interests of the 
public.26 Licensure of the various provider types is discussed in the corresponding sections of chapters 3, 
4, 5, 6, and 7 in Professional Practices.
Individual Professional Licensure
Every state and the District of Columbia require licensure of all allopathic (M.D.) and osteopathic (D.O.) 
physicians.27 Although the exact requirements for licensure vary by state, each state requires candidates 
to submit proof of “good moral character, adequate educational preparation [at an accredited medical 
school], appropriate practical experience, and successful completion of a licensure exam.”28
A physician applying for licensure typically is found to be of good moral character absent his or her 
involvement in illegal activities.29 Most physicians satisfy the exam requirement by submitting to the 
licensure board proof of their successful completion of the United States Medical Licensing Examina-
tion or the Comprehensive Osteopathic Medical Licensing Examination.30 However, because some 
practicing physicians may have been licensed under a previously administered exam, some state licens-
ing boards may consider a combination of other examinations as sufficient for licensure, as long as those 
exams were completed prior to 2000.31 Once licensed, most states’ scope of practice definitions allow 
physicians to perform almost all healthcare related activities, as the practice of medicine is the broadest 
definition in healthcare licensure.
As part of the Health Care Quality Improvement Act of 1986, the United States Congress established 
the National Practitioner Data Bank to improve the availability of information obtained during the peer 
review process.32 The Department of Health and Human Services (HHS) is responsible for oversee-
ing the system. The act requires state medical and dental licensing boards to report disciplinary action 
taken against a licensed professional, in regard to his or her professional competence and professional 
conduct.33 Hospitals also are required to periodically check the status of the database for each member 
of their medical staff, and individual practitioners may request their own records, however, the general 
public does not have access the data bank.34
In addition to physicians, all states require the licensure of dentists, registered nurses, practical 
nurses, dental hygienists, pharmacists, optometrists, physical therapists, podiatrists, chiropractors, and 
administrators of nursing homes.35 Frequently, physician assistants, midwives, psychologists, social 
workers, opticians, physical therapy assistants, audiologists, and speech pathologists also are subject to 
state licensure laws.36 As with physician licensing, state rules vary on licensure requirements for these 
professions. 
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Physician Versus Nonphysician Scopes of Practice 
Because the licenses issued to nonphysician practitioners are limited in scope so as not to run afoul of 
the prohibition against the unlicensed practice of medicine, these professionals must be careful to only 
practice within the limits set forth by relevant statutes. This has led nurses and allied health profession-
als to lobby legislatures and seek judicial rulings to expand the practice limits placed on their licenses. 
Recent changes in technology, better education for nurses and allied health professionals, physician 
shortages, and the government’s and third party payor’s insistence on controlling healthcare costs, have 
led to expanded roles for nonphysician professionals.37 
Practitioners are liable for violation of state laws that regulate the range of services they are permit-
ted to provide. Additionally, Medicare fee schedules indirectly influence professionals by navigating the 
degree and magnitude of reimbursement rates, as well as which services are covered.38 Overseen by the 
Centers for Medicare and Medicaid Services (CMS), Medicare reimbursement rates vary based on the 
level of specialization of each type of practitioner. For nonphysician practitioners, reimbursement rates 
are dictated by incident-to policies, which state the percentage of a service cost that a nonpractitioner 
may be reimbursed through Medicare.39 These rates vary based on the level of supervision required (if at 
all) and the type of services provided (see chapter 4 in Professional Practices).40 Further, the final rule 
of the 2010 Medicare physician fee schedule (MPFS) modified supervision requirements for in-hospital 
outpatient services to allow certain nonphysician practitioners (for example, clinical psychologists, 
physician assistants, nurse practitioners, clinical nurse specialists, certified nurse-midwives, and licensed 
clinical social workers) to be direct supervisors for all outpatient therapeutic services allowable under 
state laws.41
In some cases, Medicare rules and state laws overlap, which may be cause for controversy. For ex-
ample, Certified Registered Nurse Anesthetists are authorized to administer anesthesia, without supervi-
sion, to Medicare patients if a state’s governor petitions CMS on the basis of state need (see chapter 4 
in Professional Practices).42 Contention between physicians and mid-level providers has led to several 
lawsuits regarding this topic by physician groups interested in protecting physician provision of certain 
services.43 
As the overlap between the scope of practice for physicians and nonphysicians increases, malprac-
tice liability, which jeopardizes the licenses of both the supervising physician and the nonphysician 
professional, may increase as well.44 For more information on mid-level provider competition with phy-
sicians see chapter 4 in Professional Practices.
Specialty Licensure and Certification
Technological advances during the past forty years have led to an increase in the specialization of 
healthcare personnel.45 Accompanying this rise in specialization is the development of new categories 
of providers within the traditional healthcare professions, including pediatric nephrologists and hospital-
ists, physicians whose primary focus is the delivery of care in hospitals.46 The creation of these special-
ties has been mirrored by a rise in various professional medical associations, which have created their 
own systems for credentialing specialists.47 Although certification requirements vary by specialty, they 
typically include additional educational attainment, examinations, and work experience.48 Unlike a state 
licensure board, a professional association cannot bar a licensed physician from practicing in a particu-
lar specialty for failing to obtain board certification, although board certification is viewed favorably by 
hospitals and healthcare service providers as an indicator of competence.49
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Advances in technology also have led to the development of new categories of healthcare providers, 
including radiological technologists and speech pathologists, as well as the state licensing programs and 
private certifying agencies governing these providers.50 
Healthcare Facility and Practice Licensure
Although the licensing of healthcare entities typically is handled by state governments, significant inter-
play exists between state and federal government regulations. Most states require entities to meet prac-
tice standards set forth by Medicare as a condition of licensure, and Medicare requires state licensure as 
a condition of reimbursement.51 As with other types of professional licensure, the licensure of healthcare 
facilities is intended to ensure that patients receive quality healthcare. 
State regulation designates which healthcare facilities must be licensed. All states require hospitals 
to be licensed, and most states also require nursing homes to be licensed.52 In addition, many states re-
quire further licensure of specialized areas within an already licensed facility, including hospital phar-
macies, clinical laboratories, and hospital-based ambulatory surgery centers (ASCs).53
In order to maintain licensure, facilities may need to meet certain building requirements and limit 
the number of beds allowed.54 In addition, regulations, such as locally adopted zoning laws, occupancy 
permits, building codes, and building permits, may place increased demands on healthcare entities. 
Physicians typically are not required to license their solo or group practices, because the state exer-
cises control over these facilities through control of each physician’s license.55 However, as the provision 
of medical care continues to shift to the outpatient setting, more states have expanded the scope of their 
licensing regulations to require the licensure of facilities performing outpatient procedures similar to 
those performed in inpatient facilities for which a license is ordinarily required.
Accreditation 
Accreditation is the process by which private organizations assess participating institutions and pro-
grams and issue accreditation certificates to institutions that meet their requirements. Ensuring the 
quality and safety of services is the focus of most accreditation standards; however, many also include 
documentation and other requirements.56 If a participating institution or program fails to maintain the 
requisite standards, they may not incur penalties other than the loss of their accreditation. In most states, 
there is no link between accreditation and institutional licensure, although, some states will forego fur-
ther inspection and accept accreditation by organizations, such as the Joint Commission, as the basis for 
the state licensure of certain providers.57 
Accreditation can be beneficial to organizations for purposes of federal compliance. Medicare grants 
deemed status to hospitals accredited by the Joint Commission58 or the American Osteopathic Associa-
tion (AOA).59 Deemed status allows providers to participate in the Medicare program unless a later 
Medicare validation survey finds noncompliance with the conditions of participation requirements set 
forth in federal regulations.60 Accreditation is also important because some payors will only contract 
with accredited providers.61 
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Major accrediting bodies in the United States include the Joint Commission on Accreditation of 
Healthcare Organizations (JCAHO), the AOA, and the National Committee for Quality Assurance 
(NCQA). 
The Joint Commission
JCAHO is a nongovernmental organization that strives to ensure the safety and quality of healthcare 
services provided to the public.62 The Joint Commission pursues this goal by conducting on-site reviews 
and setting standards for institutional governance, support services, and patient care.63 Facilities seek 
Joint Commission accreditation because it helps ensure the provision of quality services, attract quality 
staff, qualifies them to receive Medicare reimbursement, and in some states, is a licensure requirement.64 
The Joint Commission provides accreditation for ambulatory care centers, behavioral health centers, 
critical access hospitals, home health services, general hospitals, laboratory services, long-term care 
facilities, office-based surgery centers, and international healthcare providers.65
American Osteopathic Association
The AOA is the main board certifying entity for osteopathic physicians (D.O.), and it is the accrediting 
body for every osteopathic healthcare facility and medical college.66 The AOA strives to promote the 
practice of osteopathic medicine by ensuring quality in education, research, and the delivery of health-
care services. In terms of accreditation, the AOA functions much like the Joint Commission.67
National Committee on Quality Assurance
The National Committee for Quality Assurance (NCQA) is a nonprofit organization that works with 
employers, doctors, policymakers, patients and health plans to improve the quality of healthcare through 
the accreditation of managed care plans.68 NCQA performs this duty, much like other accrediting bodies, 
through the setting of standards and collection of outcome and performance data.69
Certificate of Need (CON)
A Certificate of Need (CON) program is one in which government determines where, when, and how 
capital expenditures will be made for public healthcare facilities and major equipment.70 CON is based 
on the theory that, in an unregulated market, healthcare providers will provide the latest costly technol-
ogy and equipment, regardless of duplication or need.71 Despite CON’s aim to reduce healthcare costs 
by preventing duplication of services, healthcare costs have continued to rise.72
Despite CON’s aim to reduce healthcare costs by preventing duplication of 
services, healthcare costs have continued to rise.
“Improving Health Care: A Dose of Competition: Chapter 8: Miscellaneous Subjects,” A Report by the Federal 
Trade Commission and Department of Justice, July 2004, p. 2.
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Overview: The Federal Certificate of Need Program
CON statutes and regulations specify those healthcare facilities, medical equipment, and services which 
require applications and approval to operate. The enactment of federally mandated CON laws was the 
product of government-mandated health policy planning efforts that dated back to the post–World War 
II era. While federal regulations provided legislation and enforcement provisions, however, program 
development and implementation generally took place at the state or local level.73
The enactment of federally mandated CON laws was the product of 
government mandated health policy planning efforts that dated back to the 
post–World War II era.
“Beyond Health Care Reform: Reconsidering Certificate of Need Laws in a “Managed Competition” System,” 
Patrick John McGinley, 23 Fla. St. U. L. Rev. 141, 145-148 (1995).
The National Health Planning and Resources Development Act of 1974 pushed CON regulations to 
the forefront of government healthcare cost containment efforts.74 The act required that federal agencies 
pass health policy planning guidelines and establish “a statement of national health planning goals.”75 It 
prompted states to enact CON programs by guaranteeing federal funding for state CON review programs 
and conditioning the receipt of certain healthcare funding on enacting CON programs.76 It also specified 
that state CON programs must meet federal guidelines in order to receive federal funding.77 In response 
to the act, all fifty states developed some form of CON review program.78
Congress repealed the 1974 legislation in 1987, which caused fourteen states to discontinue their 
CON programs.79 Despite the discontinuation of a formal CON program, all fourteen states retain certain 
regulatory mechanisms intended to prevent duplication of services.80
CON laws were modeled after federal legislation, but current CON regulation is based on various 
state statutes, rules, and regulations that designate an agency or board to administer the approval pro-
cess.81 State CON programs are administered according to statutes and regulations controlling market 
entry for regulated facilities, services, and equipment. Hospitals, nursing homes, certain freestanding 
clinics, home health agencies, and ASCs are often among the healthcare facility providers covered by 
CON.82 CON also often applies to healthcare services, including the change of one service to another, 
the purchase of medical equipment, and new technology. State CON programs generally have two func-
tions: (1) to develop a health plan promoting equitable access to healthcare services and (2) to review 
CON applications submitted by healthcare providers.83
CON regulatory policy has been highly contentious in the state legislative arenas for many years, 
and it has been the subject of significant administrative agency study and review. Beyond these activi-
ties, the grant or denial of a CON application frequently has resulted in complex and costly litigation. 
In the four decades that CON has existed, approximately 800 reported legal cases have involved CON 
issues.84 During this period, CON also has been the subject of numerous academic and governmental 
scientific research studies, as well as the subject of thousands of news and journal articles. 
One argument against CON regulatory policy is that its intervention disrupts natural market forces 
and limits competition.85 Seeking to preserve competition in healthcare markets, the Federal Trade Com-
mission (FTC) consistently has criticized CON as a failed public health regulatory policy that creates 
barriers to new market competitors.86
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The Federal Trade Commission and CON
The FTC has evaluated the impact of CON on competition for many years. A 1988 FTC study estimated 
that total hospital costs might decline by 1.4 percent, or $1.3 billion per year, if all states with CON laws 
doubled the dollar thresholds at which they require CON review of hospital expenditures.87
A 1988 FTC study estimated that total hospital costs might decline by 1.4 
percent, or $1.3 billion per year, if all states with CON laws doubled the 
dollar thresholds at which they require CON review of hospital expenditures.
“The Effect of State Certificate-of-Need Laws on Hospital Costs: An Economic Policy Analysis,” By Daniel  
Sherman, Federal Trade Commission, Jan. 1988, p. vi, www.ftc.gov/be/econrpt/232120.pdf (accessed  
October 10, 2009).
In November, 2002, FTC Chairman Timothy J. Muris announced that the FTC would hold joint 
hearings with the Department of Justice (DOJ) on competition in healthcare in the following year.88 On 
July 23, 2004, following the conclusion of the hearings, the FTC and DOJ issued a joint report in which 
the agencies recommended that states decrease barriers to entry into provider markets.89 Following the 
testimony, the agencies suggested that instead of reducing costs, there is evidence that CON programs 
actually drive up costs by “fostering anticompetitive barriers to entry.”90 In addition to raising prices, 
the FTC has condemned CON regulation as causing lower quality and reduced innovation in healthcare 
markets.91
The FTC and DOJ stated their belief that ASCs are beneficial for consumers and that state CON laws 
pose an anticompetitive barrier to entry. In response to ASC provider allegations that general hospitals 
have attempted to use CON laws to prevent ASCs from entering the market, the agencies committed to 
aggressively pursue activities of anticompetitive conduct.92 However, they acknowledged that antitrust 
laws do not prevent individual hospitals from unilaterally approaching state governments in connection 
with CON proceedings.93 
Currently, thirty-six states and the District of Columbia retain some sort of CON program.94 See box 
3-1 for a complete list of states with CON legislation.
As of mid-2008, thirty-six states and the District of Columbia retained  
some sort of CON program.
“Certificate of Need: State Health Laws and Programs,” By National Conference of State Legislatures, April 30, 
2009, www.ncsl.org/IssuesResearch/Health/CONCertificateofNeedStateLaws/tabid/14373/Default.aspx (accessed 
June 24, 2009).
The Application Process
Every state has its own unique CON application process. However, general procedures tend to guide the 
application process in all states. The typical application process involves submission of an application 
for review, agency review for consistency with planning criteria, and a public hearing and decision by 
the granting authority.95 If an application is approved, the project must typically begin within a speci-
fied amount of time.96 If a CON holder fails to fulfill the requirements of the CON, the state may retain 
the right to revoke it.97 In some states, a CON may be transferable, but laws governing such rights differ 
from state to state.
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The Appeal Process
Because CON is an administrative process, an ap-
peal of a negative application decision would first 
go through the proper administrative channels, 
which could then be appealed to the appropriate 
state court.98
Privacy Laws
Because practitioners, providers, and organiza-
tions have regular access to patient medical 
records, the handling of confidential healthcare 
information must be regulated to protect patients 
and ensure that their privacy is secure. Specifi-
cally, the Health Insurance Portability and Ac-
countability Act of 1996 (HIPAA) regulates 
access to medical information, and the Red Flags 
Rules regulate access to financial information. 
With healthcare organizations typically managing 
both patient medical information and billing for services, practices with varying degrees of complexity 
and size are expected to comply with both laws.
Health Insurance Portability and Accountability Act of 1996
Although HIPAA serves many purposes, it is most widely used for safeguarding the privacy of pro-
tected health information (PHI), or individually identifiable health information.99 This protection 
extends to information relating to the “past, present or future physical or mental health condition of an 
individual; the provision of healthcare services to an individual; or the past, present or future payment 
for the provision of healthcare to an individual.”100 The HIPAA Privacy Rule provides standards for the 
use and disclosure of PHI by covered entities, as well as rights for individuals to control how their PHI 
is used.101 The Privacy Rule governs such covered entities as, “health plans, healthcare clearinghouses, 
and any health care provider who transmits health information in electronic form in connection with a 
transaction for which the Secretary of HHS [Department of Health and Human Services] has adopted 
[HIPAA] standards.”102 Transactions by healthcare providers falling under the HIPAA Privacy Rule in-
clude claims, benefit eligibility inquiries, referral authorization requests, and other transactions for which 
HHS has established particular standards.103 These transactions are covered regardless of whether they 
are performed by the healthcare provider themselves, a billing service, or any other third party under 
contract with the provider.104 When a covered entity contracts with a third-party entity to perform billing 
or other business associate activities, including, among other activities, claims processing, data analy-
sis, and utilization review, the covered entity must impose specific safeguards of PHI.105 The business 
associate agreement and the covered entity cannot authorize the business associate to use PHI in a way 
that would violate the Privacy Rule.106 Even the proper destruction of PHI is protected under HIPAA. 
Approved technologies and methods of destroying records are listed in 74 Fed. Reg. 42742.























23. New Hampshire 












36. West Virginia 
37. Wisconsin
Source: “National Directory State Certificate of Need Programs: Health Planning 
Agencies,” By American Health Planning Association, 2008, p. 5.
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Health Information Technology for Economic and  
Clinical Health (HITECH) Act
Recently, the American Recovery and Reinvestment Act of 2009 (ARRA) made changes to HIPAA’s 
health information privacy and security provisions.107 The ARRA used the Health Information Technol-
ogy for Economic Clinical Health (HITECH) Act in order to promote widespread adoption of health 
information technology, particularly electronic health records (EHR).108 Provisions in the HITECH 
Act also protect the privacy and security of PHI by allowing patients to request an audit trail that shows 
all disclosures of their PHI, prohibiting the sale of a patient’s PHI without his or her authorization, and 
requiring individuals to be notified if there is an unauthorized disclosure or use of their PHI.109 This lat-
ter provision also requires practices to publicly post information about security breaches affecting ten or 
more patients who cannot be directly contacted, and it requires public notification to the HHS website, 
prominent media outlets, and the secretary of HHS of breaches affecting 500 patients or more.110 Though 
these new notification requirements were effective as of September 23, 2009, enforcement was delayed 
until February 17, 2010.111 The exceptions to the HITECH Act for PHI include
1. unintentional access to, acquisition of, or use of PHI by a worker of the covered entity, acting in 
good faith, within the scope and course of duties, as long as act does not lead to disclosure under 
HIPAA;
2. inadvertent disclosure from one worker of the covered entity to another, when both workers were 
authorized to access information and no future disclosure occurs; and
3. unauthorized disclosure to an unauthorized person, when there is reasonable belief that the 
recipient would not retain information.112
Medicare National Provider Identifiers (NPI)
Originally, all providers seeking reimbursement under Medicare were given a unique physician identi-
fication number (UPIN). UPINs were discontinued as of June 2007 and replaced by National Provider 
Identifiers (NPI) to meet the “Administrative Simplification Standard” required under HIPAA.113 The 
NPI is a ten-digit unique identification number required for all covered healthcare providers expect-
ing reimbursement under Medicare, Medicaid, or any federal health program.114 NPIs contain an entity 
type code, one being used for individual practitioners (for example, physicians, dentists, nurses, chi-
ropractors, pharmacists, and physical therapists) and two being for healthcare provider organizations 
(for example, hospitals, group practices, ambulance companies, medical suppliers, etc.).115 Mid-level 
providers who “furnish healthcare but do not necessarily conduct covered transactions” also are eligible 
for NPIs.116 The use of NPIs is intended to improve, “the effectiveness and efficiency of the health care 
industry in general, by simplifying . . . administration . . . and enabling the efficient electronic transmis-
sion of certain health information.”117
Red Flags Rules
On November 9, 2007, the FTC and other agencies published a list of “red flags,” which indicate the 
possibility of identity theft, and mandated the implementation of an identity theft prevention program.118 
The deadline for required, written compliance programs has since been deferred until June 1, 2010.119 
This rule is intended to include all businesses defined as creditors (a “business or organization that . . . 
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provide[s] good or services and bill[s] customers later”) that deal with covered accounts. Under the Red 
Flags Rules, a covered account includes:
1. “Consumer account you offer customers that’s primarily for personal, family or household pur-
poses that involves or is designed to permit multiple payments or transactions; or,
2. Any other account that a financial institution or creditor offers or maintains for which there is a 
reasonably foreseeable risk to customers or to the safety and soundness of the financial institu-
tion or creditor from identity theft, including financial, operational, compliance, reputation, or 
litigation risks.”120
Healthcare institutions will have to (1) review their billing practices and payment procedures and 
(2) create a program to ensure compliance.121 Written compliance programs must include strategies and 
procedures for identifying existing “red flags,” avoiding future “red flags” violations, preventing and 
mitigating identity theft, and developing and implementing a procedure for re-evaluating and updating 
program protocols.122 Although varying degrees of detail are required depending on organizational com-
plexity, all enterprises, healthcare and otherwise, are subject to regulation under the Red Flags Rules.123
The Patient Safety and Quality Act of 2005
The Patient Safety and Quality Act (PSQIA) of 2005 effective January 19, 2009, established a voluntary 
reporting system for medical errors to increase the availability of such quality reporting and to more 
efficiently address issues related to patient care and quality.124 Under PSQIA, confidentiality provisions 
to protect “patient safety work product” were established such that reporting organizations may main-
tain compliance with HIPAA and other regulations, guidelines, and rules.125 Patient safety work product 
includes any information that is collected while reporting and analyzing patient safety events.126 Under 
PSQIA, Patient Safety Organizations are charged with collecting and analyzing data under the supervi-
sion of the Agency for Healthcare Research and Quality.127
Fraud and Abuse Laws
The corporatization of healthcare triggered a surge of fraud and abuse regulation of practice and practi-
tioner arrangements.
False Claims Act (FCA)
The False Claims Act (FCA) is a federal law that creates civil liability for any person who “knowingly 
presents, or causes to be presented, to an officer or employee of the United States government or a mem-
ber of the Armed Forces of the United States a false or fraudulent claim for payment or approval.”128 
Since Congress amended the FCA in 1986, it has become one of the primary weapons used to combat 
healthcare fraud, particularly when used in conjunction with the federal physician self-referral (Stark) 
law and the federal antikickback statute.129 The 1986 amendments strengthened the statute’s qui tam, or 
whistleblower provision.130 Under the statute’s qui tam provisions, any private citizen can enforce the 
FCA by filing a complaint alleging fraud against the federal government.131 Qui tam actions are often 
brought by former employees, but they can also be brought by competitors.132 The DOJ assumes primary 
responsibility for prosecuting the claim if it believes the claim has merit.133 The whistleblower is entitled 
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to share in a portion of any recovery the government makes.134 Because the FCA provides for treble 
damages plus an additional penalty for each false claim, potential liability can be tremendous.135 
Although potential violations of the FCA include upcoding and billing for unnecessary services, re-
cent DOJ enforcement actions have shifted from targeting intentional criminal activity to targeting legiti-
mate providers. For example, an action was brought in 2002 against a Kentucky orthopedic surgeon for 
failing to properly supervise residents.136 However, in 1998, the Office of the Inspector General (OIG) 
and the DOJ issued guidelines limiting enforcement actions.137 Still, qui tam actions pose a significant 
threat to providers, as the potential to share in the recovery of any ill-gotten funds creates a strong incen-
tive for private individuals to bring these actions. 
In addition to direct violations, the FCA is also used to prosecute violations of Stark laws (see Stark 
Law) and the federal antikickback statute (see Antikickback Statute). In particular, physician acceptance 
of kickbacks (that is, monetary bribes, free travel, and various other prerequisites) from pharmaceuti-
cal and medical device manufacturers recently have come under increased scrutiny as violations of the 
FCA.138
Recently, the Physician Payments Sunshine Act of 2009 has been introduced 
to address illegal kickback activities. If passed, the act will require makers of 
pharmaceuticals, medical devices, and biologics to issue public statements 
concerning the money they give to doctors that exceeds $100 every year. 
Penalties for knowingly failing to disclose information under the act could 
be as high as $1 million per violation. Senators Chuck Grassley (R-IA) and 
Herb Kohl (D-WI) have been working on getting the Physician Payments 
Sunshine Act passed for a couple of years, and they seem confident that it 
will be passed by the 111th Congress.
“Grassley, Kohl Continue Campaign to Disclose Financial Ties Between Doctors and Drug Companies,”  
Press Release, United States Senate Special Committee on Aging, Jan. 22, 2009, http://aging.senate.gov/record.
cfm?id=307097 (accessed June 25, 2009).
Fraud Enforcement and Recovery Act of 2009 (FERA)
In 2009, the federal government enacted the Fraud Enforcement and Recovery Act of 2009 (FERA), 
which focuses on expanding government resources to combat fraud in the housing and mortgage arena 
and expands the scope of the FCA.139 FERA changes what the United States Supreme Court has inter-
preted to be the FCA’s definition of “knowingly” to ensure the designation is more in line with the intent 
of the law.140 Under the new definition, a person who acts knowingly, “1) has actual knowledge of the 
information; 2) acts in deliberate ignorance of the truth or falsity of the information; or, 3) acts in reck-
less disregard of the truth or falsity of the information.”141 In addition, FERA reduces the government’s 
burden of proof, no longer requiring it to show specific intent to defraud. It now requires only a show-
ing by a preponderance of the evidence of “deliberate ignorance” or “reckless disregard of the truth or 
falsity” of information.142
FERA also expanded the definition of “claim” to include any request for money or property offered 
to a government employee or official, as well as requests to contractors working on behalf of the gov-
ernment.143 The expanded definition also includes any attempt to defraud the government regardless of 
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whether the government is currently in posses-
sion of the money or whether the accused party 
intended to defraud the government.144 Further, 
organizations are only liable if they “knowingly” 
retain improper payments.145
State False Claims Acts
Twenty-three states, the District of Columbia, and 
the individual cities of New York and Chicago 
have enacted false claims acts.146 For the complete 
list, see box 3-2.
Additionally, some other states may have false 
claims acts that apply specifically to healthcare 
fraud, but which may or may not have qui tam 
provisions. See box 3-3.
Violations of state false claims acts can result in fines as high as $15,000 per false claim.147 Although 
the state statutes commonly mirror the federal FCA, some differences can include expanded liability 
provisions in state false claims acts, jurisdictional bars not found in the federal FCA, and damage and 
penalty provisions that may differ from the federal law.148
It is projected that the number of states with false claims acts will grow in the coming years, as 
Congress passed legislation in 2005 creating financial incentives for states to create their own acts.149 
In the Deficit Reduction Act (DRA),150 the federal government incentivized state governments to enact 
state false claims acts similar in scope to the federal FCA by promising to return 10 percent of the funds 
recovered from Medicaid enforcement actions to the state.151 Prior to DRA, that money would have gone 
to the federal government.152 Since its implementation in January 2007, the incentive has compelled 
many states to amplify their existing false claims laws, and it has encouraged more states to develop new 
false claims acts.153
The OIG for HHS is charged with reviewing state false claims laws to ensure they meet the require-
ments for the DRA incentive program. Programs must154 
1) establish liability to the state for false or fraudulent claims described in the FCA with respect to 
any expenditures related to the state Medicaid plans described in section 1903(a) of the Social 
Security Act,
2) contain provisions that are at least as effective in rewarding and facilitating qui tam actions for 
false or fraudulent claims as those described in the FCA,
3) contain a requirement for filing an action 
under seal for sixty days with review by 
the state attorney general, and 
4) contain a civil penalty that is not less than 
the amount of the civil penalty authorized 
under the FCA.155


























Source: “State False Claims Acts,” The False Claims Act Legal Center, Taxpayers Against 
Fraud Education Fund, http://www.taf.org/statefca.htm (Accessed February 10, 2010).
Box 3-3:  States With False Claims Act Legislation and no 







Source: “Health Care Fraud: Enforcement and Compliance,” By Robert Fabrikant, et al., 
Law Journal Press, 2007, p. 4-72.4, n.1.
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To date, the OIG has reviewed the false claims acts of twenty states, finding fourteen to be in com-
pliance with the requirements of the DRA.156 The OIG found that the false claims laws of the other six 
states were not as effective at facilitating and rewarding qui tam actions as the federal FCA.157
In addition, the DRA also requires that entities receiving more than $5 million annually from Medic-
aid establish an employee education plan covering state and federal false claims laws and whistleblower 
protections.158 The education plan must provide information on the federal FCA, administrative remedies 
for false claims and statements, any civil or criminal penalties under state false claims laws, and whistle-
blower protections under federal and state law.159 The DRA made this education requirement a prereq-
uisite of Medicaid participation for entities making or receiving payments totaling more than $5 million 
a year from participation in Medicaid; failure to comply with the January 2007 deadline meant possible 
exclusion from the program.160
Antikickback Statute
Enacted in 1972, the federal antikickback statute makes it a felony for any person (physician, allied 
health professional, or paraprofessional with a Medicare provider number) to “knowingly and willfully” 
solicit or receive or to offer or pay any “remuneration” directly or indirectly in exchange for the referral 
of a patient for a healthcare service paid for by a federal healthcare program.161 Violations of the anti-
kickback statute are punishable by up to five years in prison, criminal fines up to $25,000, or both.162
The original statute was amended in 1987 with the passage of the Medicare and Medicaid Patient 
and Program Protection Act of 1987 (MMPPPA) to include an alternative civil remedy: exclusion from 
the Medicare program.163 The Balanced Budget Act of 1997 added a civil monetary penalty of treble 
damages, or three times the illegal remuneration, plus $50,000 per violation.164 Civil penalties are 
believed to be a more effective way of enforcing the statute because the government need not prove the 
violation by the criminal standard of beyond a reasonable doubt.165 Instead, to impose a civil penalty, 
the government need only prove the violation by the lesser standard of a preponderance of the evidence, 
meaning at least 51 percent of the evidence points to a certain conclusion.166
RegulatoRy and CouRt InteRpRetatIons of statute
The OIG periodically issues “Special Fraud Alerts” providing insight into how the OIG believes the 
statute should be applied to particular business arrangements and which arrangements will violate the 
statute. The OIG has issued “Special Fraud Alerts” on a number of topics including, joint venture ar-
rangements and rental agreements for space in physician offices.167
Both the OIG and case law have adopted expansive interpretations of the statute.168 Therefore, many 
financial relationships, such as the exchange of anything of value between providers, could result in a 
potential violation.169
Thornton Letter—Office of the Inspector General
In 1992, the OIG Associate General Counsel D. McCarty Thornton launched a direct attack against 
physician owners of specialty care practices.170 He sent a letter to the Internal Revenue Service (IRS) 
regarding kickback concerns related to an acquisition involving a charitable 501(c)(3) buyer.171 Thorn-
ton claimed that any amount paid to physicians in excess of the fair market value of the practice’s hard 
assets was suspect and could be considered inducement for referrals.172 Effectively, this prohibited 
payments for goodwill, value of an ongoing business unit, covenants not-to-compete, exclusive dealing 
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arrangements, patient lists, and patient records.173 In many cases, the Thornton letter resulted in a dimi-
nution of practice asset value considered by some to be an unconstitutional taking of property, as the 
effect of the letter made it difficult for specialists to sell their practices for a reasonable amount.174
The Thornton letter resulted in a diminution of practice asset value consid-
ered by some to be an unconstitutional “taking of property,” which made it 
impossible for specialists to sell their practices for a reasonable amount.
“Aspects of Fraud in Healthcare Valuation,” by Robert James Cimasi, Speech to National Association of Certified 
Valuation Analysts, June 2, 2006, p. 12.
“One Purpose” Test
The “one purpose” test, established in United States v. Greber, is one of the most far reaching interpreta-
tions of the statute. Under the one purpose test, the antikickback statute is violated if even one purpose 
of the arrangement is to offer illegal remuneration.175 Subsequently adopted by the OIG, under the one 
purpose test, providers reasonably can expect referrals to result from a business arrangement, but the ex-
pectation must not be a reason for entering into the arrangement.176 Critics of the one purpose test claim 
that it treats a legitimate relationship with a referral component in the same manner as an arrangement 
primarily intended to violate the statute.177 Opponents also argue that it is impossible for providers to 
expect referrals and not consider referrals when entering into a business arrangement.178
safe HaRboRs
Due to the broadness of the antikickback statute, legitimate business arrangements also may be prohib-
ited. For example, if the statute was interpreted literally, a physician would not be allowed to receive 
dividend payments from a publicly traded pharmaceutical company if the physician prescribed prod-
ucts produced by the company.179 Therefore, Congress created a number of statutory exceptions and 
gave HHS authority to protect other business arrangements through safe harbors.180 Safe harbors detail 
specific regulatory criteria that must be met to shield an arrangement from liability, and they are meant 
to protect practices unlikely to result in fraud or abuse.181 The failure to comply with every requirement 
does not mean that the arrangement is illegal,182 if there is a low risk of fraud and abuse.183
The MMPPPA directed HHS to promulgate regulations specifying payment practices that did not 
violate the statute. Congress created the following statutory exemptions from the antikickback statute, 
protecting legitimate business arrangements, including
1) properly disclosed discounts;
2) payments to bona fide employees for employment;
3) certain payments to group purchasing organizations;
4) co-insurance waivers to Medicare services for patients qualifying for certain public health ser-
vice programs; 
5) payment practices specified by the HHS secretary in regulations promulgated under the MMPP-
PA or nonmonetary remuneration necessary and used solely to receive and transmit electronic 
prescription information in accordance with the standards promulgated under 42 U.S.C.  
1395w-104;
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6) certain risk-sharing and arrangements with managed care organizations;
7) waiver or reduction by pharmacies of any cost-sharing imposed under Medicare Part D which 
has met certain conditions under 42 U.S.C. 1320a-7a(i)(6)(A);
8) any remuneration between a federally qualified health center and a Medicare Advantage organi-
zation pursuant to a written agreement; and
9) any remuneration between a healthcare center entity and any entity providing goods, items, ser-
vices, donations, loans, or a combination thereof to that entity pursuant to a contract, lease, grant, 
loan or other agreement if such agreement contributes to the ability of the healthcare center to 
serve an underserved population.184
These safe harbors were intended to “permit physicians to freely engage in business practices and 
arrangements that encourage competition, innovation and economy.”185 HHS has created a number of 
safe harbors since 1989, and it clarified existing safe harbors in 1999. The 1991 safe harbors included 
promulgations protecting investments in large publicly held healthcare companies and investments in 
small healthcare joint ventures.186 In 1999, HHS added safe harbors protecting investments in healthcare 
entities located in underserved areas, investments in ambulatory surgical centers (ASCs), and invest-
ments in group practices.187
The most important safe harbors for the purposes of physician integration protect certain physician 
investment interests. Certain investment interests were protected because, “Congress did not intend to 
absolutely bar any investment by physicians in other health care entities.”188 Certain business invest-
ments “represent the extension of a physician’s office space and not a means to profit from referrals.”189 
Business arrangements which are “functionally an extension of a physician’s office” pose less “risk of 
improper payments for referrals.”190 The OIG intended to protect these physician investment interests, 
because the OIG believed that the risk of improper referrals was relatively low when the physician 
personally performed services at, for example, the ASC on his or her own patients.191 The OIG also was 
influenced by CMS’s policy of promoting greater utilization of ASCs. Physicians were a natural source 
of capital for ASCs because hospitals were reluctant to invest in ASCs that might compete with their 
surgery departments.192 These investment safe harbors were intended to protect arrangements that “can 
significantly reduce costs for Federal health care programs, while simultaneously benefiting patients.”193 
In particular, HHS wanted to avoid “chill[ing] group practice integration that is crucial in an increas-
ingly managed care environment.”194
There are a total of twenty-five safe harbors under the antikickback statute. As used in section 1128B 
of the act, box 3-4 includes all of the twenty-five safe harbors and are not considered remuneration as 
long as the safe harbor’s requirements are satisfied.
Box 3-4: Safe Harbor Regulations
The following twenty-five safe harbor regulations can be found in the antikickback statute:
1)  Returns on investment interests. Payments that are in the form of a return on an investment. 
2)  Space rental. Payments for the use of premises made by a lessee to a lessor.
3)  Equipment rental. Payments for the use of equipment made by equipment lessees to equipment lessors.
4)  Personal services and management contracts. A principal’s payments to an agent for the agent’s services.
5)  Sale of practice. A payment made by one practitioner for the purchase of the practice of another practitioner.
6)  Referral services. Payments for the exchange of anything of value between a “participant” and a referral service. 
7)  Warranties. Payments or the exchange of anything of value under a manufacturer’s or supplier’s warranty.
8)  Discounts. A discount given on an item or service for which a payment may be made in full or in part by Medicare, Medicaid, or other 
federal healthcare programs. 
(continued)
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Box 3-4: Safe Harbor Regulations (continued)
9)  Employees. A payment made by an employer to an employee who has a bona fide employment relationship with the employer to 
deliver any item or service for which a payment may be made in full or in part by Medicare, Medicaid, or other federal healthcare 
programs. 
10)  Group purchasing organizations (GPO). Payments made by a vendor of goods or services to a GPO, pursuant to an agreement to 
furnish the goods or services. 
11)  Waiver of beneficiary coinsurance and deductible amount. A reduction or waiver of a Medicare or state healthcare program benefi-
ciary’s coinsurance or deductible. 
12)  Increased coverage, reduced cost-sharing amounts, or reduced premium amounts offered by health plans. The additional coverage 
of items or services offered by health plans to enrollees, reductions in the enrollee’s obligation to pay the health plan or healthcare 
provider, or reductions in premiums for items and services covered by the health plan, Medicare, or a state healthcare program. 
13)  Price reductions offered to health plans. Price reductions found in a contract between a provider and a health plan for the provision 
of items or services to enrollees covered by the health plan, Medicare, or a state healthcare program. 
14)  Practitioner recruitment. Payments or the exchange of anything of value given by an entity to influence the relocation of a practitio-
ner who has been practicing in his or her current specialty for less than one year, or to influence any other practitioner, to relocate 
their practice into a health professional shortage area (HPSA) for their specialty that is served by the entity. 
15)  Obstetrical malpractice insurance subsidies. Payments made by hospitals or entities that are providing malpractice insurance when 
the payments are used to subsidize or pay all of the costs of malpractice insurance premiums for practitioners who routinely engage 
in obstetrical practice as a part of their medical practice in a primary care HPSA. 
16)  Investments in group practices. Payments, in the form of a return on an investment, made to a practitioner investing in his or her own 
practice or a group practice. 
17)  Cooperative hospital service organizations (CHSO). Payments between a CHSO and its patron hospital, tax-exempt entities described 
in section 501(e) of the Internal Revenue Code of 1986, when the CHSO is owned by two or more patron hospitals.
18)  Ambulatory surgery centers (ASC). Payment that is a return on an investment, as long as the entity is certified in accordance with 
part 416 of this title, its operating and recovery room space is exclusively dedicated to the ASC, all patients referred to the entity by 
an investor are fully informed of the investor’s ownership interest, and all the following applicable standards are met within one of 
the following categories:
 a.  Surgeon-owned ASCs: To fall within the safe harbor for surgeon-owned ASCs
  i.  the investment terms offered to an investor may not be tied to the previous or expected number of referrals, services furnished, 
or the amount of business for the entity otherwise generated by the investor;
  ii.  at least one-third of the surgeon investor’s practice income for the prior fiscal year or the prior twelve-month period must come 
from the surgeon’s performance of procedures; 
  iii.  neither the entity nor any investor can loan funds or guarantee a loan for an investor, if the investor uses any portion of the loan 
to acquire the investment interest;
  iv.  an investor’s payment in return for his or her investment must be directly proportional to the amount of capital he or she in-
vested; and
  v.  ancillary services performed for beneficiaries of federal healthcare programs must be related to the primary procedures per-
formed at the entity and may not be billed separately to Medicare or other federal healthcare programs. 
 b.  Single-Specialty ASCs: To fall within the safe harbor for single-specialty ASCs
  i.  the investment terms offered to an investor may not be tied to the previous or expected number of referrals, services furnished, 
or the amount of business for the entity otherwise generated by the investor;
  ii.  at least one-third of the surgeon investor’s practice income for the prior fiscal year or the prior twelve-month period must come 
from the surgeon’s performance of procedures; 
  iii.  neither the entity nor any investor can loan funds or guarantee a loan for an investor, if the investor uses any portion of the loan 
to acquire the investment interest;
  iv.  an investor’s payment in return for his or her investment must be directly proportional to the amount of capital she or she 
invested;
  v.  ancillary services performed for beneficiaries of federal healthcare programs must be related to the primary procedures per-
formed at the entity and may not be billed separately to Medicare or other federal healthcare programs; and
  vi.  patients receiving medical benefits or assistance under any federal healthcare program must not be discriminated against by 
the entity or any physician investor.
 c.  Multi-Specialty ASCs: To fall within the safe harbor for multi-specialty ASCs
  i.  the investment terms offered to an investor may not be tied to the previous or expected number of referrals, services furnished, 
or the amount of business for the entity otherwise generated by the investor;
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Box 3-4: Safe Harbor Regulations (continued)
  ii.  at least one-third of the surgeon investor’s practice income for the prior fiscal year or the prior twelve-month period must come 
from the physician’s performance of procedures; 
  iii.  physician investors must perform at least one-third of their procedures for the prior fiscal year or the prior twelve-month period 
at the investment entity; 
  iv.  neither the entity nor any investor can loan funds or guarantee a loan for an investor, if the investor uses any portion of the loan 
to acquire the investment interest;
  v.  an investor’s payment in return for his or her investment must be directly proportional to the amount of capital he or she 
invested;
  vi.  ancillary services performed for beneficiaries of federal healthcare programs must be related to the primary procedures per-
formed at the entity and may not be billed separately to Medicare or other federal healthcare programs; and
  vii.  patients receiving medical benefits or assistance under any federal healthcare program must not be discriminated against by 
the entity or any physician investor.
 d.  Hospital or Physician ASCs: To fall within the safe harbor for hospital or physician ASCs
  i.  the investment terms offered to an investor may not be tied to the previous or expected number of referrals, services furnished, 
or the amount of business for the entity otherwise generated by the investor;
  ii.  neither the entity nor any investor can loan funds or guarantee a loan for an investor, if the investor uses any portion of the loan 
to acquire the investment interest;
  iii.  an investor’s payment in return for his or her investment must be directly proportional to the amount of capital he or she 
invested;
  iv.  patients receiving medical benefits or assistance under any federal healthcare program must not be discriminated against by 
the entity, an investor in the entity, or any physician investor;
  v.  ancillary services performed for beneficiaries of federal healthcare programs must be related to the primary procedures per-
formed at the entity and may not be billed separately to Medicare or other federal healthcare programs;
  vi.  the hospital’s report, or any other claim for payment from a federal healthcare program, may not include any costs associated 
with the ASC unless the federal healthcare program requires their inclusion; and 
  vii.  the hospital cannot directly or indirectly make or influence referrals to any investor or entity. 
19)  Referral arrangements for specialty services. Exchanges of value between individuals and entities, where one party has agreed to refer 
a patient for specialty care payable in full or in part by Medicare, Medicaid, or any other federal healthcare program in return for an 
agreement to refer the patient back at an agreed upon time or circumstance. 
20)  Price reductions offered to eligible Managed Care Organizations (MCOs). Payments in the form of price reductions offered between 
eligible MCOs and any first-tier contractor for providing for or arranging for items or services, or between a first-tier contractor and a 
downstream contractor or between two downstream contractors for the provision or arrangement of items or services. 
21)  Price reductions offered by contractors with substantial financial risk to MCOs. Payments in the form of price reductions offered be-
tween a qualified managed care plan and a first-tier contractor for the provision of or arrangement for items and services, or between a 
first-tier contractor and a downstream contractor or between two downstream contractors for the provision of or arrangement for items 
or services. 
22)  Ambulance replenishing. Gifts or transfers of drugs or medical supplies from a hospital or other receiving facility to an ambulance pro-
vider in order to restock the drugs and medical supplies used in connection with the transport of the patient. To qualify for this excep-
tion, the ambulance must be used to provide emergency ambulance services an average of three times per week. 
23)  Health centers. The transfer of any goods, items, services donations, loans, or a combination thereof from an individual or an entity to a 
health center.
24)  Electronic prescribing items and services. Nonmonetary remuneration that is necessary for, and used solely to, send and receive elec-
tronic prescription information. 
25)  Electronic Health Record Items and Services. Nonmonetary remuneration that is necessary for, and used predominantly to, create, 
maintain, transmit, or receive electronic health records.
Source: “Exceptions” 42 C.F.R. 1001.952(a)-(x) (2004).
Although these exemptions allow federally funded healthcare programs to lessen their liability under 
the antikickback statute, many business interactions may still be suspect under Stark law.
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Stark Law
The federal physician self-referral, or Stark law, prohibits physicians from referring Medicare or Med-
icaid patients to an entity for designated health services (DHS), defined by HHS, if the physician, or an 
immediate family member, has a financial relationship with that entity.195 HHS defines physician under 
Stark law, as a “doctor of medicine or osteopathy, a doctor of dental surgery or dental medicine, a doctor 
of podiatric medicine, a doctor of optometry, or a chiropractor, as defined in section 1861(r) of the [So-
cial Security] Act.”196 Since its promulgation in 1989, the Stark law has gone through multiple revisions 
that have both increased the scope of its provisions and added exceptions to what kind of transactions 
the prohibitions apply.
Prohibitions of physician self-referral are similar to the antikickback legislation, in that both laws 
prohibit conduct which induces physicians and allied health professionals to profit from referring pa-
tients to particular facilities. The difference between the two statutes is that the self-referral prohibition 
addresses the financial incentives of the physician who makes the referral, and the antikickback statute is 
concerned with the financial relationship between providers.197 The other important difference between 
the regulations is that the self-referral prohibitions apply only to Medicare and Medicaid, but the anti-
kickback legislation applies to all federally funded state healthcare programs.198
The physician self-referral prohibitions are named after the legislation’s chief supporter, Congress-
man Fortney “Pete” Stark (D-CA). Congressman Stark supported the legislation based on studies indi-
cating that despite the broad scope of the antikickback statute, self-referrals were prevalent in the health-
care industry.199 One such study, published by the OIG in 1989, reported on physician investments in 
healthcare facilities and found that patients at physician-owned laboratories received more services than 
other Medicare patients.200
Stark I
The Ethics in Patient Referrals Act (Stark I) was promulgated in 1989 and was implemented in various 
stages during the early 1990s.201 Stark I prohibited physicians from making referrals to clinical laborato-
ries if the physician, or an immediate family member of the physician, had an ownership or investment 
interest in the lab.202 Further, the lab was prohibited from billing for those services.203
Stark II
In 1993, Stark I was amended to expand the prohibition against referrals to clinical laboratories in which 
physicians had an ownership or investment interests, to ten additional categories of DHS (see definition 
of DHS).204 Stark II was to be implemented in two phases, the first of which became effective on Janu-
ary 4, 2002.205 In 2004, the second phase of Stark II was published, which implemented Stark II as an 
interim final rule to replace the 1995 Stark I final rule.206
Stark II, PhaSe III
On September 5, 2007, CMS issued the final rule establishing the Stark II Phase III regulations, which 
contained many changes that were predicted to have a significant impact on healthcare provider relation-
ships.207 One requirement, as set out in the Phase I regulations, stipulated that there exist at least two 
financial relationships between the physician and the DHS entity in order for an indirect compensation 
arrangement to exist.208 The Phase III regulations changed the definition of an indirect compensation 
arrangement so that physician members, employees, and contractors of the physician organization were 
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now deemed to stand in the shoes of the physician organization, that is, they would have the same com-
pensation direct compensation arrangement as the physician organization itself.209 As a result, a hospital 
that has a contract for professional services with a physician group, considered indirect under the Phase 
I regulations due to a financial relationship between individual physicians and their group practice as 
well as a relationship between the group practice and the hospital, is now considered to have a direct 
compensation arrangement.210 Under this revision of the rule, a physician organization is no longer 
considered an intervening entity for purposes of establishing an indirect compensation arrangement, and 
arrangements between providers, and DHS entities may need to be structured differently to avoid Stark 
liability.211
This change applies to physician-owners, physician-employees, and physician-contractors of a phy-
sician organization.212 However, other arrangements, such as an arrangement between a DHS entity, a 
leasing company, and a physician, are analyzed as an indirect compensation arrangement.213
Stark IV
Stark IV refers to the changes made to the Stark law in the 2009 Inpatient Prospective Payment System 
(see chapter 2, Facility-Based Reimbursement Rates).214 Most notably, Stark IV modified the stand in 
the shoes provision, changed the definition of “entity,” and prohibited per-click leasing under four of the 
exceptions to the Stark law.
Stand in the Shoes
In Stark IV, CMS modified the stand in the shoes provision first introduced in Stark II Phase III. Under 
the final Stark IV version of the provision, physicians who have an ownership or investment interest in a 
physician organization are considered to stand in the shoes of the physician organization for the purpose 
of Stark laws.215 Accordingly, the physician collapses into the physician organization, resulting in the 
physician organization no longer being considered an intervening entity for the purpose of establishing 
an indirect compensation arrangement with a DHS.216 This mandatory provision applies only when the 
ownership or investment interest includes the ability or right to receive financial benefits.217 However, in 
situations in which a physician organization employs both physician owners and nonowner physicians, 
DHS entities are allowed to treat the nonowner physicians as standing in the shoes of the physician 
organization so that two different compensation analyses are not required.218 Exempted from the provi-
sions are arrangements which meet the requirements of the academic medical centers exception.219 Ad-
ditionally, the rule refrained from finalizing stand in the shoes provisions originally proposed for DHS 
entities.220
Expansion of “Entity” to Include Under Arrangement Service Providers
CMS also changed the framework of under arrangements in Stark IV, such that both the physician-
owned entity (which provides the service), as well as the hospital (which bills for the service), are 
considered DHS entities for purposes of Stark law.221 The result of this provision is that it will preclude 
physician-owned entities from performing services on hospital patients under arrangements with the 
hospitals, unless the physician-owner(s) can satisfy the ownership exception under Stark. CMS con-
cluded that any entity that performs a service under arrangement for a hospital which is then billed by 
the hospital is now considered a DHS entity, even if that service would not have been considered a DHS 
entity if the service was done outside the hospital setting. The only exception to this final conclusion is 
for lithotripsy services, procedures using shock waves to break up stones in urinary organs.222
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Prohibition of “Per-Click” Arrangements and Percentage-Based Rent
Stark IV, effective October 1, 2009, also modified the exceptions for space and equipment leases, fair 
market value compensation, and indirect compensation arrangements to prohibit basing the charge for 
rented space and equipment on a per-click, or per-unit basis, as they are seen as gainsharing agree-
ments.223 A gainsharing agreement is a pay-for-performance system that rewards employees for boosts 
in productivity and reductions in costs associated with poor quality.224 This means that physicians and 
DHS entity lessors may not charge physician lessees rent based on the number of services provided by 
the lessees which are referred to them by the lessors. CMS concluded that on-demand time-based rental 
arrangements also are considered per-click arrangements and, therefore, fall under the limitation, as 
well.225
Similarly, CMS finalized a rule prohibiting rental charges based on a percentage of revenues earned 
in the rented space or with the rented equipment, regardless of whether the services were referred from 
the lessor.226 Excluded from this prohibition are arrangements in which physicians pay on a percent-
age basis for management and billing services.227 CMS also declared that the rule would not prohibit 
gainsharing arrangements, as long as they are properly structured incentive payment and shared saving 
programs.228
exCeptIons to staRk law
The very broad prohibition of physician self-referrals is limited by a number of statutory exceptions. The 
exceptions are intended to promote practice integration and to protect arrangements in which there is 
little risk of abuse.229 Similar to concerns on the restrictive nature of the antikickback statute, Congress 
intended to protect group practices to avoid loss of integration.230 There are thirty-five total exceptions to 
the Stark law, and the statute gives the secretary of HHS the authority to promulgate additional excep-
tions.231 A significant difference between the antikickback legislation and Stark is that, under Stark, any 
financial relationship between a healthcare entity and a physician must fall within one of the statutory 
or regulatory exceptions.232
The thirty-five exceptions to the Stark law are divided between exceptions that apply to both owner-
ship or investment interests and compensation arrangements,233 exceptions that apply to only ownership 
or investment interests, and exceptions that apply to only compensation arrangements.234 Exceptions 
which apply to both ownership and investment interests and compensation agreements include excep-
tions for
1. physician services; 
2. in-office ancillary services; 
3. services furnished by organization to enrollee of health plan; 
4. academic medical centers; 
5. qimplants furnished by an ASC; 
6. EPO and other dialysis-related drugs; 
7. preventative screening tests, immunizations, and vaccines; 
8.  eyeglasses and contact lenses following cataract surgery; and 
9. intrafamily rural referrals.235 
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Exceptions that apply to only ownership or investment interests include exceptions for 
1. publicly traded securities,
2. mutual funds, and
3. specific providers (for example, rural providers, hospitals located in Puerto Rico, and whole 
hospital ownership).236
There are a total of thirty-five exceptions to the Stark law, and the secretary 
of HHS has the authority to promulgate additional exceptions.
42 C.F.R. 411.355-411.357; 42 U.S.C. 1395nn(a)(1)(A).
The final subpart to this last exception, commonly known as the whole hospital exception, allows a 
physician to have an ownership interest in a hospital if the physician performs services at the hospital.237
Finally, exceptions that apply to only compensation arrangements can be found in box 3-5.
fedeRal and state effoRts to elImInate staRk wHole HospItal exCeptIon
The whole hospital exception allows physician self-referrals to 
hospitals in which they have an ownership stake as long as the 
physician is authorized to perform services at the hospital and 
the ownership or investment interest is in the entire hospital.238 
When proposed, there was little worry that this arrangement 
would create a risk of abuse, as it was believed that “ownership 
interests in an entire hospital would be so diluted that it would 
have no effect on referral decisions.”239
Proponents of the whole hospital exception contend that it 
allows for the development of specialty and niche providers, 
which leads to healthcare services being provided in a more cost 
effective manner, while also maintaining and improving quality 
and beneficial outcomes.240 However, the exception’s opponents 
argue that because specialty hospitals are smaller in size, they 
are comparable to the individual departments within general 
hospitals.241 Therefore, opponents argue, physician ownership 
of specialty hospitals raises the same concerns as does the ban 
on physician ownership in specialty departments within general 
hospitals: the risk that a physician’s referral decisions and clini-
cal judgment will be affected by the ability to influence his or 
her own income.242
Although healthcare has traditionally been regulated by the 
states, the federal government, as the largest payer of health 
care services, can mandate how these services are provided in 
the United States. Accordingly, opponents of the whole hospi-
tal exception repeatedly have lobbied the federal government 
to eliminate or mitigate the effects of the safe harbor. In 2001, 
Box 3-5:  Compensation Arrangement 
Exceptions
A list of Stark Law compensation arrangement 
exceptions include:
1. Rental of office space
2. Rental of equipment
3. Bona fide employment relationships
4. Personal service arrangements
5. Physician recruitment
6. Isolated financial transactions
7. Certain arrangements with hospitals
8. Group practice arrangements with hospitals
9. Payments by attending physicians
10. Charitable donations by attending physicians
11. Nonmonetary compensation
12. Fair market value compensation
13. Medical staff incidental benefits
14. Risk sharing arrangements
15. Compliance training
16. Indirect compensation arrangements
17. Referral services
18. Obstetrical malpractice insurance subsidies
19. Professional courtesy
20. Retention payments
21. Community-wide health information 
technology systems
22. Electronic prescription items and services
23. Electronic health records items and services
Source: “Exceptions to the Referral Prohibition Related to 
Ownership or Investment Interests” 42 C.F.R. 411.356  
(October 1, 2008).
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congressmen Pete Stark (D-CA) and Jerry Kleczka (D-WI) unsuccessfully introduced the Hospital 
Investment Act with the intention of limiting the whole hospital exception.243 The act would have re-
quired newly formed specialty hospitals to undertake an initial public offering, instead of merely offer-
ing investment opportunities to the physicians practicing at the hospital, a requirement that would have 
rendered the startup of specialty hospitals too expensive to undertake.244
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) imple-
mented an eighteen-month moratorium on the development of new specialty hospitals.245 The morato-
rium represented a compromise between congressmen Kleczka and Stark, who believed that the whole 
hospital exception should be removed for all hospitals, and Senator Breaux, who advocated removing 
the exception only for specialty hospitals.246 The moratorium officially ended on June 8, 2005.247 How-
ever, the DRA, enacted on February 8, 2006, continued the suspension of CMS’s enrollment of new spe-
cialty hospitals until six months after enactment of the DRA or the release of the final report on specialty 
hospitals by CMS required by the DRA, whichever came earlier.248
The eighteen-month moratorium on the development of new specialty 
hospitals, implemented by the MMA, lasted until June 8, 2005, only to be 
reinstated by the DRA on February 8, 2006.
“Medicare Prescription Drug, Modernization, and Improvement Act of 2003” §507(a)(1)(B); “Moratorium on 
Specialty Hospitals Expires” By Jennifer Gordon, Dallas Business Journal, http://assets.bizjournals.com/dallas/
stories/2005/06/20/story8.html (accessed June 25, 2009); “Payment Provisions in Original Medicare Program 
Immediately Affected by The Deficit Reduction Act,” Press Release, Centers for Medicare and Medicaid Services, 
February 10, 2006, www.cms.hhs.gov/apps/media/press/release.asp?counter=1779 (accessed March 2, 2005).
On August 8, 2006, CMS released its report on specialty hospitals, Final Report to the Congress and 
Strategic Implementing Plan (Report).249 The report’s recommendations included many aspects designed 
to make investing in specialty hospitals less attractive, such as a downward adjustment of specialty hos-
pital reimbursement.250 Additionally, the report recommended aligning physician and hospital interests 
to promote “better hospital physician collaboration,” ensuring that all hospitals be in compliance with 
the Emergency Medical Treatment and Active Labor Act (EMTALA) (see Emergency Medical Treat-
ment and Active Labor Act) when they provide services and requiring investment disclosure by physi-
cians informing patients of their ownership interest before treatment.251 Finally, the report recommended 
subjecting specialty hospitals to greater Stark and antikickback statute scrutiny.252
In recent years, efforts to eliminate or mitigate the effects of the whole hospital exception have 
continued at the federal level. For example, both Congressman Stark’s proposed amendment to the 
Children’s Health and Medicare Protection Act of 2007 and the U.S. House of Representatives’ legisla-
tion, the Paul Wellstone Mental Health and Addiction Equity Act of 2008 (see chapter 6 in Professional 
Practices), unsuccessfully attempted to restrict physician ownership of hospitals.253
State law efforts to eliminate or mitigate the effects of the Stark law’s whole hospital exception can 
take various forms including licensure, quality inspections, facility requirements, facility taxes, state 
CON laws, and state self-referral regulations.254
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Licensure
Licensing provides a framework for the delivery of quality healthcare services, but it does not guaran-
tee that quality care will be provided.255 Historically, states have required that hospitals be licensed (see 
Healthcare Facility and Practice Licensure). Under the licensure schemes in most states, a specialty 
hospital is considered to be a general hospital for the purposes of licensure.256
Licensing legislation also has been proposed as an attempt to prevent competition by physician-
owned specialty hospitals. In 2007, a community hospital CEO in California unsuccessfully pushed for a 
bill that would have prohibited the building of hospitals in the district if they did not have an emergency 
department.257
Quality Inspections and Facility Requirements
Quality inspections and facility requirements subject medical facilities to periodic inspections and the 
attainment of minimum standards.258 For example, a New York law, the New York Patient Protection 
Bill, which took effect in July 2009, created a new rule requiring that physicians performing office-based 
surgery have their offices accredited.259 The new bill forced many doctors, especially those in urban 
areas with offices not conducive to a remodel, to seek office space elsewhere.260 Although New York’s 
standards were enacted to ensure patient safety, it is reasonable to assume that opponents of the whole 
hospital exception may attempt to utilize rigid quality inspection and facility requirement standards in an 
effort to thwart competition from specialty hospitals.
Facility Taxes
Some states have attempted to level the playing field between general and specialty hospitals through 
certain tax initiatives. In June 2004, the New Jersey legislature imposed a tax on certain ambulatory 
care facilities, specifically excluding those owned by a hospital.261 The measure places a 3.5 percent tax 
on gross revenues of ambulatory care centers and a 6 percent tax on gross receipts from cosmetic pro-
cedures, with the revenues raised to be used to compensate hospitals for charity care.262 Facilities taxed 
include, ASCs, facilities providing diagnostic imaging services, and outpatient cancer centers.263 The 
facility itself is taxed under the corporate business tax, and the physician-owners are taxed under the 
personal income tax code.264
Certificate of Need
CON regulation requires that health care providers obtain state approval before either developing new 
services, or expanding existing services (see Certificate of Need (CON)).265 Because stringent CON regu-
lation effectively can prevent or limit specialty and niche providers from entering a state, thereby pro-
tecting general hospitals from competition, the use of CON laws has become one of the primary attacks 
on physician-owned hospitals at the state level.266 As of 2008, thirty-six states and the District of Colum-
bia had CON laws.267
Antikickback and Self-Referral Laws
Forty-two states and the District of Columbia have laws prohibiting kickbacks and limiting self-
referrals. For the complete list see box 3-6.
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updates to state self-RefeRRal laws
New Jersey Update to “Codey Act”
After the 2007 decision in Health Net of New 
Jersey, Inc. v. Wayne Surgical Center, LLC, 
physicians in New Jersey who referred patients 
to an ASC in which they had an ownership inter-
est were suddenly at risk of being in violation of 
New Jersey’s anti–self-referral law, the Codey 
law.268 Most unexpectedly, the Health Net deci-
sion rejected a widely relied upon 1997 New 
Jersey Board of Medical Examiners (BME) 
advisory opinion, which held that an ASC con-
stitutes an “extension of the physician’s medical 
office,” such that the arrangement did not violate 
Codey.269
After the ruling in Health Net, the BME ad-
opted emergency rules declaring that doctors who 
referred patients to physician-owned ASCs were 
not in danger of violating the law.270 In response, 
legislators in New Jersey, led by Senate President 
Richard Codey (the namesake of the original law), 
proposed an amendment to the Codey law which would allow self-referral to physician-owned ASCs.271
In 2009, New Jersey amended the Codey law to permit physician referrals to facilities in which 
they have a financial stake, if the physicians perform the procedure personally, their compensation as 
an owner is equal to their ownership interest, all patient related decisions at facilities with nonphysician 
owners are made by physicians, and the physicians inform the patients of their ownership share at the 
time of referral.272 In addition, the statute also prohibits the issuance of new registrations for surgical 
practices and ambulatory care facilities unless one of the limited exceptions applies.273
Physician Compensation Restrictions
geneRally
Increased regulatory scrutiny related to avoiding violations of federal fraud and abuse laws in transac-
tions between healthcare providers affects the compensation paid to physicians for professional clini-
cal, on-call, medical directorship, as well as administrative and executive related services. For example, 
physician compensation arrangements are scrutinized under the traditional concepts of fair market value 
(FMV), as well as under the related threshold of commercial reasonableness,274 that is, compensation 
arrangement may be simultaneously at FMV and also be determined to be commercially unreasonable. 
A failure to meet these two standards may result in a violation of the FCA if the healthcare provider 
knowingly submits a claim for reimbursement to a government entity for services under compensation 
arrangements which are deemed to be Stark and antikickback violations.275 Accordingly, compensation 
arrangements for physician clinical and executive services (for example, medical directorships) must 
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Source: “Health Care Fraud: Enforcement and Compliance” By Robert Fabrikant, et al., 
Law Journal Press, New York, NY: 2007, p.2-64.
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be both at FMV and commercially reasonable to avoid liability under the Stark law, the antikickback 
statute, and the FCA.276 The impact of fraud and abuse regulation on structuring physician compensation 
plans is discussed further in chapter 3 of Consulting with Professional Practices.
Compensation arrangements for physician and executive services must be 
both at FMV and commercially reasonable to avoid liability under the Stark 
law, the antikickback statute, and the FCA.
“All Eyes on Physician-Hospital Arrangements,” By Lewis Lefko, HealthLeaders Media, Jan. 24, 2008, www. 
healthleadersmedia.com (Accessed September 18, 2008).
The test for commercial reasonableness is a threshold that is distinct from that of the standard of 
FMV. FMV looks to the reasonableness of the “range of dollars” paid for a product or service; the 
standard of commercial reasonableness looks to the “reasonableness of the business arrangement 
generally.”277
defInItIons of faIR maRket Value
Federal fraud laws define fair market value somewhat differently than it is defined by traditional busi-
ness valuation principles. Under Stark II Phase I, the Health Care Financing Administration (HCFA; 
now CMS) defined FMV as “the value in arm’s-length transactions, consistent with general market 
value.”278
General market value is defined as:
[T]he price that an asset would bring as a result of bona fide bargaining between well-informed 
buyers and sellers who are not otherwise in a position to generate business for the other party, or 
the compensation that would be included in a service agreement as a result of bona fide bargain-
ing between well-informed parties to the agreement who are not otherwise in a position to gener-
ate business for the other party, on the date of acquisition or the asset or at the time of the service 
agreement.279 [emphasis added]
Elaborating on that definition in 2001, HCFA provided the following guidance for determining when 
a payment for services provided is at FMV:
We believe the relevant comparison is aggregate compensation paid to physicians practicing in 
similar academic settings located in similar environments. Relevant factors include geographic 
location, size of the academic institutions, scope of clinical and academic programs offered, and 
the nature of the local health care marketplace. . . . we intend to accept any method [for establish-
ing FMV] that is commercially reasonable and provides us with evidence that the compensation 
is comparable to what is ordinarily paid for an item or service in the location at issue, by parties 
in arm’s-length transactions who are not in a position to refer to one another. . . . The amount of 
documentation that will be sufficient to confirm FMV . . . will vary depending on the circum-
stances in any given case; that is, there is no rule of thumb that will suffice for all situations.280
In 2004, CMS noted that valuation methods under Stark law, “must exclude valuation where the 
parties to the transaction are at arm’s-length but in a position to refer each other.”281 Because FMV under 
Stark law does not “necessarily comport with the usage of the term in standard valuation techniques and 
methodologies,” a purely market-driven determination of FMV may not always be considered commer-
cially reasonable for the purposes of federal fraud laws.282 For example, even if an arrangement meets 
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traditional FMV standards, if it does not meet commercial reasonableness standards, it may not with-
stand scrutiny under Stark.
In the Stark II Phase II legislation, dated March 2004, CMS stated that it “will consider a range of 
methods of determining [FMV] and that the appropriate method will depend on the nature of the transac-
tion, its location, and other factors.”283 Additionally in the Stark II Phase II legislation, CMS created a 
voluntary safe harbor provision within the regulatory definition of FMV for hourly payments to physi-
cians for their personal services, which could have been used with regard to any hourly compensation 
paid by any DHS entity.284 Under the FMV safe harbor, there were two methodologies that would result 
in an hourly arrangement being considered to be at FMV: (1) when the physician’s hourly rate is less 
than or equal to the hourly rate for emergency room physician services in the relevant geographic market 
(provided there are at least three hospitals with emergency rooms) or (2) when the physician’s hourly 
rate is calculated by averaging the 50th percentile of the national compensation level for physicians with 
the same specialty (or general practice if specialty is not identified) in at least four of six listed salary 
surveys, then dividing that figure by 2,000 hours.285 Subsequently, the United States Appellate Court for 
the D.C. Circuit discerned in Renal Physicians Association v. HHS that these two safe harbor tests would 
also result in the consideration of an agreement being presumptively reasonable.286
However, concerns about the impracticality and infeasibility of the CMS FMV voluntary safe harbor 
forced CMS to eliminate that provision in the September 2007 Stark II Phase III rule. At that time, how-
ever, CMS emphasized that it will continue to scrutinize the FMV of arrangements and indicated that 
“[p]arties to a transaction may calculate FMV ‘using any commercially reasonable methodology that is 
appropriate under the circumstances and otherwise fits [within] the definition’ of FMV for purposes of 
Stark.”287
Further, in the Stark II Phase III provisions, CMS stated, in response to a request for confirmation as 
to whether a FMV hourly rate could be used to compensate physicians for both physician clinical and 
administrative services and whether that hourly rate could be used to determine an annual salary, that
A fair market value hourly rate may be used to compensate physicians for both administrative 
and clinical work, provided that the rate paid for clinical work is fair market value for the clinical 
work performed and the rate paid for administrative work is fair market value for the administra-
tive work performed. We note that the fair market value of administrative services may differ 
from the . . . value of clinical services. A fair market value hourly rate may be used to determine 
an annual salary, provided that the multiplier used to calculate the annual salary accurately re-
flects the number of hours actually worked by the physician.288
FMV is also a critical requirement under several antikickback safe harbors.289 Although FMV is not 
specifically defined within the antikickback statute,290 the OIG has provided guidance on this issue and 
stated in Thornton’s widely circulated 1992 letter that 
When considering the question of FMV [Fair Market Value], we would note that the traditional 
methods of economic valuation do not comport with the proscriptions of the Anti-Kickback 
statute. Items ordinarily considered in determining the FMV may be expressly barred by the Anti-
Kickback statute’s prohibition against payments for referrals. Merely because another buyer may 
be willing to pay a particular price is not sufficient to render the price to be paid FMV. The fact 
that a buyer in the position to benefit from referrals is willing to pay a particular price may only 
be a reflection of the value of the referral stream that is likely to result from the purchase.291 
V1-C-Chapter 03.indd   148 9/28/10   3:18 PM
Chapter 3 : R egul atory Environment
149
Definitions of Commercial Reasonableness
HHS has interpreted commercially reasonable to mean that an arrangement appears to be “a sensible, 
prudent business agreement, from the perspective of the particular parties involved, even in the absence 
of any potential referrals.”292 The Stark II Phase II commentary also suggests that, “an arrangement will 
be considered ‘commercially reasonable’ in the absence of referrals if the arrangement would make 
commercial sense if entered into by a reasonable entity of similar type and size and a reasonable physi-
cian of similar scope and specialty, even if there were no potential DHS referrals.”293
When determining the commercial reasonableness of a compensation arrangement, one should con-
sider (1) if it is necessary to have a physician perform a certain service and (2) if it is necessary to have 
a physician of that specialty perform a certain service. For example, the FMV compensation for more 
specialized physicians and surgeons generally is higher than that of general practitioners and nonphysi-
cian practitioners. As a result, if a specialized physician is receiving compensation within the higher 
range of FMV to perform duties that a less skilled practitioner could perform for less compensation, 
the arrangement may not be deemed to be commercially reasonable despite the fact that it is within the 
range of FMV for that specialist. In such situations, there tends to be a presumption of fraud, unless the 
healthcare provider can demonstrate that using the physician specialist was reasonably necessary for 
specified reasons (for example, experience) or that the position’s requirements could not have been done 
sufficiently by a less-skilled practitioner.
The IRS has listed several specific factors to weigh in determining the commercial reasonableness of 
a physician compensation arrangement:
(1) Specialized training and experience of the physician
(2) The nature of duties performed and the amount of responsibility
(3) Time spent performing duties
(4) Size of the organization
(5) The physician’s contribution to profits
(6) National and local economic conditions
(7) Time of year when compensation is determined
(8) Whether the compensation is in part or in whole payment for a business or assets
(9) Salary ranges for equally qualified physicians in comparable organizations294
The IRS also will examine the independence of the board or committee that establishes a physician’s 
compensation arrangement.295
Steps to Establishing Commercial Reasonableness
With regard to FMV under Stark law and the antikickback statute, a 2002 federal district court stated, 
“Payments exceeding FMV are in effect deemed ‘payment for referrals.’ ”296 Later courts have developed 
more analytical approaches to determining if a compensation arrangement will survive fraud and abuse 
scrutiny, particularly, by looking to whether physicians are actually performing the services outlined in 
the arrangement. As an example of the potential liability of hospitals and physicians for not abiding by 
commercial reasonableness standards, a 2009 case against an Iowa hospital system settled for $4.5 mil-
lion after the DOJ alleged that Iowa’s Covenant Medical Center compensated five referring physicians at 
rates far above FMV.297
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The DOJ alleged that the Covenant physicians—specifically, two orthopedic surgeons, two neurosur-
geons, and a gastroenterologist—were reportedly among the highest-paid physicians in the entire United 
States, making as much as $2.1 million, despite Covenant’s nonprofit status.298 In the Covenant case, the 
hospital asserted that the specialist physicians had been working in understaffed areas of the hospital.299 
However, the DOJ cited significant discrepancies between the compensation of the five Covenant physi-
cians and other physicians in the region and around the country. These findings led the DOJ to conclude 
that the hospital was paying the physicians for referrals, in violation of the Stark law.300 The Covenant 
settlement clearly reflects the government’s increased vigilance against remuneration related to physi-
cian compensation arrangements that do not meet FMV and commercial reasonableness thresholds.
In those circumstances in which the physicians are not actually performing those services that are 
required within the scope of the compensation agreement, courts have found that the compensation ar-
rangement does not meet standards of commercial reasonableness.301 For this reason, a typical medical 
director agreement, for example, requires that contemporaneous logs are kept that document the number 
of actual hours worked, as well as the fulfillment of the tasks, duties, responsibilities, and accountabili-
ties that are mandated in the compensation agreement for the medical director position.302 It is important 
to note that several types of medical directorships may exist, including those related to quality manage-
ment, patient care, clinical research, patient relations, business development and community outreach, 
clinical operations, and medical information services.
As part of the development of the commercial reasonableness threshold, a more specific test to 
determine whether an arrangement is commercially reasonable was proposed by a government expert.303 
In the 2004 case, U.S. v. SCCI Hospital Houston, a whistleblower suit which eventually was settled, the 
United States challenged the commercial reasonableness of the compensation paid by the hospital to 
three physician medical directors.304 In this case, the government’s financial expert stated that commer-
cial reasonableness depends on the agreement being “essential to the functioning of the hospital.”305 The 
expert noted that in order to be commercially reasonable, there had to be “sound business reasons for 
paying medical director fees to referring physicians.”306
The expert in the SCCI Hospital Houston case looked to several factors in assessing commercial rea-
sonableness, including (1) the size of the hospital, number of patients, patient acuity levels, and patient 
needs; (2) the quality, activities, and involvement of medical staff and the need for medical direction; (3) 
the number of regular committees and meetings that require physician involvement; and (4) the quality 
of hospital management and interdisciplinary coordination of patient services.307 The expert also stated 
that “commercial reasonableness . . . depends on the hospital performing a regular assessment of the ac-
tual duties performed by the medical director [, as well as assessing] how effectively the medical direc-
tor is performing his duties and whether there is a bona fide need for continuing the services.”308
Although medical director compensation may be based on an hourly payment (with the maximum 
number of hours specified in the contract) or an annual payment (determined by a projected number of 
hours multiplied by a FMV hourly rate), it may be critical to surviving regulatory scrutiny for the em-
ployer to track and document the actual number of hours the medical director spends performing the ser-
vices, as well as to make sure that the documentation is consistent with the hours outlined in the medical 
director contract.309 Accordingly,
[j]ustifying the need for . . . medical director services goes hand-in-hand with showing that the 
services are actually furnished. Any situation with more than one medical director for a single 
department is likely to be viewed with suspicion. If such arrangements exist, hospitals should be 
especially thorough in demonstrating the necessity for the arrangements.310 
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In 2000, the OIG issued a notice that suggested that a compliance program in which regular inter-
nal monitoring and auditing is conducted may be an effective way to both ensure that services provided 
are considered to be reasonable and necessary and to determine whether any incentives for unnecessary 
services exist.311 Reflecting the importance of reasonable necessity, the OIG determined in a 2007 advi-
sory opinion, that an on-call physician compensation arrangement that did not meet an antikickback safe 
harbor was nevertheless reasonable, because the structure of the arrangement was tailored to the specific 
unmet needs of the hospital.312
In summary, compensation arrangements will likely be deemed commercially reasonable if (1) the 
arrangements are at FMV, (2) the arrangements list the actual duties being performed by the physician, 
(3) services performed are reasonably necessary to the provider based on the details of the situation, and 
(4) the services could not be adequately provided for less compensation.
InteRnal ReVenue seRVICe and tHe InteRnal ReVenue Code
IRS Tax Status
Healthcare providers may qualify for a federal tax exemption if they meet the IRS requirements for 
charitable organizations under section 501(c)(3) of the Internal Revenue Code (IRC).313 In 2002, non-
profit hospitals nationwide saved an estimated $12.6 billion from tax exemptions.314 Such benefits of 
federal tax exemption come with concordant burdens. To maintain tax-exempt status, an organization 
has to prove that it benefits the public in return for the public’s foregoing of tax collections. To be tax-
exempt under the IRC, an organization must be organized and operated exclusively for exempt purposes, 
and none of its earnings may be allocated to private shareholders or individuals.315 Exempt purposes in-
clude those which are charitable, religious, educational, and scientific. The federal tax regulations define 
charitable activities as relief of the poor, the distressed, or the underprivileged; lessening the burdens 
of government; lessening neighborhood tensions; and combating community deterioration and juvenile 
delinquency.316 Most healthcare organizations that are tax-exempt under federal law have that status 
because they are classified as charitable organizations.317
In 1969, the IRS expanded the definition of the term “charitable” and declared that to qualify as a 
healthcare provider that promotes health as its charitable purpose, an organization must meet the com-
munity benefit standard described in revised ruling 69-545, as well as the other requirements of IRC 
501(c)(3).318 The community benefit standard list several things that are important to section 501(c)(3) 
qualification for general acute care hospitals, such as a community-based board without financial inter-
ests in the institution, a full-time emergency room open to all without regard to ability to pay, treatment 
of Medicare and Medicaid patients without discrimination, and appropriate mission-related use of net 
earnings.319
With at least $12.6 billion at stake, clear communication between tax-exempt organizations and the 
IRS is crucial. The IRS sought to ease the reporting process for nonprofit healthcare providers in 2007 
by issuing an updated version of Form 990, the return that charities and other tax-exempt organizations 
are required to file annually. The redesign of Form 990 is based on three guiding principles: (1) enhanc-
ing transparency, (2) promoting tax compliance, and (3) minimizing the burden on the filing organiza-
tion.320 The most significant changes to Form 990 include (1) adding a summary page that provides “a 
snapshot of the organization’s key financial, compensation, governance, and operational information;” 
(2) “requiring governance information, including the composition of the board and financial practices;” 
and (3) revising and adding “schedules that will focus reporting on certain areas of interest to the public 
and the IRS.”321
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2010 IRS Audits and Compliance with Section 409A
Beginning in February 2010, the Tax Exempt and Government Entities Division of the IRS called for 
random audits of tax-exempt organizations to ensure their compliance with section 409A. The IRS is 
seeking a thorough examination of all executive compensation and benefit arrangements, including exec-
utive retirement contracts and deferred compensation arrangements.322 The increased enforcement comes 
amid a growing public outcry against excessive executive compensation arrangements in both for-profit 
and nonprofit companies. Similar to the new Form 990, the goal of the audits is to increase transparency 
and hold tax-exempt organizations accountable for the benefits they receive.
If an exempt organization is found to not be in compliance with section 409A, then the IRS has the 
ability to impose (1) additional payroll taxes and interest, (2) significant tax penalties on individuals for 
failure of nonqualified deferred compensation plans to meet the requirements of section 409A, and (3) 
substantial monetary sanctions if the IRS determines that the executive compensation arrangement con-
stitutes an excess benefit transaction.323 An excess benefit transaction is a transaction in which an eco-
nomic benefit is provided by an applicable tax-exempt organization, directly or indirectly, to or for the 
use of a disqualified person, and the value of the economic benefit provided by the organization exceeds 
the value of the consideration received by the organization.324
The IRS is expected to examine up to 1,500 exempt organizations across all industries over a three-
year period.325 If fringe benefits for executives in these exempt organizations were incorrectly treated as 
tax-free, they could result in additional taxes owed by both the recipient and the employer.326
speCIfIC applICatIon of fRaud laws to pHysICIan CompensatIon
On September 20, 2007, the OIG issued Advisory Opinion No. 07-10, regarding the compensation paid 
for physician services related to on-call coverage.327 The opinion stated that the key inquiry for determin-
ing whether the compensation arrangement for providing emergency on-call coverage violates the anti-
kickback statute, “is whether compensation is: (i) [at] fair market value in an arm’s length transaction for 
actual and necessary items or services; and, (ii) not determined in any manner that takes into account the 
volume or value of referrals or other business generated between the parties.”328
The subject arrangement involved a nonprofit hospital experiencing a shortage of physicians to 
provide emergency department coverage and follow-up care due to the high volume of indigent patients 
unable to pay for services.329 Some hospitals have responded to certain specialists’ refusal to provide ser-
vices without compensation by paying per diem rates to physicians who entered into a two year contract 
to provide care in the emergency department.330
Although the OIG found that the subject arrangement did not “fit squarely into the terms of the safe 
harbor” for personal services and management contracts, because the amount of compensation was not 
set in advance and varied monthly, the compensation arrangement was nevertheless deemed low risk 
because (1) the per diem rates were at FMV without regard to referrals, the physicians were required to 
treat any patient who entered the emergency department until discharge with no additional compensa-
tion, and the physicians provided certain volunteer (uncompensated) services; (2) the emergency depart-
ment was understaffed prior to on-call compensation being paid, therefore, the likelihood that the ar-
rangement was instituted to provide remuneration to physicians for referrals was minimized; and (3) all 
physicians were given a chance to participate in the on-call program on equal ground, and the program 
was not being used to reward physicians for referrals.331
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Federal Antitrust Laws
Antitrust is a body of law which aims to combat anticompetitive behavior. The Sherman Antitrust Act 
(Sherman Act), which prohibits any “contract, combination . . . or conspiracy, in restraint of trade or 
commerce,”332 and Section 5 of the FTC Act, which prohibits “unfair methods of competition in or af-
fecting commerce. . .,”333 are the federal government’s two primary means of combating unfair competi-
tion and abuse of monopolistic power. Further, Section 2 of the Sherman Act prohibits the abuse of mo-
nopoly power.334 The Sherman Act has been used to combat kickbacks and self-referral joint ventures, 
which have been recognized and an impediment to competition by providers outside the self-referral or 
kickback network.335
The Sherman Act also has been used to address concerns related to physician integration under 
physician–hospital organization models, independent practice associations (IPAs), and the ability of 
such organizations to negotiate on behalf of physician members.336 The FTC typically examines such ar-
rangements under a rule of reason analysis, balancing procompetitive and anticompetitive effects of the 
integration arrangement on the market.337
Recently, a FTC finding of illegal price fixing by a Texas IPA was upheld by a federal appellate 
court.338 The court held that negotiation (on behalf of physician members) that doesn’t involve risk 
sharing with payors or any form of improved efficiency from clinical integration runs afoul of antitrust 
laws.339
Traditionally, IPAs have only been able to negotiate on behalf of their members if the joint-contract-
ing agreement has an element of risk-sharing built into it or if the IPA has embarked on a clinical inte-
gration scheme to improve efficiency among its members.340 However, even under this latter exception, 
only two clinically integrated IPAs have successfully survived antitrust challenges.341
Additionally, many community hospitals have come under scrutiny by antitrust authorities for 
engaging in exclusionary practices in an effort to respond to the negative financial impact of physician-
owned facilities (POFs).342 Many hospitals have attempted to shut POFs, particularly specialty hos-
pitals, out of the market, which has resulted in some POFs initiating antitrust suits, claiming that such 
exclusionary behavior violates the Sherman Act.343 Many of these cases have failed because antitrust 
authorities generally are protective of general hospitals that have taken measures to combat, what they 
claim to be, cream skimming by specialty hospitals.344 However, some courts have found in favor of 
POFs in cases when a general hospital abused its market power to pressure other hospitals and payors 
into agreeing to exclude the POF from the market.345
While antitrust challenges by POFs will not always fail, still important and unresolved issues exist 
that the courts have yet to determine. One of the most important elements of any antitrust challenge is 
the requirement of an agreement between competitors in the restraint of trade.346 In a majority of these 
cases, the allegations of agreement are launched at hospital boards that are in supposed agreements with 
their medical staffs.347 The circuits are split, however, on whether or not a hospital and members of its 
medical staff can be considered separate entities for the purposes of forming an agreement to restrain 
trade.348 Some circuits argue that a medical staff is simply a subpart of a larger hospital entity and, there-
fore, cannot be judged as separate decision-making entities.349 In the absence of an agreement by sepa-
rate entities, unilateral activity, as long as it is not predatory, is legal.350 However, courts also are split 
on the question of whether certain actions taken by hospitals in response to POFs can be considered to 
have legitimate business justifications.351 If a general hospital can show that its actions are in pursuit of 
a legitimate business goal, such as protecting its ability to cross-subsidize unprofitable services so that it 
may continue to provide those services to the community or to protect from cream skimming, then some 
courts may find the actions justified even if detrimental to the POF.352
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Racketeer Influenced and Corrupt Organizations Act (RICO)
The Racketeer Influenced and Corrupt Organizations Act (RICO)353 is a federal law that carries both 
criminal and civil penalties with the aim of protecting the public from, “parties who conduct organiza-
tions affecting interstate commerce through a pattern of criminal activity.”354 The general prohibition of 
RICO is against using a business to commit a crime. When applied to healthcare, RICO makes it ille-
gal for any person to (1) use or invest any income derived from a pattern of racketeering activity in an 
enterprise and (2) acquire or maintain control of any enterprise through a pattern of racketeering activity. 
Additionally, it is illegal (3) for any person employed by, or associated with any enterprise to conduct 
the affairs of the enterprise through a pattern of racketeering activity.355 It is also a violation of RICO to 
conspire to engage in any of these three activities.356 A pattern of racketeering activity involves commit-
ting at least two acts of racketeering activity.
RICO has been used to prosecute physicians, attorneys, and patients who conspire to defraud payors 
by filing false claims related to fictitious automobile accidents, billing for services not actually rendered, 
and unnecessarily prescribing controlled substances.357
Other Federal Regulations
Occupational Safety and Health Act (OSHA)
The Occupational Safety and Health Act of 1970 (OSHA) established standards for occupational health 
and safety, and it requires states to enact legislation implementing standards and procedures developed 
by the Department of Labor.358 OSHA promulgated regulations include those designed to protect health 
care employees from blood borne diseases, latex allergies, needle sticks, tuberculosis, patient violence, 
ionizing radiation, and anesthetic gasses that leak into the surrounding room during medical procedures, 
among others.359
Clinical Laboratory Improvement Act (CLIA)
Congress passed the Clinical Laboratory Improvement Act (CLIA) and its subsequent amendments in 
order to improve the accuracy, reliability, and timeliness of test results.360 The act requires laborato-
ries to regulate all laboratory testing performed on humans, except the testing performed for research 
purposes.361 CMS assumes the responsibility for overseeing the CLIA program.362 CLIA requires that 
healthcare providers who perform laboratory testing on specimens derived from humans in order to gain 
information for the diagnosis, prevention, or treatment of disease or the assessment of health to abide by 
federally established quality standards in order to operate these services.363
United States Nuclear Regulatory Commission (NRC)
The United States Nuclear Regulatory Commission (NRC) is an independent agency created by Con-
gress in 1974.364 The goal of the agency is to ensure the safe use of radioactive material for civilian 
purposes through a combination of regulatory requirements, licensing, safety oversight, operational 
evaluation, and support activities.365 Under section 274 of the Atomic Energy Act of 1954, the NRC 
is authorized to delegate its authority to oversee certain licensees to state regulatory commissions, or 
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agreement states.366 An agreement state then has the authority to regulate the use of nuclear material by 
certain licensees. To date, the NRC has entered into agreements with thirty-seven states.367
The NRC or the agreement state regulates the medical use of radioactive material through the li-
censing of medical facilities and physicians, inspection of facilities, and enforcement of regulations and 
procedures. The types of medical use regulated by the NRC and the agreement state include the produc-
tion of radiation from imaging devices used by hospitals, physicians, dental offices, and podiatry offices; 
the use of nuclear material to deliver pain reliving or therapeutic doses to parts of the body; and medical 
research involving the use of nuclear material in human subjects.368
Emergency Medical Treatment and Active Labor Act 
(EMTALA)
The Emergency Medical Treatment and Labor Act (EMTALA) was enacted in 1986 by the Consolidated 
Omnibus Budget Reconciliation Act of 1985 and applies only to hospitals that participate in the Medi-
care program and have an emergency room.369 EMTALA requires covered hospitals to provide “medical 
screening” to any patient coming to the hospital’s emergency department.370 Anyone suffering harm as a 
“direct result” of a hospital’s violation of EMTALA can bring a claim against the hospital.371 Addition-
ally, EMTALA provides for civil penalties against the hospital.372
Of note is that EMTALA does not require hospitals to have an emergency department. Some spe-
cialty hospitals, however, are required by state licensure laws to have an emergency department.373
Tort Reform
Malpractice, defined as “professional misconduct or unreasonable lack of skill,” has always been a risk 
inherent in the practice of medicine.374 Medical malpractice litigation became popular in the 1970s, and 
since then, medical malpractice litigation has been a recurring problem in healthcare, as physicians have 
been forced to practice defensive medicine, leading to the overprovision of care and increased healthcare 
costs.375 As malpractice litigation has increased due to improved technology and increased volume of 
patients, physicians have been forced to pay higher premiums for malpractice insurance, causing some 
physicians to move out of states with high premiums, close their medical practices, take early retirement, 
or choose to go naked, that is, practice without malpractice coverage.376 While many physicians have not 
had to take such drastic action, high malpractice premiums have led to increases in the cost of services, 
and, therefore, to increased costs of consumer health insurance premiums.377
Tort reform proponents have alleged that the United States has the most 
expensive tort system in the world, with costs per citizen of about $845 per 
person in 2003.
“Tort excess: the necessity for reform from a policy, legal and risk management perspective.” by David Dial, et al., 
p.1, http://server.iii.org/yy_obj_data/binary/727182_1_0/tortreform.pdf (accessed September 8, 2009).
Malpractice litigation stems from the U.S. tort system, which allows patients who are injured in 
some way, to sue the wrongdoer, or tortfeasor.378 If found liable, the tortfeasor is held accountable for 
his or her actions, and the injured party is able to recover for damages incurred as a result of the tort.379 
Damages in a malpractice suit generally are classified as economic (loss of wages, etc), noneconomic 
(pain and suffering, etc), or punitive damages (intended to punish and deter future behavior).380 Tort 
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reform proponents have alleged that the United States has the most expensive tort system in the world, 
with costs per citizen of approximately $845 per year in 2003.381 Despite the fact that the vast majority 
of cases are settled out of court, an estimate of the 2001 direct costs of the U.S. tort system was $205.4 
billion.382
state toRt RefoRm
In response to this problem, there have been multiple tort reform initiatives, at both the state and federal 
level, aimed at capping malpractice damages.383 Many states have caps already in place.384 Such caps, 
often modeled after California’s Medical Injury Compensation Reform Act (MICRA), place limits on 
pain and suffering awards to plaintiffs.385 Similarly, in 2003, the Texas legislature passed a $750,000 
cap on damages ($250,000 per defendant).386 As of 2009, thirty-seven states had passed laws that place 
limits on noneconomic or punitive damages in medical malpractice suits.387 Of the thirteen states that do 
not place caps on damages, five have determined such caps to be unconstitutional, and four have consti-
tutional provisions which outlaw caps on damages.388
In addition to damages caps, another method used to provide limits on financial risk to insurers has 
been the establishment of statutes of limitations on claims made by plaintiffs.389 Other methods of tort 
reform called for by proponents would enable or enhance the ability of defendants to countersue claim-
ants who file frivolous lawsuits.390 Another way to lower malpractice premiums would be to create 
compensation programs outside of the court system to handle malpractice cases.391 Additionally, a more 
proactive and preventative approach to prevent lawsuits by lowering medical malpractice awards (and 
therefore premiums) would include building rapport with patients, reducing medical errors, and estab-
lishing honesty policies for full disclosure of errors.392
fedeRal toRt RefoRm
Though medical malpractice law has traditionally been regulated at the state level, the federal govern-
ment has taken an interest in tort reform. A 2002 HHS report alleged that the legal system was to blame 
for rising medical malpractice premiums, citing California’s noneconomic damages cap as a model for 
national tort reform.393 While there have been efforts at federal tort reform, a federal cap on damages has 
yet to be signed into law. The most recent effort to cap damages at the federal level, the Help Efficient, 
Accessible, Low-Cost, Timely Healthcare Act of 2009, was introduced before the House of Representa-
tives in February 2009.394 This bill is a new attempt to pass a federal cap on noneconomic damages in 
medical malpractice suits, which has been a continuing congressional goal since the same bill was first 
introduced in the House in 2002.395 Similar bills have repeatedly passed in the House, however, no ver-
sion of the bill has yet to be passed in the United States Senate.396
Proponents of tort reform historically have pushed for caps on punitive damage awards.397 However, 
more viable reform proposals include shifting tribunals (for example, from judicial to administrative 
panels) or creating federal safe harbors for physicians who practice in accordance with credible compar-
ative-effectiveness research.398 Additionally, insurance companies are experimenting with disclosure-and 
offer programs, in which providers offer compensation to patients immediately upon disclosure of a 
negative outcome, reducing the number of malpractice lawsuits.399
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Conclusion
The healthcare regulatory environment is constantly changing. As physicians and other providers find 
it more and more difficult to survive under crippling regulations and reimbursement rates, they are 
being forced to find ways around regulations directed at limiting the ways in which they may receive 
remuneration for services provided. The numerous modifications of the Stark law are a good example 
of how CMS has had to continuously modify existing regulations in an effort to keep up with providers 
who are finding new ways to join together and use new technologies to survive in a regulation-ridden 
environment.
As healthcare reform pushes forward, it is unlikely that providers will be faced with fewer regula-
tions. It is more likely that reform efforts will focus on increased regulation and increased prosecution 
of regulatory violations. Notable recent events have demonstrated that agencies such as the HHS, the 
DOJ, and the FTC are cracking down on any activity that could have the potential to drive up the cost of 
healthcare services. All of these agencies have demonstrated their commitment to combating healthcare 
fraud and are likely to continue to promulgate new regulations to accomplish this task in the future.
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4 Impact of 
Competitive Forces
There are perhaps few things upon which all men are so agreed 
as that the problems which beset them today surpass in difficulty 
those which confronted any previous generation. It is maintained 
that never has knowledge been so complex nor the pace of life 
so insistent; that never has it been so difficult to take thought 
on those larger considerations which allow men to appreciate 
the trend of events and the measures by which they might be 
controlled.
Harold Himsworth, 1953
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Key Concept Definition Citation
Normal Markets versus 
Healthcare Markets
Competition in healthcare is unique from competition in other 
sectors because traditional theories of economic forces do not 
always govern the choices made.
n/a
“Corporatization” of Medicine The transformation of vertically organized bureaucracies into 
government-owned corporations that are exposed to market-like 
pressures. In healthcare, this means the establishment of publically 
owned hospitals as private corporations. Corporatization is usually 
seen along with autonomization.
“Understanding Organizational Reforms: The Corporatization 
of Public Hospitals” by April Harding and Alexander S. Preker, 
Health, Nutrition, and Population, The World Bank, September 
2000, p. vii, 15.
“Three-Legged Stool” Model of 
Healthcare
Cost, quality, and access are each considered distinct elements of 
healthcare administration.
“Why Competition Law Matters to Health Care Quality,” by 
William M. Sage, David A. Hyman, and Warren Greenberg, 
Health Affairs, Vol. 22, No. 2, (March/April 2003), p. 35–36.
Emergency Medical Treatment 
and Labor Act
Hospital emergency departments are required to provide care under 
certain circumstances, even to patients who are uninsured and 
unable to pay for that care.
“Could U.S. Hospitals Go The Way Of U.S. Airlines?” by Stuart 
H. Altman, David Shactman, and Efrat Eilat, Health Affairs, Vol. 
25, No. 1, (Jan/Feb 2006), p. 11.
“Most Favored Nation” Status A provider contractually agrees to not charge an insurance 
company any more than it charges any other customer.
“Improving Health Care: A Dose of Competition: Chapter 6, 
Competition Law: Insurers,” A Report by the Federal Trade 
Commission and Department of Justice, July 2004, p. 20.
Trend Toward Physician 
Ownership
Physicians have become owners and investors in surgical facilities, 
such as ambulatory surgery centers, and specialty hospitals, that 
compete with the same general hospitals to which the physicians 
traditionally have referred patients.
“Hospital-Physician Relations: Cooperation, Competition, or 
Separation?” by Robert A. Berenson, Paul B. Ginsburg, and 
Jessica H. May, Health Affairs, Web Exclusive,  
(Dec. 5, 2006), p. w34.
Effect of Declining Patient 
Volumes
Hospitals began offering additional services and entering into the 
practice of providing insurance and primary care services, taking 
on a powerful role as both provider and insurer through integrated 
delivery systems. In addition, hospitals to begin merging with each 
other so that they could leverage their consolidated bargaining 
power against private insurers.
“Competition in Health Care: It’s Evolution Over the Past 
Decade,” by Paul B. Ginsburg, Health Affairs, Vol. 24, No. 6, 
Nov/Dec 2005, p. 1513–14.
Federal Specialty Hospital 
Moratorium of the Medicare 
Prescription Drug, Improvement, 
and Modernization Act of 2003
Placed an eighteen-month moratorium on physician investment 
in, and referrals to, specialty hospitals in which the referring 
physician had an ownership or investment interest in order to study 
the impact of specialty hospitals on Medicare payment rates and 
referral practices. Expired in 2005.
“CMS Outlines Next Steps and Moratorium on New Specialty 
Hospitals Expires,” Press Release, Centers for Medicare 
and Medicaid Services, June 9, 2005, www.cms.hhs.gov/
apps/media/press/release.asp?Counter=1478 (accessed 
November 9, 2009).
Conflict of Interest Credentialing The limiting or terminating physician-investors’ privileges and 
medical staff membership.
“Banning Physician Self-Referral is an Important Step 
Toward Health Reform,” by Rich Umbdenstock and Chip 
Kahn. HA News Now, www.ahanews.com/ahanews_app/jsp/
display.jsp?dcrpath=AHANEWS/AHANewsArticle/data/AHA_
News_090720_ Physician&domain=AHANEWS (accessed 
November 9, 2009).
Michael Porter’s Five 
Competitive Forces
(1) The threat of new market entrants. (2) The bargaining power of 
suppliers. (3) Threats from substitute products or services. (4) The 
bargaining power of buyers. (5) Rivalry among existing firms.
“Competitive Strategy: Techniques for Analyzing Industries 
and Competitors:,” by Michael E. Porter, The Free Press, 
1980, p. 4.
Strategies to Out-perform 
Competitors or Maintain a Market 
Position Against Competition 
Porter’s three generic strategies are (1) overall cost leadership, (2) 
differentiation, and (3) market niche or segmentation.
“Making Competition in Health Care Work.” by Michael E. 
Porter, et al., Harvard Business Review, July/August, 1994.
Medical Tourism The practice of patients traveling to countries to receive medical 
procedures at a fraction of what they would cost in the United States.
“Could U.S. Hospitals Go The Way Of U.S. Airlines?” by Stuart 
H. Altman, David Shactman, and Efrat Eilat, Health Affairs, Vol. 
25, No. 1, (Jan/Feb 2006), p. 18.
Medicare Improvements for 
Patients and Providers Act of 
2008 
Includes a provision requiring accreditation of physicians who 
provide the technical component for advanced diagnostic imaging 
services (for example, magnetic resonance imaging , computed 
tomography, and nuclear medicine or single photon emission 
computed tomography) for which payment is made under the 
Medicare physician fee schedule. All suppliers of the technical 
component of advanced diagnostic imaging services will need to be 
accredited by January 2012.
“Medicare Improvements for Patients and Providers Act of 
2008,” Pub. L. 110-275, 122 Stat. 2494, July 15, 2008, Sec. 
135(a).
McCarran-Ferguson Act Limits federal scrutiny of insurers and places states in primary 
control of antitrust enforcement.
“McCarran-Ferguson Act” 15 U.S.C 1011 et seq.  
March 9, 1945.
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Overview
Competition in healthcare is unique from competition in other sectors because traditional theories of 
economic forces do not always govern the choices made by professional practice enterprises within the 
healthcare industry. Unlike other markets, in which competition is viewed positively as a necessary ele-
ment of capitalism, competition in the healthcare sector frequently is considered to be resistant to the 
universal availability and accessibility of quality care.
Although traditional notions of economic supply and demand, and the inherent concept of competi-
tion, have gained influence over healthcare professional practice enterprises in recent years, these fac-
tors historically were subjugated to a normative argument in favor of the mission-centered provision of 
services regardless of cost. This has led to the perception that healthcare demand is supply-driven and 
operates within an inelastic pricing mechanism, the circumstances of which will be discussed in detail 
later in this chapter.
As the relationship between price and quality of care generally is defined by providers rather than 
patients, consumers (that is, patients) are less equipped to make informed purchase decisions than they 
are in other markets. Further, the intensive regulation of medical professionals, new technologies and 
treatments, and evolving drug therapies may delay or disable the development of substitutes, and, there-
fore, stymie innovation, which is one of the fundamental drivers of quality improvement and the under-
lying dynamic of an organization’s ability to compete.
In addition to the impact of regulation on the delivery of healthcare services (discussed in chapter 3, 
Regulatory Environment), the government’s role as the single largest payor for healthcare services exerts 
enormous pressure on providers to reduce costs. The impact of these changes has not been limited to 
Medicare and Medicaid fees; it is also reflected in reimbursement policies of other third-party payors. 
This pre-eminent influence on, and pervasive dominance of, government over the healthcare industry 
presents a significant and essentially unique differential between healthcare and other industries.
Finally, the past two decades have seen the accelerated transformation of U.S. healthcare professions 
into a service industry enterprise, whereby many believe that professional health services have been 
unitized, protocolized, and homogenized in order to facilitate their “sale,” just like if they were any other 
market commodity (for example, frozen orange juice, soy beans, or pork bellies). These changes have 
accelerated the “corporatization” of medicine as demonstrated by the increase in for-profit healthcare in 
hospitals, outpatient technical component providers [for example, independent diagnostic testing facili-
ties (IDTFs) and ambulatory surgery centers (ASCs)], and large for-profit health insurance payors.
Economics of Healthcare
Healthcare costs are not just rising, they are growing at a proportionally greater rate compared to the rise 
in cost of other goods and services in the U.S. economy.1 The percentage of the gross domestic product 
(GDP) devoted to healthcare services has grown from 6 percent in 1965 to almost 18 percent at the time 
of publication, and it is projected to surpass 20 percent by 2018.2 Although many causes exist for this 
gap between growth in healthcare spending and growth in GDP, note that the impact of the economic 
recession, which started in 2008, was more severe on GDP than it was on healthcare spending, though 
the growth rate of the latter did decline slightly.3
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The percentage of the gross domestic product (GDP) devoted to healthcare 
services has grown from 6 percent in 1965 to almost 18 percent at the time 
of publication, and is projected to surpass 20 percent by 2018.
“Three Decades of Government-Financed Health Care in the United States,” by Patrick Fleenor, Tax Foundation, 
August 1994, www.taxfoundation.org/files/bd006ece1a4b8166023dbc913175b7b7.pdf (accessed November 11, 
2009); “Health Spending Projections Through 2018: Recession Effects Add Uncertainty to the Outlook,” by Andrea 
Sisko, et al., Health Affairs, Web Exclusive, Feb. 24, 2009, p. w347.
Some economists have cited the aging population as the reason for the increase in healthcare’s share 
of the GDP. Other voices have asserted that greed among health maintenance organizations (HMO), 
pharmaceutical companies, hospitals, and medical providers, such as doctors and nurses, is responsible.4 
In reality, the rise in healthcare expenditures is, at least in large part, the result of much deeper economic 
forces. As economist William J. Baumol explains, “the relative increase in healthcare costs compared 
with the rest of the economy is inevitable and ineradicable part of a developed economy. The attempt [to 
control relative costs] may be as foolhardy as it is impossible.”5
Documented and significant differences exist in productivity growth between the healthcare sector 
of the economy and the economy as a whole. Healthcare services have experienced significantly lower 
productivity growth rates than other industry sectors for three main reasons. First, healthcare services 
are inherently resistant to automation, so innovation (in the form of technological advancement) has 
not made the same impact on healthcare productivity as it has on productivity in other industries. The 
manufacturing assembly line robot increases assembly line productivity by accelerating the process and 
reducing labor input. In contrast, most medical technology is still applied in a labor-intensive process, 
that is, patients are cared for one at a time, and diseased or ill patients cannot be disposed of as routine 
work product error like automated factories can cost-effectively reject a percentage of defective items. 
Healthcare providers cannot (and, most would agree, should not) try to operate as factories, because 
each patient is unique and disease is widely variable. This makes providers unable to adapt to the pro-
ductivity gains and efficiency derived from mass production techniques.6
Second, unlike other labor-intensive industries, healthcare is local in nature and cannot be imported. 
Despite the technology advances described previously, healthcare services mainly are provided by 
skilled workers within a local market in which the providers compete locally and are compensated at 
higher levels.7
Third, healthcare consumers believe that quality of service is correlated with the amount of labor 
expended in its provision, in contrast to mass production, in which the number of man-hours per unit is 
not an important predictor of product quality.8
Supply and Demand in Healthcare
Historically, healthcare was considered a “special” economic market, in which quality of care tradition-
ally trumped general economic notions of the consumer-driven model of supply and demand. Competi-
tion law, which considers quality as only one element of a good or service, inherently conflicts with 
the traditional perspectives of providers who see quality as “an irreducible minimum standard, to be 
determined by physicians without reference to cost.”9 Prior to the mid–twentieth century, healthcare was 
dominated by these providers who justified anticompetitive behavior under the guise of quality control 
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(see chapter 6 of Professional Practices for a discussion of the highly publicized Wilk v. American  
Medical Association, in which the American Medical Association (AMA) attempted to boycott chiro-
practic practices, stating that doctors of chiropractic were unscientific practitioners, as well as chapter 4 
of Professional Practices regarding the highly contested 2008 Missouri Supreme Court decision to al-
low the independent practice of nurse midwives under constitutional law).10 In the mid- to late-twentieth 
century, however, the stringency of competition policy was heightened in order to address such behavior 
among providers, and, as such, competition laws have begun to regulate the healthcare sector, as an eco-
nomic market, more directly.11
Prior to the mid–twentieth century, healthcare was dominated by  
these providers that justified anticompetitive behavior under the  
guise of quality control.
“Why Competition Law Matters to Health Care Quality,” by William M. Sage, David A. Hyman, and Warren  
Greenberg, Health Affairs, Vol. 22, No. 2, (March/April 2003), p. 39.
Additionally, competition law now addresses the traditional notion of the “three-legged stool” model 
of healthcare, under which cost, quality, and access are considered distinct elements of healthcare ad-
ministration. As the impact of competition law on healthcare policy has grown, these three “legs” have 
demonstrated their interconnectedness, with price being viewed as having a direct impact on quality of 
care. Competition laws have been used to combat the practice of increasing prices above competitive 
levels, as well as to prevent providers from excising certain competitors from the market in the pursuit 
of “higher quality of care” (see chapter 3, Federal Antitrust Laws).12
Also unique to the healthcare sector is the widespread notion of providing services irrespective of 
the client’s (that is, the patient’s) ability to pay. Under laws such as the Emergency Medical Treatment 
and Labor Act (EMTALA), general hospital emergency departments are required to provide care under 
certain circumstances, even to patients who are uninsured and unable to pay for services rendered.13 Ad-
ditionally, the power of Medicare and Medicaid forces providers to operate at a loss for many services, 
because those programs typically reimburse providers only for a fraction of the amount the services cost. 
As these payors provide nearly 60 percent of a hospital’s revenue, the general relationship between cost 
and price found in other markets is not commonly followed in the healthcare sector.14
Medicare and Medicaid provide nearly 60 percent of a hospital’s revenue.
“Could U.S. Hospitals Go The Way Of U.S. Airlines?” by Stuart H. Altman, David Shactman, and Efrat Eilat, Health 
Affairs, Vol. 25, No. 1, (Jan/Feb 2006), p. 14.
Further, competition in healthcare does not divide neatly between supply and demand, further con-
tributing to the complexity that distinguishes competition within healthcare market from other industry 
sectors. Ultimately, the major players on the supply side of the healthcare industry are powerful private 
insurance companies and large hospital systems. Despite the fact that providers actually supply services 
to treat patients, insurance companies are able to limit access to services through the use of provider net-
works, and hospitals are incentivized to keep costs low by treating only what is necessary, knowing that 
readmission will mean additional reimbursement.15
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Additionally, many community hospitals are finding it increasingly difficult to cross-subsidize 
expensive treatments due to competition from specialty providers and increased demands for price 
transparency by consumers.16 Difficulties in accessing capital to support the provision of money-losing 
services have pushed many smaller hospital systems to consolidate with larger, for-profit systems.17
At the same time, insurers operate as consumers of healthcare services by paying for the services 
provided and deferring that cost from the actual consumer, the patient.18 On this side of the equation, 
large insurance companies have been able to enjoy monopsony (that is, single purchaser; opposite of 
monopoly) power in the United States which has allowed them to demand “most favored nation” status 
in their contracts with providers; that is, the provider contractually agrees to not charge the insurance 
company any more than he or she charges any other customer.19 This has allowed insurance companies 
to prevent competitors from entering the market, which, combined with numerous mergers, has led to 
a highly concentrated insurance market and paved the way for insurers to set malpractice premiums at 
rates so high, and reimbursement payments at rates so low, that they are driving physicians and small 
hospitals out of business or forcing them to join large hospital system conglomerations.20
At the same time, consumers enduring the repercussions of high insurance premiums are choosing  
to switch to more consumer-driven healthcare insurance by contributing to a health saving account 
(HSA) from which to pay their medical expenses, then supplementing the HSA with high-deductible 
health plans (HDHP) to cover catastrophic conditions.21 (For more information about HSAs, see  
chapter 2, Health Savings Accounts (HSA)). This shift to consumer-driven healthcare has changed the 
demand environment of the healthcare industry such that providers are now dealing directly with pa-
tients, who are starting to scrutinize more closely the procedures and services they purchase.22 By mak-
ing these purchasing decisions directly, rather than relying on an insurance provider to pay most of the 
cost of treatment, the ability of healthcare consumers to affect demand in the healthcare market has in-
creased, and the demand side of this sector is finally beginning, in some capacity, to mimic that of other 
industries.23
Impact of Government Regulation
Healthcare institutions are subject to extensive regulatory control at both the state and federal levels of 
government. Some of the most significant regulations address the financial relationships between pro-
viders (see chapter 3, Stark Law). State and federal fraud and abuse laws have profoundly affected the 
provision of healthcare services in the United States because they, in part, prohibit particular financial 
relationships between healthcare providers. Proponents of these laws contend that practitioner medical 
judgment is influenced by financial relationships with referral sources.24 However, substantial regulation 
has the capacity to limit free market competition in the healthcare industry.25 Additionally, the influ-
ence of the government as both regulator and purchaser of healthcare services has the potential to distort 
consumer responses to prices, as well as harm consumers directly by creating disincentives for the provi-
sion of quality care by reducing rewards for innovation, despite the aim of regulations to prevent market 
forces from running amok and hurting quality (for more information related to government regulation of 
the healthcare industry, see chapter 3, Regulatory Environment).26
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Supply: Cooperation and Competition Between Hospitals  
and Physicians
Historically, physicians and hospitals each provided distinct services to patients, with physicians provid-
ing physician services, and hospitals providing surgical and other related services to patients referred 
to the hospital in which the physicians enjoyed staff privileges.27 Under this symbiotic dynamic, there 
was relatively little to no competition between physicians and hospitals.28 However, this trend has begun 
to shift as physicians have become owners and investors in surgical facilities, such as ASCs and spe-
cialty hospitals, that compete with the same general hospitals to which the physicians traditionally have 
referred patients. Additionally, the willingness of physicians to volunteer for responsibilities within a 
hospital has declined significantly in recent years, marking another shift toward a more competitive and 
adversarial relationship between physicians and hospitals (for more detail related to the organizational 
structure of healthcare services in the current market, see chapter 1 of Professional Practices).29
Hospitals
During the 1990s, the focus of managed care on the role of primary care physicians as “gatekeepers” 
resulted in declined patient volumes for hospitals.30 With reduced patient volumes, hospitals began offer-
ing additional services and entering into the practice of providing insurance and primary care services, 
taking on a powerful role as both provider and insurer through integrated delivery systems.31 Declining 
patient volumes also prompted hospitals to begin merging with each other so that they could leverage 
their consolidated bargaining power against private insurers.32 As time progressed, concerns regard-
ing access to capital have led to continued hospital consolidation, such that smaller, typically nonprofit, 
hospitals are faced with the grim choice of going bankrupt or joining larger, for-profit hospital systems 
to survive.33
A particular impact of competition on hospitals is that they are asked to provide money-losing 
services in an environment in which price-competitiveness is promoted. Traditionally, hospitals could 
cross-subsidize cost-ineffective services (for example, those falling under Medicare or Medicaid, 
services provided to indigent patients, etc.) by charging more to insured patients who were not price-
sensitive and did not have the capacity to know the difference.34 However, the rise of competition with 
specialty hospitals and niche providers (see Threat of New Market Entrants) has led to increased price 
transparency, which allows those insured patients who have been footing the bill for money-losing 
services to demand that prices reflect the services actually provided to them, and nothing more.35 The 
potential decrease in demand for services that are priced too high could force hospitals to eliminate cost-
ineffective services in the struggle to compete with other hospitals and specialty providers.36
Competition Between General and Specialty Hospitals
Although specialty and niche providers are not new providers, the increase in their number has led 
to concerns that more and more providers will be able to “cherry-pick” and “cream-skim” the most 
profitable patients and procedures away from community hospitals. Specialty hospitals focus on provid-
ing only cost-effective or profitable services, and they refuse to provide services that result in a net loss 
or treat patients who cannot pay.37 Further, the development of new technology has made it possible for 
physicians to perform, in their office or ASC, services traditionally provided by hospitals.38 Specialty 
hospitals and ASCs have been able to compete better than community hospitals for more profitable pa-
tients by (1) concentrating only on specific diagnosis-related groups (DRG), (2) treating far fewer costly 
Medicaid patients, and (3) opting out of emergency room facilities and services, the latter to forego 
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the related regulatory requirements under laws, such as EMTALA, that pertain to the provision of care 
regardless of a patient’s ability to pay.39
Specialty hospitals and ASCs treat some of the most profitable diseases in a predominantly out-
patient setting. These facilities have grown due to the increased incidence of these diseases, as well 
as changes in consumer demands and new technologies. “Specialty hospitals are also able to achieve 
economies of scale and scope by providing high volumes of a limited scope of services and lowering 
fixed costs by reengineering the care delivery process.”40 This narrow focus helps achieve profitability 
and makes such facilities more competitive than more generalized providers, because “greater diversifi-
cation into a wider array of activities has the potential to lead to diminished financial performance.”41
The ability to provide services at a reduced cost is a double-edged sword for ASCs. Under the Medi-
care system, reimbursement rates for hospital outpatient departments (HOPD) are substantially higher 
than reimbursement rates for the same procedures performed in an ASC or a physician’s office.42 For 
most services performed in an ASC, payment is made under a system that aligns ASC reimbursement 
rates at a percentage of the Outpatient Prospective Payment System (OPPS) rates.43 Because of the need 
to ensure budget neutrality between the old ASC payment system and the revised system, the reimburse-
ment rate for ASC procedures was set at 65 percent of the OPPS rate in 2008.44 Centers for Medicare 
and Medicaid Services (CMS) cut this rate again in 2009,45 with a zero percent adjustment for inflation,46 
and only increased the conversion factor for payments to ASCs by 1.2 percent for 2010, despite an 
increase of 2.1 percent for HOPDs for the same year.47 Because CMS accounts for an average of 34 per-
cent of ASC revenue, changes to CMS reimbursement rates greatly affect the ability of ASCs to provide 
quality patient care services (see chapter 1 of Professional Practices).48
Medicare and Medicaid account for an average of 34 percent of an 
ambulatory surgery center’s (ASC’s) revenue.
“10 interesting facts and statistics for ASCs,” by S. Becker, Becker’s ASC Review, January 2008, www.beckersasc.
com/ambulatory-surgery-center/surgery-center-education/10-interesting-facts-and-statistics-for-ascs.html 
(accessed May 17, 2010).
Further, physicians who provide outpatient services in their offices only receive the physician fee 
component reimbursement rate under the Medicare physician fee schedule.49 When procedures are 
performed in a HOPD, hospitals (in the absence of bundled payments) receive both the physician fee, 
with which they reimburse their doctors, and the facility fee reimbursed under the OPPS rate.50 Further, 
although the payment differential between HOPDs and ASCs is standardized for the most part, the pay-
ment differential between services provided in HOPDs or ASCs and services provided in physicians’ 
offices varies substantially by payor and service (for more detail on Medicare reimbursement see  
chapter 2, Medicare).51
Campaign Against Physician Ownership
Competition between hospitals and physicians has been intensified by a growing tension between the 
American Hospital Association (AHA) on one side and the American Medical Association (AMA) 
and Physician Hospitals of America on the other side, a tension which has risen out of the debate over 
physician ownership of specialty hospitals.52 At its heart, the controversy regarding specialty and niche 
providers is a turf war between physicians and hospitals related to the technical component revenues 
from procedures and diagnostic testing. Physicians, who have seen decreased reimbursement rates for 
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the professional fee component of their services under the Medicare physician fee schedule, have begun 
to invest in ancillary services and technical component (ASTC) revenue stream enterprises (for example, 
ASCs, IDTFs, and specialty hospitals) so that they may also be reimbursed for the procedure under the 
OPPS.53
As many also assert that the practice of physician investment in healthcare from which they seek to 
earn a profit is a practice that is normatively controversial and should be avoided, physician owners of 
ASTC revenue stream enterprises have come under attack at the hands of regulators that have been lob-
bied incessantly by powerful community hospital systems.54 In particular, opponents of specialty hospi-
tals consistently have lobbied for the elimination of the “whole hospital exception” to the Stark law (see 
chapter 3, Stark Law), which allows physicians to refer patients to facilities in which they have owner-
ship or investment interest as long as the ownership or investment interest is in the whole hospital and 
not just a subdivision of it.55
Legislative proposals to remove the whole hospital exception in 2003 prompted the General Ac-
counting Office (GAO) to investigate the development and effects of specialty hospitals.56 In April 2003, 
GAO issued its first report on the market share and physician ownership of specialty hospitals.57 The 
GAO found that specialty hospitals represented a growing share of the hospital market and that there has 
been rapid growth in the number of specialty hospitals.58 The GAO also found that physicians owned 70 
percent of all specialty hospitals.59 The GAO issued a more detailed report in October 2003 analyzing 
the impact of specialty hospitals on general hospitals. The October report found that specialty hospitals 
were less likely to have emergency rooms than general hospitals, treated fewer Medicaid patients than 
general hospitals, and derived less income from inpatient services than general hospitals.60
In response to this report, the United States Congress, as part of the Medicare Prescription Drug, 
Improvement, and Modernization Act of 2003 (MMA), placed an eighteen-month moratorium on physi-
cian investment in, and referrals to, specialty hospitals in which referring physicians had an ownership 
or investment interest in order to study the impact of specialty hospitals on Medicare payment rates 
and referral practices.61 Typically, the whole hospital exception to the Stark law would have protected 
such physicians who have an ownership or investment interest in the whole hospital from violating the 
Stark law by referring patients to that facility. However, the MMA’s eighteen-month moratorium on the 
development of new specialty hospitals62 was the culmination of a multiyear battle against this perceived 
loop-hole in the Stark law allowing physicians to have ownerships interests in hospitals. The temporary 
moratorium appears to represent a compromise between the faction wanting to eliminate the whole hos-
pital exception for all hospitals and the faction concerned only with the perceived threat from specialty 
and niche providers.
The AHA, a long-time supporter of restrictions limiting physician self-referrals and investment, 
supports extending the specialty hospital moratorium contained in the MMA.63 Recognizing that it may 
be difficult for physicians to unite against the hospital industry, the AMA has demonstrated its support 
of specialty hospitals and a “level playing field” between general and specialty hospitals.64 The AMA 
has stressed that it supports competition between healthcare providers because it “promotes delivery of 
high-quality, cost effective healthcare.”65 However, the AMA does not speak for all physicians on this 
issue. The American Academy of Family Physicians (AAFP) has announced its support for extending 
the specialty hospital moratorium. The AAFP has sided with the AHA, believing that specialty hospitals 
could cream-skim patients with profitable diagnoses.66
Although the specialty hospital moratorium expired without being perpetuated in 2005, the debate 
regarding physician ownership of specialty hospitals continues, with organizations such as the AHA 
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accusing specialty hospitals of leaving community hospitals with the brunt of uninsured and underin-
sured patients.67 At the same time, physicians counter that physician-owned facilities (POFs) are able to 
offer improved competition leading to lower costs, higher quality, better outcomes, increased efficiency 
derived from more focus on specific services, more convenient services than offered by general hospi-
tals, and better amenities. POFs also offer physicians greater control over delivery of services and the 
ability to supplement their otherwise decreasing revenues.68
Exclusionary Boycotts
In response to the threat from specialty hospitals, many community hospitals also have started to fight 
back in ways that may be perceived as being in violation of antitrust laws. In situations when specialty 
hospitals are owned in whole or in part by physicians with privileges on the medical staff of a general 
acute care hospital and when the specialty hospital competes with the general hospital either on an inpa-
tient or outpatient basis, many general hospitals have engaged in activities that attempt to shut the POF 
out of the market. Some of these practices include refusing to assist or cooperate with specialty hospi-
tals, pressuring other members of the medical staff or community physicians to not do business with 
the specialty hospital, pressuring payors to exclude specialty hospitals from the payors’ networks, and 
limiting or terminating physician-investors’ privileges and medical staff membership (conflict of inter-
est credentialing).69 In response to these practices, some POFs have initiated antitrust suits, claiming that 
general hospitals are engaging in illegal exclusionary boycotts.70
Although courts typically have favored general hospitals that have been trying to combat cream 
skimming by specialty hospitals, one notable case brought by Heartland Surgical Specialty Hospital, a 
Kansas City–area hospital, in 2005, demonstrates that courts will not always overlook anticompetitive 
behavior by hospitals. The specialty hospital filed an antitrust lawsuit alleging horizontal conspiracies 
between multiple health plans and multiple hospitals, as well as vertical conspiracies between the hos-
pitals and payors directly, resulting in pressure on payors, as well as direct agreements with them, to 
exclude the specialty service hospital from their networks.71 The eventual settlement in this case demon-
strates that antitrust laws still protect against entities with market power from using that market power to 
pressure others (in this case, other hospitals and payors) into agreeing to exclude a competitor from the 
market.72
pHysicians
Competition in the healthcare industry operates predominantly at the level of hospitals, health plans, 
and provider networks, rather than at the level of healthcare delivery with an independent practitioner.73 
This has incentivized physicians to join together in one of many types of emerging healthcare models 
(see chapter 2 of Professional Practices) so that they may improve their positioning vis-à-vis third-party 
payors. However, because physician manpower shortages are projected through the first quarter of this 
century, the independent practice of medicine may become less common.
Consolidation with Other Physicians
There has also been a noticeable shift in competition among physicians in recent years. Originally, many 
physicians operated as independent competitors, perhaps allied only with the hospital(s) to which they 
referred patients.74 The more recent trend has been for physicians to join networks with other physi-
cians and to clinically integrate their services in an effort to lower costs and improve quality.75 Managed 
care has placed pressure on these organizations to reduce costs, maintain quality, and protect market 
share.76 A key driver of physician integration has been the potential negotiating power it merits, namely 
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for contracting with hospitals and Managed Care Organizations (MCOs).77 The independent practice 
association (IPA) has been one of the more successful physician integration models.78 Other forms of 
physician integration include group practices without walls, physician practice management companies 
(PPMCs), and consolidated medical groups.79 These organizations have not achieved the success levels 
of IPAs.80 However, management services organizations (MSOs) have been successful in the integration 
of both providers and healthcare institutions.81 They generally offer an array of medical support ser-
vices, including billing and administrative support.82 They also help negotiate contracts with third-party 
payors.83 For detail on each of these types of physician integration models see chapter 2 of Professional 
Practices.
Manpower Shortage
In 1980, the Graduate Medical Education National Advisory Committee projected a surplus of 70,000 
physicians in the year 2000, which led to the implementation of a cap on medical school enrollment 
to control supply of physicians to the market. Due to tightly controlled managed care in the 1990s, the 
projections of a physician surplus in the next decade were reaffirmed, and the number of graduates per 
year remained unchanged for nearly twenty-five years.84 As economic recession hit in 2008, the physi-
cian workforce, like many other professions, experienced a shortage that is expected to continue through 
the next decades, reaching a possible a shortage of 159,000 physicians by the year 2025.85 The shortage 
can be attributed to both the increased demand resulting from the growing baby boomer population and 
the misaligned cap on medical school enrollment.
The physician workforce shortage is expected to continue through the  
next two decades, reaching a possible a shortage of 159,000 physicians  
by the year 2025.
“The Complex Dynamics of the Physician Workforce: Projected Supply and Demand through 2025” by Michael J. 
Dill and Edward S. Salsberg, Center for Workforce Studies, Association of American Medical Colleges, November 
2008, p. 6.
Primary care is one of the practice areas suffering most from the physician shortage, which likely 
can be attributed to the gap in pay between primary care physicians and specialists.86 Further exacerbat-
ing this particular shortage is the focus of medical schools on advanced specialization arising out of low 
reimbursement rates for academic medical centers (AMCs). As a result, AMCs are forced to rely on 
higher reimbursement rates for training by subspecialists, leading to a focus on subspecialties.87 Addi-
tionally, many surgeons have specialized so much that they do not feel qualified to provide emergency 
services, with some surgeons only providing outpatient care.88
Demand: Third-Party Payors and Consumer-Driven 
Healthcare
Although chapter 2, Reimbursement Environment, provides an extensive discussion of third-party payor 
reimbursement, it is important to remember that the power of third-party payors as purchasers of health-
care services is significant. Insurers essentially hold all the cards when dealing with both providers and 
patient-consumers. Although there will always be a significant amount of patient demand, how that de-
mand affects the market is affected by the existence of an intermediary between supplier and consumer 
that takes most of the purchasing burden off the consumer, as a result eliminating traditional demand 
forces that work in other markets to keep prices at reasonable levels.
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insurance and Managed care
With regard to demand, the presence of third-party payors in the healthcare industry may be capable of 
distorting the traditional supply and demand model by shifting the risks associated with ill health from 
patient (consumer) to a third party that pays for the management of those risks.89 By shifting that risk, 
consumers are insulated from the cost of the services needed to manage their health and, therefore, do 
not make entirely informed choices when balancing costs with benefits, resulting in an imperfect de-
mand curve.90 Conversely, insurance companies bear the costs associated with healthcare but generally 
do not capture the full benefits, which may further discredit the application of a traditional supply and 
demand model to the healthcare competitive market.91
Health insurance further affects the healthcare marketplace by offering misaligned incentives to phy-
sicians who are reimbursed by third-party payors at levels that do not reflect quality of care, but rather, 
focus mainly on the procedural volumes.92 As a result, physicians may be neither rewarded nor punished 
based on the quality of their work.93 This has the effect of insulating physicians from traditional competi-
tive forces which force low-performing participants out of other markets.94
MCOs, such as HMOs and preferred provider organizations (PPOs), also can distort the traditional 
competitive marketplace model by integrating the financing and delivery of healthcare services under 
the administration of one organization.95 MCOs may be attractive to consumers because they offer lower 
premiums, deductibles, and co-payments than traditional third-party payors.96 However, MCOs also 
take many choices out of a patient’s hands by creating restricted networks of providers from which the 
insured must choose in order to obtain those lower prices.97 One way of reducing the cost of care em-
ployed by MCOs is to contract with select physicians who agree to lower costs in order to be admitted 
to the MCO’s provider network. In this way, MCOs force price competition between providers, which 
allows them to negotiate volume discounts with providers, something that would not be possible for 
individual consumers to do on their own.98
However, when the popularity of more restrictive forms of managed care began to wane at the end 
of the twentieth century, flexibility began to re-emerge in managed care, which has re-introduced tra-
ditional supply and demand back into the health industry. As the popularity of point-of-service (POS), 
PPOs, and pay-for-performance (P4P) plans has grown, patients have been able to once again take a 
more active role as consumers in the healthcare marketplace.99 POS plans allow patients to use out-of-
plan specialty physicians for some services as long as they start with an in-plan primary care gatekeeper; 
PPOs allow patients to choose out-of-plan providers listed as preferred providers without the need for a 
gatekeeper.100
MCOs are beginning to push their way into smaller markets, offering broader provider networks in 
the process. There is nothing new about mergers in the managed-care arena—consolidation has grown 
steadily for years. However, industry analysts and investment bankers predict that 2005 saw several new 
trends emerge to help accelerate the kinds of mergers and acquisitions that have become commonplace 
in the managed-care marketplace.101 According to a recent AMA report, a single insurer dominates in 
most of the nation’s markets.102 In the combined HMO and PPO markets, 96 percent of metropolitan 
areas have few competing health insurers, with the dominant insurer having a market share of 30 per-
cent or greater.103 In 64 percent of the markets, the dominant insurer had a market share of 50 percent or 
greater.104
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public payors
Prior to 1983, Medicare and most private insurers reimbursed providers on a fee-for-service (FFS) basis, 
which paid hospitals and physicians based on the cost and the number of services they provided.105 
Beginning in 1983, however, CMS adopted the hospital Inpatient Prospective Payment System (IPPS) 
as a means of combating rising costs associated with FFS.106 The IPPS reimbursed hospitals based on 
the DRG of the patient’s diagnosis at the time he or she was discharged, which reflected the average 
cost treating patients in that DRG.107 By reimbursing hospitals at this fixed amount, the IPPS introduced 
a more competitive, market-like environment for hospital reimbursement and encouraged hospitals to 
reduce costs so that procedures remained profitable.108 Similarly, the hospital Outpatient Prospective 
Payment System (OPPS) was implemented in 2000 to accomplish the same competitive environment for 
outpatient procedures by reimbursing hospitals based on one of a number of Ambulatory Payment 
Classifications (APCs).109
consuMer-driven HealtHcare
The prevalence of third-party payors that deflect a substantial portion of the true cost of services away 
from the consumer (that is, the patient) is unique to the United States.110 However, the rise of consumer-
driven healthcare (CDHC) shows that healthcare markets may be shifting away from the traditional 
model and that the market distortion which arises out of the third-party payor system may be beginning 
to dissolve (see chapter 2, Consumer Driven Health Plans—The Shift From Demand Benefits to Defined 
Contributions). A significant competitive trend in health insurance is the rise of individual, high-pre-
mium insurance plans coupled with HSAs.111
However, the rise of Consumer-Driven Healthcare (CDHC) shows that 
healthcare markets may be shifting away from the traditional model and 
that the market distortion which arises out of the third-party payor system 
may be beginning to dissolve.
“Could U.S. Hospitals Go The Way Of U.S. Airlines?” by Stuart H. Altman, David Shactman, and Efrat Eilat, Health 
Affairs, Vol. 25, No. 1, (Jan/Feb 2006), p. 16.
CDHC is a growing trend based on neoclassical economic theory and studies that have shown that 
insured individuals with higher deductibles tend to purchase less healthcare services than do insured 
individuals with low deductibles.112 CDHC advocates the idea that consumers who pay for services 
directly are more likely to compare price to quality and demand higher-quality care, a theory which sup-
ports the use of HSAs coupled with HDHPs.113 Generally, HSAs are personalized accounts into which 
an individual contributes. An individual’s employer may contribute as well. The individual then may 
withdraw funds to cover healthcare expenses.114 HSAs put the purchasing power directly into the hands 
of the patient, who may use the tax-free funds to cover basic qualified medical expenses, including pre-
ventive care and over-the-counter drugs.115 HDHPs are then used in the traditional insurance context to 
pay the costs associated with catastrophic events like trauma and chronic disease.116
Although proponents of CDHC argue that the use of HSAs and HDHPs will promote better analysis 
of cost and quality at the point of service,117 skeptics argue that there is not enough evidence to dem-
onstrate that CDHC leads to better informed choices based on quality.118 Nonetheless, CDHC plans 
have the capacity to alter the traditional healthcare marketplace, which has become accustomed to the 
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third-party payor system. The mere existence of CDHPs may alter the healthcare industry landscape 
to look more like markets in other industries in which consumers make purchasing decisions and more 
carefully scrutinize what they receive for their money. Additionally, by making consumers more aware 
of the actual cost of procedures, this trend may affect the ability of hospitals to cross-subsidize for costly 
care.119
Barriers to Free Market Competition in  
Healthcare Delivery
Perfectly competitive markets exist only in economic theory. In reality, industries and markets have 
varying constraints on competition. The healthcare industry often has been characterized as unique in 
its many significant barriers to free market competition. Much of the inhibition from market controls on 
price and quality result from factors that can be expressed in three general categories:
• The nature of health creates an unpredictable, urgent, and infinite level of demand.
• The ubiquitous involvement of insurance, private and governmental, as an intermediary in the pur-
chase of healthcare interferes with consumer motivations and consequently their choice of provid-
ers and services.
• The difficulties in measuring healthcare quality and beneficial outcomes (both of quantifying and 
qualifying) and the lack of information on the relative costs of healthcare providers and services 
also inhibits consumer selection, further removing incentives to providers to increase quality and 
lower costs.
Included among the many barriers to competition in healthcare delivery are the following:
 1. Patients don’t purchase services directly from providers.
 2. Patients don’t compare prices between providers.
 3. The government is the largest purchaser of healthcare.
 4. Private purchasers often lack market power.
 5. Patients, purchasers, and providers lack information.
 6. Many providers have monopoly or near monopoly power (yet antitrust laws prevent some po-
tentially beneficial integration).
 7. Providers are rewarded for increasing costs.
 8. Capital investments are overly subsidized.
 9. Certificates of Need, regulation, and licensing laws are entry barriers to competing and substi-
tute providers and services.
10. Exit barriers protect low quality providers.
The government is the largest purchaser of healthcare services.
“The Next Antitrust Agenda: The American Antitrust Institute’s Transition Report on Competition Policy to the 
44th President of the United States,” by The American Antitrust Institute, Albert A. Foer, Ed., Vandeplas Publishing 
(2008), p. 344.
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The Application of Porter’s Five Forces to Hospitals and 
Physician Groups
Harvard Business School Professor Michael Porter is considered by many to be one of the world’s lead-
ing authorities on competitive strategy and international competitiveness. Porter argues that all busi-
nesses must respond to five competitive forces: (1) the threat of new market entrants, (2) the bargaining 
power of suppliers, (3) threats from substitute products or services, (4) the bargaining power of buyers, 
and (5) rivalry among existing firms.120 When attempting to understand competitors and select competi-
tive strategies, a review of these five forces may be useful to understand the underlying fundamentals of 
competition.121
Healthcare often is described as being different from other industries for a number of reasons  
including the
1. large role of governmental regulation and reimbursement,
2. seemingly limitless demand for healthcare,
3. necessity of having local providers,
4. removal of consumers from the direct purchasing decisions because of employer driven insur-
ance purchasing, and
5. difficulties in quantifying health and the quality and costs of care.
Yet these differences may be found individually in other industries, and, increasingly, the barriers 
to competition in healthcare are under pressure to be removed, diminished, or altered because of ris-
ing costs. Therefore, Porter’s five forces model may well be applicable to healthcare just like any other 
industry.122 Porter has further explored the value of his model as a process or framework for use when 
examining competition in healthcare.123
Porter’s model applies to a company operating within a given industry, therefore, it is necessary to 
define “healthcare industry,” which contains numerous subsets interacting with each other including, 
among others, hospitals, nursing homes, medical practices, home health agencies, sub-acute providers, 
ASCs, and urgent care centers. The totality of these facilities and providers along with the administra-
tors, equipment suppliers, pharmaceutical companies, and other support and managerial providers may 
be considered for this exercise in definition, because they share the common goal of maximizing human 
health. This is not an easily quantifiable outcome, but it can be viewed as the common denominator 
among all the factions in the healthcare industry, and advances are being made in the sciences of quality 
and outcomes research.
A hospital that does not acknowledge the local independent family medical practice or cardiology 
group as working in the same industry as a competitor (as well as a customer) may have missed the 
point. There is a complex relationship between the various subsets of the healthcare industry, and any 
competitive evaluation should assess this relationship from several different perspectives.
Porter recommends three generic strategies to out-perform competitors or maintain a market position 
against competition: (1) overall cost leadership, (2) differentiation, and (3) market niche or segmenta-
tion. Each of these is a strategy that has a different set of ethical consideration related to its application 
by healthcare providers in a care and treatment environment.124
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tHreat of new Market entrants
Historically, many hospitals and physicians have believed that there is a low risk (or even no risk) of 
new market competitors due to the entry barriers in their segments of the industry. Healthcare has been 
viewed as a localized industry because providers must personally administer services to their patients. In 
the current healthcare environment, however, new entrants do not necessarily compete within their local 
market. Advances in technology and communication, as well as the ability to recruit providers nation-
ally, are changing some aspects of the direct physician–patient relationship such that this emphasis on 
localized competitive markets is no longer universal or absolute. Traditionally, healthcare has differed 
from many industries because financial return does not always drive the decision process. However, the 
overall threat from evolving market entrants on a given healthcare industry sector may be related to the 
size of the financial return in that particular segment of the industry.
Rise of Niche Providers
The predominance in the market of limited-service providers, that is niche or specialty providers, has 
grown in recent years.125 The AHA broadly defines niche providers to include “heart hospitals, orthope-
dic hospitals, surgical hospitals, ASCs, cancer hospitals and centers, dialysis clinics, pain centers, imag-
ing centers, mammography centers, and a host of other narrowly focused providers.”126 The AHA does 
not include other types of specialty and niche services, such as trauma and intensive care, which require 
extensive specialization and are provided solely within the traditional inpatient community hospital 
setting. However, the definition of niche provider changes depending on who is attempting to classify 
this subjective and potentially broad range of limited-service providers. The definition may be expanded 
to include surgical hospitals, ASCs, specialty hospitals, and virtually all providers who provide a spe-
cialized service outside of a hospital setting. Alternately, the definition may be limited to only those 
providers treating patients with either a cardiac or orthopedic condition or those performing surgical 
procedures.127
Healthcare providers falling into the broad niche provider category focus on a section or group of 
buyers, a segment of a product line, or a specific area of a geographic market. The assumption is that 
by focusing on a narrow target, healthcare providers can provide value to customers more effectively 
than rivals who compete more broadly. The past decade has seen explosive growth in both inpatient and 
outpatient limited service providers, increasingly owned, at least in part, by the physicians who refer 
patients to them.
Boutique and Concierge Medicine
Concierge, or boutique, medical practices began in 1996 in Seattle and are now in several major metro-
politan areas. Concierge medical practices are concentrated principally on the East and West coasts, with 
most practices focused on providing primary care services.128 Concierge medicine is basically a return 
to old fashioned medicine, in which physicians limit their client base and devote more time to each 
patient (for more information, see chapter 2, Concierge Medicine, and chapters 1 and 2 of Professional 
Practices). Patients usually can see their physician within a day of requesting an appointment, and most 
have twenty-four-hour access to their physician by beeper or cell phone. Concierge medical practices 
typically charge patients an annual retainer fee, which provides for guaranteed, around-the-clock access 
to standard healthcare services, as well as increased access to personalized physician care.129 Physicians, 
tired of long hours, not having enough time with their patients, and dealing with overbooked caseloads, 
are turning to concierge medicine as a way of balancing their work and their life and providing quality 
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care for their patients.130 Patients who have physicians in this type of practice appreciate the perks re-
ceived in exchange for a yearly fee—similar to annual membership dues. These fees can range anywhere 
from $1,000 per year to $10,000 per year depending on the patient’s age, benefits received, area of the 
country, and type of practice.131 Amenities vary by practice, but some include more time with the physi-
cian (for example, a thirty-minute office visit), increased access to physicians, newsletters or condition-
specific information sent by e-mail, accompaniment on medical visits to outside specialists, and house 
calls.132
Although concierge medicine may provide many benefits for patients, including more and in some 
cases, nearly unlimited access to their physicians, it has been met with some scrutiny. Some say that this 
type of medicine is elitist—that it is available only to wealthy patients who can pay the annual fees.133 
However, many physicians report that the bulk of their clients are middle-income people who are will-
ing to pay more for this kind of care.134 Boutique medicine is not a substitution for traditional insurance. 
Patients typically will keep their traditional health insurance to pay for any tests or scans ordered by the 
concierge physician.135 Medicare beneficiaries cannot be charged more than 115 percent of the rate for 
services, and many politicians have said that the annual fee requirement is significantly greater than the 
Medicare rate and, consequently, is illegal billing.136
Certificate of Need
A Certificate of Need (CON) program is one in which government determines where, when, and how 
capital expenditures will be made for public healthcare facilities and major equipment.137 By their very 
nature, CON programs are anticompetitive, a principle that serves as, de minimis, part of the rationale 
for the inception of CON programs, in response to concern that market forces were not adequate to 
prevent providers from overinvesting in equipment and facilities and, as a result, driving-up the cost of 
healthcare.138 CON is based on the theory that, in an unregulated market, healthcare providers will utilize 
the most up-to-date, costly technology and equipment, regardless of duplication or need.139 However, 
various shifts in the healthcare industry in the years since CON legislation (see Certificate of Need 
(CON)) was introduced have fueled disputes against the implementation of CON programs in order to 
avoid excess capacity.140
A central argument against CON regulatory policy is that intervention disrupts the natural market 
forces and is significantly anticompetitive. As a result, CON often serves as a barrier to new market 
entrants and has been viewed by many healthcare economists as a strong disincentive to the introduction 
of potentially advantageous innovations and technologies. In any industry, the underlying dynamic is the 
same, and competition compels companies to deliver increasing value to customers.141 The fundamen-
tal driver of this effort in continuous quality improvement and cost reduction is innovation.142 Without 
incentives to sustain innovation in healthcare, short-term cost savings soon will be overwhelmed by the 
desire to widen access to care, the growing health needs of an aging population, and a perceived resis-
tance to receiving care that may be anything less than the best treatments available.143 Inevitably, the 
failure to promote innovation will lead to lower quality or more rationing of care—two results viewed as 
equally undesirable.144
This bears semblance to the continuing consensus among health economic analysts that competi-
tion between providers drives patient quality of care and beneficial outcome, as well as a force for cost 
efficiency. Hospitals in more competitive markets have exhibited lower levels of spending on average 
than hospitals found in less competitive markets.145 Healthy competition appears to offer patients and 
payors a means of economic leverage by creating choices for consumers and raising quality standards as 
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providers compete for patient loyalty. When patient choice is diminished, decisions about access, qual-
ity, and beneficial outcomes become the sole purview of oligopoly market players that, as decision mak-
ers acting in the absence of healthy competition, are free to ignore patient demands and needs.
In markets that are competitive, attempts to promote the implementation of CON legislation are per-
ceived as a notable shift from its original purpose of supporting competition by preventing overinvest-
ment in healthcare facilities.146 Most notably, proponents of CON programs argue that CON legislation 
may prevent healthcare markets from becoming oversaturated with ASCs and other specialty hospitals; 
this is a position that has helped community hospitals use the regulatory environment in their campaign 
against POFs.147
For now, the federal specialty hospital moratorium (see Campaign Against Physician Ownership) 
has ended, and many states are moving forward with their own initiatives to prevent market entry of 
POFs through state CON regulations.148 In light of continued evidence refuting the efficacy of CON 
legislation in reducing healthcare costs, arguments are now being made to support the use of CON in 
preventing physician self-referral and continuing the viability of community hospitals’ charity care 
policies.149
Rise of Urgent Care Walk-In Clinics
Urgent care centers are becoming increasingly popular in the United States. Acute care patients, tired 
of the progressively longer waits for appointments with primary care physicians or for emergency room 
services, are attracted to the convenience of urgent care centers (for example, the extended hours, the 
availability of walk-in appointments, etc.).150 With the supply of primary care physicians projected to 
dwindle during the next two decades, combined with many family physicians declining to accept new 
Medicare FFS patients and fewer emergency departments nationally, urgent care utilization may con-
tinue to rise.151 However, research remains unclear regarding the impact of urgent care centers on cost, 
quality, and access to care.152
Medical Tourism
Another competitive force in the healthcare industry is the growing incidence of medical tourism. Medi-
cal tourism is the practice of patients traveling to countries, such as India, Thailand, or any number of 
other countries, to receive medical procedures at a fraction of what they may cost in the United States.153 
By avoiding structural, regulatory, and legal barriers that are present in the United States, foreign hospi-
tals may be freer to innovate in ways that potentially can decrease the cost of many procedures.154 Gener-
ally, these procedures are performed by skilled physicians, who sometimes trained in the United States, 
who may employ the latest technology with a risk of infection and mortality no higher than in the United 
States.155 This trend demonstrates how globalization has reached the healthcare industry, and, as with 
globalization in other sectors, it could mean that new competition for domestic suppliers is worldwide.
tHe bargaining power of suppliers
Healthcare suppliers are primarily professional services providers but can also include anyone or any-
thing involved in the provision of improved quality patient care. Physicians are, in this sense, suppliers 
(as long as they are not employees of the organization in which they practice).156 Other suppliers may in-
clude such entities, including medical supply companies, pharmaceutical companies, and outsourcers.157 
Suppliers may have the potential to affect healthcare professional practices if they are able to influence 
practice spending.158 Healthcare supplier prices often are controlled or influenced by government fee 
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schedules for reimbursing certain products or services.159 The bargaining power of suppliers is subject to 
increasing regulatory and reimbursement pressures. Healthcare is different from other industries in that 
the suppliers are often also the customers, as in hospital–physician relationships.160
Hospital Suppliers
The thrust of the campaign by community hospitals against specialty and niche providers is the desire 
to maintain monopoly or oligopoly power in the marketplace, as hospital consolidation continues to 
bolster the bargaining position of hospitals vis-à-vis insurers.161 This position is supported by the argu-
ment that monopolistic hospitals may use that power to (1) maintain access for those who need it, (2) 
cross-subsidize uninsured patients and expensive procedures, and (3) maintain high quality standards 
through the intake of steady patient volumes.162 Although community hospitals may need a substantial 
volume of patients to be able to make up the cost of money-losing procedures and patients, the separa-
tion between payor and consumer in the healthcare market also allows hospitals to use their monopoly 
power to set prices above what a monopoly might be able to charge in other markets.163 In a marketplace 
in which elasticity of demand already is inhibited by necessity in many cases, the presence of insurance 
companies acts as a buffer between supplier and consumer and allows the supplier (that is, the hospital) 
to charge the insurer high prices that have no direct impact on the consumer.164
Physician or Provider Suppliers
In contrast to hospitals, the impact of physician providers on the healthcare competitive market contin-
ues to diminish due to regulatory (see chapter 3, Regulatory Environment) and reimbursement (see chap-
ter 2, Reimbursement Environment) restraints, which include payment bundling, physician restrictions 
regarding group ventures under antitrust laws, and the decline of the primary care physician with the rise 
in MCOs and specialties.
The first reason for the declining effect of physician providers, is that “bundling” is a fairly new 
method of payment promoted by CMS (see chapter 2, Payment Bundling). Bundled payments change 
the way doctors and hospitals are reimbursed by Medicare; the FFS system would allocate two sepa-
rate payments: one to the hospital for treating a patient and one to the physicians for their relative value 
units.165 Using the bundled payment system, Medicare would allocate one payment to be split between 
the hospital and the physicians for services rendered.166
Although, in theory, bundled payments should improve the quality of care and streamline the re-
imbursement process by eliminating charges for unnecessary services, there is some backlash among 
physicians, mainly because hospitals would be determining how they get paid. For example, special-
ists could be compensated more favorably than primary care doctors.167 In a 2009 letter to the Senate 
Finance Committee, the AHA voiced concerns, stating that the “bundling of hospital and post-acute 
payments is problematic” and “(p)roposals to bundle Medicare payments for general acute hospital and 
post-acute care (PAC) services call for a paradigm shift in health service delivery.”168 The AMA com-
mented in a 2008 letter to the Committee on Ways and Means, stating that “bundling payments provides 
more incentives for efficient care but also carries the risk that appropriate services are withheld or lim-
ited.”169 The concerned parties agree bundling needs to be tested in many different venues and contexts 
before a reliable system can be managed.
Another reason for the waning physician provider impact is the many antitrust laws restricting physi-
cians from joining together in groups such as IPAs. By definition, an IPA is a “legal entity organized 
and directed by physicians in private practice to negotiate contracts with insurance companies on their 
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behalf.”170 Although advantageous because they perform a variety of services for the medical practice, 
including negotiating contracts, organizing the delivery of care, and disbursing payments to physicians, 
IPAs have been attacked by antitrust legislation.171 For example, a violation of Section One of the Sher-
man Antitrust Act could involve one of three things: (1) “an agreement between two or more indepen-
dent physician practices regarding prices for medical services;” (2) “an agreement among two or more 
independent physician practices regarding patients they will treat and services they will offer;” or (3) 
“two or more independent physician practices agreeing not to deal with a particular competitor, health-
care entity, or managed care plan.”172 Because of these restrictions, some IPAs have violated antitrust 
laws.173 As physician influence within independent or group practices exceeds that of physicians within 
organizations, the decline of the IPAs due to antitrust law has damaged their impact in the healthcare 
market.
The final reason for the drop in physician provider influence on the healthcare competitive market-
place is the decline of the primary care doctor due to the rise of MCOs and the emphasis on specialties. 
In a seminal 1994 report by the AMA, the organization indicated that enrollment in managed care plans 
had jumped from 12.5 million people in 1983 to 45 million ten years later.174 In conjunction with this 
finding, the AMA found that between 1986 and 1993, “the proportion of US medical school graduates 
matched to residencies in one of three potential generalist streams (internal medicine, pediatrics, and 
family medicine) declined from 52 percent to 38 percent, and the majority of those in internal medicine 
and pediatrics became subspecialists.”175 Statistics from 2008 by the Association of American Medical 
Colleges suggest that this trend continues, “with the supply of primary care physicians that many already 
believe to be insufficient are likely to intensify as demand outpaces supply faster for primary care than 
any of the specialty groups.”176 The decline in general surgeons is no different. The promise of better 
working hours, less on-call time, and less involvement in the business end of the practice have attracted 
more students to specialties.177 Notably, 70 percent of graduating surgical residents chose specialized 
instead of general surgery in 2007.178
As such, instead of building relationships with patients and focusing on preventative care, many doc-
tors are now opting for the specialty track. Growing disparities in compensation likely affect this trend. 
A 2006 study showed primary care physicians at the bottom of the physician pay scale, making almost 
$300,000 less per year than radiologists—the highest paid specialty—in 2004.179 However, a 2005 study 
by Barbara Starfield et al. indicated that a “greater supply of family physicians is associated with an 
earlier detection of breast cancer, colon cancer, cervical cancer, and melanoma.”180 The study also found 
that primary care physicians were better at managing health problems before the problems became seri-
ous enough to require hospitalization.181
Hospital System and Physician Practice Realignment
Due to economic incentives and changing legislation regarding competition, hospitals and physicians 
have increased their collaboration both through employment and joint ventures.
Hospital Acquisition of Physician Practices
Recently, hospitals have returned to the 1990s trend of directly employing physicians and increasingly 
competing for physicians’ time and loyalty. As more physician-owned specialty hospitals open, this 
allows a growing number of physicians to refuse on-call emergency room duties and other traditional 
medical staff responsibilities.182 Although hospitals mainly employed primary care physicians during the 
1990s, the recent employment trend has seen a rise in the number of specialists employed by hospitals.183
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Joint Ventures Between Community Hospitals and Niche Providers
In an attempt to strengthen relationships and align economic incentives to enhance market position 
and financial success between physicians and hospitals, many specialty providers, such as orthopedic 
surgeons, are entering into joint ventures with one another.184 As competition for technical component 
revenue streams between physicians and hospitals remains intense, new forms of joint ventures and 
revenue-sharing options are developing in an attempt to repair their recently contemptuous relationship 
and to offer patients increased quality services and access.185 “Ambulatory surgery centers and imaging 
centers are the most popular hospital–physician enterprises founding our communities. Threatened with 
potential loss of volume, hospitals have found innovative ways to share income streams with specialists 
that comply with Stark laws or other regulations.”186 Several key factors play a role in the growth of joint 
ventures between hospitals and physicians. As mentioned previously, in the past twenty years, physician 
incomes have decreased due to managed care and government reimbursement constraints. Consequently, 
many physicians have found hospital investments to be an enticing opportunity to supplement decreas-
ing income.187 The economic benefits of a physician and hospital joint venture, including the develop-
ment of ASC joint ventures, are significant. Collaboration between physicians and hospitals creates an 
economy of scale not achieved if each continued to operate independently, thereby increasing hospital 
and health system interest.188 Some hospital executives believe joint ventures with physicians increase 
their facility’s quality of service, leading to increased profit for their hospital.189
According to Jay Klarsfeld, M.D., many advantages exist to a hospital–physician joint venture.190 
Hospitals make most of their money from inpatient services, and opening a separate outpatient surgery 
center often is not economically feasible; because ASCs perform outpatient procedures economically 
and safely, it behooves hospitals to form business relationships with physician-owners. When these hos-
pitals send patients to their new surgery center affiliates, they share in the profit.191 Additionally, when 
physicians have pull in the design process and ownership of an outpatient facility, things run smoother 
and more efficiently.192 Studies have shown that when, “physicians have an economic stake [they] show 
up on time, don’t waste minutes in the OR, and make smarter purchasing decisions.”193 Physicians have 
advantages as well. Most hospitals have a reputation in the community as being safe and reliable, and 
the physician-owner shares this good reputation in a joint venture, making his or her ASC more cred-
ible.194 These physicians also gain exposure to hospital vendors, and association with hospitals can be 
helpful in purchasing.195
tHreats froM substitute products or services
Nontraditional healthcare providers increasingly are competing with their traditional counterparts. 
Nontraditional providers, such as chiropractors, have taken a larger market share, and some healthcare 
systems and MCOs have embraced the changes in patient preferences and developed networks of these 
providers. Technology has fueled the entry of new competitors in many other industries, and health-
care is no exception. Patients searching for medical advice on the Internet is a trend that the industry 
must consider. With advances in medical imaging communication, technology groups of radiologists in 
remote locations can outsource x-ray film readings for hospitals at lower prices (see chapter 5, Telemedi-
cine and Telehealth). The role of the pharmacy and pharmacist is changing and may become a threat to 
some portion of the service, advice, or monitoring business of medical offices. Competition can come in 
many forms and affect many subsets of healthcare services. Planning and analyzing potential substitute 
products and services requires creative thinking as well as in-depth, substantive research.
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One of the primary differences between the healthcare industry and other industries in regard to 
substitute products and services may well be the regulation of medical professionals, treatments, and 
drugs that may delay or prohibit substitutes. The regulation, therefore, stymies innovation—previously 
discussed as the fundamental driver of quality improvement and the underlying dynamic of a company’s 
ability to compete.
“Purple Pill”
Increasingly, drugs serve as alternative treatment options, and often at a lower cost, reducing hospital 
stays or need for costly surgeries or procedures. For example, the introduction of the Purple Pill revo-
lutionized the treatment of bleeding ulcer patients. Administering a proton-pump inhibitor like Prilosec 
(omeprazole) prior to endoscopy stopped patients’ bleeding faster than patients who took a placebo, 
thereby reducing both the need for surgery and the length of hospital stays.196
Battle Lines Among Providers
Competition exists not only among hospitals and physician-owned facilities but also among different 
types of providers (for example, ophthalmologists versus optometrists; anesthesiologists versus Certified 
Registered Nurse Anesthetists, obstetricians and gynecologists versus certified nurse midwives). As dis-
cussed in chapter 6 of Professional Practices, physician suppliers compete with allied health profession-
als for the provision of many primary care services. Similarly, as discussed in chapter 4 of Professional 
Practices, physicians also are experiencing competition from mid-level providers whose ability to prac-
tice without the supervision of a physician is growing due to less stringent regulations in certain states. 
For example, nurse practitioners (NPs) are capable of obtaining their own Medicare provider numbers, 
which allows them to bill Medicare directly for services provided without the need for a supervising 
physician.197 This ability has resulted in a growing number of nurse practitioners who provide primary 
care services to patients who never actually see a physician until they need services which are beyond an 
NP’s capability.198
One of the most prevalent areas of competition is related to providers of imaging services. The is-
sue of in-office ancillary imaging pits radiologists against other physicians. Radiologists continue to 
face increased competition from referring physicians.199 A study funded by the Radiological Society of 
North America in 2004 claimed that self-referral lead to increased utilization of diagnostic imaging.200 
The study recommended that the radiologist professional community lobby the federal government to 
enact regulations making self-referrals more difficult. According to the chief researcher, Dr. David C. 
Levin, “[o]rthopedic surgeons really don’t belong in the business of owning MR [magnetic imaging] 
scanners.”201
The result of such efforts was reflected in the passage of the Medicare Improvements for Patients 
and Providers Act of 2008 (MIPPA).202 After the American College of Radiology announced plans to 
lobby for legislation requiring Medicare to define standards for physicians performing diagnostic imag-
ing, and the Medicare Payment Advisory Commission (MedPAC) staff members stated “it’s important 
for CMS to set national standards for each imaging modality . . . ,” Congress included in the MIPPA 
a provision requiring accreditation of physicians who provide the technical component for advanced 
diagnostic imaging services (for example, magnetic resonance imaging, computed tomography, and 
nuclear medicine or single photon emission computed tomography) for which payment is made under 
the Medicare physician fee schedule.203 After the secretary of the Department of Health and Human Ser-
vices (HHS) designates accreditation organizations in 2010, all suppliers of the technical component of 
advanced diagnostic imaging services will need to be accredited by January 2012.204
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tHe bargaining power of buyers
Most healthcare services are paid for by insurance, whether private or governmental. Most private health 
insurance is purchased through employers that, to a great degree, make most of the buying decisions. 
Employer coalitions have emerged, but most command leverage on price rather than quality or value. 
This often leaves healthcare providers as the only advocates for consumers, because buyers are not. Cor-
porate buyers have asserted substantial, if disproportionate, influence over healthcare companies but not 
necessarily always in the best interests of the consumers or the community at large.
Recently, however, payors have begun to shift toward P4P plans that assess certain performance out-
comes and offer financial incentives to providers that attain them (see chapter 2, Pay-For-Performance 
(P4P)). P4P programs have been shown to improve quality of care,205 and by offering financial incen-
tives to providers, P4P also will allow consumers to recognize quality of care when making choices for 
provision of services.206
Power of the Insurance Lobby
The rise of antitrust law in the healthcare marketplace indirectly has led to support of insurance compa-
nies’ preferences by the courts. As agents for the consumers protected under the laws (that is, patients), 
insurance companies have emerged as the dominant force in articulating competitive preferences for 
price and quality. Courts have deemed insurance providers to be the best voice for the needs of con-
sumer patients, and, therefore, have overlooked the traditional competitive transgressions of insurance 
companies (that is, selective contracts with health professionals or onerous contractual requirements on 
network providers).207
Further adding to the power of the industry, insurance companies as an industry sector have enjoyed 
an exemption from federal antitrust laws since 1945. The McCarran-Ferguson Act limits federal scrutiny 
of insurers and places states in primary control of antitrust enforcement.208 State legislation is preserved 
in the bill, but whether states are powerful enough to prevent insurance companies from engaging in 
price fixing, bid rigging, and market allocations, deterring competition, and impairing consumers has 
been questioned.209
Power of Medicare and Other Public Payors
The government is the country’s largest third-party payor. Through programs like Medicare, Medicaid, 
and TRICARE, it exerts one of the most influential competitive forces in the health insurance industry. 
As the largest national purchaser of health services, the government exerts influence over not only the 
public delivery of health services but also over the private sector.210 Many private insurers negotiate their 
own arrangements with providers, but some private third-party payors base their arrangements on the 
Medicare payment systems or use those systems as a starting point for negotiations.211
Medicare’s influence on competition in certain sectors is limited, however. Under the MMA, the 
secretary of HHS is prohibited from negotiating drug prices with pharmaceutical manufacturers under 
Medicare Part D, a prohibition which also inhibits free market competition in healthcare.212 Instead, 
negotiations are undertaken by private insurers and Pharmacy Benefit Managers (PBMs) that then offer 
prices they obtain through those negotiations to Medicare beneficiaries.213 Under this system, the Medi-
care program is unable to use its power as, what would be, the largest purchaser of prescription drugs, to 
bring the cost of such drugs down.214 Proponents of the noninterference provision argue, however, that 
it prevents the federal government, which is motivated by taxpayers, voters, and Medicare beneficiaries 
alike, monopsony power to affect the price of prescription drugs, consequently stifling the ability of 
pharmaceutical companies to earn the profits that allow them to develop new drugs.215
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rivalry aMongst existing firMs
Integrated physician organizations and other types of emerging healthcare organizations (EHOs) may be 
viewed as new market entrants or simply as a reorganization of existing providers in order to better com-
pete. Provider organization and EHO volumes have grown significantly through integration, consolida-
tion, and mergers, but, in many ways, their effectiveness as competitors is still uncertain. The collapse of 
PPMCs, poor performance of hospital managed physician practices [including physician-hospital orga-
nizations (PHOs)], the failure of capitated groups and IPAs in California, and the current trend toward 
divestiture of acquired practices would seem to indicate that EHOs have not been effective competitors. 
Nonetheless, a strong argument could be made that the competitive forces that led to the formation of 
these integrated organizations still exist and that these initial failures have more to do with mismanage-
ment and poor planning than the concept of physician integration itself (see chapter 2 of Professional 
Practices).
Integration, affiliation, and collaboration among providers may, in some cases, be viewed as a means 
of circumventing competition, unless the clinical benefits to patients can be demonstrated. Because 
the overarching mission of the healthcare delivery system is inherently human value-based, it is often 
deemed to be in conflict with the economic and financial goals of healthcare organizations, especially 
in the for-profit arena, as well as incompatible with the competitive forces that have been successful 
in other industries. These differences in basic values and their expression between businesses in other 
industries, as well as the various existing organizations in healthcare, are deeply rooted and important to 
understand in assessing the impact of rivalry on the potential for competition to succeed in stimulating 
quality and efficiency.
Antitrust Issues
Antitrust law traditionally has been used to combat anticompetitive behavior arising from professional- 
and payer-imposed barriers to competition, as well as against consolidations (either by collaboration or 
merger) by provider groups and health systems.216 However, at the beginning of this decade, strict anti-
trust enforcement in the healthcare sector tended to shift away from providers and toward pharmaceu-
ticals in a larger shift away from strict application of antitrust law to the healthcare sector generally.217 
During that timeframe, antitrust jurisprudence began to shift to a significantly increased level of judicial 
deference to professionalism in health market transactions, which chilled the ability of federal antitrust 
authorities to bring effective enforcement actions against violators.218 Additionally, federal enforcement 
agencies generally won cases against hospital mergers between the mid-1980s and the mid-1990s; those 
agencies lost all the hospital merger cases brought in federal court between 1995 and 2001.219 During 
this timeframe, courts tended to take a purely economic look at elements of antitrust decisions, such as 
a provider’s market share and price, ignoring other elements germane to healthcare, such as patients’ 
personal and logistical considerations when choosing a provider.220
Promulgated by recent healthcare reform efforts, the Federal Trade Commission (FTC) and Depart-
ment of Justice (DOJ) have expressed renewed concern regarding the adequacy of existing standards for 
horizontal mergers, maintaining that fortified measures of antitrust enforcement are crucial to cutting 
costs and improving quality of healthcare.221 Most recently, the DOJ and FTC have focused their efforts 
on evaluating the affect of horizontal consolidation of certain healthcare organizations (for example, 
pharmaceutical giants, payors, outpatient clinics, and hospitals) to determine whether their respective 
market sectors experience a decrease in competition as a result.222
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As legislators continue to focus on reducing the cost of healthcare while improving quality and ac-
cess, antitrust enforcement is likely to take on a larger role in the healthcare sector. With the promotion 
of a public option as part of healthcare reform legislation, more focus has been placed on the benefits of 
competition in the healthcare insurance marketplace, and the proposed repeal of the McCarran-Ferguson 
Act (see Power of the Insurance Lobby) demonstrates how legislators will continue work to improve 
competition throughout the healthcare industry in an effort to reduce costs and improve quality.223
The FTC and DOJ have taken special interest in the impact of hospital consolidation on market com-
petition. Most research conducted to date suggests a potential correlation between hospital consolidation 
and higher prices for hospital services; the magnitude of price increase estimated by these studies ranges 
from 5 percent to greater than 50 percent.224 While some dispute exists on the impact of consolidation on 
quality of care, studies utilizing methods perceived to be robust tend to show a reduced level of qual-
ity.225 Surmising a sudden surge of hospital consolidation as a result of impending reform initiatives 
and continued technological growth, the FTC and DOJ may heighten the stringency of regulations and 
guidelines in order to ensure competitive veracity within the hospital sector.226
clinical integration
One area of antitrust enforcement that did not suffer as significant a decline toward the beginning of the 
new millennium involves collective actions by healthcare professionals that thwart competition and vio-
late Section 1 of the Sherman Antitrust Act, which prohibits agreements between competitors in restraint 
of trade.227 Commonly taking the form of IPAs and PHOs that wish to clinically integrate, these cartels 
generally are found to violate antitrust laws. In the wake of two FTC advisory opinions favorable toward 
clinical integration, however, it is likely that IPAs and PHOs will see a resurgence the near future.
Clinical integration among provider networks traditionally has been scrutinized by the FTC as  
generally being anticompetitive and in violation of antitrust laws. Part of the reason for this is that 
provider networks typically involve competing providers that agree to fix prices between them. Such 
practices are per se unlawful under antitrust law.228 However, since the 2002 FTC Advisory Opinion for 
MedSouth229 and the 2007 Advisory Opinion for the Greater Rochester Independent Practice Association 
Inc. (GRIPA), it has now become clear that clinical integration is not necessarily considered to be a per 
se violation of antitrust regulations.230 If the subject transaction is not deemed to be a per se violation, 
the FTC reviews joint contracting arrangements under a rule of reason analysis, determining whether the 
arrangement would actually lead to procompetitive outcomes. The benefits of clinical integration are that 
it allows a network of competing providers to participate in both joint-pricing and risk sharing, therefore 
leading to improved efficiency that will benefit consumers.231
It is important to note, however, that the MedSouth and GRIPA opinions do not mean that all clini-
cal integration programs will be approved by antitrust enforcement agencies. In fact, more recently than 
GRIPA, an FTC decision striking down a clinical integration program in Texas from 2005 was affirmed 
by the Fifth Circuit Court of Appeals in 2008.232 When analyzing any clinical integration scheme, the 
FTC will first ask whether the proposed collaboration offers the potential for proconsumer cost savings 
or qualitative improvements in the provision of healthcare services, and then ask whether any price or 
other agreements exist among participants, in particular the terms on which they will deal with health-
care insurers, and if the terms are reasonably necessary to achieve those benefits.233 If both questions are 
answered affirmatively, only then will the FTC consider the procompetitive and anticompetitive effects 
of the collaboration.234 At that point, “as long as such collaborations cannot exercise market power, they 
are unlikely to raise significant antitrust concerns, precisely because they have the potential to benefit, 
not harm, consumers.”235
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Above all, it is important to note that the antitrust enforcement agencies support precompetitive 
clinical integration of provider networks as a means of increasing efficiency and reducing costs, espe-
cially in an environment where these two objectives are part of the overall goals of healthcare reform. 
Collaborations among providers often implement efficiency-producing tools, such as electronic health 
records, and collaboration among clinicians to create guidelines, measure performance, and develop 
remedial measures and consequences for failure to meet those guidelines.236
Antitrust enforcement agencies also will continue to carefully scrutinize hospital mergers to ensure 
that no one hospital gains enough market share such that patients are deprived of choices, and that the 
hospital is able to increase prices to both patients and insurers.237
Healthcare Reform and Its Effect on Competition
The fundamental debate that historically has impeded healthcare reform efforts has centered on the costs 
associated with providing universal, comprehensive care. In light of twenty-first-century healthcare 
reform, this debate has led to competition for the overall healthcare dollar, that is, there is only so much 
money to go around, and everyone in the industry is vying for it. As demonstrated in this chapter, the 
power of the insurance companies, pharmaceutical companies, and hospitals has subjugated the power 
of the independent physician or provider such that providers are no longer operating on a level playing 
field.
It is not an exercise in paranoia to view the overall effect of the attacks on physician ownership as 
being aimed not only at rolling back the calendar to an earlier time but also an attempt to severely dimin-
ish the overall role and status of physicians in the delivery of care continuum. This profoundly concern-
ing onslaught against the professional stature and economic interests of physicians arises not only from 
hospital and insurance industry advocacy campaigns but even from widely cited purported supporters of 
physician independence, such as Harvard Professor (and former New England Journal of Medicine edi-
tor), Arnold S. Relman, MD (see chapter 1, Historical Development).238
From the perspective of many, the inevitable outcome of these efforts at placing additional restric-
tions on physician independence will be to these professionals and their practice of medicine, to the 
status of, at best, the healthcare equivalent of sharecropping, and, at worst (per Relman), the status of 
hired help. This begs the question whether physicians and their patients, who have benefited from inde-
pendent physician ownership of ASTC enterprises, will now acquiesce to being “kept down on the farm” 
or whether they either can or will resist the forces arrayed against them.
Reform of the Insurance and Pharmaceutical Industries
insurance industry
In the past ten years, there have been more than 400 health insurer mergers, which have resulted in a 
highly consolidated market and negative consequences for consumers.239 Part of the reason for this con-
solidation is that there have only been two cases in the past seven years in which the DOJ has required 
the restructuring of a merger agreement between two insurers.240 The prevalence of these mergers with-
out a strong enforcement of antitrust law has permitted a variety of anticompetitive behavior by major 
insurers, resulting in higher costs (whether from higher premiums, deductibles or co-pays), compro-
mised patient care, and a record high level of uninsured Americans.241
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In order to reverse the trend of insurer consolidation, healthcare reform proposals are likely to in-
clude provisions for identifying exclusionary conduct by insurers. As some critics blame the ability of 
insurers to consolidate (and the resulting monopoly/monopsony power enjoyed by large firms) on the 
federal antitrust exemption for insurance companies contained in the McCarran-Ferguson Act, reform 
initiatives have suggested a repeal of the exemption.242 Although the act exempts all types of insurance 
providers, the application of the act to the healthcare industry has drawn particular criticism from the 
DOJ and lawmakers, both of which claim that the exemption has led to anticompetitive behavior that has 
resulted in higher healthcare costs to both providers and patients.243
Reform efforts aimed at repealing this exemption are part of the current healthcare reform agenda,244 
but proponents of the exemption argue that states have done a good job to prevent anticompetitive 
behavior by insurers, and that there is no conclusive evidence that such repeal will have any positive 
impact on the insurance industry.245 Legislators in support of the repeal were motivated by soaring insur-
ance costs and an increasing number of uninsured Americans, however, they noted that the repeal signi-
fied the first step in a continuing evaluation of the antitrust system.246 Beyond the repeal of the insurance 
company exemption, such legislation demonstrates the beginning of potential widespread impact of 
health reform on antitrust enforcement, particularly when a single-payor system is the end goal of many.
pHarMaceutical industry
Related to the insurance industry is the constantly maturing PBM industry. This area of the healthcare 
industry has grown as consumer use of pharmaceutical drugs has grown and insurers have worked phar-
macy benefits into their plans.247 Forty to fifty PBMs exist around the country, and some insurers manage 
pharmacy benefits internally, however, only three major national PBMs are in operation, so careful at-
tention to ensuring fair competition in this industry is important as more and more healthcare spending is 
devoted to pharmaceuticals.248 Specific competition concerns include the impact of factors such as PBM 
pricing, generic substitution, therapeutic interchange, and repackaging practices, in addition to industry 
practices such as PBM ownership of mail-order pharmacies.249
It should be noted, however, that recent reform efforts have addressed the possibility of removing 
the noninterference provision, discussed previously from the MMA, which would result in granting the 
secretary of HHS the ability to negotiate directly with pharmaceutical companies.250 In such an event, the 
market power of PBMs may cease to be a threat to healthcare competition.
Commoditization of Healthcare
Payment for healthcare services has evolved over time, starting with the implementation of Medicare 
in 1965 under a FFS paradigm, followed by the creation of the prospective payment system (PPS) for 
hospital and physician services through the 1980s and 1990s, to the current framework based on bundled 
payments that combines institutional and professional charges, or inpatient and post-discharge fees, 
into a single payment.251 Beginning with the implementation of the PPS, whereby patients are classified 
into DRGs based on the average cost of services for a particular diagnosis, healthcare services are now 
bought and sold based on homogenous units of payment.252 Even MedPAC’s Payment Basics publica-
tions discuss Medicare reimbursement under the heading of “the products that Medicare buys.”253
With the recent focus on bundling, hospitals are incentivized to provide the appropriate amount of 
care to make the procedure cost-effective, rather than the appropriate amount of care to treat the pa-
tient’s condition.254 Similar to how healthcare evolved under capitation systems, hospitals will receive 
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payments based on a charge per episode of care methodology, which the hospitals will then distribute to 
physicians and other providers within the hospital who provided care for that patient.255 The charge-per 
system places the focus on the amount of money a hospital will receive for a given diagnosis and will 
place the focus on reducing services to save money as well as incentivize hospitals to hire physicians 
who are not as expensive (that is, not as well qualified) in order that the hospital facility may retain as 
much of the payment as possible.256
Further evidence of the commoditization of the American healthcare system is reflected in the pres-
ence of a marketplace for durable medical equipment (DME), whereby DME manufacturers submit 
competing bids to Medicare based on the charge per unit, the lowest of which is then chosen to be the 
only Medicare provider of DME in ten different metropolitan areas.257 The competitive bidding program 
was implemented in 2008, but an eighteen-month moratorium was then placed on it under MIPPA in 
response to pressure from DME suppliers that claimed that the program would lower quality of care 
and reduce access.258 Set to relaunch in 2010, the DME competitive bidding program demonstrates how 
competition has influenced the healthcare industry by turning healthcare into a commodity that can be 
freely bought and sold.
Conclusion
The healthcare professional practice, while still a business, has been buffered from the full onslaught 
of commercialism, including the ever-present attraction of competition. Whether to control quality or 
cost, outside forces have regulated competitive forces within the healthcare industry. Supported by the 
provider shortage increased population demands (that is, the baby boomers) regulations of the scope of 
mid-level providers have been lessening. This, along with a staining economy, causing physicians to 
expand the services they offer, is creating an overlap of services, which will likely continue to increase 
fueling the emergence of new competitors in the healthcare market. In addition, the rise in consumer 
driven healthcare will continue to change the way in which healthcare professional practice, as a busi-
ness, is run, further removing the buffer between healthcare and pure commercialism. As the impact of 
competitive forces rises, in response to a changing system, government regulations will also adapt to the 
new healthcare environment.
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5 Technology 
Development
In these days when science is clearly in the saddle and when our 
knowledge of disease is consequently advancing at a breathless 
pace, we are apt to forget that not all can ride and that he also 
serves who waits and who applies what the horseman discovers.
Harvey Williams Cushing, 1926
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Key Concept Definition Source Location
Rural Health Care Pilot Program Created by the Federal Communications Commission to 
increase patient access to telemedicine and support the 
transfer of EMRs. Sixty-seven nationwide projects in forty-
two states and 6,000 health facilities are eligible for the 
$417 million in grants under the program. 
“FCC Update on Rural Healthcare Pilot Program Initiative,” 
by Federal Communications Commission, April 16, 2009, 
fcc.gov/Daily_Releases/Daily_Business/2009/db0416/
DOC-290141A1.pdf. (Last Accessed July 14, 2009).
The Medicare Telehealth 
Enhancement Act (HR 2068) 
Provided $30 million in grants to health facilities to pay 
for telehealth equipment and expand telehealth support 
services. Also expected to address Joint Commission 
of Accreditation of Healthcare Organizations (JCAHO) 
and Centers for Medicare and Medicaid Services (CMS) 
credentialing issues.
“Medicare Telehealth Enhancement Act of 2009”, 111th 
Congress, Bill H.R. 2068, introduced April 23, 2009; 
“Telemedicine Boosts Access to Needed Care” By Robert 
J. Waters, Roll Call, sponsored by Congress.org, June 8, 
2009. 
Licensed Independent Practitioners 
(LIPs)
JCAHO accreditation, according to JCAHO standards, 
suffice to license practitioners who diagnose or treat 
patients by way of telemedicine link. CMS, however, 
requires LIPs to be credentialed at their originating site. 
“Existing Requirements for Telemedicine Practitioners 
Explained” Joint Commission Perspectives, Feb. 2003.
The Joint Commission Revised 
Standards (section MS.13.01.01)
The revised standards released in November 2008 
compromise the difference between JCAHO and CMS 
standards, but the commission reverted back to their 
original opinion in March of 2009.
“The Joint Commission and Telemedicine: The Final 
Word?” Accreditation Monthly, May 13, 2009.
GRNOPC1 Geron Corporation’s investigational new drug that became 
the first human embryonic stem cell-based therapy 
approved for clinical trial. It is used in patients with acute 
spinal cord injury.
“Geron receives FDA clearance to begin world’s first 
human clinical trial of embryonic stem cell-based therapy,” 
by Geron: Visionary Therapeutics, January 23, 2009, www.
geron.com/media/pressview.aspx?id=1148 (accessed  
July 1, 2009).
Molecular Diagnostics A more accurate and effective diagnosis than traditional 
methods. The capabilities of molecular diagnostics have 
since evolved to include genetic disorder screening, pre-
implantation screening, and cancer screening procedures.
“Proteomics—Technologies, Markets, and Companies,” 
by LeadDiscovery, www.leaddiscovery.co.uk/registration/ 
(accessed July 1, 2009).
CMD tTechnology Allows practitioners to diagnose cancer, choose and 
develop personalized treatment plans, and identify 
predispositions twice as quickly as other assays and for 
only a fraction of the drug development costs.
 “Cancer Molecular Diagnostics Take the Stage: CMDS Are 
at the Forefront of Evolving Healthcare Practices,” Genetic 
Engineering and Biotechnology News, Vol. 29, No. 7,  
April 1, 2009.
Advanced Imaging Modalities Magnetic resonance imaging, computerized tomography 
(CT), and nuclear medicine; these modalities are also the 
expensive services, accounting for 54 percent of total 
imaging expenditures.
“Medicare Part B Imaging Services: Rapid Spending 
Growth and Shift to Physician Offices Indicate Need for 
CMS to Consider Additional Management Practices,” 
Government Accountability Office, June 2008,  
GAO-08-452.
Multidetector Row CT (MDCT) MDCT has raised the standard for image quality and 
accuracy in identifying differences in patient. In addition 
to greater acuity, MDCT (namely 64-slice technology) also 
operates at an increased speed compared to previously 
existing CT technology.
“CT Flexes Muscle in Coronary Disease Detection,” By 
James Brice, Diagnosticimaging.com, November 2005, 
available at www.diagnosticimaging.com/showArticle.
jhtml?articleID=174402602 (accessed July 14, 2006).
“Fusion” Imaging A hybrid technology that combines nuclear medicine 
cameras with CT detection methods.
“Nuclear Medicine Usage, Grows, Led by PET,” IMV 
Medical Information Inc. Newsline, Vol. 47, No. 10, (2006), 
p. 13N. 
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Key Concept Definition Source Location
“Meaningful use” Services of meaningful use will benefit from the recovery 
provisions (that is, test exchange methods), reporting 
of the percentages of patients older than age fifty 
screened for colorectal cancer, and the receipt of annual 
mammograms.
“Fed Advisors review ‘meaningful use’ recommendations 
for health IT,” Greg Freiherr, DiagnosticImaging,  
June 16, 2009, www.diagnosticimaging.com/display/
article/113619/1423016?CID=rss (accessed June 29, 
2009). 
Image Guided Radiotherapy (IGRT) Technology implemented by one-third of all radiation 
oncology sites at the time of publication and implements 
ultrasound, x-ray, and CT most frequently.
“IMV Reports Increased Use of Image-Guided Radiotherapy 
in Radiation Oncology,” by the Gale Group, BusinessWire, 
(2007), (accessed June 29, 2009). 
Stereotactic Rradiosurgery A nonsurgical innovation that serves as an increasingly 
preferred alternative to invasive surgery for soft tissue 
tumors.
“DOTmed Industry Sector Report: Linear Accelerators  
and Simulators,” by Barbara Kram, DOTmed News, 
November 19, 2008, www.dotmed.com/news/story/7013/ 
(accessed June 29, 2009).
Minimally Invasive Procedures Procedures that avoid many of the risks traditionally 
associated with surgical procedures through use of several 
small incisions to guide fiber-optic cameras to areas that 
necessitate treatment.
Minimally Invasive Surgery,” Mayo Clinic, 2009, www.
mayoclinic.org/minimally-invasive-surgery/ (accessed  
April 6, 2009).
Cell Culture Market Influential in the manufacture of biopharmaceuticals, most 
specifically vaccines, monoclonal antibodies, recombinant 
proteins, and stem cells.
“Biopharmaceutical benchmarks 2006: The rate of 
biopharmaceutical approvals has leveled off, but some 
milestones bode well for the future,” by Gary Walsh, Nature 
Biotechnology, Vol. 24, No. 7, July 2006, p. 769–76.
Molecular Engineering Molecular revision has defined development and 
advancement in biopharmaceuticals.
“Biopharmaceutical benchmarks 2006: The rate of 
biopharmaceutical approvals has leveled off, but some 
milestones bode well for the future,” by Gary Walsh, Nature 
Biotechnology, Vol. 24, No. 7, July 2006, p. 769–76.
Genedicine The first gene therapy commercially approved (2004) for 
treatment of head and neck squamous cell carcinomas.
“Biopharmaceutical benchmarks 2006: The rate of 
biopharmaceutical approvals has leveled off, but some 
milestones bode well for the future,” by Gary Walsh, Nature 
Biotechnology, Vol. 24, No. 7, July 2006, p. 769–76.
Public Health Service Act “Rx Watchdog Report, Trends in Manufacturer Prices 
of Specialty Prescription Drugs Used by Medicare 
Beneficiaries, 2004-2007,” by Stephen W. Schlondelmeyer, 
Leigh Purvis, and David J. Gross, American Association of 
Retired Persons, September 2008.
Legislation that has kept generic biopharmaceuticals from 
being marketed.
Da Vinci System A robotic system that was introduced in 1996 that 
revolutionized minimally invasive surgery by overcoming 
the limitations of both traditional surgical procedures and 
conventionally implemented noninvasive technology.
“Minimally Invasive and Robotic Surgery”, by M.J. Mack, 
Surgical Endoscopy, Vol. 20 (2006), p. S488-S492; “Robot-
Assisted Surgery,” Mayo Clinic, 2009, www.mayoclinic.org/
robotic-surgery/ (accessed April 6, 2009).
Automated Endoscopic System for 
Optimal Positioning (AESOP)
The first laparoscopic camera holder. “Robotic assisted laparoscopic radical prostatectomy: a 
review of the current state of affairs,” by V.R. Patel, M. 
F. Chammas Jr., and S. Shah, Int. J. Clin. Pract, February 
2007, Vol. 61, No. 2, p. 309–14.
EndoWrist Technology Allows the surgeon to fully rotate his or her hand, therefore 
giving the surgeon the capacity to reach around, beyond 
or behind The EndoWrist technology provides the surgeon 
with seven degrees of freedom. 
“Robotic Technology in Surgery: Past, Present, and Future,” 
By David B. Camarillo, Thomas M. Krummel, & J. Kenneth 
Salisbury, The American Journal of Surgery, Supplement to 
October 2004, 2S–15S.
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Overview
Demographic shifts, the economic downturn, and changes in market-based technology collectively have 
contributed to the restructuring of the healthcare industry over the years. Currently, financially strug-
gling healthcare and pharmaceutical industries face two problems: (1) the increasing incidence and 
prevalence of chronic disease in an aging population and (2) the introduction of new infectious diseases 
that are more aggressive than those of preceding generations.1 Restructuring of the current healthcare 
industry, therefore, has become vital in order to contend with these pressures, and a successful transition 
is predominantly conditional upon insightful use of current technological instruments and innovative 
development of new advanced methodologies.
Improvements in diagnostic and therapeutic medicine, paired with the efficient use of available 
resources in both management and clinical arenas, have the capacity to improve quality of care while 
minimizing the number of medical errors. Through the effective use of electronic health records and 
prescription management systems, providers are able to save money for themselves, as well as for their 
patients. Also, progressive and dynamic research findings in molecular and imaging technology continue 
to affect the diagnostic industry’s influence as a driver of the therapeutic market.2 
Management Technology
Inpatient Versus Outpatient Care: A Bilateral Market
The development of minimally invasive technology, pharmaceutical advances, increased demand for 
services, and higher costs associated with inpatient care has fueled a growth in outpatient care whereby 
outpatient visits nearly doubled from 67 million in 1995 to 102 million in 2006. Simultaneously, the 
technology utilized in inpatient care has augmented the quality and efficiency of care for inpatient bene-
ficiaries over the age of sixty-five, which has nearly doubled from 1970 to 2006.3 This demographic shift 
indicates that efforts to maximize technological implementation in the delivery of home care and patient 
compliance monitoring systems should be employed to increase both access to and quality of care.
Outpatient visits nearly doubled from 67 million in 
1995 to 102 million in 2006.
“Health, United States, 2008 (with chartbook),” by the National Center for Disease Statistics, Centers for Disease 
Control and Prevention, U.S. Department of Health and Human Services, 2009.
Electronic Health Records (EHR)
Electronic health records (EHR) work through a system of longitudinal data collection and main-
tenance to “automate and streamline the clinician’s workflow.” The EHR has the ability to generate a 
complete record of a clinical patient encounter, as well as supporting other care-related activities directly 
or indirectly by way of an interface that includes evidence-based decision support, quality management, 
and outcomes reporting.4 Facilities that use EHR systems increase the ease with which practitioners can 
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file, manage, organize, and find their patients’ demographic data, progress notes, problems, medications, 
vital signs, past medical histories, immunizations, laboratory data, and radiology reports.5
Trends in eHr 
Though paper health records have been used effectively in the past, drawbacks exist to administrative 
systems that continue to utilize nonelectronic documentation of patient information.6 In addition to hin-
dering the delivery of quality medical care, studies have indicated that paper records are costly, cumber-
some, and easily misplaced, and they are difficult to use for meaningful decision analysis.7 Furthermore, 
paper records cannot be effectively searched or used to track, analyze, or chart voluminous clinical 
medical information, and they cannot be easily copied or saved off-site.8 
The first EHRs were adopted in the 1960s, but many healthcare professional practices at the time did 
not view updates to their “anachronistic” medical record systems as a priority, despite the advent of tech-
nologies such as power files, audiotapes, microfilm, electronic data processes, and cathode ray tube real-
time read-outs.9 Many of today’s EHRs are based on the work conducted in academic medical centers 
for use by major government clinical care organizations. The most notable of these include
• COSTAR (the Computer Stored Ambulatory Record), developed at Harvard Medical School and 
placed in the public domain in 1975;
• HELP (Health Evaluation through Logical Processing), developed at Latter-Day Saints Hospital 
at the University of Utah (brought to market by the 3M Corporation), which pioneered decision 
support features; 
• TMR (The Medical Record), developed at Duke University Medical Center;
• THERESA, developed at Grady Memorial Hospital at Emory University, which encouraged direct 
physician data entry;
• CHCS (Composite Health Care System), used by the Department of Defense;
• DHCP (De-Centralized Hospital Computer Program), developed and used by the Department of 
Veterans’ Affairs (VA); and
• Technical Data System(TDS), developed by Lockheed in the 1960s and 1970s.10
Early attempts to design and implement EHR technology encountered several difficulties, and 
although many improvements have been made, 
certain lingering problems in today’s systems 
may explain why EHRs have not yet been widely 
implemented (See table 5-1 for status of EHR 
implementation as of 2009).
Although EHR implementation, is progressing 
at a relatively slow rate, it has continued to increase 
steadily since 2003. Notably, an estimated 43.9 
percent of office-based physicians reported using an 
EHR system of some form in the first few months 
of 2009, although only 6.3 percent of systems were 
considered “fully functional.”11
Table 5-1:  Status of Electronic Health Record 
Implementation (2009)*
Stage of Implementation Percentage
Not Yet Begun  5%
Developed a Plan 15%
Signed a Contract  2%
Begun to Install in One Facility 37%
Fully Operational in One Facility 24%
Fully Operational Across Whole Organization 17%
Unknown  1%
* “20th Annual 2009 HIMSS Leadership Survey” By HIMSS, Healthcare CIO Final 
Report, April 6, 2009, p. 24.
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Cost-Benefit Analysis
Using computer-based programs to track patients’ medical records, approve physician orders, and pre-
scribe medication can drastically improve patient outcomes and reduce costs. According to the Ameri-
can Medical Association, practices that implement EHR technology will benefit from a system of docu-
menting patient vitals and test results, better supporting documentation in malpractice claims, improved 
reporting regarding patient practices, and improved communication between physicians.12 Furthermore, 
results from a recent study published in Health Affairs suggests that implementation of EHRs could save 
more than $81 billion per year by preventing disease, reducing medical errors, and promoting efficiency 
within the healthcare system.13 
Additionally, the implementation of an EHR system allows for computerized physician order entry 
(CPOE), which may reduce adverse drug events in inpatient and ambulatory settings.14 These point-of-
care technology systems make patient clinical data readily available, and they provide physicians with 
access to scientific information essential to patient care and decision-making.15
Practices that utilize EHR technology reduce their costs associated with utilizing and maintaining 
traditional paper medical records.16 In addition to superior physician accessibility, EHRs allow physi-
cians to enter key findings and progress notes at the point of care, minimizing duplicate documentation.17 
Additionally, problems with legibility are eliminated, reducing potential interpretation errors and saving 
time.18 
Barriers to Implementation
Obstacles, such as cost and physician resistance to change, have delayed the widespread adoption of 
EHRs.19 Some physicians admit that the cost of new technology is the greatest challenge for the conver-
sion from paper health records to EHR.20 However, research suggests that physicians who use EHRs 
with sophisticated Medicare coding support could see a revenue increase of up to 30 percent more than 
physicians who continue using paper records.21 Some cardiology practices have already reported sub-
stantial EHR benefits, including lower Medicare rejection rates, fewer days in accounts receivable, the 
ability to increase their number of patients without an increase in staff, increases in revenue, and reduc-
tions in transcription and postage costs.22 One multispecialty practice observed $2.5 million per year in 
EHR related savings.23 
Physicians who use EHRs with sophisticated Medicare coding support  
could see a revenue increase of up to 30 percent more than doctors  
who continue using paper records.
“The Benefits of Evidence Based Medicine in EHR Systems,” by Tom Doerr, MD, EHR Scope, (Spring 2008).
The cost associated with utilizing EHR technology can vary based on facility size, patient volume, 
and type of software, which extends beyond the software license. Often, the cost of the software is only 
50 percent of the cost for a new system.24 Furthermore, it is estimated that the total cost per provider can 
be upward of $10,000; if the loss of productivity associated with initial implementation is accounted for, 
the cost of transitioning to an EHR system could be greater than $20,000.25
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As with all medical records, EHRs must align with current Health Insurance Portability and Account-
ability Act (HIPAA) regulations (see chapter 3, Health Insurance Portability and Accountability Act of 
1996 (HIPAA) for further discussion of these regulations). Due to ease of transfer and accessibility, prac-
titioners and healthcare facilities that use EHR technology must be cautious about compliance. 
In 2007, the Federal Trade Commission (FTC) issued a set of regulations known as the Red Flags 
Rules, requiring that certain entities develop and enforce written identity theft prevention and detection 
programs by August 1, 2009. These programs are targeted at all transferable personal files, including 
EHRs, and are discussed further in chapter 3, Red Flags Rules. 
Reimbursement
In response to the slow transition to EHRs, the government has prioritized proactive legislation promot-
ing universal access to electronic records. Congress recognized the impending healthcare crisis in its 
American Recovery and Reinvestment Act (ARRA), signed by President Barack Obama on February 17, 
2009.26 The ARRA allotted $19.2 billion to ensure that every patient has a complete, interoperable EHR 
by 2014. The net return of this investment will include long-term cost savings, improved outcomes, and 
increased ease of communication between physicians. In an effort to incentivize the implementation of 
EHR use, beginning in 2011, funding will increase reimbursement for Medicare and Medicaid providers 
(up to $65,000 per physician and $11 million per hospital) that use EHRs.27 Conversely, in 2015, physi-
cians who are not using EHRs will be penalized through reduced reimbursement.28 
The ARRA allotted $19.2 billion to ensure that each American has a 
complete, interoperable EHR by 2014.
“Healthcare and the American Recovery and Reinvestment Act,” by Robert Steinbrook, MD, The New England 
Journal of Medicine, March12, 2009, http://content.nejm.org/cgi/content/full/NEJMp0900665 (accessed  
February 20, 2009).
Specific provisions of the ARRA, namely, Title IV of Division B and Title XIII of Division A, 
collectively are known as the Health Information Technology for Economic and Clinical Health Act 
(HITECH Act). These sections of the ARRA incentivize implementation of EHR and establish “mean-
ingful use” criteria for EHR utilization by healthcare entities and providers.29 For healthcare providers to 
qualify for HITECH incentives, they must demonstrate fulfillment of three requirements for “meaningful 
use” of EHRs: 
(1) Use of certified EHR technology in a meaningful manner (for example, electronic prescrib-
ing); (2) that the certified EHR technology is connected in a manner that provides for the elec-
tronic exchange of health information to improve the quality of care; and, (3) that, in using certi-
fied EHR technology, the provider submits . . . information on clinical quality measures and such 
other measures selected by the Secretary.30
In addition to the aforementioned criteria for “meaningful use,” upheld by both Medicare and 
Medicaid, which currently link many EHR incentive programs, Medicaid also requires that healthcare 
providers receiving incentives under HITECH must indicate efforts to “adopt, implement, or upgrade 
certified EHR technology” wherever possible.31 States also reserve the right to implement additional 
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requirements for “meaningful use” beyond the minimum standard upheld by Medicare, which will 
undergo additional changes as definitions for “certified EHR technology” and a “qualified EHR” are 
finalized.32
Electronic Prescribing: Computerized Physician Order  
Entry (CPOE)
Computerized physician order entry (CPOE) allows physicians and providers to electronically order 
laboratory, pharmacy, and radiology services.33 Electronically entering orders minimizes error by elimi-
nating the hassle and ambiguity associated with handwritten orders.34 CPOE is designed to “streamline 
medication ordering by standardizing the process, introducing controls, eliminating bad handwriting, 
making an order easily traceable to a provider; additionally, with decision support installed, CPOE can 
also help assure adherence to evidence-based guidelines.”35
More than 1 million serious medication errors occur every year in the United States.36 One adverse 
drug effect (ADE) adds, on average, $2,000 to the cost of hospitalization, which is currently more than 
$7.5 billion per year nationwide.37 An ADE is an injury caused by drugs, typically in the form of an al-
lergic reaction or adverse physiological response to a certain combination of medications. Preventable 
ADEs are injuries that are caused by human error, such as prescribing or administering the wrong dose 
of a drug.38 A 2008 study by the Leapfrog Group, a large consortium of healthcare purchasers, found that 
CPOE systems can reduce the frequency of ADEs by as much as 88 percent.39 
Only 8 percent of hospitals have fully implemented CPOE systems. In 
addition, CPOE hospitals tend to be larger, nonprofit, and teaching hospitals.
“Full Implementation of Computerized Physician Order Entry and Medication-Related Quality Outcomes:  
A Study of 3364 Hospitals”, by Feliciano B. Yu et. al, American Journal of Medical Quality, American College of 
Medical Quality, June 5, 2009, p. 1.
Trends in CPoe 
CPOE systems were first introduced in the late 1960s, but CPOE use was fairly sporadic until a 1999 
study by the Institute of Medicine (IOM), “To Err Is Human,” found that 44,000 deaths annually are at-
tributable to medical errors and touted CPOE adoption as the solution to this newly recognized national 
crisis.40
Between 2004 and 2005 the agency for healthcare research and quality 
awarded more than $166 million in funding for health IT, much of which 
focused on implementation and evaluation of CPOE.
“Inpatient Computerized Provider Order Entry (CPOE): Findings from the AHRQ Health IT Portfolio”, by Brian E. 
Dixon and Atif Zafar, U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality, 
January 2009, http://healthit.ahrq.gov/images/jan09cpoerport/cpoe_issue_paper.htm (accessed June 22, 2009), p. 2.
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CPOEs have received much public attention following the IOM’s call for the use of electronic 
prescribing systems in all healthcare organizations by 2010 and the decision by the Leapfrog Group to 
encourage CPOE adoption by hospitals as a means to improve care and reduce costs.41 Despite these 
initiatives, a 2009 study published in the American Journal of Medical Quality found that only 8 percent 
of hospitals have a fully implemented CPOE system. Additionally, these hospitals tended to be larger, 
nonprofit, teaching hospitals.42 For a hospital to qualify as having a “fully implemented” system, 75 per-
cent of all orders must go through its CPOE system, the system must alert physicians of possible errors, 
and it must require a physician response if an alert is overridden.43
In 2008, 472 U.S. hospitals had a CPOE system in place. Of those organizations using CPOE, 62 
percent were described as having aggressive use (50 percent or more of orders are entered into CPOE 
system) (see table 5-2). Additionally, the following table 5-3 details the breakdown of CPOE usage 
measured by percentage of orders that are filled out through the hospital’s CPOE system.44 









Number 95% 102% 60% 229%
Percentage 20%  22% 13%  49%
* “Computerized Physician Order Entry Usage in North America: The Doctor is In” By Stacilee Oakes Whiting and Adam Gale, HIT Report from KLAS, Healthcare Quarterly, Vol. 
11, No. 3 (2008) p. 94.
Table 5-3:  Approximate Uses of Computerized Physician Order Entry (CPOE) in Inpatient and  
Ambulatory Settings, 2008*
% of MD’s Using CPOE % of All Patient Orders MD’s Enter
% of Medication Orders 
Electronic vs. Paper
% MD’s Entering Notes 
Electronically
Level of Use Inpatient Ambulatory Inpatient Ambulatory Inpatient Ambulatory Inpatient Ambulatory
Pilot 18  4 21  9 21 15 65 45
Moderate 22 12 19 25 16  8  9 11
Significant 10 12 22 20 19  8  5  4
Deep 46 70 38 48 44 65 19 35
* “Computerized Physician Order Entry Usage in North America: The Doctor is In” By Stacilee Oakes Whiting and Adam Gale, HIT Report from KLAS, Healthcare Quarterly,  
Vol. 11, No. 3 (2008) p. 95.
Other national organizations also have promoted the adoption of CPOE based on its potential to im-
prove quality and reduce medical error. These include the Joint Commission on Accreditation of Health-
care Organizations (Joint Commission) and the President’s Information Technology Advisory Commit-
tee.45 Despite this initiative and support, hospital ownership and teaching status have historically been 
cited as important factors in whether a hospital is likely to implement a CPOE system (see table 5-4).46
Government hospitals have been the most likely to start implementing CPOE systems (including 
nonfederal community, city-, state-, and county-owned government hospitals) at three and seven times 
the rates of adoption by nonprofit and for-profit hospitals, respectively.47 Larger government hospitals 
have been more prone to incorporating CPOE technologies, and teaching hospitals have been roughly 
three times as likely as nonteaching hospitals to adopt the technology.48 
Studies indicate that institutions that adopt CPOE systems primarily are focused on the safe and 
proper delivery of clinical services.49 Political interests in clinical safety are more prevalent in govern-
mental facilities than in for-profit hospitals. Physicians are also the stakeholders most opposed to the 
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adoption of CPOE systems and accordingly, “[i]t 
may be that physicians are sufficiently powerful to 
prevent (CPOE) adoption at private hospitals but 
not sufficiently powerful to delay (CPOE) adop-
tion at public institutions.”50 Additionally, the large 
percentage of teaching hospitals implementing 
CPOE systems could be explained as a correlation 
between education and a heightened commitment to 
innovation, as “. . . results suggest that information 
about CPOE systems has not spread widely enough 
among key physicians or hospital decision makers 
outside of teaching institutions.”51
Cost-Benefit Analysis
Prudent prescription and medication use has a substantial impact on the total cost of healthcare.52 Over-
all, the financial impact of reported CPOE use has had a positive effect on the net operating income of 
an institution.53 
A 2008 survey by the Massachusetts Hospital CPOE Initiative calculated that Massachusetts saved 
$2.7 million per hospital annually with the adoption of CPOE technology.54 The initiative found that the 
increased savings for Massachusetts hospitals essentially would generate sufficient return in approxi-
mately twenty-six months to cover the costs of installing and adapting CPOE software and protocols. 
In addition, the average annual benefits to Massachusetts payors amounts to approximately $900,000 
per hospital. The initiative concluded that statewide adoption of CPOE systems would save, on average, 
$170 million a year, preventing 55,000 ADEs from occurring.55 
Although some studies have shown that implementation of CPOE systems has resulted in consider-
able gains in ordering process efficiency, other potential benefits of CPOE systems appear to have been 
disproved.56 For example, although CPOEs are touted for their potential to promote effective leadership 
and other quality performance indicators, studies have so far shown that hospitals with complete CPOE 
systems do not systematically outperform, with regard to these factors, those without.57 In addition, 
studies of CPOE systems are constrained by the technology’s comparative youth, continued evolution, 
emphasis on evaluation of potential rather than actual errors, and limited dissemination.58
Despite these cost concerns, research has indicated that many hospitals respond proactively to fi-
nancial incentives, especially for-profit hospitals, which have been shown to make calculated decisions 
based on profitability.59 “Investments in patient safety—although a moral obligation—usually provide 
financial benefits to payors and purchasers rather than to the organization, a point not lost on stressed 
organization leaders.”60 Additionally, changing the reimbursement environment to favor adoption of 
CPOE systems could offer a short-term solution to increasing investment in these systems.61 
Between 2004 and 2005, the Agency for Healthcare Research and Quality (AHRQ) awarded more 
than $166 million in funding for health information technology (IT), much of which focused on imple-
mentation and evaluation of CPOE. This amount only covered part of the capital needed to secure and 
implement a CPOE system. Providers were required to utilize alternate funding sources, including 
payors, state-based loan programs, and organizational IT budgets. However, with shrinking organiza-
tional budgets and competing IT projects, the task of funding CPOE implementation can be daunting for 
hospital administrators.62 A 2008 survey of Massachusetts hospitals found that, on average, capital costs 
Table 5-4:  Computerized Physician Order Entry (CPOE) 





No CPOE System 24.1% 41.4% 54.1%
Early-Stage Adoption 12.7%  9.6%  6.8%
Middle-Stage 
Adoption 15.2% 12.1%  3.8%
Fully Implemented 10.1%  2.2%  0.0%
* “U.S. Adoption of Computerized Physician Order Entry Systems” By David M. 
Cutler, Naomi E. Feldman and Jill R. Horitz, Health Affairs, Vol. 24, No. 6 (Nov./ 
Dec. 2005), p. 1657.
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associated with implementing a CPOE system was slightly more than $2 million and ongoing use and 
maintenance was just more than $425,000.63 
On average, one adverse drug effect adds $2,000 to the cost  
of hospitalization, which is more than $7.5 billion per year  
nationwide in hospital costs.
“Leapfrog Hospital Survey Results” The Leapfrog Group, 2008, p. 3.
Clinical Decision Support (CDS)
Clinical decision support (CDS) is a technology that provides clinicians with real-time feedback for a 
wide range of diagnostic and treatment related decisions as they are entering electronic patient records.64 
CPOE systems with CDS can minimize the incidence of medical errors by informing practitioners of 
potential drug interactions, patient allergies to prescribed medication(s), medication contraindications, 
and renal- and weight-based dosing. CDS systems provide pop-up warnings when a complication exists 
with an order. However, “alert fatigue” can occur when there is a combination of critical medical alerts 
and a high volume of marginally medically consequential alerts.65 An overabundance of warnings may 
desensitize and even annoy practitioners.66 
Quality of Care Improvements
A recently published study in the American Journal of Medical Quality found significant positive asso-
ciations between specific objective quality indicators and CPOE implementation.67 Hospitals with CPOE 
systems noted that errors related to legibility of paper orders were eliminated. Also, alerts regarding al-
lergies, potential drug interactions, and dosing standards, improved patient safety, and “stat” orders were 
fulfilled quicker, because pharmacies were receiving the orders instantly.68 
In addition to preventing ADEs, CPOE systems alert physicians of available generic options for any 
prescription drug, alert clinicians of redundant orders or laboratory test entries, and list the drug delivery 
methods suitable for any prescribed drug to prevent delivery errors (for example, intravenous admin-
istration of orally administered drugs). CPOE systems could be even more beneficial in long-term care 
facilities because residents are prescribed, on average, more than six concurrent drug therapies, which, 
exacerbated by problems associated with advanced age, can increase the risk of an ADE.69 Table 5-5 
shows expected minimal rates of improvement for preventable adverse occurrences with implementation 
of CPOE.
Barriers to Implementation
In addition to the costs associated with implementing a CPOE system (see Cost-Benefit Analysis), sev-
eral other challenges should be considered: technical issues, costs, and clinician compliance.70
Technical Issues
It should be noted that there is no “one size fits all” CPOE system, so many hospitals may need to cus-
tomize their systems, including the integration of current systems.71 This process necessitates thorough 
project planning and execution, which may hinder production and cause unforeseen delays. 
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Given the customization needed to integrate a 
CPOE system into any facility’s infrastructure, a 
fair amount of training is required to ensure that cli-
nicians, technicians, and practitioners will maintain 
and use the system consistently and correctly.72 
Unintended Errors
CPOE system technology introduces other po-
tential unintended errors, which include delivery 
of orders on incorrect patients, errors of clinician 
omission, lack of communication among clinical 
staff regarding the status of an order, loss of in-
formation during care transitions, and overlapping 
medication orders.73 A 2005 study found that one CPOE system facilitated twenty-two types of medica-
tion error risks, generated by the fragmentation of data and failure to integrate the hospital’s multiple 
computer and information systems and human-machine interface flaws reflecting machine shortcomings 
in light of generally accepted workplace practices and dynamics.74 However, as systems become more 
advanced, some of these unforeseen problems are decreasing in frequency. In 2003, the average number 
of electronic patient entries being re-entered was 48 percent, whereas in 2008, this percent dropped to 21 
percent.75 
Physician Unwillingness
Another potential barrier to use of CPOE is provider reluctance. User satisfaction has been identified as 
an important predictor of the success of CPOE adoption and compliance.76 Generally, younger interns 
and residents are more willing to use CPOE, although older, more experienced physicians tend to be less 
satisfied with CPOE.77 
One of the primary complaints from physicians is that it takes longer to enter an order electronically. 
Physicians also have reported a loss of professional autonomy, because CPOE systems can prevent 
them from ordering the type of tests or medication(s) they prefer, force them to comply with clinical 




Individual states have enacted laws to reduce medical errors. The California Health and Safety Code 
Section 1339.63 states, “As a condition of licensure under this division, every general acute care hospital 
. . . special hospital . . . and surgical clinic . . . shall adopt a formal plan to eliminate or substantially re-
duce medication-related errors. . . . This plan shall include technology implementation, such as, but not 
limited to, computerized physician order entry.”79 This law required all plans to be submitted by 2002, 
with the licensure changes taking affect January 1, 2005. A similar law in Massachusetts requires state-
wide implementation of CPOE systems by 2012.80
On a federal level, there have been several bills proposed in both the United States House of Repre-
sentativesand the Senate regarding implementation of CPOE systems.81 Although none of the bills spe-
cifically requiring CPOE implementation have been passed, the Patient Safety and Quality Improvement 
Table 5-5:  Minimal Expected Rates of Improvement for 
Preventable Adverse Events with Computerized 
Physician Order Entry*
Preventable Event Year 1 Year 2 Year 3
ADEs 15% 50% 70%
Expensive Drugs 20% 60% 80%
Renal Dosing 15% 60% 93%
I.V. to Oral 50% 75% 82%
Redundant Labs 50% 75% 85%
* “Saving Lives, Saving Money: The Imperative for Computerized Physician Order 
Entry In Massachusetts Hospitals” By Mitchell Adams et al., Massachusetts 
Technology Collaborative, New England Healthcare Institute, Feb. 2008, p.18.
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Act of 2005 called for a report including suggestions on the reduction of medical errors to be submitted 
to the IOM.82 In addition, the Centers for Medicare and Medicaid Services (CMS) 2004 final rule en-
titled, “Medicare and Medicaid Programs; Hospital Conditions of Participation: Quality Assessment and 
Performance Improvement,” created a quality assessment and performance improvement program to 
reduce medical errors, including medication errors.83
Reimbursement
In the past, financial incentives to support investments in CPOE technology were lacking. One reason 
for this is that public payors paid the same reimbursement for unsafe care as they did for safe care.84 To 
combat this, some private insurers are leading the charge to incentivize hospitals to incorporate CPOE.85 
The Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) created an incentive 
program for professionals to start e-prescribing. Section 132 of MIPPA establishes incentives for 2009 
through 2013, in which Medicare professionals who are successful e-prescribers will receive payments 
of 2 percent for 2009 and 2010, 1 percent for 2011 and 2012, and 0.5 percent for 2013. The goal of these 
incentives is to allow the Government Accountability Office (GAO) to submit a report on the implemen-
tation of the incentives for electronic prescribing to Congress by September 1, 2012.86 
Outsourcing Billing Services
With physician professional practices under economic pressure to cut costs and adhere to heightened 
regulations regarding security and compliance, a greater number of practices use outsourcing as a “tool 
for survival and growth.”87 
Outsourcing in healthcare has yielded higher efficiency levels and more cost-effective outcomes 
and also has provided increased physician and patient satisfaction.88 Many health practices are utilizing 
foreign companies for medical billing in response to those companies’ guarantees of dramatic savings 
compared to their American counterparts.89 
Despite the financial benefits of outsourcing billing, it also raises issues of compliance with HIPAA. 
A 2005 study showed that although many outsourcing service providers have implemented HIPAA re-
quirements, others have chosen not to comply, citing “no public relations or brand problems anticipated 
with noncompliance” and “no anticipated legal consequences for non-compliance.”90 With lawmakers 
increasing penalties for noncompliance with privacy laws, it is likely that outsourcing services provid-
ers will begin to increase their compliance efforts. The HITECH Act, enacted as part of ARRA,91 delin-
eates a tiered system for determining the appropriate penalties for HIPAA privacy violations.92 HITECH 
provisions significantly increase the penalties for violations of HIPAA, allowing for penalties up to $1.5 
million.93 
Telemedicine and Telehealth
Telemedicine is the transfer of electronic medical data (high resolution images, sounds, live video, and 
patient records) from one location to another in order to enhance the quality and efficiency of patient 
comfort and care. This technology utilizes a variety of telecommunication technologies, including, 
but not limited to ordinary phone lines, integrated services digital network, fractional to full T-1 lines, 
ATMs, the Internet, and satellites.94 Telehealth is closely related to telemedicine and is used to describe 
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the broader definition of remote healthcare that does not always involve clinical services, although the 
two terms are often used interchangeably.95
Utilizing communication equipment to link healthcare practitioners and patients in different loca-
tions increases cost efficiency; reduces transportation expenses, improves patient access to specialists 
and mental health providers, improves quality of care, and enhances communication among providers.96 
Telemedicine services have been integrated successfully into approximately sixty different medi-
cal subspecialties.97 The United States has approximately 200 telemedicine networks, involving close 
to 3,500 medical and healthcare institutions.98 Some of the services offered through telemedicine are 
specialized and primary care consultations, imaging services, remote patient monitoring, remote medi-
cal education and consumer information, networked programs linking hospitals to rural clinics, point-
to-point connection using private networks between hospitals and ambulatory care sites, primary or 
specialty care to home connections, home to monitoring centers, and Web-based e-health patient service 
sites. Today, nearly five hundred hospitals in the United States outsource some of their medical imaging 
services, often referred to as teleradiology.99 
Telemedicine services have been successfully integrated into approximately 
sixty different medical subspecialties.
“What is Telemedicine and Telehealth?” American Telemedicine Association, info@americantelemed.org  
(accessed June 30, 09).
Trends in TelemediCine
The range of telemedicine technology is divided into two main application groups. Store and forward 
is the transfer of digital images between locations, most commonly seen in teleradiology and telepathol-
ogy (the use of pathology slides for diagnostic consultation).100 Two-way interactive television is used 
in telemedicine for face-to-face consultation. These real-time consultations often occur between patients 
or nurses in rural environments and practitioners.101
Some states, supported by Blue Cross Blue Shield (BCBS), have begun to implement virtual clinics 
using telehealth technologies. The virtual clinic is a pilot project, so far only fully adopted in Hawaii, in 
which for a flat fee, a patient can communicate with a physician using a webcam and an instant messag-
ing program over the Internet for approximately ten minutes. Patrick Geraghty, the president of BCBS of 
Minnesota (one state beginning implementation), claims that these virtual clinics will change the current 
model of how physicians get paid and will save patients from expensive trips to the emergency room 
and clinic. Roy Schoenberg, M.D., the creator of the virtual clinic software, describes how the software 
connects patients to generalists, pediatricians, or other specialists who will have instant accesses to their 
patients’ EHR provided by BCBS data. Currently, only in-state licensed physicians are allowed to par-
ticipate in the program.102
Advances in robotics now allow telehealth to have a tangible component. Mercy Hospital in Cali-
fornia recently unveiled a robot diagnostic tool (costing approximately $500,000) that can be operated 
by a neurospecialist remotely to examine stroke victims.103 Additionally, Night Hospitalist Company 
LLC (NHC) provides telephonic medical care from 7 p m  to 7 am  for hospitals with ongoing staff-
ing shortages. NHC employs both allopathic and osteopathic physicians, who are licensed in multiple 
states, to provide medical services from their homes for $500 per night. NHC costs $50 to $70 per hour, 
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approximately half the cost of an in-house hospitalist.104 Another pilot telehealth initiative, the RP-7 
robot, at Eagle Hospital in Atlanta, Georgia, can maneuver through hospital floors through a telehealth 
link. Currently, ten hospitalists are participating in the pilot program.105
Digital telemedicine is allowing X-rays to be read overnight in India, psychotherapy to be con-
ducted remotely, and mammograms to be screened automatically through digital scanning. This 
explosion of technology applications holds not only the promise of more efficient and more 
effectively distributed care but also the potential for significant disruption for certain medical 
specialties.106
Cost-Benefit Analysis
The federal government has predicted that by 2020, there will be a shortage of approximately 24,000 
physicians and nearly 1 million nurses.107 For hospitals suffering from physician shortages, telemedicine 
facilitates hospitalist recruitment, providing more attractive work hours and the ability for a single prac-
titioner to provide services to multiple hospitals at one time. In general, solving the physician shortage 
may help control “burnout” for hospitalists, leading to higher productivity and longevity of practitioners. 
In addition, telemedicine has enhanced access for hospitalists and their patients to medical specialists 
and better technology. Telemedicine also allows hospitals to expand their market service area by em-
ploying telemedicine technology at outlying medical clinics and offices.108
Telemedicine also allows hospitals to expand their market area by 
employing telemedicine technology at outlying medical clinics and offices.
“Night-Shift Solutions” By Lisa Ryan, The Hospitalist, April 2009, www.the-hospitalist.org/detains/article/183090/
NightShift_Solutions.html (accessed June 20, 2009).
The VA is the largest provider of remote medical services, delivering an estimated 350,000 patient 
services remotely.109 Through telemedicine, the VA has reduced the average length of stay at hospitals 
by 25 percent and has reduced hospitalization by 19 percent for patients using home health services.110
Through telemedicine, the VA has reduced the average number of days 
hospitalized by 25 percent and reduced hospitalization by 19 percent for 
patients using home health.
“New VA Study Shows Home Telehealth Makes Health Care More Effective” Government Health IT News,  
Jan. 7, 2009.
Many healthcare practitioners have obtained federal funds for investments in telemedicine tech-
nology through grants, contracts, and direct services. In 2003, the American Telemedicine Associa-
tion (ATA) estimated that approximately $279 million was spent on federal grants and contracts in 
telemedicine. 
The ARRA set aside $2.5 billion to be put into affiliated grants and loans for telemedicine. The act 
also called for complete adoption of EHRs by 2014, without which the implementation of telemedicine 
may have been hindered.111 Further, the Medicare Telehealth Enhancement Act of 2009 (HR 2068) will 
provide $30 million in grants to health facilities to pay for telehealth equipment and expand telehealth 
support services.112
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Finally, the Federal Communications Commission created the Rural Health Care Pilot Program to 
increase patient access to telemedicine and support the transfer of EHRs. Sixty-seven nationwide proj-
ects in forty-two states and 6,000 health facilities are eligible for the $417 million in grants under the 
program.113
Barriers to Implementation
The two main barriers to telemedicine implementation are (1) reimbursement obstacles from Medicare 
and certain private health insurers and (2) medical licensing. Depending on the licensing practices of the 
state, practitioners who use interstate telemedicine may have to be licensed in each of the states in which 
they treat patients, which can be time-consuming and expensive.114 
Some physicians refrain from using telemedicine systems due to liability issues and skepticism 
regarding the competency of the technology. Generally, patients expect physicians at their bedside, not 
a video or voice transmitted through the Internet or satellite. Without traditional bedside care, there may 
be a greater likelihood of lawsuit if a problem occurs.115
As with any form of technology, startup and training costs are associated with telemedicine. These 
vary depending on the technology being implemented and have the potential to hinder implementation 




Physicians practicing medicine in any state must be approved by the licensure board of that state. As of 
2006, twenty states have restrictive licensure laws regarding interstate telemedicine.116 
These licensure laws require a practitioner to be fully licensed in each state in which he or she pro-
vides medical care in order to deliver telemedicine care across state lines, but it can be expensive and 
time consuming for a practitioner to maintain licenses in more than one state.117
However, licensure laws typically have several exceptions that allow interstate telemedicine without 
a license from both states, such as if 
1. interstate telemedicine is infrequent,
2. a contractual relationship with compensation is not formed, 
3. consultations are between two parishioners only (no patient involvement), 
4. educational purposes, 
5. telemedicine is used in a medical emergency or natural disaster, 
6. the referring practitioner retains primary medical control, or 
7. telemedicine is used in service of the U.S. military.118
Reciprocal or limited licensure provides an interstate license for use with telemedicine that prac-
titioners can apply for through a simple application process and for reduced licensing fees. Reciprocal 
licenses work through a mutual exchange of privileges and permit one state to recognize the license a 
practitioner holds in another jurisdiction and subject practitioners to the rules from in the jurisdiction 
where the practitioner resides.119 This license is solely for practicing telemedicine and may not be used 
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by practitioners to provide bedside care in another state. As of 2006, reciprocal licenses were only ac-
cepted in Alabama, California, and Oregon.120 See table 5-6 for a summary of state participation in vari-
ous types of interstate licensing practices. As an exception to this rule, an interstate license for nurses, 
first created in 2000, has been widely accepted and used through the National Council of State Boards 
of Nursing. A nurse residing in a state that participates in the Nurse Licensure Compact may hold a 
license in his or her home state and practice either physically or remotely in another state, while being 
subject to the practice laws and regulations of both states.121
Table 5-6: Summary of Telemedicine Interstate Licensure Types, 2006*
Type No Action Restrictive Reciprocal Nursing
Number of States 28 20 3 30
* “Telemedicine Licensure Report” Center for Telemedicine Law, Office for the Advancement of Telehealth, June, 2003; Updated numbers from “Interstate Licensure of 
Telemedicine Practitioners” By Glenn W. Wachter, Telemedicine Information Exchange, March 10,2000, updated By TIE on Nov. 15, 2006, http://tie.telemed.org/articles/article.
asp?path=article&article=interstateLicensure_gw_tie0 (Accessed 7/1/09). 
Federal 
Similar to any electronic transfer of patient medical information, telemedicine practitioners must comply 
with HIPAA regulations. Telehealth and telemedicine are also subject to Joint Commission standards.122 
Current Joint Commission standards focus on services provided by licensed independent practitioners 
(LIPs) who diagnose or treat patients by way of a telemedicine link.123 Under the current standards, most 
recently revised in 2004, a hospital may rely on the site of the LIP providing the service (referred to as 
the distant site) for credentialing as long as that site is accredited by the Joint Commission. Otherwise, 
the LIP must be credentialed at the site where the patient is located (the originating site).124
Telehealth and telemedicine are also subject to the JCAHO standards.
“Hospital-wide PACS Need Tighter Data Security” Diagnostic Imaging PACS Supplement, Feb. 2000, www.dimag.
com/db_area/archives/2000/0002pnews.3-7.html (accessed March 31, 2000).
The same Joint Commission standards apply to practitioners who provide interpretive services 
(teleradiology and telepathology) and those who provide consultations.125 These services are usually 
contracted out for and must therefore also meet the contracted service standard (LD.3.50).126 In contrast, 
CMS requires LIPs to be credentialed at the originating site. In November 2008, the Joint Commission 
revised its standards to reflect this discrepancy but reverted back to its original opinion in March 2009.127 
HR 2068, introduced to Congress on April 23, 2009, was referred to the House Ways and Means com-




In 2006, at least twenty-nine states had private insurers that were reimbursing for telemedicine ser-
vices, with at least twenty-five states having passed legislation mandating some level of private payor 
reimbursement of telemedicine.129 Some states, including Louisiana, California, Oklahoma, Texas, and 
Kentucky, have all-inclusive legislation prohibiting health insurers from denying coverage for services 
appropriately provided through telemedicine and subject to individual insurance contracts.130 
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A 2003 private payor survey conducted by the ATA found that 53 percent of telemedicine programs 
offer billable service and receive private payor reimbursement.131 As of 2006, thirty-four states reim-
burse through Medicaid for telehealth services, and nineteen states have specific legislation that provides 
for Medicaid reimbursement.132 
Federal
The Balanced Budget Act of 1997 limited the scope of Medicare telehealth coverage to consultation 
services. Section 223 of the Medicare, Medicaid and SCHIP Benefits Improvement and Protection Act of 
2000 (BIPA), however, revised Medicare reimbursement to cover telehealth serviced on or after October 
1, 2001, to include consultations, office visits, individual psychotherapy, and pharmacologic manage-
ment. Services were only covered for cases with interactive audio and video telecommunication systems 
when the patient was present and participating in the telemedicine visit. Eligible geographic areas in-
cluded rural health areas with practitioner shortages and counties not classified as part of an established 
metropolitan statistical area.133
Section 149 of MIPPA amended BIPA to reimburse services provided on or after January 1, 2009, for 
telehealth services performed in the office of a physician or practitioner, hospital, critical access hospital 
(CAH), rural health clinic, federally qualified health center, hospital-based or CAH-based renal dialysis 
facility, skilled nursing facility, or community medical center. In addition, as of 2009, both the distant 
physician or practitioner and patient are required to be present at the telehealth “visit” and interacting in 
real-time communication.134 
Clinical Technology
The Gateway: Genetics, Genomics, and Genome Technology 
The landmark discoveries accompanying the advent of genome sequencing transformed the field of 
clinical medicine. In 2001, The Human Genome Project at the National Institute of Health completed 
the initial mapping of the human genome, a milestone that fueled interest in the field of genomics.135 
The technological advancements that followed served as the foundation for a new genre of pharmaceuti-
cal and therapeutic medicine. Biotechnology and biopharmaceuticals are influential drivers in today’s 
market, accounting for 93 percent of dollars spent on healthcare merger and acquisition activity in May 
2009.136
In 2001, The Human Genome Project at the National Institute of Health 
completed the initial mapping of the human genome.
“The era of ‘omics unlimited,” by Raj P. Kandpal, Beatrice Saviola, and Jeffrey Felton, BioTechniques, Vol 46, April 
2009 (special issue), p. 351–55. 
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Biotechnology and biopharmaceuticals are influential drivers in today’s 
market, accounting for 93 percent of dollars spent on healthcare merger  
and acquisition activity in May 2009.
“Drug Deals Dominate M&A: Biotech and Pharma Outspend All Other Sectors,” by the Healthcare M&A Monthly, 
Vol. 14, Issue 6, June 2009, p. 1.
Genomics is the evaluation of the hereditary information provided by an organism’s DNA and the 
application of research findings to the fields of genetic engineering and enhancement, cloning, stem cell 
research, and eugenics.137 The National Center for Human Genome Research Institute (NCHGRI) 
is comprised of more than fifty researchers who are each dedicated to specific facets of genetic and 
genomic research and contribute accordingly to one of seven branches of the NCHGRI: Cancer Genet-
ics, Genetic Disease Research, Genetics and Molecular Biology, Genome Technology, Inherited Disease 
Research, Medical Genetics, and Social and Behavioral Research.138
Stem Cell Research
Within any living organism, each cell is specialized to a specific biological system. Stem cells are 
unspecialized cells capable of renewing themselves through cell division, sometimes after long periods 
of inactivity, and adapting their function to accommodate a certain type of tissue or organ under the 
proper conditions. The unique regenerative capacity of stem cells has the potential to change the way 
health problems, such as diabetes and heart disease, are treated. As such, efforts to advance reparative 
medicine (therapies that heal the body’s natural tissue) by developing efficacious cell therapies are at 
the forefront of medical research.139 On January 23, 2009, the first human embryonic stem cell (hESC)-
based therapy was approved for clinical trial; Geron Corporation announced clearance of their Investiga-
tional New Drug application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury. 
GRNOPC1 manipulates the growth-stimulating properties of nerve cells to provide rehabilitation for 
acute spinal cord injuries.140
On January 23, 2009, the first human embryonic stem cell (hESC)-based 
therapy was approved for clinical trial.
“Geron receives FDA clearance to begin world’s first human clinical trial of embryonic stem cell-based therapy,” 
by Geron: Visionary Therapeutics, January 23, 2009, www.geron.com/media/pressview.aspx?id=1148 (accessed 
July 1, 2009).
Stem cell research is also used to investigate the causes of birth defects, enhance drug development 
by providing molecular insight, and expedite the drug approval process by facilitating preliminary drug 
testing. Additionally, understanding the differences between embryonic and nonembryonic stem cell 
proliferation may be the key to understanding—and treating—cancer.141
The completion of the draft human genome sequence in 2001 was followed by research inquiries 
targeting transcripts (transcriptomics), RNAi/miRNAs (interferomics and micro-RNomics), proteins 
(proteomics), interacting proteins (interactomics), DNA and chromatin modifications (epigenomics), 
and metabolites (metabolomics).142 Developments in these areas contributed significantly to the mo-
lecular understanding of biology, pathology, and pharmacology; any advances in molecular research 
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are dictated by progress in these genomic substrata.143 Furthermore, molecular diagnostics represent the 
sector of the genomics market with the most promise.144
Diagnostic Technology
Diagnostic medicine is the utilized in both acute and chronic care for the purposes of prevention, screen-
ing, monitoring of health conditions, and disease detection and management. This staple of healthcare 
claims that, “A penny of prevention is worth a pound of cure . . . The pharmaceutical industry has long 
been focused on treatment of disease but it will be far more cost-effective to prevent disease than cure 
it, and this will be a driver of innovation.”145 Recent diagnostic advances support an attitude of preven-
tion that, though inherently accepted, has not been practiced sufficiently in healthcare to date. In order to 
truly realign demand and delivery of healthcare services, future developments may need to be directed at 
a diagnostic market increasingly driven by prevention and early detection. 
moleCular diagnosTiCs
Molecular diagnostics originally were used to screen for infections (for example, HIV, hepatitis, and 
tuberculosis) more accurately and effectively than traditional methods.146 The capabilities of molecular 
diagnostics since have evolved to include genetic disorder screening, pre-implantation screening, 
and cancer screening procedures, thereby facilitating the transition toward preventative healthcare.147 
Similarly, advances in genetic engineering and enhancement, pharmacogenetics, and pharmacogenomics 
have lead to a fusion of molecular diagnostics and therapeutic measures for specialized screening 
and treatment plans; this fusion is characteristic of personalized medicine. The capabilities afforded 
by molecular diagnostics have relied on developments in polymerase chain reaction (PCR)-based 
technology, electrochemical detection of DNA, biochip technology, nanotechnology, and proteomic 
technologies.148 The developments that materialized as a result of these molecular capabilities continue 
to affect the molecular, nonmolecular, and in vitro diagnostic markets.149 
The field of cancer diagnostics, utilizing molecular technologies, has been influential in the transition 
to personalized care. Cancer molecular diagnostics (CMD) most likely will not replace traditional patho-
logical examinations but rather serve to supplement and enhance these methods by employing them in 
conjunction with microarrays, reverse transcriptase polymerase chain reaction (RT-PCR), mass spectro-
metric proteomic analyses, and protein chips.150 CMD technology will allow practitioners to diagnose 
cancer, choose and develop personalized treatment plans, and identify predispositions twice as quickly 
as other assays for only a fraction of the drug development costs.151
Trends in Molecular Diagnostics 
The global market for molecular diagnostics encompasses more than 500 companies and, as of 2008, the 
United States controlled the majority of the market.152 The area of greatest promise lies in developing 
companion diagnostics that incorporate therapeutic care.153 
Regulatory and Reimbursement
In the past, molecular diagnostic innovations fell outside the stringent compliance requirements set by 
the Federal Drug Administration (FDA). In response to increased demand, regulations targeting in vitro 
diagnostic multivariate integrated assays (IVDMIA) and analyte-specific reagents (ASRs) were issued to 
increase FDA supervision of the field and elevate quality standards.154 These draft guidelines, published 
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by the FDA’s Office of In Vitro Diagnostic Device Evaluation and Safety in July 2007 and September 
2007, for IVDMIA and ASR regulation, respectively, will serve as a challenge for developers, especially 
for companies entering the market for the first time.155
Despite that diagnostic testing influences 70 percent of all healthcare decisions made, diagnostics 
only comprises 2 percent of overall Medicare spending. In a healthcare system historically focused on 
the quality of acute care provided, reimbursement for services targeting prevention and chronic disease 
management have not been thoroughly assessed since the 1980s.156 
Despite the fact that diagnostic testing influences 
70 percent of all healthcare decisions made, diagnostics 
only comprise 2 percent of Medicare spending.
“Medicare Needs to Get With the Times” The Burrill Report, Burrill and Company, 2009.
imaging TeCHnology
Medical imaging is defined as a “non-invasive process used to obtain pictures of the internal anatomy 
or function of the anatomy using one of many different types of imaging equipment and media for creat-
ing the image.”157 Imaging is one the fastest growing categories of services covered under Medicare 
Part B across all modalities, namely computed tomography (CT), magnetic resonance imaging (MRI), 
nuclear medicine, ultrasound, x-ray, and other standard imaging techniques.158 Under the 2005 Deficit 
Reduction Act, CMS moved to constrain spending on these services. The act stated that, with certain 
exceptions, physician payments under the CMS fee schedule must be capped at the levels established for 
independent diagnostic testing facilities under the Outpatient Prospective Payment System (OPPS).159 
See chapter 2, Facility-Based Reimbursement Rates for more detail regarding billing under OPPS. In 
June 2008, the GAO released a report affirming the findings that procured CMS’s decision. Spending for 
imaging services more than doubled from 2000 to 2006, increasing to approximately $14 billion, with 
80 percent of this growth explained by the increased quantities of complex imaging services.160 
Trends in Imaging Technology 
Continuous development and improvement of existing technology has characterized much of imaging 
development. For example, ultrasound is undergoing extremely promising improvements, with greater 
speed and enhanced quality affording higher frequency, better resolution, and three-dimensional (3D) 
imaging. This increased strength will foster an array of possibilities, including added specificity of 
results, a reduction in the necessity of biopsies, and more standardized ultrasound use. One substantial 
drawback to ultrasound is its reliance on operator competence. Compounded by the healthcare man-
power deficit, the shortage of professionals qualified to perform ultrasound procedures can be affected 
additionally by lagging reimbursement and liability concerns. Accordingly, professionals believe the 
repercussions of relying on operator capabilities will result in increased interest in technologies that 
promote ease-of-use.161
Of all the imaging services contributing to the $14 billion in imaging spending, the highest observed 
growth rates were attributable to advanced imaging modalities (MRI, CT, and nuclear medicine), with 
an average annual growth rate of 17 percent. These modalities are also the most expensive services. 
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Advanced imaging accounted for 54 percent of total imaging expenditures, with spending having more 
than doubled from $3 billion in 2000 to $7.6 billion in 2006.162
Advances in Magnetic Resonance Imaging
Functional MRI (fMRI), a combined positron emission tomography (PET) and MRI system, enables 
physicians to observe brain function while patients perform physical and mental tasks.163 fMRI is one 
of the most popular methods of brain imaging in today’s market.164 Open MRI systems, or short bore 
magnet systems, are another example of technological improvements to existing imaging technologies. 
These systems reduce claustrophobia for patients but generate images of comparable quality to those 
produced by traditional imaging technology.165 
As a result of these technological advances, an estimated 26.6 million MRI procedures were per-
formed in 2006, representing an average annual growth rate of 3 percent, and a 10 percent total increase 
from the 24.2 million procedures conducted in 2003.166 Spending on MRI services accounted for nearly 
half of the $4.6 billion increase in Medicare spending from 2000 to 2006.167 The ease of use afforded by 
these technological expansions has resulted in increased outpatient procedures; in 2006, 84 percent of all 
MRI procedures were performed on an outpatient basis versus 16 percent on an inpatient basis.168 
Advances in Computed Tomography
Computed tomography (CT) has transformed both diagnostic and interventional medicine. The quality 
of CT images appears to surpass the anatomical detail of competing imaging technologies due to the 
cross-sectional scanning capabilities they afford.169 Since its creation in 1970, use of CT technology has 
grown rapidly, with a 600 percent increase in utilization between the mid-1980s and the mid-1990s.170 
As of 2000, approximately 46 million scans per year were taken in the United States.171 Additionally, CT 
appears to expedite and improve initial triage of patients on an outpatient basis in the emergency room, 
allowing patients to either return home or be admitted for evaluation.172 The number of visits for which 
diagnostic imaging services were ordered grew from 28.3 percent in 1996 (3.2 percent being CT) to 44.2 
percent in 2006 (11.6 percent being CT).173 
Multidetector Row Computed Tomography (MDCT)
The advent of multidetector row (also known as multi-slice) CT (MDCT) technology has redefined 
imaging on the molecular and cellular levels, and thereby enhanced patient management and care.174 
Through the evolution from the 4-slice CT scanner, the 16-slice CT scanner, and finally, the 64-slice CT 
scanner, MDCT has raised the standard for image quality and accuracy allowing for the production of 
3D images.175 Recent market research indicates that CT accounts for 13 percent of all diagnostic proce-
dures in the United States, and that the 64-slice CT is the most popular CT technology in use.176
64-Slice CT is the most popular CT technology in use, as it made  
cardiac and cerebral CT imaging possible.
“Nuclear cardiology adopts hybrid and dynamic imaging” by David Berman, M.D., Diagnostic Imaging.com, 10/06, 
www.diagnosticimaging.com/display/article/113619/1193342 (accessed February 10, 2009).
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In addition to producing images with greater acuity, the 64-slice CT also operates at an increased 
speed compared to previously existing CT technology. The average scanning time for the 64-slice scan-
ner was 313 seconds, which was sixty-four seconds faster than second generation 16-slice scanners.177 A 
64-slice CT scanner can complete a scan in as little as eight to twelve seconds, compared to a traditional 
CT scanner’s time of twenty to thirty seconds.178 
With diagnostic imaging trends indicating that continued growth in the field is largely due to adult 
diagnosis and screening procedures by proxy of the available MDCT technology, the four areas of most 
interest at present are CT cardiac screening, CT colonography, CT lung screening, and CT whole body 
screening.179 
Dynamic Volume Computed Tomography
The latest in CT technologies, the 256- and 320- detector row systems, collectively are referred to 
as dynamic volume CT. Dynamic volume CT technology is capable of imaging an entire organ with 
isotropic resolution in one rotation and as a complete volume. The temporally uniform data are then 
reconstructed as a whole unit, thereby reducing the chance of artifacts and misregistrations in the image 
caused by creating a composite image.180 In addition to being quicker and more accurate, dynamic 
volume CT exposes a patient to a significantly lower dose of radiation than both 64-slice imaging and 
invasive diagnostic technologies. Similarly, dynamic volume CT scanning is sensitive enough to allow 
physicians to detect subclinical problems, facilitating earlier diagnosis and treatment.181 
“Fusion” Imaging—Nuclear Medicine and Combined Technologies
The adoption of CT in nuclear medicine has resulted in a hybrid technology known as “fusion” imaging 
that combines nuclear medicine cameras with CT detection methods.182 Positron emission tomography-
CT (PET-CT) as well as single, photon emission computed tomography-CT (SPECT-CT) systems have 
various qualities that may prove advantageous in addressing the problems posed by each independent 
system. By using a dual-system (SPECT-CT or PET-CT), patients can undergo both procedures at once, 
resulting in minimized error rates and better images.183
According to IMV Medical Information Inc. (IMV), a leading market research firm, “PET-CT scan-
ners have become the preferred technology for PET imaging, as the integration of functional PET im-
ages with anatomical visualization of CT has allowed more accurate and faster diagnosis.”184 
PET technology allows for substantially higher sensitivity than single-photon imaging technologies, 
such as SPECT.185 However, due to the longer half-life of single-photon emitters, SPECT tracers last 
six hours; PET tracers have only a seventy-five second half-life. A longer half-life enables the use of a 
wider observational time window.186 SPECT is much more available, widely used, and more affordable 
than PET-CT technology (a SPECT camera costs between $400,000 and $600,000, and the PET-CT 
can cost $2 million). Finally, the 1.6 million PET-CT procedures performed in 2007 cannot compete in 
quantity with the 15.9 million SPECT procedures performed during the same time period.187 However, 
SPECT is subject to longer scan times and can produce low-resolution images that are prone to artifacts 
and attenuation (especially in larger patients).188 
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PET technology allows for substantially higher sensitivity than single-
photon imaging technologies like the SPECT.
“PET versus SPECT: strengths, limitations, and challenges,” by Arman Rahmim and Habib Zaidi, Nuclear Medicine 
Communications, Vol. 29, (2008) p. 193–207.
IMV also reported increased use of SPECT-CT, capable of CT-based attenuation correction which, 
paired with CT calcium scanning, will significantly increase accuracy and interpreter confidence. Due 
to the insufficient sensitivity of current SPECT imaging technology, SPECT-CT may become the stan-
dard way in which SPECT studies are performed.189 Recent market research indicates that nearly half of 
SPECT sales globally are in fact SPECT-CT sales.190 
Despite these international trends, 75 percent of purchases in the United States are still SPECT. 
However, SPECT-CT trends are unlikely to mimic the dynamic increases in PET-CT use. Compounded 
by the current reimbursement environment, the main barrier to the SPECT-CT market is a shortage in 
technetium, the isotope most frequently needed for such nuclear procedures.191 Additionally, the major-
ity of SPECT procedures are performed in the field of cardiology, where SPECT-CT is only beneficial 
if it can generate sixty-four or more slices.192 Often, the cost allocated to such technologies is beyond 
the budgeting capacity of many cardiology departments.193 By contrast, PET-CT technology has been 
incorporated into many oncology practices, where budgets appropriately match the necessity of such 
technology.194
PET-CT technology has been most incorporated in oncology practices, in 
instances when budgets appropriately match the need.
“Great expectations and the saga of SPECT-CT,” by Greg Freiherr, Diagnostic Imaging, June 25, 2009, www.
diagnosticimaging.com/display/article/113619/1425226?CID=rss (accessed June 29, 2009).
Telemedicine and Imaging: Picture Archives and Communications Systems (PACSs) and 
Other Advances in Teleradiology
Teleradiology is the electronic transfer and storage of electronic imaging data. It is the market’s solution 
to ensuring a greater number of radiologists in the marketplace (average annual growth in the number 
of radiologists in the United States is 1.5 percent to 2 percent) and to increase in the number of images a 
radiologist must interpret (between 6 percent and 12 percent). Teleradiology allows for an increased reli-
ance on remote reading of scans, which helps imaging providers by alleviating the off-hour burden that 
night reads can cause to radiology groups.195
Other advances in teleradiology technology have allowed for the connection of digital x-rays and 
other imaging modalities to picture archives and communications systems (PACSs), which has 
greatly improved efficiency of imaging care by providing improved access to images with reduced 
delays Many of these systems are derived from infrastructures implemented in hospital radiology depart-
ments and have since expanded into a wide area of networks for healthcare systems and managed care 
organizations.196
NightHawk Radiology Services, founded in 1993, was the nation’s first company providing night 
reads using teleradiology. By November 2006, NightHawk’s market capital value was approximately 
$550 million,197 and the company reported significant profits as recently as 2008. By 2009, however, 
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NightHawk’s earnings moved from profit to loss, due in part to physician hesitation based on potential 
liability and lack of confidence in the telemedicine providers’ competence.198 Additionally, the extensive 
licensing and credentialing requirements of physicians who provide services by way of large teleradiol-
ogy companies provide services across the country further complicates the practice of teleradiology.199 
Despite the negative effect of customer attrition in the first quarter of 2009, however, NightHawk and 
others maintain that business opportunities continue to grow.200 
Companies providing day reads in subspecialty areas are beginning to show market expansion.201 
Full-field digital mammography makes telemammography and computer-aided detection possible, in-
creasing facility appeal without additional burden on staff. Furthermore, digital mammography has the 
potential to decrease patient anxiety because the technologist can stay in the exam room for the duration 
of the screening, and this technology has proven to be useful in imaging dense breast tissue, thereby 
improving quality of care.202 
Regulatory and Reimbursement
Specifically with regard to PET technology, federal regulations recently were updated to ensure compli-
ance of drug production and manufacturing practices with federal regulations regarding safety and qual-
ity of radiologic tracers used in PET procedures. New regulations require all PET production facilities to 
comply with the updated requirements effective on December 12, 2011, and include updating standard 
operating procedure for manufacturing of all PET drugs and PET drug product and activities related to 
quality assurance; facilities; equipment; personnel; and production, process, and laboratory controls.203
Therapeutic Technology 
moleCular PHarmaCology
Biopharmaceuticals are drugs and biologics that treat an organism through the genetic manipulation of 
foreign DNA. Biologics are therapeutic products that are developed using living sources, such as vac-
cines, blood and blood products, and allergenic extracts and tissues.204 The manufacturing of biophar-
maceuticals, most specifically vaccines, monoclonal antibodies, recombinant proteins, and stem cells, 
relies heavily on the cell culture market.205 In turn, the necessary in-depth knowledge of cell culture that 
fortifies molecular pharmacology was made possible with the advent of the genomic era. 
The FDA has approved drugs and biologics in eight categories of biopharmaceuticals: recombinant 
blood factors, recombinant thrombolytics and anticoagulants, recombinant hormones, recombinant 
growth factors, recombinant interferons and interleukins, recombinant vaccines, monoclonal antibody-
based products, and miscellaneous recombinant products.206 
Trends in Molecular Pharmacology 
Advances in Proteomics
Therapeutic protein technology has seen developments of innumerable implications. Insulin, the first 
recombinant protein to be approved, remains the prototype for biopharmaceutical development. It was 
among the first biopharmaceuticals to undergo molecular engineering, a process which has since de-
fined development and advancement in biopharmaceuticals.207 Seven faster or time releasing engineered 
analogs for insulin have been approved, and with breakthroughs in drug delivery technology, Exu-
bera inhalable recombinant insulin recently became the first biopharmaceutical to receive approval for 
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nonparenteral drug delivery (namely pulmonary but also oral, nasal, transmucosal, and transdermal 
delivery routes).208 With the incidence of diabetes on the rise, it is probable that the demand and market 
for such products will continue to grow. 209
Nucleic Acid-Based (RNAi) Therapeutics
Recent market reports predict RNAi therapeutics to generate sales of approximately $1 billion by 2015. 
These biopharmaceuticals show tremendous promise in countless areas, the most notable of which are 
Hepatitis C and cancer treatment.210 MicroRNAs are believed to regulate almost one-third of the entire 
genome, and they are anticipated to change therapeutic capabilities. “MicroRNAs developed as regula-
tors over millions of years to regulate complex disease. (They) may turn out to be enormously beneficial 
in terms of drug discovery.” 211 Though this area of technology has developed at a relatively slow pace, 
with fifteen years of research and only two approved products, approval of the first commercial gene 
therapy (molecular means of cancer treatment), Genedicine, reset the tone for nucleic acid-based RNAi 
drug development.212 Approval of Genedicine by the State Food and Drug Administration of China for 
treatment of head and neck squamous cell carcinoma will facilitate further developments in RNAi thera-
peutics and gene therapy.213
Regulatory and Reimbursement
As of 2006, 165 recombinant proteins, monoclonal antibodies, and nucleic acid-based drugs had been 
approved by the United States and Europe as treatments for cancer, diabetes, growth disturbance, he-
mophilia, and hepatitis. 214 As of 2007, the market size was estimated to be $75 billion, and spending 
is expected to continue to increase substantially through 2012.215 Although biopharmaceuticals are 
nowhere near the peak of their development, they are already expensive, with some biologics costing 
approximately $100,000 per year. Furthermore, research by the American Association of Retired Persons 
(AARP) has shown that prices of these biopharmaceuticals are rising at a rate greater than both inflation 
and the prices of other prescription drugs.216 
The high-priced market for biopharmaceuticals is a result of a disparity in the approval processes 
of biologic and nonbiologic drugs. To date, the majority of biologics have been regulated by the Public 
Health Service Act, which prohibited generic biopharmaceuticals from being marketed.217 Biopharma-
ceutical companies require a substantially longer monopoly period to see a return on their investment, 
which can lead to higher prices charged for their products.218
A 2008 AARP watchdog report suggests that the wholesale price of specialty drugs rose 8.7 percent 
during the course of 2007, while the average market price of those drugs rose 42.9 percent between De-
cember 2003 and December 2007. In contrast, nonspecialty branded drugs rose only 7.4 percent, and the 
price of generics fell 9.6 percent.219 These inflated prices have not been received well by insurers, many 
of which have raised the percentage of medication costs that patients are expected to pay. Some insur-
ers require that their patients use cheaper alternatives before approving the use of an expensive biologic 
option.220 
Supporting legislation to accelerate the process of developing and approving biosimilars by way 
of an FDA process for biosimilar or follow-on generic drug approval could potentially save taxpayers, 
insurers, and patients billions of dollars.221 Based on the Congressional Budget Office’s (CBO’s) 2008 
estimates, proposed legislation made possible by presidential budget provisions could save the federal 
government $6.6 billion in ten years and ensure biotech companies twelve years of market exclusivity 
for new drug development.222 
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radiaTion THeraPy
Trends in Radiation Therapy 
Much like imaging technology, radiation therapies have been developed, adapted, and improved since 
the discovery of the x-ray in 1895.223 Radiation therapy uses high energy light beams or charged par-
ticles to stunt the proliferation of cancer cells, which are very susceptible to damage from radiation due 
to rapid proliferation and an inability to regenerate.224 However, radiation therapy also has the potential 
to damage healthy cells. Most side effects of radiation therapy are short term and are usually confined 
to the area being treated. Typically, treatments are administered on an outpatient basis and over the 
course of multiple sessions.225 Radiation may be administered alone or simultaneously with chemo-
therapy either prior to, or in the absence of surgery. Approximately 50 to 60 percent of cancer patients 
are treated using radiation at some point during their disease.226 The continuous development of increas-
ingly sophisticated imaging technologies and procedures has resulted in earlier diagnoses and improved 
outcomes for patients through radiation therapies.227
Devices
Technology is the leading driver of radiation therapy’s competitive market.228 The development of linear 
accelerators and gamma knives has increased therapeutic capability, precision, and ease of use, all of 
which enhance the quality of care. These tools are utilized in the various modalities to deliver highly ad-
vanced therapy procedures, such as intensity modulated radiation therapy and stereotactic radiosurgery. 
In addition to executing treatment plans developed based on imaging scans, image guided radiotherapy 
is implemented by one-third of all radiation oncology sites to date, with ultrasound, x-ray, and CT imag-
ing technologies used most frequently.229 As radiation therapy has become one of the dominant methods 
of cancer treatment, demand is likely to increase as the population ages.230 
Linear Accelerators
The linear accelerator (LINAC) is the device most commonly used in external beam radiation therapy 
treatments (see Procedures) for patients with cancer. 231 Linear accelerators deliver uniform doses of 
high-energy x-rays to the localized area of a patient’s tumor. LINAC accelerates electrons to allow the 
electrons to collide with a heavy metal target, which scatters the high energy x-rays. A portion of these 
x-rays are collected and then shaped to form a beam that matches the patient’s tumor. 232 The beam 
emanates from a gantry that rotates around the patient. During this process, the patient lies on a mov-
able treatment couch.233 Lasers are utilized to ensure that the patient is properly positioned to receive 
the treatment. Radiation can be delivered to the tumor from various angles by rotating the gantry and 
the treatment couch. By modifying LINAC systems to include multileaf collimators, they can be used in 
intensity modulated radiation therapy.234 However, without the necessary modifications, LINAC systems 
simply are machines used for stereotactic radiosurgery.235 A new linear accelerator can cost anywhere 
from $1.5 million to $3 million.236
Gamma Knives
Development of the gamma knife revolutionized stereotactic radiosurgery by employing computer-
ized robotic technology to move patients at submillimeter increments during treatment. This maximizes 
the procedure’s practical utility, allowing a physician to accurately target safe but high-dose radiation 
treatment.237 Gamma knife treatments are administered in a single session and require CT or MRI com-
munication with the gamma knife’s computer planning system to identify targets and normal anatomical 
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structures and calculate the gamma knife treatment parameters. The gamma knife can be used for treat-
ment of a variety of health problems, namely malignant and benign brain tumors, blood vessel defects, 
and functional problems. Research is currently underway to implement gamma knife technology in 
epilepsy and Parkinson’s disease treatments.238 
Procedures
External beam radiation therapy (EBT) involves the administration of high-energy x-ray beams to 
kill cancer cells and treat tumors.239 Often, some x-ray, ultrasound, or CT imaging is used prior to the 
delivery to ensure that the path of the beam will align with the target area.240 Proton therapy is adminis-
tered in a similar manner, but instead of administering x-ray beams, beams of protons are used to irradi-
ate a variety of tumors, skull base sarcomas, and eye melanomas.241 Alternately, brachytherapy, a form 
of internal radiation therapy, is used to treat a smaller area in a shorter period of time, at higher doses of 
radiation by placing radiopharmaceuticals directly inside or next to the tumor.242 Brachytherapy can be 
temporary or permanent, with variable administration rates and doses. During permanent brachytherapy, 
also known as seed implantation, a radioactive seed is placed in or near the tumor where it gradually 
decreases in radioactivity over a predetermined period of time. After the seed is rendered inactive, it 
remains in the body with no lasting effect on the patient.243
Intensity-Modulated Radiation Therapy (IMRT)
Intensity Modulated Radiation Therapy (IMRT) is an advanced form of radiation therapy using 3D 
imaging and treatment delivery. It differs from 3D conformal radiation therapy (3D CRT), which uses 
linear accelerators to administer varying intensities of radiation without IMRT capabilities.244 Alter-
nately, IMRT treatments, custom-tailored using 3D CT images alongside computer generated dose 
calculations, most effectively treat the unique three-dimensional shape of a tumor. This method allows 
for increased precision in the administration of high dose radiation while preserving the surrounding 
tissue.245 
A 2004 survey of U.S. radiation oncologists indicated that 73 percent of respondents used IMRT, 
compared with 32 percent in 2002. Of those practitioners who had not used IMRT as of the 2002 sur-
vey release, 65 percent had begun using IMRT by 2004. Of all survey participants, 81 percent had used 
IMRT to enable the administration of high-dose radiation to their patients.246 In recent years, market 
studies have shown that EBT has fallen short of IMRT, whose market growth may be attributed to 
higher dose capabilities with less damage.247
Stereotactic Radiosurgery
Stereotactic radiosurgery is a nonsurgical procedure involving the single, high-dose delivery of tar-
geted gamma-ray or x-ray beams used to treat different parts of the body. It serves as an increasingly 
preferred alternative to invasive surgery for soft tissue tumors (for example, brain tumors).248 Most fre-
quently, stereotactic radiosurgery is administered in one session; however, physicians may recommend 
fractionated stereotactic surgery (two to five treatments) or stereotactic radiotherapy (more than five 
treatments) in circumstances in which tumors are larger than an inch in diameter. Linear accelerators, 
proton beams or heavy-charged particle beams, and gamma knives are all used to perform stereotactic 
procedures.249 
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roboTiCs and surgiCal TeCHnology
Trends in Robotics and Surgical Technology
Historical Developments in Minimally Invasive Surgery
Laparoscopy, a form of minimally invasive surgery, involves the insertion of a slender, tubular endo-
scope and other surgical instruments through the abdomen wall, allowing a practitioner direct internal 
visual navigation and control of a surgery.250 Laparoscopy and other forms of minimally invasive sur-
gery have evolved from continuous improvements in surgical technology to increase ease-of-use, com-
fort, and accuracy. In the early 1990s, countless attempts at robotic prototyping were made, namely in 
the area of laparoscopic surgical procedures, but nothing materialized.251 The U.S. military, with the in-
tention of designing a prototype to provide remote operative care in combat regions, actually pioneered 
the realm of surgical robotics. Introduced by Intuitive Surgical in 1996, this prototype came to be known 
as the da Vinci system, and it was approved by the FDA in 2000. Simultaneously, Computer Motion re-
leased to the market the first laparoscopic camera holder, which it called Automated Endoscopic System 
for Optimal Positioning, or AESOP.252
The da Vinci System Versus Laparoscopy 
Minimally invasive procedures lessen many of the risks traditionally associated with surgery through the 
use of several small incisions to guide fiber-optic cameras to the area(s) of interest.253 Some minimally 
invasive instruments, such as the da Vinci System, employ robotic equipment, which serves as an added 
benefit compared to laparoscopic methods due to increases in maneuverability, visibility, and precision. 
Laparoscopic techniques project a mirror image onto the screen which has proven to be counterintuitive 
for physicians. Robotic technology features digital correction to cater to the physician’s intuitive, natural 
tendencies, and thereby increases overall accuracy.254 
The da Vinci System revolutionized minimally invasive surgery by overcoming the limitations of 
both traditional surgical procedures and conventionally implemented noninvasive laparoscopic technol-
ogy. The procedure performed with this technology was originally limited to cardiac endoscopy, but 
it has expanded to include gastrointestinal, cardiothoracic, gynecologic, urologic, and other specialty 
surgical procedures.255 The da Vinci system uses small incisions for the placement of robotic append-
ages, which result in fewer scars that require less healing time, decrease patient discomfort, shorten post-
operative hospital stays, lower hospital costs, and decrease patient morbidity and mortality.256 Further, 
effective use of the da Vinci system reduces total operative time while minimizing blood loss.257 
The da Vinci System revolutionized minimally invasive surgery by 
overcoming the limitations of both traditional surgical procedures and 
conventionally implemented noninvasive laparoscopic technology.
“Robotic Surgery,” By Joan Trombetti, DotMed News, January 7, 2009, www.dotmed.com/news/story/7463  
(accessed July 6, 2009).
A keynote feature of the da Vinci system is its EndoWrist technology, which allows a surgeon to 
fully rotate his or her hand, therefore giving the surgeon the capacity to reach around, beyond, or behind. 
The EndoWrist technology provides the surgeon with seven degrees of freedom (that is, the number of 
different rotations by the robot “hand”), more than most other surgical robots on the market.258
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A fairly recent sojourn in minimally invasive surgery, robotic-assisted laparoscopic prostatectomy, 
combines da Vinci robotics with laparoscopy and “allow[s] for greater surgical precision . . . [leading] to 
improvements in cancer control, potency, and urinary function.” The da Vinci system has also been used 
to treat small and complex renal tumors.259 
Despite its proven benefits in the field, the system has its limitations. Surgeons struggle with the lack 
of tactile feedback. This would be remedied by strain sensor feedback, which is under development for 
implementation in future models. Additionally, the size and complexity of robotic appendages still limit 
the extent to which accurate movement can be controlled.260 Further, the system requires a significant 
amount of space—something that many hospitals and facilities cannot spare.261
Demand for Robotic Surgery
Despite the difficulties associated with robotic surgery, minimally invasive technologies are replacing 
traditional methods as quickly as the technology will allow. The global market was valued at an esti-
mated $6 billion in 2005; it is expected to reach $18 billion by 2015. Laparoscopic technology repre-
sents 25 percent of the market, mainly utilized in abdominal and pelvic procedures, which accounts for 
$600 million per year.262
During the past twenty years, the number of general surgical, gastrointestinal, gynecological, neu-
rosurgical, orthopedic, pediatric, radiosurgical, and urological procedures that employ either robotically 
assisted or robotically controlled capabilities has grown steadily, most frequently through adoption of 
the da Vinci system.263 As of September 2008, 1,032 da Vinci units had been purchased internationally, 
776 of which belong to facilities in the United States. In the third quarter of 2008 alone, ninety-one 
systems were sold, and Intuitive Surgical observed a 50 percent growth in its revenue to $236 million. 
Until recently, the da Vinci system was the only approved system on the market; however, in early 2009, 
CUREXO Technology Corporation announced FDA clearance of its robotic orthopedic surgical device, 
ROBODOC, for total hip arthroplasty.264
The CBO’s 2007 report, The Long-Term Outlook for Healthcare Spending, predicts that the United 
States will see a rise in total healthcare spending from 16 percent of GDP as of March 2007 to 25 per-
cent in 2025, 37 percent in 2050, and 49 percent in 2082.265 These projections are fueled by the perpetual 
technological advancement, dynamic availability of the most accelerated technologies, fear of potential 
malpractice suits, and efforts to procure economic gain that support the necessary supply factors to per-
petuate this inevitable expansion. Diagnostic and therapeutic technologies continue to emerge, replacing 
out-dated and risky techniques with less invasive, yet more expensive, alternatives. This ongoing devel-
opment of new technologies undoubtedly contributes to the role of the United States as the global leader 
in healthcare expenditures.266
According to the National Center of Health Statistics, a marked increase of inpatient elderly care has 
been seen in the past forty years, and the aging demographic does not suggest that this trend is slowing 
down in the near future. In 2006, 38 percent of the inpatient population was older than sixty-five, and 24 
percent was older than seventy-five, as compared with 20 percent and 9 percent, respectively, in 1970.267 
In addition to the rising costs are the technical demands associated with the accumulating intrica-
cies that make noninvasive procedures desirable. The required skill sets are challenging and demand 
extensive training, and improper use of these technologies can be more dangerous than the older alter-
natives.268 Although the da Vinci system has been used successfully in an array of surgical procedures, 
many surgeons remain skeptical of its continued use in the medical profession. For example, researchers 
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have found a gradual annual increase in the number of operational robots in the United States (approxi-
mately 400), with 25 percent of all cardiac surgical programs having procured a robot and performing 
approximately 1,700 robotic or robotically assisted surgeries annually. However, only a handful of 
institutions are performing the majority of these surgeries. Due to the excessive start-up and per proce-
dural costs of robotic surgery, as well as the complexity of many procedures, such as cardiac and tho-
racic surgeries, many institutions do not use the da Vinci robot as much as was expected, often utilizing 
it only for less complicated procedures (for example, urological surgery). Although minimally invasive 
technology is clearly a potential asset in the future of surgery, it is uncertain at what point and to what 
extent robotic surgery will become a regularly feasible procedure for many specialized and intensive 
surgical programs.269 
A “tortuous learning curve” paired with economic barriers to use necessarily indicate that surgeons 
proficient in robotic surgical procedures are scarce; however, surgeons and other medical profession-
als agree that this is bound to change.270 With time, evolving criteria, perspectives, and credentials will 
foster a new “breed” of surgeons, trained to take full advantage of the benefits that robotic, noninvasive 
procedures provide.271 Upon approving the da Vinci robot for cardiac procedures, the FDA mandated 
training of all surgical teams and professionals intending to use the product.272 Surgeons who have 
pioneered the infusion of robotic technology into their programs believe that success is imminent with 
the right team; dedication to administrative and clinical commitment; a properly devised curriculum 
targeted at surgeons, their teams, and other members of their departments; multispecialty training; and 
patience.273 As more institutions and surgical teams follow in their footsteps, a new tier of surgical com-
petition will lead to different expectations in medical care.
Regulatory and Reimbursement
Although each insurance company differs in what procedures it reimburses, Medicare covers all laparo-
scopic and thorascopic procedures.274 Currently, reimbursement for procedures that use robotic technolo-
gies is limited to the agreed-upon reimbursement for the baseline procedure.275 However, as more studies 
show that noninvasive cardiac technology is improving patient outcome metrics, and policymakers move 
toward incentive-based programs that improve the quality of robotically assisted procedures, robotic 
procedures may procure higher reimbursement.276 
Home Health Technology
Home care patients represented approximately 2.5 percent of the U.S. population as of July 1, 2000.277 
In 2006, 2.9 million people reportedly used home health services, an increase from 2.6 and 2.8 million 
in 2003 and 2004, respectively.278 Additionally, the growing segment of older Americans will invariably 
contribute to the increased use of home infusion therapies. Although the Bureau of Health Professions 
predicted in 2006 that, between 2000 and 2020, the U.S. population would increase by 18 percent, the 
number of Americans aged sixty-five and older is anticipated to reach 54 million (a 54 percent increase), 
accounting for 16 percent of the total population.279 Approximately 69 percent of those receiving home 
care services are older than age sixty-five.280 In addition, the growing baby boomer population will con-
tinue to inflate the number of candidates for home health care when they become eligible for Medicare 
beginning in 2011.281
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Trends in Home infusion THeraPy
Infusion therapy, growing in popularity, involves the administration of medications, nutrients, or other 
solutions intravenously, subcutaneously, enterally, or epidurally (into the bloodstream, under the 
skin, into the digestive system, or into the membranes surrounding the spinal cord). Specific home infu-
sion therapies include anti-infectives, chemotherapy, pain management, parenteral and enteral nutri-
tion, hydration therapy, and immunotherapy.282 By 2030, it is expected that approximately 20 percent 
of Americans will be older than the age of sixty-five, which will lead to an increase in the demand for 
home- and community-based services.283 One of the most common services received at home is infusion 
therapy, with about 4,000 regional providers reported in 2005.284 
The implementation in 1983 of the Prospective Payment System (PPS) for inpatient hospital services 
with its diagnosis-related group (DRG) payment system touched off a number of dramatic changes in 
the healthcare field (see chapter 2, Facility-Based Reimbursement Rates for further discussion of the 
PPS and DRG payment system). These changes affected not only inpatient hospital care but also virtu-
ally every aspect of the U.S. healthcare delivery system. As a result of the DRG payment methodology, 
traditional indicators of inpatient hospital utilization showed substantial changes. Between 1980 and 
1990, the number of hospitals and hospital beds declined, admissions and average daily census fell, and 
average length of stay decreased. Combined, these indicators of inpatient utilization pointed the way to a 
dramatic shift in the way healthcare services would be delivered. The types of services provided, as well 
as the location of service delivery, began to shift from the inpatient to the outpatient setting. As length of 
stay for Medicare patients shortened in the early 1980s, the percentage of Medicare patients discharged 
to home health increased from 9.1 percent in 1981 to 17.9 percent in 1985.285
The decrease of traditional inpatient utilization led to a virtual explosion of healthcare services in 
other areas, both on the hospital campus as well as in freestanding facilities located in the community. 
However, the location of service delivery also moved into the most convenient location possible—the 
patient’s home.286 This change in service delivery location significantly altered beneficiary access to 
care. As of 2008, approximately 99 percent of beneficiaries were located in an area for which at least one 
home health agency provided service, and 97 percent had access to services provided by two or more 
home health agencies.287 Despite adequate patient access to home health services, the number of provid-
ers continues to grow, exceeding the growth rate in Medicare enrollees.288 As of 2007, there existed more 
than 9,200 active home health agencies that participated in the Medicare payments program for home 
health care.289
The home infusion therapy market is comprised of approximately 3,000 to 4,000 national, regional, 
and local providers, with the majority operating primarily in either local or regional markets. Specifi-
cally, approximately one third are local or individually owned businesses, another third are hospital-
based providers, and the remaining third are national providers.290 
regulaTory and reimbursemenT 
Medicare remains the largest single payor of home healthcare services, paying for 37 percent of all home 
health expenditures in 2006, although private insurance represented a small portion of home health 
payments. “Out-of-pocket” spending growth decreased from 5.2 percent in 2005 to 3.8 percent in 2006, 
largely due to the introduction of Medicare Part D.291 In fact, total out-of-pocket spending declined from 
14 percent in 2001292 to 10 percent in 2006.293 However, it is estimated that the rate of out-of-pocket 
expenditures will increase to 6 percent by 2017. This would bring parity to the ratio of out-of-pocket 
spending to private health insurance spending.294 
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Although Medicare Part D covers both the ingredient costs and dispensing fees associated with home 
infusion therapy, it excludes any costs associated with equipment, supplies, and professional services.295 
Due to regulatory actions in 2008, home health reimbursement was cut 2.5 percent, and an anticipated 
12 percent cut in spending is projected through 2012.296 
Industry stakeholders and proponents of home infusion therapy continue to work with CMS to 
improve coverage and payment policies.297 Pharmacy experts claim that infusion therapy is a less risky 
market for reimbursement changes than other home healthcare services.298 According to a 2008 “Market 
Watch: Home Infusion Therapy and Specialty Pharmacy Services” industry report published by The 
Braff Group, reimbursement for home infusion therapy is expected to remain relatively stable, despite 
the projected decreases in durable medical equipment and home health agency reimbursement.299
Despite the relatively stable reimbursement environment, numerous attempts have been made by 
both the House of Representatives and the Senate to pass legislation for the reimbursement of equip-
ment, supplies, and professional services. Senators proposed bills in 2007 and 2008 (S 870 and S 3505, 
respectively) that were not passed.300 Additionally, in 2006 and 2007, the House of Representatives 
unsuccessfully proposed HR 5791 and HR 2567.301 
On January 15, 2009, Eliot Engel (D-NY) proposed The Medicare Home Infusion Therapy Coverage 
Act of 2009 (HR 574). The bill proposed that Part D coverage of home infusion services include equip-
ment, supplies, and professional services.302 Experts harbor mixed opinions on the fate of this bill based 
on the current administration’s overburdened agenda, even though this economic justifications fare in 
favor of passing the bill, which was still in the House Ways and Means Committee as of March 2010.303
Conclusion
Over the course of human history, healthcare trends have been driven by advances in our medical capa-
bilities, which are largely dependent on our technological progress. With the current market demand for 
both chronic and acute services undergoing continuous growth, available technologies, as well as future 
technological developments, will augment the healthcare practice with the clinical and administrative 
tools necessary to provide efficient, effective, and affordable healthcare services.
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America’s health industry that 
big leaps in health care safety, 
quality, and customer value will be 
recognized and rewarded. 
“Leapfrog Hospital Survey Results” The 
Leapfrog Group, 2008, p. 3.
www.leapfroggroup.org
“Inpatient Computerized Provider 
Order Entry (CPOE): Findings from 
the AHRQ Health IT Portfolio”
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statistics resulting in the Agency 
for Healthcare Research and 
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“Inpatient Computerized Provider Order 
Entry (CPOE): Findings from the AHRQ 
Health IT Portfolio”, By Brian E. Dixon and 
Atif Zafar, U.S. Department of Health and 
Human Services, Agency for Healthcare 
Research and Quality, January 2009, 
http://healthit.ahrq.gov/images/
jan09cpoerport/cpoe_issue_paper.htm 
(accessed June 22, 2009), p. 1. 
n/a
“Computerized Physician Order 
Entry Usage in North America: The 
Doctor is In” 
Statistics regarding levels of 
hospital integration of CPOE 
systems.
“Computerized Physician Order Entry 
Usage in North America: The Doctor is 
In” by Stacilee Oakes Whiting and Adam 
Gale, HIT Report from KLAS, Healthcare 
Quarterly, Vol. 11, No. 3 (2008), p. 94.
n/a
“U.S. Adoption of Computerized 
Physician Order Entry Systems”
Statistics and trends about the 
United States’s adoption of CPOE 
systems.
“U.S. Adoption of Computerized Physician 
Order Entry Systems” by David M. Cutler, 
Naomi E. Feldman and Jill R. Horitz, 
Health Affairs, Vol. 24, No. 6 (Nov./  
Dec. 2005), p. 1660.
n/a
“Saving Lives, Saving Money: 
The Imperative for Computerized 
Physician Order Entry In 
Massachusetts Hospitals”
The ramifications and necessity 
of CPOE use in hospitals. Also a 
highly quoted and comprehensive 
study regarding CPOE use in 
Massachusetts hospitals. 
 “Saving Lives, Saving Money: The 
Imperative for Computerized Physician 
Order Entry In Massachusetts Hospitals” 
by Mitchell Adams et al., Massachusetts 
Technology Collaborative, New England 




A good source for up to date news 
about telemedicine and telehealth.
http://tie.telemed.org http://tie.telemed.org
“Biopharmaceutical 
benchmarks 2006: The rate of 
biopharmaceutical approvals has 
leveled off, but some milestones 
bode well for the future” 
Information regarding the 
biopharmaceutical market.
“Biopharmaceutical benchmarks 2006: 
The rate of biopharmaceutical approvals 
has leveled off, but some milestones 
bode well for the future,” by Gary Walsh, 
Nature Biotechnology, Vol. 24, No. 7,  
July 2006, p. 769–76.
n/a
“Rx Watchdog Report, Trends in 
Manufacturer Prices of Specialty 
Prescription Drugs Used by 
Medicare Beneficiaries,  
2004-2007” 
Trends in biopharmaceutical 
pricing.
“Rx Watchdog Report, Trends in 
Manufacturer Prices of Specialty 
Prescription Drugs Used by Medicare 
Beneficiaries, 2004-2007,” by Stephen 
W. Schlondelmeyer, Leigh Purvis, and 
David J. Gross, American Association of 
Retired Persons, September 2008.
n/a
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“Report to the Congress: Home 
Health Services”
MedPac report. “Report to the Congress: Home Health 
Services”, MedPac, March 2008, p. 171.
n/a
National Institutes of Health A resource for stem cell research. “Stem Cell Information: Stem Cell 
Basics,” by the National Institutes of 
Health resource for stem cell research, 
April 28, 2009, http://stemcells.nih.gov/
info/basics/ (accessed June 29, 2009).
http://stemcells.nih.gov
Associations




Description Source Hyperlink Contact 
Information
International The International 
Radiosurgery 
Association (IRSA)
The IRSA provides information 










www.irsa.org The International 
Radiosurgery Association
3002 N. 2nd Street
Harrisburg, PA 17110 
Phone: 717-260-9808
International Radiological 
Society of North 
America (RSNA)
Founded in 1915, RSNA is a 
membership of medical imaging 
professionals committed to 
patient care through education 
and research. RSNA hosts the 












www.rsna.org Radiological Society of 
North America, Inc. 
820 Jorie Blvd.







The ATA is the leading resource 
and advocate promoting access to 
medical care for consumers and 


















1100 Connecticut Avenue, 
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Suite 540 
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6 Healthcare Reform: 
Past as Prologue to 
the Future
Everybody knows that the dice are loaded
Everybody rolls with their fingers crossed
Everybody knows that the war is over
Everybody knows the good guys lost
Everybody knows the fight was fixed
The poor stay poor, the rich get rich
That’s how it goes
Everybody knows
Everybody knows that the boat is leaking
Everybody knows that the captain lied
Everybody got this broken feeling
Like their father or their dog just died
Everybody talking to their pockets
Everybody wants a box of chocolates
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Overview
Motivated by the current economic conditions, trends in the reimbursement, regulatory, competitive, and 
technology aspects of the healthcare environment have facilitated the emergence of a historical reform 
initiative. As this Guide goes to press, sweeping changes in federal healthcare policy have been enacted, 
following months of partisan controversy, political drama, and often rancorous debates. The Patient 
Protection and Affordable Care Act, HR 3590, was signed into law on March 23, 2010, and one week 
later, President Barack Obama signed the Health Care and Education Reconciliation Act of 2010, HR 
4872, into law. As singular and perhaps as chaotic as these events may seem to have been, they may not 
be unexpected within the context of the history of healthcare reform efforts. 
A Historical Perspective on Healthcare Reform
Political and legislative initiatives related to U.S. healthcare reform date back to the early 1900s. Presi-
dent Theodore Roosevelt and the Progressive movement were among the first major political parties to 
endorse the idea of health insurance, and President Franklin D. Roosevelt (FDR) continued to support 
efforts for national health reform, mainly with the Social Security Act, which was passed by the United 
States Congress in 1935. Healthcare reform efforts continued through the late 1930s and early to mid-
1940s with the establishment of the Department of Health and Human Services (HHS) in 1939 and other 
national efforts to support a national health insurance plan. Early healthcare reform efforts also faced 
significant opposition, however. Following his election to a full term, President Harry S. Truman at-
tempted to pass FDR’s healthcare reform program, but it was defeated as a result of strong opposition 
from the American Medical Association (AMA) and the American Hospital Association (AHA), the 
latter which equated national health insurance to communism.1
Healthcare reform reached a major milestone with the creation of the Medicare and Medicaid pro-
grams, which President Lyndon B. Johnson signed into law in 1965. However, as growing healthcare 
expenditures began to raise concern throughout the 1970s, cost-containment efforts replaced national 
healthcare coverage initiatives as the main focus of lawmakers. This emphasis on cost savings and the 
corresponding lack of support for healthcare reform initiatives continued through President William 
J. Clinton’s administration. His healthcare reform initiatives, led by First Lady Hilary Clinton and Ira 
Magaziner, ultimately failed to garner adequate support for passage of the Health Security Act of 1993.2
The 2010 healthcare reform legislation marks the beginning of a new era in the long history of 
healthcare reform. The 2010 healthcare reform will substantially affect many, if not all, aspects of the 
delivery of healthcare in the United States by affecting healthcare providers, insurers, employers, and 
individual citizens. 
Figure 6-1 provides an overview of key historical healthcare reform events that paved the way for 
the current 2010 healthcare reform legislation.
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What Is Driving Healthcare Reform?
Exploding Time Bomb: Changing Patient Population  
Demographic
As mentioned throughout this Guide, the changing patient population demographic is one of the major 
factors driving healthcare reform. The changing age and ethnic distribution of the population substan-
tially affects the demand for healthcare reform, and the projected growth of the U.S. elderly population 
plays an important role in the anticipated demand for healthcare services. Based on the 2000 census, the 
population age sixty-five and older has been projected to grow from an estimated 39.4 million in 2010 to 
53.2 million in 2010, an increase from 13.2 percent to 16.5 percent of the total population.3 Additionally, 
the elderly population typically has a greater per capita use of healthcare services.4
The ethnicity of the U.S. patient population is also changing, with the 2000 census figures indicating 
an increasing degree of racial and ethnic diversity.5 As the minority population increases, the demand for 
the services tailored to this population may also increase.6 It is estimated that by 2020, physician patient-
care hours devoted to minority patients will have increased to 40 percent from an estimated 31 percent 
in 2000.7 The healthcare delivery system will need to identify disparities in access to care and differ-
ences in culture that impact the provision of care in order to adjust the availability of healthcare workers 
adequately trained to meet the healthcare needs of this growing segment of the U.S. population.8
Healthcare Expenditures
Rising healthcare expenditures as a percentage of gross domestic product (GDP) also significantly drove 
healthcare reform efforts. In 2009, total national health expenditures (NHE) in the United States grew 
to $2.5 trillion, a 5.7 percent increase from 2008.9 Concurrently, the nation’s GDP shrank by 1.1 per-
cent, and as a result, NHE increased from 16.2 percent to 17.3 percent of the GDP—the largest one-year 
increase in history.10 NHEs are predicted to continue to rise substantially in the next few years. A March 
2010 study in Health Affairs estimated that NHE would increase from $2,569.6 billion in 2010 (com-
prising 17.3 percent of the GDP in 2010) to $4,482.7 billion in 2019 (comprising 19.3 percent of the 
GDP).11 A 2009 study published in Health Affairs found that the rise in medical prices most greatly con-
tributes to the rise in expenditures for personal healthcare, which represents a large proportion of NHE.12
Despite a growing demand for healthcare services, the patient population continues to experience 
a financial strain to afford healthcare, with out-of-pocket spending for healthcare services rising faster 
than the typical household income from 2001–04.13 From 2001–06, the number of Americans indicating 
high financial burdens due to healthcare spending increased by approximately 1 percent a year, rising 
from 16.4 percent to 19.1 percent from 2004–06 alone.14
Increased Scrutiny of Fraud and Abuse
In addition to the goals for increased and affordable healthcare coverage, the 2010 healthcare reform 
legislation also responds to concerns related to fraud and abuse in the healthcare system. The legislation 
includes significant initiatives aimed at reducing fraud and increasing transparency in the Medicare and 
Medicaid programs, through such efforts as implementing transparency requirements for pharmaceuti-
cal and medical device manufacturers and amending various federal enforcement tools, including the 
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federal antikickback statute (AKS), the False Claims Act (FCA), and the federal physician self-referral 
law (Stark law).15
The healthcare reform legislation incorporates the Sunshine Act by requiring extensive reporting and 
public disclosure of financial arrangements between certain provider customers and manufacturers of 
drugs, medical devices, medical supplies, and biologics.16 This disclosure is intended to encourage vol-
untary avoidance of conflicts of interest that potentially can jeopardize the quality, integrity, and safety 
of clinical care, biomedical and academic research, and medical education, as well as lead to violations 
of federal fraud and abuse regulations.17
In addition to the new transparency and disclosure requirements, the healthcare reform legislation 
also amends various fraud and abuse enforcement activities. One new requirement is that overpayments 
made by Medicare or Medicaid must be reported within sixty days after the date the recipient identified 
the overpayment. The requirement further states that failure to make a timely repayment gives rise to 
liability under the FCA.18 
The healthcare reform legislation also makes two changes to the intent standards relating to fraud 
and abuse. First, the legislation amends the AKS by stating that a person need not have actual knowl-
edge of or specific intent to commit a violation of the statute for the government to prove a kickback vio-
lation.19 Secondly, the healthcare reform provides that “a claim that includes items or services resulting 
from a violation (of the AKS) constitutes a false or fraudulent claim for purposes,” of the FCA, which 
results in a law that any violation of the AKS is sufficient to state a claim under the FCA.20 
The new legislation also significantly changes the FCA by eliminating the jurisdictional bar for alle-
gations based on publicly disclosed information and by relaxing the requirements for a qui tam action to 
be eligible as an “original source.”21 These changes have the potential to increase providers’ FCA expo-
sure by allowing for a greater number of whistleblowers to bring a claim.22 Alternatively, the healthcare 
reform legislation also requires the secretary of HHS to set up a Stark law self-referral disclosure pro-
tocol, which will permit HHS to receive payment lower than the full Stark law measure of damages in 
appropriate circumstances, an initiative which will potentially provide considerable monetary relief for 
certain providers.23 
Healthcare Provider Manpower: Supply and Demand
As discussed in several other sections in this Guide, recent reports have indicated that the United States 
will face a growing physician manpower shortage, especially in primary care. This trend is driven by 
several factors, including the longer life expectancy of the aging baby boomer population, which typi-
cally utilizes a greater proportion of healthcare services than the nonelderly population.24 Additionally, 
the number of practicing physicians in the United States is predicted to remain fairly stagnant during the 
next decade due to physician lifestyle changes, which have resulted in a reduction of the total number 
of work hours, and retirement of current physicians (approximately 99,000 of which were older than 
age sixty-five in 2008).25 In its November 2008 report, the Association of American Medical Colleges 
(AAMC) indicated that solving the predicted physician shortage would not only depend on training 
more physicians but also on reconfiguring healthcare delivery and increasing efficiency.26 
The 2010 healthcare legislation responds to this projected shortage in physician manpower by (1) in-
creasing the number of graduate medical education training positions; (2) giving priority to primary care 
and general surgery fields and to those states with the lowest resident physician-to-patient population; 
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(3) increasing workforce supply and support by providing health professionals with training-related 
scholarships and loans; (4) promoting training in the areas of preventive medicine and public health; (5) 
increasing the capacity for nurse education, the support for nurse training programs, and the number of 
loan repayment and retention grants; (6) creating a career ladder to nursing; and (7) establishing a Pre-
vention and Public Health Fund for prevention, wellness, and public health activities.27
Restructuring Reimbursement
The continuing controversy regarding physician reimbursement levels and the sustainable growth rate 
(SGR) formula for determining the annual conversion factor (CF) under the Medicare physician fee 
schedule are partial drivers of the efforts that have supported the progression of healthcare reform initia-
tives under the Obama administration. At the same time, the movement from a capitated fee reimburse-
ment system to a fee-for-service (FFS) and managed care payment system has facilitated an increase in 
NHE. This growth in NHE during the past several years has prompted recent efforts to downshift reim-
bursement for physician services (for example, by way of bundled payments) in an effort designed to 
contain healthcare costs. 
Repeal of the SuStainable GRowth Rate (SGR) 
The SGR method replaced the Medicare Volume Performance Standard (MVPS) provision in 1997 to 
provide annual target updates to the physician fee schedule for Medicare Part B. The SGR formula is 
designed to control aggregate growth in Medicare expenditures by raising or lowering the proposed pay-
ment target to reflect actual cumulative expenditures.28 The calculation of SGR relies upon four factors, 
according to the Centers for Medicare & Medicaid Services (CMS):
1. “The estimated percentage change in fees for physicians’ services;
2. The estimated percentage change in the average number of Medicare fee-for-service  
beneficiaries;
3. The estimated 10-year average annual percentage change in real GDP per capita; and,
4. The estimated percentage change in expenditures due to changes in law or regulations.”29
The purpose of instituting the SGR formula was two-fold: (1) to ensure patient access to physician 
services; and, (2) to predictably control federal spending on Medicare part B.30 Since its enactment, 
actual Medicare expenditures remained below target expenditures through 2001. Thus, the updates to 
the physician fee schedule were close to the Medicare economic index (MEI), and for two consecutive 
years, 2000 and 2001, the actual physician fee schedule update was more than twice the MEI.31 How-
ever, every year since 2002, actual expenditures have exceeded target expenditures, with a 65 percent in-
crease in per-beneficiary expenditures on Medicare services between 1997 and 2005.32 Because of actual 
expenditures exceeding target expenditures, the SGR formula dictated a reduction in the fee schedule.33 
Despite this, Congressional action to suspend the impending cuts to payments for physician services 
every year since 2003 has resulted in a widening gap between the cumulative spending and cumulative 
target each year the proposed cuts were overridden.34 Table 6-1 illustrates the proposed and actual physi-
cian fee schedule conversion factor (CF) updates for the years 1997 through 2010.  
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According to estimates by the CBO, under the current 
SGR mechanism, the cumulative gap between target and 
actual expenditures will continue to grow, perhaps increas-
ing to a peak deficit of approximately 40 percent, until 2014, 
when it is predicted that actual spending will dip below 
target levels once again.35
CuRRent ConGReSSional StatuS  
ReGaRdinG the SGR: fix oR Repeal
The 2010 healthcare reform bill did not contain language to 
permanently repeal or change the SGR formula. However, 
on November 19, 2009, the U.S. House of Representatives 
passed a bill by a vote of 243 to 183, which would perma-
nently repeal the SGR, replacing it with a framework that 
would update the Medicare physician payment schedule by 
GDP + 2 for evaluation and management services, and GDP 
+ 1 for other services.36 In anticipation of the Senate vote on 
this legislation, Congress temporarily postponed the 2010 
cut, originally set to take effect on January 31, 2010.  Upon 
reconvening on April 12, 2010, the Senate decided to tem-
porarily fix the planned 21.3 percent Medicare physician fee 
cut by delaying implementation of the SGR formula until 
June 1, 2010.37
On May 20, 2010, text of the “American Jobs and Closing Tax Loopholes Act of 2010” was intro-
duced by Congress. On May 28, 2010, the House of Representatives chose to separate the text regarding 
the postponement of the Medicare physician payment cut from the remainder of the bill text and subse-
quently approved the physician payment legislation by a vote of 245 to 171. While this bill would not re-
peal the SGR, it would delay the scheduled June 1, 2010 cut to physician payment rates under Medicare 
until 2012, providing a 2.2% increase to rates from June 1 to December 31, 2010, and a 1% increase for 
2011, with the rate for 2012 to be, once again, determined depending on a targeted growth rate.38
To avoid disruption in the delivery of health care services to beneficiaries and payment of claims 
for physicians, on May 27, 2010, CMS directed its contractors to hold claims for services paid under 
the MPFS for the first 10 business days of June (i.e., through June 14, 2010).39 This hold only applied 
to MPFS claims with dates of service of June 1, 2010, and later. With the expectation of Congressional 
action in the near future, CMS extended this hold and directed its contractors to continue to hold June 1, 
2010 and later claims through Thursday, June 17, 2010, with the plan to lift the hold on Friday, June 18, 
2010.40
Yet, with an agreement not yet reached, and the expiration of CMS’s hold rapidly approaching, on 
Wednesday, June 16, 2010, the proposed nineteen month fee fix was reduced to seven months in an at-
tempt to gain the 60 percent supermajority needed to pass the legislation. However, even after shaving 
off twelve months, the “test vote” on the measure failed to pass, with every Republican and twelve Dem-
ocrats voting against the bill, in a 52-45 vote.41 Forced to restart the process, Democrats gave doctors 
Table 6-1:  Proposed and Actual Annual Up-





1997  2.0%  0.6%
1998  2.2%  2.3%
1999  2.3%  2.3%
2000  2.4%  5.5%
2001  2.1%  5.0%
2002  –4.8% -4.8%
2003  –4.4%  1.7%
2004  –4.5%  1.5%
2005  –3.3%  1.5%
2006  –4.4%  0.2%
2007  –5.0%  0.0%
2008 –10.1%  0.5%
2009 –15.1%  1.1%
2010 –21.3%  2.2%
*  “Estimated Sustainable Growth Rate and Conversion Factor, for 
Medicare Payments to Physicians in 2010” Centers for Medicare & 
Medicaid Services, November 2009, p. 7.
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even shorter relief from the impending one-fifth Medicare cuts in their payments, by giving doctors only 
a 6 month reprieve in the looming cuts, and only increasing the physician reimbursement rate by 2.2% 
through November 30, 2010.42
Late Thursday night, June 17, 2010, the Senate reached a deal and passed a short-term six month 
physician pay cut, blocking the 21 percent reimbursement cut scheduled to go into effect on June 18, 
2010, after making the physician fee fix a separate provision from the larger H.R. 4213.43 This update 
came after failing earlier Thursday to pass the entire H.R. 4213, which not only would have provided 
the physician payment relief, but also included provisions to extend tax and jobless benefits.44 With 
Senate approval, the newly crafted compromise bill returned to the House, but the House was unable 
to consider the measure before Monday, as they had already broken for the weekend.45 The House was 
expected to pass the bill quickly, since in May, they approved a more expansive version of the bill that 
stayed the physician fee cuts until 2012. However, because House Democrats were seeking to pass a 
longer-term fix for the payment, they did not approve the bill until Thursday June 25, 2010, forced to 
concede to the $6.5 billion, six-month stand-alone physician fix as a compromise.46
The House’s passage and enactment of the Senate’s bill reversed the 21.3 percent cut to Medicare 
physician payments that had been in effect since the previous Friday, affecting all claims submitted and 
processed after June 1, 2010, and it provided the expected 2.2 percent increase for claims dated from 
June 1, 2010 to November 30, 2010.47 On Friday, June 26, 2010, President Obama signed into law The 
Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act. Once the bill became 
law, CMS directed its contractors to begin processing the physician and provider claims at the new in-
creased rate.48
President Obama has pushed for an extension of the payment freeze until the end of the year,49 while 
others, including the American Medical Association, have pushed for a permanent repeal. The Con-
gressional Budget Office has estimated, however, that permanently fixing the Sustainable Growth Rate 
formula, will cost $276 billion over the next decade, which is a thirty three percent increase from the 
initial estimation of $207 billion.50 This projected cost of a permanent repeal has been a major issue for 
Congress, which has in turn resulted in Congress choosing to postpone the date and shorten the length of 
the cut.
Meanwhile, during the debate about fixing the Sustainable Growth Rate, the uncertainty about the 
SGR’s future has significant present day implications. With forty-five million Americans counting on 
Medicare, physicians face substantial difficulty maintaining viable practices in an environment with 
such extreme financial uncertainty. Increasing numbers of doctors are simply choosing to cease accept-
ing Medicare patients altogether,51 and the uncertainty from one month to the next ultimately threatens 
patients’ access to care by undermining the ability of physicians to plan for the future.
downShiftinG ReimbuRSement
As Medicare reimbursement has remained stagnant or has decreased for the professional component of 
healthcare reimbursement since the 1990s, physicians have looked to the ancillary services and techni-
cal component (ASTC) revenue stream to supplement their income, by way of ownership investment in 
ambulatory surgical centers, independent diagnostic testing facilities, and specialty or surgical hospitals. 
However, legislative and regulatory opposition at the federal and state levels to limit physician owner-
ship of or investment in ASTC revenue stream enterprises have served to restrict physicians in private 
practice to receiving only professional fee component revenues. This is viewed by some as relegating 
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physicians to the status of “sharecroppers” or “hired help” or compelling many physicians to acquiesce 
by accepting employee status under the substantial control of hospital systems or large corporate players.
The reduction in reimbursement levels for physicians may have had more widespread effects than 
adversely affecting physician revenue and income levels. An article published in the Journal of the 
American Medical Association in February 2010 found that a sample of more than 40,000 physicians 
reported that their hours worked have decreased an average of 7.2 percent from the periods 1996–98 
through 2006–08 (from an average of 54.9 to 51 hours per week).52 Additionally, the authors found that 
inflation-adjusted physician fees had decreased by approximately 25 percent between 1996 and 2006, 
which coincided with the decrease in physician hours worked, suggesting that the decrease in physician 
work hours may have been partially a result of decreasing incentives due to reduced levels of reimburse-
ment.53 This trend has also become a concern to health workforce analysts, who predict an impending 
physician shortage.54 
The continuing two-pronged attack on niche providers pertains to both specialty physicians and phy-
sician owners of practices and specialty hospitals. It includes (1) increasing the reduction of reimburse-
ment yield, most notably for traditionally high-reimbursement yield specialty procedures (for example, 
echocardiography, nuclear imaging, etc.); and (2) the continued attack on physicians sharing in the 
ownership of the ASTC revenue stream, as evidenced by the provisions restricting physician ownership 
of specialty hospitals in the 2010 healthcare reform legislation.
As revenue streams available to physicians are limited by these changes, current trends, such as the 
rise of hospital acquisitions of physician practices and employment of physicians, especially for more 
profitable specialties that are well-suited to provide services in a hospital-based setting (for example, 
cardiology, orthopedics, radiology, etc.), are likely to continue.
Experts predict that competitive pressure, as well as newly adopted and pending revenue cycle 
management regulations, will force providers to assess their revenue cycle management systems. This 
assessment will likely result in providers making system upgrades and purchasing new systems during 
the next several years.55 Providers with older revenue cycle management systems could possibly upgrade 
these systems to improve patient satisfaction and convenience and also to more efficiently manage their 
revenue cycle.56 Patient satisfaction, convenience, and increased efficiency may result from a patient’s 
ability to pre-register, schedule, and pay for his or her services through the provider’s website, among 
other things.57 Furthermore, providers will likely benefit from new systems that improve efficiency by 
easily checking payors’ rules to ensure that the services to be performed are covered, automatically 
creating bills from patients’ electronic medical records, bypassing clearinghouses and submitting claims 
directly to payors, enabling providers to receive electronic funds transferred directly from payors to the 
provider’s bank, and allowing providers to integrate their financial and clinical data.58 Nonetheless, the 
significant changes to the reimbursement landscape lay an unsteady and uncertain foundation for the 
future of reimbursement for providers.
bundlinG paymentS
Bundling is a method of reimbursement that combines institutional and professional charges into a single 
payment.59 Recently, legislators have advanced several proposals to reduce Medicare costs. The propos-
als employ various methods of bundling payments to hospitals and physicians for services provided 
during the course of a patient’s treatment plan. The Senate Finance Committee’s “Proposals to Improve 
Patient Care and Reduce Health Care Costs,” demonstrated this trend in a plan to use the bundling of 
payments for inpatient and post-discharge care.60 
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Proponents of bundled payments argue that the move toward bundled payments could provide higher 
coordination between providers and more efficient levels of care.61 Critics, on the other hand, articulate 
concern about the level of savings and patient care improvement that blanket bundling of payments actu-
ally will generate. For example, the AMA expressed concern that such bundling proposals could result 
in the withholding or limiting of appropriate post-discharge or inpatient services.62 The AMA also called 
for the appropriate distribution of the payments to individual providers, risk-adjustment for patients 
whose care exceeds the amount accounted for in the bundled payment, and safeguards to ensure that 
patient care decisions remain in the hands of the individual providers.63 Similarly, in a letter to the Sen-
ate Finance Committee, the AHA stated that the Obama administration’s approach to bundling payments 
was “problematic” and would require a “paradigm shift in health service delivery,” resulting in the 
revision or withdrawal of numerous regulations promulgated to manage the current healthcare delivery 
and payment system.64 Finally, the AAMC, which supports the concept of care coordination provided 
through bundling, criticized Medicare’s Acute Care Episode Demonstration program for not ensuring 
that payments are made directly to all parties (that is, physicians) who provide the services.65 
Although no actual bundling policy has been implemented, recent actions by both the Senate and 
CMS have demonstrated that such initiatives are on the healthcare horizon and may soon become a part 
of the healthcare reimbursement environment. For example, the 2010 healthcare reform legislation in-
cludes a provision for the creation of a new demonstration project to pay bundled payments for episodes 
of care that include hospitalization (effective January 1, 2012, through December 31, 2016).
The changing patient population demographic, rising levels of healthcare expenditures, growing con-
cern about fraud and abuse, continuing controversy about physician reimbursement, growth in NHE, and 
the SGR formula for determining the annual conversion factor are all significant drivers of the efforts 
that have propelled healthcare reform initiatives under the Obama administration.
Passage of the Patient Protection and Affordable 
Care Act and the Health Care and Education  
Reconciliation Act of 2010 
Legislative Events Leading to the Passage of  
Healthcare Reform
With the Obama administration in the White House, and a Democratic majority in both the Senate and 
the House of Representatives, the favorable time to approach healthcare reform appeared imminent to 
some. However, with the election of a Republican senator in Massachusetts and waning public approval 
of the healthcare initiative driven by rising unemployment rates, a declining economy, and an increase 
in the federal deficit, problems arose for those expecting a speedy legislative reform process.66 How-
ever, after long and heated debate regarding the content of potential healthcare reform initiatives to be 
included in the proposed legislation, the Patient Protection and Affordable Care Act, HR 3590, and the 
Health Care and Education Reconciliation Act of 2010, HR 4872, were enacted on March 23, 2010, and 
March 25, 2010, respectively.
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SummaRy of Key pRoviSionS
The passage of HR 3590 and HR 4872 will result in significant changes to the country’s healthcare land-
scape. Table 6-2 provides a brief overview of the various entities and sectors of the healthcare industry 
that are affected by provisions included in the 2010 healthcare reform legislation.
Table 6-2: Chart of Key Provisions
Company Provision Effective Date
Insurance Industry
 Insurance market rules September 23, 2010
 Grandfathered plans—eliminate pre-existing condition exclusions for children September 23, 2010
Grandfathered plans—eliminate pre-existing condition exclusions for adults July 6, 1905
 National high-risk pool Dissolved after 2014
Health insurance exchanges for individual states January 1, 2014
National Association of Insurance Commissioners must establish uniform definitions 
and standard methodologies
December 31, 2010
Consumer-operated and oriented plan (CO-OP) 2013
Individuals and Employers
All individuals required to obtain health insurance coverage 2014
Employers with more than fifty employees that do not offer coverage 2014
 Employers with fewer than fifty employees 2014
 Employers that offer coverage to their employees 2014
 Employers with more than 200 employees 2014
Medicare
Reduce the gap between generic and brand-name drugs 2020
Restrictions on revenue spending for Medicare Advantage plans 2014
Medicaid
Increase payments for primary care services 2013 and 2014




Provides a refundable credit for coverage under a qualified health plan January 1, 2014
Provides a sliding-scale tax credit to small employees 2010
Excise tax on individuals 2013
Excise tax on businesses  
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Table 6-2: Chart of Key Provisions (continued)
Company Provision Effective Date
Prevention and Wellness
Coordination of federal prevention, wellness, and public health activities 2014
Create Prevention and Public Health fund 2014
Create task forces on preventive services and community preventive services 2014
Fraud and Abuse Streamlined Medicare prepayment medical review limitations and additional funds 
for programs focusing on reducing healthcare fraud
[2010]
Funding Mechanisms Impose tax on high-cost insurance [?] 2013
Hiring Incentives to Restore  
Employment Act
Exemption from payment of employer’s share of Social Security employment taxes March 18, 2010, to  
January 1, 2011
Tax breaks for private-sector businesses that hire unemployed workers in 2010 February 3, 2010, to  
January 1, 2011
The various entities and sectors of the healthcare industry that are affected by provisions included in 
the 2010 healthcare reform legislation include:67
1. Insurance industry. The 2010 healthcare reform legislation subjects the insurance industry to 
increasing restrictions regarding expanding coverage requirements.
2. Individual states. All states are required to establish an American Health Benefit Exchange by 
January 1, 2014, to facilitate the purchase of qualified health plans and a Small Business Health 
Options Program (SHOP) that will assist small employers (fewer than 100 employees) in obtain-
ing coverage for employees. 
3. Individuals. Perhaps the most controversial mandate is that individuals are required to obtain or 
provide some minimum level of health insurance coverage. The healthcare legislation requires all 
individuals to obtain health insurance coverage or pay penalties. Exemptions will be granted for 
financial hardship, religious objections, American Indians, those without coverage for less than 
three months, undocumented immigrants, incarcerated individuals, those for whom the lowest 
cost plan option exceeds 8 percent of individual income, and those whose individual (or house-
hold) income was below the tax filing thresholds.68 
4. Employers. Although the 2010 healthcare reform legislation does not require employers to of-
fer health coverage to employees, employers can face significant penalties if they choose not to 
do so. Chapter 7 of Professional Practices discusses the legislation in detail as it pertains to the 
extensive provisions for both small and large employers.
5. Medicare. The program is required to provide, among other topics, a productivity adjust-
ment and reductions to market basket updates for many providers; make several concessions 
to expand primary care, coordinated care, and delivery system reform; support quality, trans-
parency, and fraud and abuse enforcement initiatives; provide a rebate for Medicare Part D 
beneficiaries required to pay out-of-pocket for prescription drug coverage in 2010; enforce 
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provisions to continuously reduce the gap between generic and brand-name drugs by 2020; add 
restrictions in 2014 on revenue spending for Medicare Advantage plans; update disproportionate 
share payments (DSH); address the impact of physician ownership; and control the diagnostic 
imaging utilization rate.
6. Medicaid. Reform initiatives related to Medicaid will be phased in between 2010 and 2014 and 
include several provisions related to expanding enrollee eligibility, prescription drug coverage, 
and primary care and preventive services coverage, among others. Additionally, Medicaid will be 
required to designate new matching payments for eligible individuals with and increase Medicaid 
payment rates for primary care physicians.
7. Public health. The 2010 healthcare reform legislation also supports public health workforce 
training and expansion, as well as support for prevention and wellness initiatives.69 Additionally, 
the initial 2010 healthcare reform legislation establishes the National Prevention, Health Promo-
tion, and Public Health Council to coordinate federal prevention, wellness, and public health 
activities, as well as the creation of a Prevention and Public Health fund to expand funding for 
prevention and public health programs. Further, the legislation creates task forces related to pre-
ventive services and community preventive services for the purpose of developing, updating, and 
disseminating evidence-based recommendations on the use of clinical and community prevention 
services.70
8. Tax provisions. The 2010 healthcare legislation contains certain tax provisions, including the 
provision of a refundable credit for coverage under a qualified health plan, effective January 1, 
2011, as well as a sliding-scale tax credit to small employers (those with fewer than twenty-five 
employees and average annual wages of less than $50,000) that purchase health insurance for 
their employees. Funding mechanisms to support the implementation of these reform initiatives 
include imposing a tax on high-cost insurance (that is, insurance that exceeds a maximum premi-
um payment level while increasing premiums for those in high-risk professions). The legislation 
additionally expands the Medicare tax base for taxpayers with higher income revenue provisions.
Timeline for Implementation of HR 3590 and HR 4872
Figure 6-2 provides an overview of the implementation timeline related to certain key healthcare reform 
initiatives.
Obstacles to the Implementation of Healthcare Reform
After passage of the 2010 healthcare reform legislation, there remains heated opposition from the Re-
publican Party regarding the content and implementation of the bill’s provisions. This may be in part due 
to differing perceptions with regard to quality and access to care. An April 2010 study in Health Affairs 
found that respondents who identified themselves as being affiliated with the Republican Party, male, of 
senior status, and wealthy were more likely than their counterparts to believe that uninsured individuals 
have little or no difficulty in obtaining healthcare.71 The fundamentally different views expressed by the 
Democratic Party, which supports government intervention, and the Republican Party, which supports 
increased market competition to control spending in a capitalist market, regarding how to best contain 
healthcare costs also suggest a division in opinion regarding the proposed reform initiatives.72
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The success of the implementation timeline will depend largely on the continued political and fis-
cal support for the measures proposed in HR 3590, and although the current political environment on 
the federal level may support the bill, individual states are responsible for much of its implementation, 
leaving ample room for delays created by lack of aggressive oversight or support.73 The states’ major 
implementation responsibilities include establishing the insurance exchanges for small businesses and 
individuals, enforcing the new insurance requirements, and administering the new Medicaid expansion.74 
Without continued support of the Obama administration, Congress, other stakeholder groups, the media, 
and the public, the strides made in healthcare reform by the passage of HR 3590 and HR 4872 may be 
countered, similar to when the Medicare Catastrophic Coverage Act of 1988 was repealed slightly more 
than a year after its passage.75 The result of the November 2010 midterm elections may play a large 
role in determining whether the current reform initiatives will maintain the majority of political support 
required to successfully implement the provisions of HR 3590 and HR 4872.76
Several of the attorneys general running for political office or up for re-election in the near future 
are challenging the reform bill.77 State attorneys general filed lawsuits in federal court, within minutes 
of President Obama’s signing of the healthcare reform legislation into law. Each lawsuit claims that the 
healthcare reform legislation violates the United States Constitution. One lawsuit, led by Florida Attor-
ney General Bill McCollum, and joined by twelve other state attorneys general, claims that the reform 
legislation exceeds Congress’s power to regulate commerce, violates the 10th Amendment protection of 
state sovereignty, and imposes an unconstitutional direct tax.78 The other suit, filed by Virginia Attorney 
General Kenneth T. Cuccinelli, states that Virginia is in a unique situation, as it is the only state to pass a 
law that creates a conflict of interest between the state law and the federal law by “protecting its citizens 
from a government-imposed mandate to buy health insurance.”79 
In addition to political obstacles to the enactment of healthcare reform, some consider physicians a 
potential barrier to some reform initiatives, namely, cost-containment measures.80 Some research studies 
have shown that the regional variance in healthcare spending is correlated with physician recommenda-
tion of additional tests of discretionary or uncertain benefit to the patient, and that reform efforts focused 
on reducing spending in high-cost regions (for example, limiting unnecessary visits, procedures, etc.) 
would greatly assist in cost-containment initiatives.81
Proposed Supplemental Reform Initiatives
Despite the monumental passage of HR 3590 and HR 4872, one thing that remains clear amid the loom-
ing uncertainty regarding what this reform means is that healthcare reform must be viewed as a process 
rather than an event. In the months (and years) ahead, additional healthcare reform initiatives will be 
proposed and implemented. The implementation of the 2010 healthcare reform legislation will be adap-
tive and possibly erratic, as its implementation not only depends on what is contained within the actual 
text of the legislation but also how it responds to outside factors, such as the public’s support of the 
legislation; the changing political and economic landscape; the private sector’s response; the healthcare 
professionals’ real-life, day-to-day application of the law; and the governors’, attorneys’ general, and 
states’ response to the reform. Accordingly, consultants advising individuals and businesses in these 
matters should keep abreast not only regarding the impact of the healthcare reform legislation that has 
been passed to date but also forthcoming proposals and initiatives. 
V1-F-Chapter 06.indd   264 9/28/10   3:21 PM
Chapter 6 : Healthcare R eform: Past as  Prolo gue to the Fu ture
265
Paying for Healthcare Reform
Reforming healthcare in America may cost the government an estimated $820 billion or more over ten 
years,82 which may be funded in a variety of ways including (1) cutting fraud and abuse within exist-
ing government health programs, (2) removing large subsidies to insurance companies, (3) increasing 
healthcare delivery efficiency through streamlining paper work and coordinating care, and (4) obtaining 
various tax revenues from individuals and companies.83 The CBO projects the legislation will save $511 
billion in medical spending and produce a net reduction in the federal budget deficit by $143 billion dur-
ing 2010-19 as a result of changes in direct spending and raising revenues.84 
Significant changes to Medicare alone are projected to result in net savings of $575 billion from 
2010–19.85 Overpayments to Medicare-managed plans identified through increased pressures on fraud 
and abuse through audits are projected to save more than $204 billion from 2010–19.86 Additionally, 
Medicare payments to providers will be adjusted for improvements in quality and productivity. These 
adjustments will apply to payments made to inpatient hospitals, long-term care facilities, inpatient 
rehabilitation facilities, psychiatric hospitals, and outpatient hospitals. The CBO projects these payment 
adjustments will save $160 billion from 2010–19.87 Under the new healthcare reform, the CBO projects 
Medicare spending growth to be slowed from anticipated increases of 6.8 percent annually to 5.2 per-
cent, which will extend the stability of the Medicare trust fund through 2026 and save an estimated $397 
billion from 2010–19.88 
CMS also estimates substantial savings in Medicare costs that can be attributed to (1) reducing Part 
A and Part B payment levels and adjusting future market backset payment updates for productivity im-
provements ($233 billion), (2) abolishing the Medicare improvement fund ($27 billion), (3) decreasing 
DSH payments ($50 billion), (4) reducing Medicare Advantage payment benchmarks and permanently 
extending the ability to adjust for coding intensity ($145 billion), (5) freezing the income thresholds for 
the Part B income-related premium for nine years ($8 billion), (6) implementing an independent pay-
ment advisory board to maintain strict Medicare expenditure growth rate targets ($24 billion), and (7) 
increasing the hospital insurance payroll tax rate by 0.9 percent for individuals with incomes above 
$200,000 and families with incomes above $250,000 ($63 billion).89 
Other sources of funding for the 2010 healthcare reform legislation may include (1) new annual fees 
paid by insurers, estimated to yield $60.1 billion from 2014–19; (2) new annual fees paid by pharmaceu-
tical manufacturers, estimated to raise $27 billion from 2013–19; (3) a 2.9 percent excise tax on medical 
device manufacturers, estimated to raise $20 billion from 2013–19; and (4) an excise tax on high-cost 
insurance plans, estimated to raise $32 billion from 2018–19.90
Healthcare Reform Impact on the Future of U.S. 
Healthcare Delivery
The CBO has estimated that the enactment of HR 3590 would reduce federal budget deficits by $118 
billion from 2010–19.91 Combined with the passage HR 4872, the federal deficit was estimated to be 
reduced by $143 billion.92 In addition to the budgetary benefits of bill passage, the CBO estimates that 
the number of people (nonelderly) who are uninsured will be reduced by approximately 32 million, and 
the percentage of nonelderly residents with insurance coverage will increase from 83 to 94 percent by 
2019.93
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Impact on Individuals
The 2010 healthcare reform legislation requires U.S. citizens and legal residents to maintain minimum 
amounts of health insurance coverage. Minimum essential coverage includes government-sponsored 
programs, eligible employer-sponsored programs, plans in the individual market, grandfathered group 
health plans, as well as some other types of coverage. To assist U.S. citizens in paying for this coverage, 
the initial 2010 healthcare reform legislation provides for refundable tax credits that eligible taxpayers 
may use toward health insurance premiums (for both the individual taxpayer and his or her family) for 
health insurance purchased through a state health benefit exchange. Each individual enrolled in a plan 
offered through an exchange will be required to report his or her income to the exchange. Based on this 
information provided by the individual, the individual will receive a premium assistance credit by the 
treasury paying the credit directly to the insurance plan in which the individual is enrolled. The individ-
ual will then pay the difference between the credit amount and the total premium charged.94
Individuals who fail to maintain this minimum essential coverage will be subject to the following 
excise taxes: $95 in 2014, $325 in 2015, and $695 in 2016 and years beyond. This penalty also is ap-
plied to any dependents who do not maintain minimum essential coverage. Individuals who qualify for 
hardship or religious exemptions are excluded.95
Significant provisions of the initial healthcare reform legislation affecting individuals are related to 
the exclusion of pre-existing conditions by health plans and the extension of health insurance coverage 
for dependent children. Effective September 23, 2010, all health insurance plans are prohibited from ex-
cluding children on the basis of a pre-existing condition. Effective later during the second half of 2010, a 
temporary national high-risk pool will be created to permit adults with pre-existing conditions to obtain 
subsidized coverage with maximum cost sharing capped at the current health savings account limit. This 
high-risk pool will be dissolved after January 1, 2014, when all insurers and group health plans will be 
prohibited from excluding persons with pre-existing conditions.96 Additionally, health plans beginning 
on January 1, 2011, must report the proportion of premium dollars spent on clinical services and quality 
improvement and other costs, and provide rebates to consumers based for any cost less than 85 percent 
for large group plans and 80 percent for individual and small group plans. In addition, starting in 2010, 
a process for reviewing increases in health plan premiums will be established, which will require insur-
ance companies to justify increases.97 
Also effective September 23, 2010, insurance plans will be required to provide dependent coverage 
for children up to age twenty-six for all individual and group policies.98 Eligible children up to twenty-
six years of age who do not qualify for other coverage must be covered under their parents’ employer’s 
plan.99 
Healthcare reforms related to Medicaid are significant, with such expanded coverage provisions ef-
fective beginning in 2010 as (1) creation of a state option to cover childless adults through a Medicaid 
State Plan Amendment; (2) creation of a state option to provide coverage for family planning services to 
certain low-income individuals, up to the highest level of eligibility for pregnant women; (3) creation of 
a new option for states to provide Children’s Health Insurance Program (CHIP) coverage for children of 
state employees eligible for health benefits, under certain conditions; (4) an increase in the drug rebate 
percentage for brand name drugs up to 23.1 percent (except the rebate for clotting factors and drugs ap-
proved exclusively for pediatric use increases to 17.1 percent); (5) an increase in the drug rebate per-
centage for noninnovator, multiple-source drugs up to 13 percent of the average manufacturer price; (6) 
extension of the drug rebate to Medicaid managed care plans; (7) provision of additional funding for the 
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Medicaid and CHIP Payment and Access Commission to include assessments of adult services (includ-
ing those persons who are dually eligible for Medicare and Medicaid); and (8) issuance of regulations by 
the secretary of HHS that establish a process for public notice and comment for section 1115 waivers in 
Medicaid and CHIP.100
Additional Medicaid reform initiatives will be effective in 2011, including the (1) prohibition of 
federal payments to states for Medicaid services related to healthcare acquired conditions; (2) creation of 
a new Medicaid state plan option to permit enrollees with at least two chronic conditions, one condition 
and a risk of developing another, or at least one serious and persistent mental health condition, to desig-
nate a provider as a health home (and provide states taking accepting the option with 90 percent Federal 
Medical Assistance Percentage for two years for health home related services such as care manage-
ment, care coordination, and health promotion); (3) creation of the State Balancing Incentive Program 
in Medicaid to provide enhanced federal matching payments to increase noninstitutionally based long 
term care services; and (4) establishment of the Community First Choice Option in Medicaid to provide 
community-based attendant support services to certain people with disabilities.101 
Such Medicaid reform initiatives for 2010 include the creation of new demonstration projects to pay 
bundled payments for episodes of care that include hospitalization (effective January 1, 2012, through 
December 31, 2016), as well as to make global capitated payments to safety net hospital systems (effec-
tive for the fiscal years 2010 through 2012). Providers of pediatric services will be allowed to organize 
as accountable care organizations (ACOs) to share in cost-savings (effective January 1, 2010, through 
December 31, 2016). Additional provisions include expanded Medicaid payments to institutions of men-
tal disease for adult enrollees who require stabilization of an emergency condition (effective October 1, 
2011, through December 31, 2015).102
Effective 2013, there will be increased Medicaid payments for primary care services provided by 
primary care physicians for 2013 and 2014, with 100 percent federal funding.103 Significantly, in 2014, 
Medicaid coverage will be expanded to all non-Medicare-eligible individuals under sixty-five-years of 
age (that is, children, pregnant women, parents, and adults without depending children) with incomes up 
to 133 percent of the federal poverty level based on a modified adjusted gross income and will provide 
for enhanced federal matching funds for new eligible enrollees. Additionally, effective 2014, there will 
be a reduction in states’ Medicaid DSH allotments and an increase in spending caps for territories.104
Specifically as related to Medicaid and CHIP, healthcare reform provisions require states to maintain 
current income eligibility levels for children in Medicaid and CHIP until 2010 and to extend funding 
levels for CHIP through 2015, with the CHIP benefit package and cost-sharing rules to continue under 
current laws. Beginning in 2015, states will be given the option to receive a 23 percent increase in the 
CHIP match rate up to a cap of 100 percent. Additionally, children who are eligible for CHIP but who 
are unable to enroll in the program due to enrollment caps will be eligible for tax credits.105
Impact on Small and Mid-Sized Employers
The impact of the 2010 healthcare reform legislation is not limited to individuals. By January 1, 2014, 
states are required to establish an American Health Benefit exchange. These exchanges will facilitate 
the purchase of qualified health plans and establish a SHOP, which will assist small employers to obtain 
coverage for their employees.106 Employers with 100 or fewer employees may enroll in the exchange. 
Effective 2017, employers with more than 100 employees may obtain coverage through an exchange at 
the discretion of the state. 
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Effective for tax years beginning in 2010 or later, an “eligible small employer” that purchases health 
insurance for its employees receives a tax credit for amounts spent for health insurance coverage for 
employees.107 An eligible small employer meets the following conditions when (1) it has no more than 
twenty-five full-time equivalent employees for the taxable year, (2) the average wages it pays during the 
taxable year do not exceed $50,000, and (3) it pays at least half of the premium cost.108 
Beginning in 2010 and up to 2013, small employers providing healthcare coverage for employees 
are eligible to receive a tax credit up to 35 percent of the employer’s contribution toward its employees’ 
health insurance premiums, if the employer contributes at least 50 percent of the total premium cost of 
50 percent of the benchmark premium.109 In 2014, the applicable tax credit percentage will increase to 
50 percent. Employers with ten or fewer employees and average wages of less than $20,000 will receive 
100 percent of the credit. Employers with fifty or fewer employees are exempt from penalties assessed 
for failure to either (1) offer no health coverage to full-time employees or (2) provide coverage to full-
time employees that is not affordable. 
Impact on All Larger Employers
Although the 2010 healthcare reform legislation does not require larger employers to offer healthcare 
coverage to employees, employers can face significant penalties if they choose not to do so. Employers 
with more than fifty employees must offer “qualified coverage” to their employees. Qualified cover-
age is minimum essential coverage that includes government-sponsored coverage, employer-sponsored 
coverage, grandfathered health plans, and plans offered in the individual market. A qualified health plan 
(1) provides the essential health benefits package, (2) limits annual cost-sharing to the high-deductible 
health plan limit, (3) limits the annual deductible for small group market plans to $2,000 for individual 
and $4,000 for adults, (4) and does not require cost-sharing for preventive services or immunization.110 
Qualified coverage also includes the availability of catastrophic coverage for individuals under the age 
of thirty.
Additionally, an “applicable large employer” (defined as an employer that employs an average of at 
least fifty full-time employees during the preceding calendar year) that (1) does not provide coverage for 
all of its full-time employees, (2) provides minimum essential coverage that is unaffordable, or (3) pro-
vides minimum essential coverage that consists of a plan in which the plan’s share of the total allowed 
cost of benefits is less than 60 percent is required to pay a penalty if any full-time employee is certified 
to the employer as having purchased health insurance through a state exchange with respect to which a 
tax credit or cost-sharing reduction is allowed or paid to the employee.111 The employer penalties as-
sessed include a $2,000 penalty for each of its full time employees, with the first thirty employees not 
counted toward the penalty calculation. If an employer offers unaffordable coverage, that is, if the pre-
mium exceeds 9.5 percent of a family’s income, the employer must pay a $3,000 penalty for each full-
time employee who is given a government subsidy and purchases coverage through a health exchange.112 
The 2010 healthcare reform legislation also requires employers that offer coverage to provide a free 
choice voucher to employees with incomes less than 400 percent of the federal poverty level whose 
share of the premium is greater than 8 percent but is less than 9.8 percent of their income and who chose 
to enroll in a plan in the health insurance exchange. This amount of the voucher will equal what the 
employer would have paid to provide coverage to the employee under the employer’s plan. Additionally, 
employers with more than 200 employees that offer group health plans are required to automatically 
enroll employees into employer-sponsored health insurance plans.113 Employers must provide employees 
V1-F-Chapter 06.indd   268 9/28/10   3:21 PM
Chapter 6 : Healthcare R eform: Past as  Prolo gue to the Fu ture
269
with notice of automatic enrollment and give the employees the ability to opt out of coverage.114 No 
effective date has been established by the secretary of Labor, who is required to issue regulations imple-
menting this requirement. Further, through December 31, 2013, the initial legislation provides for a tem-
porary reinsurance program for employers providing healthcare coverage to retirees over age fifty-five 
but who are not yet Medicare eligible. This government-funded reinsurance program reimburses em-
ployers for 80 percent of claims with amounts between $15,000 and $90,000. The funding for this pro-
gram is $5 billion for the entire period, with HHS required to establish the program by June 21, 2010.115 
Effective 2013, the healthcare reform legislation eliminates the deduction for the employer subsidy for 
employers that provide prescription drug coverage to employees eligible for Medicare Part D.116 
It should be noted that the 2010 healthcare reform legislation provides special rules for grandfa-
thered health plans. A grandfathered health plan is any group health plan or individual coverage that 
was effective on March 23, 2010, the date of the new legislation’s enactment. The healthcare legislation 
allows an employer to maintain current health coverage for individuals that are already enrolled in plans 
and for subsequently enrolled family members and new hires, which will not negate the grandfathered 
status as long as the plan allowed for dependent or family coverage on March 23, 2010.117 Collectively 
bargained agreements are grandfathered until the date on which the last of the collective bargaining 
agreements relating to the grandfathered coverage terminates.118 Grandfathered plans are generally able 
to avoid many of the new legislation’s requirements, but they are still subject to the following key provi-
sions: pre-existing conditions, dependent coverage, elimination of coverage rescissions, coverage limits, 
and, in 2014, excessive waiting periods.119 
Effective in 2018, a 40 percent excise tax on high-cost plans will be assessed to plans costing more 
than $10,200 for individual coverage or more than $27,500 for family coverage.120 The tax percentage 
will be adjusted for age, gender, and high-risk professions. Also, beginning in 2011, the healthcare leg-
islation requires employers to report the value of employee health benefits on W-2 forms. Beginning on 
or after September 23, 2010, employers with self-funded health plans or health insurers from which they 
obtain employer sponsored health insurance must make the following changes to benefits. Adult children 
up to age twenty-six are able to receive coverage from a parent’s plan, regardless of student status, mari-
tal status, and whether or not they are supported by or living with the parent. 
Additionally, the plan may not impose annual maximum benefit limits for “essential benefits,” 
except those that may be permitted by regulations at a later date. The plans cannot prohibit or limit 
coverage for pre-existing conditions for children under age nineteen. Plans that are self-funded must 
give covered individuals the right to seek external independent medical review of certain claims, for 
example, claims that are denied based upon medical necessity. Plans cannot require prior authorization 
or increased cost sharing for emergency services, even if those services are provided out-of-network. 
The plans are prohibited from discriminating in favor of highly compensated employees. Employers also 
are allowed to increase incentives for wellness program investments from 20 percent to 30 percent of the 
cost of the insurance premium.121 By 2014, an employer may not impose a waiting period greater than 
ninety days for the employee to satisfy before getting health coverage. 
Impact on Professional Practice Providers
Professional practice providers, in this era of healthcare reform, will be affected both directly and indi-
rectly by many aspects of the reform bill and reconciliation act. These include, among others, changes 
and restrictions related to reimbursement, fraud and abuse regulations, and technological and compliance 
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requirements. In addition, professional practices will face changes in the competitive marketplace due 
to proposed restrictions on other healthcare providers, for example, by the restrictions for expansion and 
growth of the specialty hospital market. Having stymied similar restrictions in several other bills during 
the past decade or so, physician-owned specialty hospitals are now subject to new provisions the 2010 
healthcare reform legislation, which places heavy restrictions on the growth or expansion of exist-
ing specialty hospitals with physician ownership.122 Not only does this provision reduce the beneficial 
effects of healthcare provider competition and create a greater likelihood of potential for hospital and 
health system monopolies, as the current regulatory and reimbursement healthcare environments facili-
tate trends of hospital consolidation and practice roll-up, but it further sustains the two-pronged attack 
on niche providers. 
In addition to the 2010 healthcare reform legislation’s affect on individuals and employers, the 
recent reform efforts also will have major implications for healthcare providers. For example, primary 
care physicians (including family medicine, internal medicine, geriatric, and pediatric physician provid-
ers) whose Medicare charges for office, nursing facility, and home visits comprise at least 60 percent of 
their total Medicare charges will be eligible for a 10 percent bonus payment for services performed from 
2011 through 2016.123 Additionally, general surgeons who conduct major procedures in a designated 
health professional shortage area will be eligible for a 10 percent bonus payment for these services from 
2011–16.124 Medicare also will increase payment for psychotherapy services by 5 percent125 and extend 
Medicare incentive payments of 1 percent in 2011 and 0.5 percent from 2012–14 for voluntary partici-
pation in Medicare’s Physician Quality Reporting Initiative (PQRI).126 Beginning in 2015, physician 
providers who do not successfully participate in the PQRI program will have their payments reduced by 
1.5 percent in 2015 and 2 percent in subsequent years.
Another reimbursement change for healthcare providers is related to the establishment of an ACO, 
which provides a framework for providers to work in a coordinated and efficient manner across the 
patient continuum of care. Under the ACO model, both hospital and physician providers will continue to 
bill Medicare under the current FFS reimbursement system, but they may be eligible to share in certain 
cost savings if the patient care delivered meets CMS quality standards and the cost of delivery (includ-
ing both Medicare Part A and Medicare Part B expenditures) is below a predetermined threshold.127
Although there appears to be an increase in reimbursement for some physician services, other physi-
cian providers will face a decrease in reimbursement. Beginning July 1, 2010, Medicare reimbursement 
for the technical component of diagnostic imaging services will be reduced by 50 percent (currently set 
at 25 percent) for subsequent procedures on consecutive body parts.128 Additionally, the market basket 
update for both inpatient and outpatient hospital services will be reduced by 0.25 percent for fiscal year 
(FY) 2010–11, 0.1 percent for FY 2012–13, 0.3 percent for FY 2014–15, 0.2 percent for FY 2015–6, 
and 0.75 percent for FY 2017–19.129
Conclusion
Some feel that the passage of HR 3590 and HR 4872 is one of the most important fundamental changes 
to federal healthcare policy, on a similar scale to the implementation of the Medicare and Medicaid 
programs.130 Analyses and published opinion regarding the necessity of healthcare reform to institute 
effective cost-containment measures on healthcare expenditures have been growing in number, lending 
more weight to proponents of reform measures.131 However, the successful implementation and potential 
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impact of the new provisions detailed in this legislation depends largely on the continued political, 
financial, and public support of federal, state, and individual stakeholders during the next few years. Ad-
ditionally, without a permanent “fix” or reconciliation of growing Medicare expenditures and the SGR 
formula, problems regarding physician reimbursement and cost containment will continue to plague the 
U.S. healthcare industry, indirectly fueling problems, such as those related to access to care, the compet-
itive healthcare environment, and the continued attack on niche providers. As evidenced by the debate 
and wide-ranging concerns and opinions regarding healthcare reform, and specifically, the provisions 
contained within the recently passed reform legislation, the public and political fight regarding the U.S. 
healthcare delivery system reform is far from over.
Young physicians, who are plagued by medical school debt, are seeking a more “comfortable” life-
style and are opting out of private, independent practices and pursuing salaried employment in hospitals 
and health systems. This trend has made it increasingly difficult for older independent practitioners to 
recruit junior partners, a struggle which, paired with the burden of rising costs and downshifting re-
imbursement, has led many physician-owners to sell their practices to hospitals and enter into salaried 
employment arrangements. 
At the same time, the legislative and regulatory agenda at both federal and state levels to limit physi-
cian ownership of or investment in ASTC revenue stream enterprises, has restricted physicians in private 
practice to receiving only professional fee component revenues. This has been viewed by some as a 
circumstance akin to relegating physicians to the status of “sharecroppers” or “hired help” or compelling 
many physicians to acquiesce to an untenable profitability squeeze and accept employee status under the 
substantial control of hospital systems or large corporate players.
Overall, this shift from small, physician- or provider-owned, independent private practices to captive 
practices within larger integrated health systems may also be viewed as the “corporatization” of health-
care professional practices, which may result in a weakening of the independent physician or provider-
patient relationship, a characteristic of the “cottage industry” healthcare delivery system of old.132 
As discussed in this Guide, recent efforts at regulatory and reimbursement reform and the increasing 
change and complexity of healthcare reimbursement, regulatory, competitive, and technological pillars 
of healthcare indicate that the current healthcare environment is one of the most dramatic and chal-
lenging times in U.S. history for healthcare professional practices.133 Given this trend in the delivery of 
care by professional practices, the days of the cottage industry of medicine may be coming to end, thus 
fulfilling the statement that, “Marcus Welby is dead!”
Healthcare reform is driven by complex, polar, and potentially conflicting market factors, including 
increased spending; a growing and graying demographic; workforce shortages and inefficiencies; prob-
lematic chronic and acute health indicators; and shortcomings in the delivery of efficient, quality care. 
The chapters in this Guide detail these issues, their implications, and the 2010 reform initiatives pro-
posed to delicately counterbalance the U.S. healthcare delivery system on the nation’s scale of justice. 
With increased regulatory scrutiny related to Stark and antitrust laws, the complete upheaval of the reim-
bursement landscape from new insurance industry rules and changing Medicare and Medicaid payments, 
the changing competitive environment of various sectors of the healthcare industry, and the rapid ad-
vance of technological developments, the 2010 healthcare reform has set the stage for a tumultuous and 
uncertain future for advisors in this era of reform. This book has addressed each of these very important 
aspects of reimbursement, regulatory, competition, and technology that are now part of an ever changing 
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and increasingly unpredictable landscape of new provider configurations, tactics, and strategies, particu-
larly in light of the 2010 healthcare reform legislation.
Chapter 2, Reimbursement Environment, provides an overview of current and future trends in health-
care reimbursement. With the recent passage of healthcare reform, it is vital for providers to maintain 
an applied understanding of healthcare payment sources (for example, Medicare, Medicaid, State Chil-
dren’s Health Insurance Program, etc.), revenue and billing procedures (for example, the resource-based 
relative value scale payment system, relative value units and their components, Current Procedural Ter-
minology codes, etc.), payment plans (for example, FFS plans, performance-based payment plans, and 
consumer driven health plans), and the new rules related to overall insurance industry practices. 
The U.S. healthcare industry is governed by a network of ever-changing state and federal regula-
tions, relating to both physician and nonphysician professionals, and is facing a completely new land-
scape of federal regulations in light of the 2010 healthcare reform, especially with increased scrutiny 
of fraud and abuse violations. Chapter 3, Regulatory Environment, contains a detailed overview of the 
general provisions that apply to the various practitioners and providers in the healthcare industry.
Changes in the healthcare competitive market may be attributed to 2010 healthcare reform, which 
attempts to address access and quality issues with individual insurance mandates and extensive quality 
requirements. These issues, and numerous others implicated by healthcare reform, shape the unique and 
dynamic healthcare competitive environment. Chapter 4, Impact of Competitive Forces, examines these 
issues in further detail within the context of Porter’s five forces of competition.
Finally, advancements in medical technology have helped to revolutionize medicine as we know it, 
and they also have been significant factors in the passage of the 2010 healthcare reform legislation. The 
future of healthcare may well depend on a compromise between the advancement of medical technologi-
cal capabilities and the cost of supporting those technologies that allows practitioners to provide the best 
quality care possible, a central issue in the 2010 healthcare reform legislation. Chapter 5, Technology 
Development, contains a discussion of the impact of technology on healthcare practices.
A multitude of unresolved issues remain related to the impact of these initial healthcare reform 
initiatives. In order to survive these dynamic changes, as during all times of significant upheaval and 
change, providers (both small and large) will need to seek the guidance of their professional advisors 
and informed managers, and consultants will need to stay knowledgeable of the changing aspects of the 
U.S. healthcare delivery system in an era of reform. This Guide was written to assist these professional 
advisors in meeting that objective.
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Accreditation: A process in which private organi-
zations assess participating institutions and pro-
grams and issue accreditation certificates to those 
that meet their requirements. Ensuring the quality 
and safety of services is the focus of most ac-
creditation standards; however, many also include 
documentation and other requirements.
Adverse Drug Effect (ADE): An injury caused by 
drugs, typically in the form of an allergic reaction 
or adverse physiological responses to a certain 
combination of medications. Preventable ADEs 
are injuries that are caused by human error.
Alert Fatigue: A CPOE error caused by a combi-
nation of critical medical alerts and a high volume 
of marginally medically consequential alerts.
Allopathic Medicine: “A method of healing 
founded on a scientific basis.”
Ambulatory Surgery Center: A Medicare-
certified healthcare facility that exclusively pro-
vides surgical services to patients not requiring an 
overnight stay.
Antitrust: A body of law charged with combat-
ing anticompetitive behavior that would impair the 
ability of free markets to function properly. Anti-
trust involves the regulation of mergers and ac-
quisitions, as well as scrutiny of behavior between 
competitors which may restrain trade.
Biologics: Therapeutic products that are devel-
oped using living sources; examples of biologics 
include: vaccines, blood and blood products, and 
allergenic extracts and tissues.
Biopharmaceuticals: Drugs and biologics that 
treat an organism through the genetic manipulation 
of foreign DNA.
Biosimilar Production: Redevelopment of new 
generation biologics.
BlueCross/BlueShield: BlueCross provides ben-
eficiaries with health insurance to cover hospital 
expenses, while BlueShield provides insurance to 
cover expenses associated with physician services. 
Together, they form BlueCross BlueShield, and 
the BlueCross Blue Shield Association (works to 
coordinate the nationwide plans by establishing 
standards for new plans and programs; assisting 
local plans with enrollment activities, national ad-
vertising, public education, professional relations, 
and statistical and research activities; and serving 
as the primary contractor for processing Medicare 
hospital, hospice, and home health claims.
Brachytherapy: Allows for treatment at higher 
doses of radiation to treat a smaller area in a 
shorter time by placing radiopharmaceuticals 
directly inside or next to the tumor. Brachytherapy 
can be temporary or permanent, with variable ad-
ministration rates and doses.
Bundling: A form of reimbursement that com-
bines institutional and professional charges into a 
single payment, including all staff for preoperative 
and postoperative care. Bundled payment schemes 
generally include outlier provisions for cases that 
become catastrophic.
Capitation: A pre-paid reimbursement method 
that pays a provider a set price for providing medi-
cal services to a defined population for a defined 
set of services, regardless of service utilization. 
Providers must manage the financial risk of pro-
viding adequate care by calculating the expected 
volume of referrals, the average cost, and their 
ability to control utilization.
Charge Capture: A process that entails the 
transfer of the provider’s coding and documenta-
tion to the actual bill. Providers are tasked with 
recording the appropriate procedure and diagnosis 
codes on an encounter form, and the business staff 
is responsible for ensuring that the encounter form 
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is accurate and then using it to bill patients and 
third-party insurers.
Cherry-pick or Cream-skim: To pick the best of 
a group and leaving the least desirable portion; for 
healthcare, choosing the most profitable patients 
and leaving the rest.
Children’s Health Insurance Program: A state-
federal partnership that provides assistance to 
children and pregnant women in families whose 
income is above the threshold for Medicaid. It was 
formerly known as the State Children’s Health 
Insurance Program.
Chiropractic: A form of alternative medicine 
originating from the belief that vertebral aligning 
would serve to remedy diseases.
Civil Monetary Penalty: Financial penalties 
levied against parties found guilty of violating the 
antikickback statute or submitting false claims for 
government reimbursement.
Civilian Health and Medical Program of the 
Department of Veteran Affairs: The Department 
of Veterans Affairs’ healthcare program for the 
spouses and children of veterans who meet certain 
eligibility requirements.
Civilian Health and Medical Program of the 
Uniformed Services: The former name for 
TRICARE.
Clinical Decision Support (CDS): A technology 
that provides clinicians with real-time feedback 
about a wide-range of diagnostic and treatment 
related information as they are entering electronic 
orders.
Commercial Reasonableness: The Department of 
Health and Human Services has interpreted “com-
mercially reasonable” to mean that an arrangement 
appears to be “a sensible, prudent business agree-
ment, from the perspective of the particular par-
ties involved, even in the absence of any potential 
referrals.” The Stark II Phase II commentary also 
suggests that “an arrangement will be considered 
‘commercially reasonable’ in the absence of refer-
rals if the arrangement would make commercial 
sense if entered into by a reasonable entity of 
similar type and size and a reasonable physician of 
similar scope and specialty, even if there were no 
potential DHS referrals.”
Computerized Physician Order Entry (CPOE): 
A computer system that permits clinical providers 
to electronically order laboratory, pharmacy, and 
radiology services.
Corpus: A collection of works written by Hip-
pocrates and his pupils. These works discuss spe-
cialties and pathologies, the practice of medicine, 
and medical ethics.
Cream Skimming: In healthcare, the purpose-
ful targeting of patients that are considered the 
most profitable customers for a given provider, for 
example, specialty hospitals have been accused of 
cream-skimming more profitable services, such as 
cardiac and orthopedic care, from general hospi-
tals, who serve a broader patient base.
Customary Prevailing and Reasonable: The 
historically implemented methodology that based 
Medicare-allowed amounts on past payments for 
the service.
Degrees of Freedom: The number of possible 
rotations that can be made by a robotic “hand.”
Designated Health Service: One of eleven cat-
egories of healthcare entities subject to the Stark 
law:
 1.  Clinical lab services 
 2.  Physical therapy, occupational therapy, 
and speech-language pathology services
 3.  Radiology and other imaging services (in-
cluding nuclear medicine as of 01/01/07)
 4.  Radiation therapy services and supplies
 5.  Durable medical equipment and supplies
 6.  Prosthetics, orthotics and prosthetic de-
vices and supplies
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 7.  Home health services
 8.  Outpatient prescription drugs
 9.  Inpatient hospital services
10.  Outpatient hospital services
11.  Parental and enteral nutrients, associated 
equipment, and supplies
Diagnostic Related Groups: A classification sys-
tem of patients by surgical procedure or diagnosis 
into major diagnostic categories for the purpose of 
Medicare reimbursement of hospitalization costs.
Disproportionate Share Hospital (DSH)  
Payments: A form of additional reimbursement 
under Medicaid for hospitals that care for a large 
number of Medicaid and uninsured patients. DSH 
payments are allotments from the federal govern-
ment that augment basic Medicaid reimbursement, 
and under federal law, states are required to sup-
plement disproportionate share hospitals in order 
to receive this additional Medicaid funding.
Eclectic Medicine: A school of medicine that uses 
herbal medicines and remedies to treat pathologic 
conditions; among less threatening therapies, 
eclectics were branded for their use of arsenic and 
mercury treatments.
Economic Demand: “Relationship between the 
price of a healthcare item or service and the quan-
tity demanded.”
Economic Supply: “Relationship between the 
price of a healthcare good, product, or service and 
the quantity provided my medical sellers.”
Electronic Health Record (EHR): A longitudi-
nal electronic record of patient health information 
generated and maintained within an institution 
containing information entered by a treating physi-
cian or clinician.
Electronic Health Record (EHR): Electronically 
maintained patient health information, such as 
patient demographics, notes, medications, medical 
history, laboratory date, or medical reports, that is 
generated by one or more encounters in any care 
delivery setting.
Enteral: Into the digestive system.
Epidural: Into the membranes surrounding the 
spinal cord.
External Beam Radiation Therapy (EBT): 
A procedure that involves the administration of 
high-energy x-ray beams to kill cancer cells and 
treat tumors. Often, some x-ray, ultrasound, or 
computerized tomography imaging is used prior to 
the delivery to insure that the path of the beam will 
align with the target area.
Fair Market Value (FMV): As defined by Stark 
II Phase I for the purpose of scrutinizing transac-
tions between healthcare professionals, FMV is 
“the value in arm’s-length transactions, consistent 
with general market value,” without taking into ac-
count any ability between parties to refer business 
to each other.
Fee Schedule: A payment system under which the 
fees for procedures are explicitly laid out and the 
physician agrees to accept those fees as full pay-
ment unless the discounted charges are less than 
the fee schedule in which case the plan pays the 
lesser of the two.
Fee-for-Service: A payment policy under which 
providers receive a fee for each service provided 
(for example, an office visit, test, procedure, etc.).
Financial Relationship: The Stark law defines 
financial relationships as an ownership or invest-
ment interest in the DHS entity or a compensa-
tion arrangement between the DHS entity and the 
referring physician or a member of his immediate 
family. The law further describes “ownership/in-
vestment interest” to include debt, equity or other 
means. The term also includes an interest in an 
entity that holds an ownership or investment inter-
est in any entity providing DHS services.
Follow-on Biologics: New generation biologics.
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Gainsharing: An arrangement “under which a 
hospital gives physicians a share of the reduction 
in the hospital’s costs (that is, the hospital’s cost 
savings) attributable in part to the physician’s 
efforts.”
Gamma Knife: Employs computerized robotic 
technology to move patients at submillimeter in-
crements during treatment.
Gene Therapy: A molecular means of cancer 
treatment.
Genomics: The evaluation of the hereditary 
information provided by an organism’s DNA and 
the application of research findings to the fields 
of genetic engineering and enhancement, cloning, 
stem cell research, and eugenics.
Health Maintenance Organization (HMO): The 
entity responsible for providing, or arranging for 
the provision of, healthcare services (including 
preventative care) for plan enrollees by way of 
contractual arrangements with providers. HMO 
enrollees must receive all of their care from the 
plan’s participating providers except for care 
provided in emergency situations or in instances in 
which the plan offers a point of service option.
Health Maintenance Organization: Any organi-
zation that, through an organized system of health-
care, provides or ensures the delivery of an agreed-
upon set of comprehensive health maintenance and 
treatment services for an enrolled group of persons 
commonly under a capitation or prepaid fixed sum 
arrangement.
Health Savings Accounts: Special accounts into 
which employers and employees both contribute, 
and from which the employee can draw funds to 
pay for health services. If the employer contrib-
utes, the value of those contributions is not taxable 
to the employee. Similarly, if the employee makes 
contributions, they count as “above-the-line” 
deductions.
Homeopathic Medicine: A school of medicine 
that involves the assessment of overall health and 
environment, not just symptoms.
Independent Practice Association: An associa-
tion of independent physicians who maintain their 
own private practices but have joined together 
to enter into an agreement to treat the plan’s 
enrollees.
Industrial Hygiene: “The science of keeping peo-
ple safe at work and in their communities. Indus-
trial hygienists (IHs) are professionals dedicated 
to the health and well-being of workers. Originally 
industrial hygienists worked primarily in factories 
and other industrial settings but as our society has 
changed, so has the definition of industrial hy-
giene. Today, IHs can be found in almost every 
type of work setting. Industrial hygienists also use 
the term OEHS or occupational and environmental 
health and safety to refer to the work that they do.”
Intensity Modulated Radiation Therapy 
(IMRT): An advanced form of radiation therapy 
using three-dimensional imaging and treatment 
delivery.
International Classification of Diseases, Ninth 
Revision (ICD-9): A system that has codes that 
supply the payor with information regarding both 
the patient diagnosis and the procedures performed 
in treating the diagnosis. The Health Insurance 
Portability and Accountability Act (HIPAA) 
requires all healthcare providers to use the ICD-9 
codes when reporting diagnosis information to 
payors. In addition, HIPAA requires that hospitals 
use the ICD-9 procedural codes when reporting 
information to payors detailing the treatment of 
hospital inpatients.
International Classification of Diseases, Tenth 
Revision (ICD-10): In early 2009, the United 
States Department of Health and Human Services 
announced a final rule that called for the replace-
ment of the current ICD-9 code set used to report 
healthcare diagnoses and procedures with the ICD-
10 code set by October 1, 2013. The adoption of 
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the new system offers several benefits, including 
the facilitation of quality data reporting, support 
for pay for performance payment methodologies, 
improved billing accuracy, and allowances for in-
ternational comparison of the incidence and spread 
of disease.
Intravenous: Through the bloodstream.
Kickback: Remuneration received in return for 
referring an individual to a person for the furnish-
ing of any item or service for which payment may 
be made under a federal health care program or 
remuneration received in return for purchasing, 
leasing, ordering, or arranging for or recommend-
ing purchasing, leasing, or ordering any good, 
facility, service, or item for which payment may be 
made under a federal health care program.
Laparoscopy: Minimally invasive surgery that 
involves the insertion of a slender, tubular endo-
scope through the abdomen wall. A laparoscopy 
involves the use of surgical instruments that the 
practitioner controls and fiber optic technology for 
visual navigation.
Legal Medicine: Referred to as “medical jurispru-
dence,” involves the implementation of medical 
expertise for legal and judicial purposes.
Licensure: A set of minimum qualifications an 
individual must possess in order to practice a given 
profession. In healthcare, almost all practitioners 
are required to be licensed, and there exist state 
statutes in place to penalize those who practice 
without proper licensure.
Linear Accelerator (LINAC): Delivers uniform 
doses of high-energy x-rays to the localized area of 
the patient’s tumor although sparing the surround-
ing normal tissue. It is the device most commonly 
used for EBT treatments for patients with cancer.
Lockboxes: Instead of handling the collection and 
processing of payments themselves, providers may 
decide to use a lockbox service. For a fee, lockbox 
services open a provider’s mail, collect payments, 
and deposit the money into the provider’s account.
Managed Care: Plans that integrate the financing 
(that is, insurance) and provision of health services 
under the administration of one organization in an 
effort to contain costs.
Medicaid: “The expanded assistance to the states 
for medical care.”
Medicaid: A means-tested, state administered 
health insurance program for individuals below 
certain income thresholds predetermined by the 
state in which they reside. The federal government 
establishes coverage requirement guidelines for the 
categorically needy (for example, children, preg-
nant women), medically needy (for example, indi-
viduals with income above the threshold but who 
have a large amount of medical bills), and special 
groups. Although the federal government deter-
mines the medical services that will be covered 
and paid for by the federal portion of the program, 
Medicaid programs vary widely from state to state 
as state governments are free to add additional ser-
vices or expand eligibility to additional groups.
Medical Imaging: A “non-invasive process used 
to obtain pictures of the internal anatomy or func-
tion of the anatomy using one of many different 
types of imaging equipment and media for creating 
the image.”
Medicare Part A: “The Democratic plan for a 
compulsory hospital insurance program under 
Social Security.”
Medicare Part B: “The revised Republican pro-
gram of government-subsidized voluntary insur-
ance to cover physicians’ bills.”
Medicare: An entitlement program available to in-
dividuals over the age of sixty-five and individuals 
with end-stage renal disease. Medicare is divided 
into four parts: (1) Part A, which covers inpatient 
hospital care; (2) Part B, which covers outpatient 
visits; (3) Part C, which people can choose as a 
managed care replacement of Part A and B; and 
(4) Part D, which covers prescription drug benefits.
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Medicare: Passed by the United States Congress 
in 1964 and signed by President Lyndon B. John-
son on July 30, 1965; comprised of three layers: 
Part A, Part B, and Medicaid.
Monopsony: “A single purchaser in a healthcare 
market without rivals.”
National Committee on Quality Assurance 
(NCQA): A nonprofit organization that works 
to improve the quality of healthcare through the 
accreditation of managed care plans. NCQA 
performs this duty, much like other accrediting 
bodies, through the setting of standards and collec-
tion of outcome and performance data.
Naturopathic Medicine: A school of medicine 
that utilizes natural elements (such as water, heat, 
and massage) in its therapies.
Niche Providers: Providers who focus on a sec-
tion or group of buyers, a segment of a product 
line, or a specific area of a geographic market. 
What specific area niche providers focus on 
changes based on who is creating the definition.
NightHawk Radiology Services: The nation’s 
first nighthawk company.
Nonparenteral Drug Delivery: A means of drug 
delivery in which the distribution is through a 
means other than a digestive one.
Nonparticipating Provider: Providers who have 
not agreed to accept the Medicare reimbursement 
amount for every claim. Yet, nonparticipating pro-
viders are allowed to accept Medicare assignment 
on a claim-by-claim basis, if they agree certain 
conditions. However, it should be noted that even 
though they have not accepted Medicare’s fee as 
payment in full, nonparticipating providers are 
subject to a “limiting charge,” that dictates what 
they may charge Medicare beneficiaries for cov-
ered services.
Nurse Licensure Compact: An interstate license 
for nurses created in 2000 by the National Council 
of State Boards of Nursing.
Osteopathic: A school of medicine that involves 
the assessment of overall health and environment, 
not just symptoms.
Participating Provider: A physician who has 
agreed to accept the reimbursement amount set by 
the Medicare Fee Schedule as payment in full for 
every claim. The physician’s office may bill the 
patient for its share of the co-insurance and its de-
ductible, but it cannot balance bill the patient, (that 
is, attempt to collect the difference between its 
usual fee and Medicare’s lower allowed charge).
Pasteurization: Widely used in the preservation 
of perishable products, pasteurization involves the 
strategic application of heat to kill microbes with-
out injuring the quality of its media (for example, 
wine, beer, etc.).
Personalized Medicine: The fusion of molecular 
diagnostics and therapeutic measures for special-
ized screening and treatment plans.
Physician-Owned Facilities: Healthcare enti-
ties in which their practicing physicians also have 
ownership investment in the facility, supplement-
ing professional income with revenue from facility 
services. Many physician-owned facilities include 
limited-service facilities, such as surgical and spe-
cialty hospitals.
Physiotherapy: A term used to describe various 
kinds of medical therapy, including hydrotherapy, 
massage, mechanotherapy, electrotherapy, and 
heat therapy.
Picture Archives and Communications Systems 
(PACS): Used to connect digital x-rays and other 
imaging modalities. Has become a must for ef-
ficient imaging services, as it provides improved 
access to images with reduced delays.
Point-of-Care Technology: New technologies 
that help to manage patient treatment plans.
Point-of-Service Plans (POS): Plans that com-
bine many of the elements of HMOs and PPOs. 
POS plans are usually an addition to an HMO 
V1-G-Glossary.indd   282 9/22/10   1:35 PM
283
The Adviser’s  Guide to Healthcare 
product that allows members the benefit of seeking 
care from non-participating providers. As with an 
HMO, when members seek care from in-network 
providers they typically pay no deductible or coin-
surance. However, similar to a PPO, members are 
free to seek services outside the network subject to 
higher cost sharing in the form of deductibles and 
coinsurance.
Preferred Provider Organization (PPO): “A 
health care delivery system where providers con-
tract with the PPO at various reimbursement levels 
in return for patient steerage into their practices 
and/or timely payment.”
Preferred Provider Organization (PPO): A 
hybrid of an HMO and traditional health insurance 
plan. It is a managed care plan that allows mem-
bers to choose from an array of healthcare provid-
ers who have contracted with the plan to provide 
services on a discounted basis.
Prospective Payment System: The federal medi-
cal system that reimburses hospitals for Medicare 
Part A services based on diagnosis related groups.
Protected Health Information (PHI): Individu-
ally identifiable health information that is trans-
mitted by, or maintained in, electronic media or 
any other form or medium. This information must 
relate to (1) the past, present, or future physical 
or mental health, or condition of an individual; 
(2) provision of healthcare to an individual; or 
(3) payment for the provision of healthcare to an 
individual.
Public Health: An area of healthcare centered 
around “community health point of view,” that 
considers “the means of defen(s)e against disease a 
social problem.”
Purple Pill: A treatment for bleeding ulcer pa-
tients, with a proton-pump inhibitor like Prilo-
sec (omeprazole), that stops bleeding prior to 
endoscopy.
Qui Tam Action: Also known as a “whistle-
blower” suit, this action is filed by an individual 
who alleges that a particular entity has submitted 
false claims for reimbursement to the government 
in violation of the False Claims Act, including 
violations of the Stark law and the antikickback 
statute. Qui tam actions may be brought by em-
ployees, former employees, competitors, subcon-
tractors, state and local governments, current and 
former federal employees, public interest groups, 
corporations, and other private organizations.
Radiation Therapies: Procedures that use high 
energy light beams or charged particles to stunt 
tumor cell proliferation thereby treating cancer.
Reciprocal (Limited) Licensure: Provides an 
interstate license for use with telemedicine prac-
titioners applied for through a simple application 
process and reduced licensing fees. This license is 
solely used for telemedicine and may not be used 
to physically practice in another state.
Reparative Medicine: Therapies that heal the 
body’s natural tissue.
Resource Based Relative Value System: A 
relative value scale that is based on the necessary 
resources used to perform a medical service.
Revenue Cycle: The process by which a provider 
practice schedules patients, diagnoses conditions, 
documents diagnoses, bills payors, and collects 
billable charges from the payor and the patient to 
recover revenue for the services provided.
Self-Insurance: Self-insuring employers make a 
conscious choice to undertake the risks associated 
with the cost of healthcare and set aside money to 
pay these costs as they arise. Often, a self-insurer 
will hire a commercial insurer or third-party ad-
ministrator to run its medical benefits program and 
adjudicate claims.
Self-Referral: The practice of referring a patient 
for a designated health service (DHS) to an entity 
in which the referring physician (or a member of 
his immediate family) has an ownership or invest-
ment interest.
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Stem Cells: Unspecialized cells capable of (1) 
renewing themselves through cell division, some-
times after long periods of inactivity and (2) spe-
cializing to a certain type of tissue or organ under 
the proper conditions.
Stereotactic Radiosurgery: A highly precise 
procedure involving the single, high-dose delivery 
of precisely-targeted gamma-ray or x-ray beams 
that is used in different parts of the body, but most 
frequently to treat brain tumors.
Store and Forward: The transfer of digital im-
ages between locations, most commonly seen in 
teleradiology and telepathology.
Studia Generalia: Universities in the Roman Em-
pire at which law, theology, and philosophy were 
taught in addition to medicine.
Subcutaneous: Under the skin.
Telehealth: Closely related to telemedicine and is 
used to describe the broader definition of remote 
healthcare that does not always involve clinical 
services, although the two terms are often used 
interchangeably.
Telemedicine: The transfer of electronic medical 
data (high resolution images, sounds, live video, 
and patient records) from one location to another 
in order to enhance the quality and efficiency of 
patient comfort and care.
Teleradiology: Electronic transfer and storage of 
electronic imaging data.
The Joint Commission: An independent, non-
profit organization responsible for the certifica-
tion and accreditation of health care organizations 
across the United States.
The National Center for Human Genome Re-
search Institute (NCHGRI): Comprised of more 
than fifty researchers that are each dedicated to 
specific facets of genetic and genomic research and 
contribute accordingly to one of seven branches of 
the NCHGRI.
Treble Damages: Damages equal to three times 
the amount of the illegal remuneration in violation 
of the antikickback statute.
TRICARE: The Department of Defense’s health-
care program for active duty military personnel; 
members of the National Guard and Reserves; 
retirees, their dependents, and survivors; and 
certain former spouses. The program uses military 
healthcare as the main provider of services, sup-
plemented by civilian healthcare providers, facili-
ties, pharmacies, and suppliers. TRICARE covers 
approximately 9.4 million beneficiaries worldwide 
through a variety of plans.
Two-Way Interactive Television: Used telemedi-
cine for face-to-face consultations.
Upcoding: Inflating bills by using diagnosis bill-
ing codes that suggest a more expensive illness or 
treatment.
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